Presentationnumber

COI

OP01 Prof. Dr. Levine, Arie: No conflict of interest||Dr. Scaldaferri, Franco: No conflict of interest||Mrs. Sarbagili Shabat, Chen: No conflict of interest||Dr. Zittan, Eran: No conflict of interest||Dr. Hirsch, Ayal: No conflict of interest||Dr. Mentella, Maria Chiara: No conflict of interest||Dr. Musca , Tania: No conflict of interest||Dr. Cohen, Nathaniel Aviv: No conflict of interest||Dr. Ron, Yulia: No conflict of interest||Mrs. Fliss Isakov , Naomi: No conflict of interest||Dr. Pfeffer, Jorge: No conflict of interest||Dr. Yaakov, Michal: No conflict of interest||Ms. Fanali, Caterina: No conflict of interest||Dr. Turchini , Laura: No conflict of interest||Dr. Masucci, Luca: No conflict of interest||Dr. Quaranta, gianluca: No conflict of interest||Mrs. Anastasia, Godneva: No conflict of interest||Dr. Weinberger, Adina: No conflict of interest||Prof. Kopylov , Uri: No conflict of interest||Prof. Maharshak, Nitsan: No conflict of interest

OP02

ECCO'21 Conflict of Interest indication

Bruce E. Sands: Reports consulting fees from 4D Pharma, AbbVie, Abivax, Allergan, Amgen, AstraZeneca, Baxalta Bioscience India, Boehringer-Ingelheim, Boston Pharmaceuticals, Capella Bioscience, Celltrion Healthcare, Ferring, Genentech, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Immunic, InDex Pharmaceuticals, Inotrem, Ironwood Pharmaceuticals, Janssen, Johnson & Johnson, Kallyope, Lilly, Morphic Therapeutic, Oppilan Pharma, OSE Immunotherapeutics, Otsuka, Palatin Technologies, Pfizer, Progenity, Prometheus Laboratories, Prometheus Biosciences IBD, Protagonist Therapeutics, Redhill Biopharma, Rheos Medicines, Salix Pharmaceuticals, Seres Therapeutics, Shire, Sienna Biopharmaceuticals, Surrozen, Takeda, TARGET RWE, USWM Enterprises, Viela Bio, Vivelix Pharmaceuticals and grants and consulting fees from Arena Pharmaceuticals, Celgene, and Theravance Biopharma R&D.|Silvio Danese: Reports consulting fees from Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion Healthcare, Ferring, Gilead Sciences, Hospira, Inc., Janssen Research & Development, LLC, Johnson & Johnson Health Care Systems, Inc., Pfizer, Sandoz, UCB, and Vifor International Inc.|Timothy Hoops, James L. Izanec, Long-Long Gao, Christopher Gasink, and Andrew Greenspan: Report employment with Janssen Scientific Affairs, LLC, a wholly owned subsidiary of Johnson & Johnson, and stock ownership in Johnson & Johnson.|Matthieu Allez, James D. Lewis, Emese Mihaly, Ellen Scherl, and Oksana Shchukina: Report participation as investigators in trials sponsored by Janssen.|Stephen B. Hanauer: Reports grant support and fees for consulting, lectures, and serving on an advisory board from AbbVie, Janssen, and Takeda consulting and or advisory board fees from Allergan, Amgen, Boehringer-Ingelheim, Bristol Myers Squibb, Celgene, Ferring, Genentech, Gilead, Merck, Novartis, Pfizer, Protagonist, Receptos, Salix, Samsung Bioepis, Seres Therapeutics, TiGenix, and Vhsquared and grant support from AbbVie, Celgene, Boehringer-Ingelheim, Gilead, Janssen, Pfizer, and Takeda.|Peter M. Irving: Reports lecture fees from AbbVie, Celgene, Falk Pharma, Ferring, Janssen, MSD, Pfizer, Sapphire Medical, Sandoz, Shire, Takeda, Tillots, and Warner Chilcott financial support for research from MSD, Pfizer, and Takeda and advisory fees from AbbVie, Arena, Genentech, Gilead, Hospira, Janssen, Lilly, MSD, Pfizer, Pharmacosmos, Prometheus, Roche, Sandoz, Samsung Bioepis, Takeda, Topivert, VH2, Vifor Pharma, and Warner Chilcott. |Vipul Jairath: Reports consulting fees from AbbVie, Alimentiv Inc. (formerly Robarts Clinical Trials), Arena pharmaceuticals, Bristol Myers Squibb, Celltrion, Ferring, Fresenius Kabi, GlaxoSmithKline, Genetech, Gilead, Janssen, Lilly, Merck, Mylan, Pendopharm, Pfizer, Roche, Sandoz, Takeda, and Topivert and speaker’s fees from AbbVie, Ferring, Janssen, Pfizer, Shire, and Takeda. |Tanja Kuehbacher: Reports lecture and consulting fees from AbbVie, Allmiral, Amgen, Arena, Bristol Myers Squibb, Celgene, Celltrion, Ferring, Falk, Gilead, Galapagos, Janssen, Merkle, Pfizer, Takeda, and Tilliots. |Edward V. Loftus Jr: Reports consulting fees from AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Calibr, Celgene, Celltrion Healthcare, Genentech, Gilead, Iterative Scopes, Janssen, Lilly, Ono Pharma, Pfizer, Sun Pharma, Takeda, and UCB and research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trial, Takeda, Theravance, and UCB.|Remo Panaccione: Reports consulting fees from AbbVie, Janssen Research & Development, LLC, and Takeda California, Inc.|William J. Sandborn: Reports grants from AbbVie, Aviva, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, GlaxoSmithKline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seers Therapeutics, Shire, Takeda, and TheraVance Biopharma consulting fees from AbbVie, Admix, Alfa sigma, Alimented (Robarts Clinical Trials, owned by Health Academic Research Trust [HART]), Alivio Therapeutics, Alamos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Aviva, Bausch Health (Salix), Beignet, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Cellario, Cellularity, Cosmo Pharmaceuticals, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer, Progenity, Prometheus Biosciences, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Scalier Biosciences, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, and Zealand Pharma and stock or stock options from Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Progenity, Shoreline Biosciences, Ventyx Biosciences, and Vimalan Biosciences. Spouse: Iveric Bio - consultant, stock options Oppilan Pharma - consultant, stock options Progenity - stock Prometheus Biosciences - employee, stock options Ventyx Biosciences – stock options and Vimalan Biosciences – stock options.

OP03 Kennedy, Nicholas Alexander:|:|Dr. Kennedy reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; grants and non-financial support from AbbVie, grants and personal fees from Celltrion, personal fees and non-financial support from Janssen, personal fees from Takeda, personal fees and non-financial support from Dr Falk, outside the submitted work.||Dr. Goodhand, James:|:|Dr. Goodhand reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study.||Ms. Bewshea, Claire: No conflict of interest||Ms. Nice, Rachel: No conflict of interest||Dr. Chee, Desmond:|:|Dr. Chee reports non-financial support from Ferring, personal fees and non-financial support from Pfizer, outside the submitted work.||Dr. Lin, Simeng:|:|Dr. Lin reports non-financial support from Pfizer, non-financial support from Ferring, outside the submitted work. ||Dr. Chanchlani, Neil: No conflict of interest||Dr. Butterworth, Jeffrey: No conflict of interest||Dr. Cooney, Rachel:|:|Dr. Cooney reports personal fees from Takeda, outside the submitted work.||Prof. Dr. Croft, Nicholas:|:|Dr. Croft reports trial funding, advisory board and speaker fees paid to his institution from AbbVie, Eli Lilly, Takeda, Shire, Pfizer and Janssen.||Prof. Dr. Hart, Ailsa:|:|Dr. Hart reports personal fees from Abbvie, personal fees from Allergan, personal fees from BMS, personal fees from Celltrion, personal fees from Falk, personal fees from GSK, personal fees from Takeda, personal fees from Pfizer, personal fees from Janssen, personal fees from Galapogos, personal fees from Astra Zeneca, outside the submitted work.||Dr. Irving, Peter:|:|Dr. Irving reports grants and personal fees from Takeda, grants from MSD, grants and personal fees from Pfizer, personal fees from Galapagos, personal fees from Gilead, personal fees from Abbvie, personal fees from Janssen, personal fees from Boehringer Ingelheim, personal fees from Topivert, personal fees from VH2, personal fees from Celgene, personal fees from Arena, personal fees from Samsung Bioepis, personal fees from Sandoz, personal fees from Procise, personal fees from Prometheus, outside the submitted work. ||Dr. Kok, Klaartje:|:|Dr. Kok reports personal fees from Janssen, personal fees from Takeda, personal fees from PredictImmune, personal fees from Amgen, outside the submitted work.||Dr. Lamb, Christopher:|:|Dr. Lamb reports grants from Genentech, grants and personal fees from Janssen, grants and personal fees from Takeda, grants from AbbVie, personal fees from Ferring, grants from Eli Lilly, grants from Pfizer, grants from Roche, grants from UCB Biopharma, grants from Sanofi Aventis, grants from Biogen IDEC, grants from Orion OYJ, personal fees from Dr Falk Pharma, grants from AstraZeneca, outside the submitted work.||Prof. Dr. Limdi, Jimmy:|:|Dr. Limdi reports personal fees from MSD, personal fees from Janssen, grants and personal fees from Takeda, grants and personal fees from Galapagos, personal fees from Tillotts, outside the submitted work.||Dr. MacDonald, Jonathan:|:|Dr. Macdonald reports grants and personal fees from Takeda Pharmaceuticals, grants and personal fees from Biogen, personal fees and non-financial support from AbbVie, personal fees from Grifols, personal fees from Sandoz, personal fees from Celltrion, personal fees and non-financial support from Janssen, personal fees from Vifor Pharmaceuticals, personal fees from Predictimmune, personal fees from Bristol Myers Squibb, non-financial support from Ferring Pharmaceuticals, outside the submitted work.||Prof. Dr. McGovern, Dermot:|:|Prof. McGovern reports grants from the Leona M. and Harry B. Helmsley Charitable Trust, during the conduct of the study; personal fees from Takeda Pharmaceuticals, personal fees from Pfizer, personal fees from Bridge Biotherapeutics, personal fees from Palatin Technologies, personal fees from Boehringer-Ingelheim, personal fees and other from Prometheus Biosciences, personal fees from Gilead, outside the submitted work.||Dr. Mehta, Shameer: No conflict of interest||Dr. Murray, Charles: No conflict of interest||Dr. Patel, Kamal:|:|Dr. Patel reports personal fees and non-financial support from Takeda, personal fees and non-financial support from Janssen, personal fees and non-financial support from Abbvie, personal fees from DrFalk, non-financial support from Ferring, outside the submitted work.||Prof. Dr. Pollok, Richard:|:|Dr. Pollok reports acting as consultant, advisory board member, speaker or recipient of educational grant from Dr Falk, Ferring, Janssen, Pharmacosmos and Takeda.||Dr. Raine, Tim:|:|Dr. Raine reports grants and personal fees from Abbvie, personal fees from BMS, personal fees from Celgene, personal fees from Ferring, personal fees from Gilead, personal fees from GSK, personal fees from LabGenius, personal fees from Janssen, personal fees from Mylan, personal fees from MSD, personal fees from Novartis, personal fees from Pfizer, personal fees from Sandoz, personal fees from Takeda, personal fees from Galapagos, personal fees from Arena, outside the submitted work.||Prof. Dr. Russell, Richard:|:|Dr. Russell reports grants from NHS Research Scotland Senior Research Fellowship, personal fees from Nestlé, personal fees from AbbVie, personal fees from Dr Falk, personal fees from Takeda, personal fees from Napp, personal fees from Mead Johnson, personal fees from Nutricia, personal fees from 4D Pharma, outside the submitted work.||Dr. Selinger, Christian:|:|Dr. Selinger reports grants and personal fees from AbbVie, grants and personal fees from Janssen, grants and personal fees from Takeda, personal fees from Dr Falk, personal fees from Pfizer, personal fees from Galapagos, personal fees from Arena, personal fees from Fresenius Kabi, outside the submitted work. Dr Philip J Smith reports speaker fees and advisory board sponsorship from Janssen, Celltrion and Takeda outside the submitted work.||Dr. Smith, Philip:|:|Dr PJ Smith reports speaker fees and advisory board sponsorship from Janssen, Celltrion and Takeda outside the submitted work.||Prof. Bowden, Jack: No conflict of interest||Dr. McDonald, Timothy: No conflict of interest||Prof. Dr. Lees, Charlie:|:|Dr. Lees reports personal fees from Abbvie, personal fees from Janssen, personal fees from Pfizer, personal fees from Takeda, grants from Gilead, personal fees from Gilead, personal fees from Galapagos, personal fees from Iterative Scopes, personal fees from Trellus Health, personal fees from Celltion, personal fees from Ferring, personal fees from BMS, during the conduct of the study.||Prof. Dr. Sebastian, Shaji:|:|Dr. Sebastian reports grants from Takeda, Abbvie, AMGEN, Tillots Pharma, personal fees from Jaansen, Takeda, Galapagos, Celltrion, Falk Pharma, Tillots pharma, Cellgene, Pfizer, Phamrmacocosmos, outside the submitted work.||Dr. Powell, Nicholas:|:|Dr. Powell reports personal fees from Takeda, personal fees from Janssen, personal fees from Pfizer, personal fees from Bristol-Myers Squibb, personal fees from Abbvie, personal fees from Roche, personal fees from Lilly, personal fees from Allergan, personal fees from Celgene, outside the submitted work; and Dr Powell has served as a speaker/advisory board member for Abbvie, Allergan, Bristol Myers Squibb, Celgene, Falk, Ferring, Janssen, Pfizer, Tillotts, Takeda and Vifor Pharma.||Prof. Dr. Ahmad, Tariq:|:|Dr. Ahmad reports grants and non-financial support from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; personal fees from Biogen inc, grants and personal fees from Celltrion Healthcare, personal fees and non-financial support from Immundiagnostik, personal fees from Takeda, personal fees from ARENA, personal fees from Gilead, personal fees from Adcock Ingram Healthcare, personal fees from Pfizer, personal fees from Genentech, non-financial support from Tillotts , outside the submitted work.

OP04 Prof. Dr. Schreiber, Stefan Wolfgang:|:|Has received consulting fees from AbbVie, BMS, Boehringer Ingelheim, Ferring, Janssen, Medimmune/AstraZeneca, MSD, Pfizer, Sanofi, Takeda and UCB; and lecture fees from AbbVie, Ferring, Hikma, Janssen, MSD, Pfizer, Takeda and UCB. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Watanabe, Mamoru:|:|Has received lecture fees from Astellas, Celgene, Celltrion, Gilead, Janssen, Kissei, Mitsubishi Tanabe, Mochida, Nippon Kayaku, Pfizer Japan, Takeda and Zeria; consulting fees from AbbVie, EA, Eli Lilly Japan, Gilead and Takeda; and grants from AbbVie, Alfresa, Asahi Kasei Medical, Astellas, Ayumi, EA, Fujirebio, Gilead, JIMRO, Kaken, Kissei, Kyorin, Kyowa Hakko Kirin, Mitsubishi Tanabe, Miyarisan, Mochida, Nippon Kayaku, Pfizer Japan, Taiho, Takeda and Zeria. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Yun, Chohee:|:|Is an employee and shareholder of Gilead Sciences, Inc. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Zhou, Yan:|:|Is an employee and shareholder of Gilead Sciences, Inc. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Mrs. Zhao, Sally:|:|Is an employee and shareholder of Gilead Sciences, Inc. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Hsieh, Jeremy:|:|Is an employee and shareholder of Gilead Sciences, Inc. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Moerch, Ulrik:|:|Is an employee and shareholder of Gilead Sciences, Inc. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Rogler, Gerhard:|:|Has received consulting fees from Abbvie, Augurix, BMS, Boehringer Ingelheim, Calypso, Celgene, FALK, Ferring, Fisher, Genentech, Gilead, Janssen, MSD, Novartis, Pfizer, Phadia, Roche, UCB, Takeda, Tillotts, Vifor, Vital Solutions and Zeller; speaker fees from Abbvie, AstraZeneca, FALK, Janssen, MSD, Pfizer, Phadia, Takeda, Tillotts, UCB, Vifor and Zeller; and grants from AbbVie, Ardeypharm, Augurix, Calypso, FALK, Flamentera, MSD, Novartis, Pfizer, Roche, Takeda, Tillotts, UCB and Zeller. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Loftus Jr, Edward V:|:|Has received consulting fees from AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Calibr, Celgene, Celltrion, Eli Lilly, Genentech, Gilead, Iterative Scopes, Janssen, Ono, Pfizer, Sun, Takeda and UCB; and grants from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trials, Takeda, Theravance and UCB. These studies were funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.

OP05 Dr. Narula, Neeraj:|:|McMaster University Department of Medicine Internal Career Award and honoraria from Janssen, Abbvie, Takeda, Pfizer, Merck, and Ferring||Ms. Wong, Emily: No conflict of interest||Dr. Dehghan, Mahshid: No conflict of interest||Dr. Mente, Andrew: No conflict of interest||Ms. Rangarajan, Sumathy: No conflict of interest||Dr. Marshall, John:|:|Honoraria from Janssen, AbbVie, Allergan, Bristol-Meyer-Squibb, Ferring, Janssen, Lilly, Lupin, Merck, Pfizer, Pharmascience, Roche, Shire, Takeda and Teva.||Dr. Moayyedi, Paul: No conflict of interest||Dr. Reinisch, Walter:|:|Speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult, |Consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC, |Advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC.||Dr. Yusuf, Salim: No conflict of interest

OP06

OP07 Dr. Lo, Bobby Zhao Sheng: No conflict of interest||Mr. Liu, ZhuoYuan: No conflict of interest||Prof. Dr. Bendtsen, Flemming: No conflict of interest||Mr. Igel, Christian: No conflict of interest||Dr. Vind, Ida: No conflict of interest||Dr. Burisch, Johan: No conflict of interest

OP08 Dr. Saraiva, Miguel: No conflict of interest||Afonso, João: No conflict of interest||Dr. Ribeiro, Tiago: No conflict of interest||Dr. Cardoso, Hélder: No conflict of interest||Prof. Ferreira, João: No conflict of interest||Andrade, Patrícia: No conflict of interest||Jorge, Renato: No conflict of interest||Lopes, Susana: No conflict of interest||Prof. Macedo, Guilherme: No conflict of interest

OP09 Verstockt, Bram:|:|B Verstockt reports financial support for research from Pfizer; lecture fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion; consultancy fees from Janssen, Guidepont and Sandoz.||Dr. Jorissen, Celine: No conflict of interest||Ms. Hoefkens, Eveline: No conflict of interest||Ms. Lembrechts, Nikki: No conflict of interest||Dr. Pouillon, Lieven:|:|Lieven Pouillon received advisory board fees from Janssen, Sandoz and Takeda; presentation fees from Abbvie and Ferring; and personal fees from Abbvie, Ferring, Norgine and Takeda.||Dr. Bossuyt, Peter:|:|P Bossuyt has received financial support for research from AbbVie, Mundipharma, Pfizer, Janssen and Mylan; lecture fees from AbbVie, Takeda, Pfizer and Janssen; advisory board fees from Abbvie, BMS, Takeda, Hospira, Guidepont, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz and Pentax.

OP10 Iacucci, Marietta: No conflict of interest||Ms. Jeffery, Louisa: No conflict of interest||Mr. Acharjee, Animesh: No conflict of interest||Dr. Nardone, Olga Maria: No conflict of interest||Dr. Smith, Samuel CL: No conflict of interest||Dr. Labarile, Nunzia: No conflict of interest||Dr. Zardo, Davide: No conflict of interest||Dr. Cannatelli, Rosanna: No conflict of interest||Dr. Shivaji, Uday N: No conflict of interest||Dr. Ungar, Bella: No conflict of interest||Dr. Buda, Andrea: No conflict of interest||Dr. Grisan, Enrico: No conflict of interest||Prof. Gkoutos, Georgios: No conflict of interest||Subrata, Ghosh: No conflict of interest

OP11 Dr. VOLK, Valery: No conflict of interest||Dr. Aden, Konrad: No conflict of interest||Dr. Tran, Florian: No conflict of interest||Dr. Mishra, Neha: No conflict of interest||Dr. Bernardes, Joana: No conflict of interest||Prof. Dr. Röcken, Christoph: No conflict of interest||Prof. Dr. Schreiber, Stefan: No conflict of interest||Prof. Dr. Feuerhake, Friedrich: No conflict of interest||Prof. Dr. Rosenstiel, Philip: No conflict of interest

Dr. Ungaro, Ryan:|:|Advisory board member or consultant for AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, and Takeda; research support from AbbVie, Boehringer Ingelheim, and Pfizer||Dr. Brenner, Erica: No conflict of interest||Dr. Agrawal, Manasi: No conflict of interest||Dr. Gearry, Richard B.:|:|Speaker fees and Scientific Advisory Boards for AbbVie and Janssen ||Dr. Kaplan, Gilaad G.:|:|Honoraria for speaking or consultancy from Abbvie, Janssen, Pfizer, and Takeda. He has received research support from Ferring, Janssen, Abbvie, GlaxoSmith Kline, Merck, and Shire. Ownership of a patent: TREATMENT OF INFLAMMATORY DISORDERS, AUTOIMMUNE DISEASE, AND PBC. UTI Limited Partnership, assignee. Patent WO2019046959A1. PCT/CA2018/051098. 7 Sept. 2018.||Dr. Kissous-Hunt, Michele:|:|Speaker/consultant for AbbVie, Janssen, Takeda||Dr. Ng, Siew C.:|:|Honoraria for speaking or consultancy from Abbvie, Janssen, Ferring, Tillotts and Takeda; research support from Ferring and AbbVie.||Dr. Rahier, Jean-Francois:|:|Lecture fees from AbbVie, MSD, Takeda, Pfizer, Ferring, and Falk, consulting fees from AbbVie, Takeda, Hospira, Mundipharma, MSD, Pfizer, GlaxoSK, and Amgen, and research support from Takeda and AbbVie. ||Dr. Reinisch, Walter:|:|Has served as a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult. He has been a consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Intrinsic Imaging, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC. He has been an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC. He has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik, and MSD. ||Dr. Steinwurz, Flavio:|:|Speaker and consultant for: AbbVie, Eurofarma, Ferring, Janssen, Pfizer, Sanofi, Takeda, and UCB.||Dr. Zhang, Xian: No conflict of interest||Dr. Lewis, James D.:|:|Personal fees from Johnson & Johnson Consumer Inc, grants, personal fees and other from Takeda Pharmaceuticals, personal fees and non-financial support from AbbVie, grants and personal fees from Janssen Pharmaceuticals, personal fees from Eli Lilly and Company, personal fees from Samsung Bioepis, personal fees from UCB, personal fees from Bristol-Myers Squibb, grants and personal fees from Nestle Health Science, personal fees from Bridge Biotherapeutics, personal fees from Celgene, personal fees from Merck, personal fees and other from Pfizer, personal fees from Gilead, personal fees from Arena Parmaceuticals, personal fees from Protagonist Therapeutics.||Dr. Kappelman, Michael D.:|:|Has consulted for AbbVie, Janssen, and Takeda, is a shareholder in Johnson & Johnson, and has received research support from AbbVie and Janssen||Dr. Colombel, Jean-Frederic:|:|Research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit

OP12 Mr. Pierre, Nicolas: No conflict of interest||Huynh-Thu, Vân Anh: No conflict of interest||Allez, Matthieu: No conflict of interest||Bouhnik, Yoram: No conflict of interest||Laharie, David: No conflict of interest||Bourreille, Arnaud: No conflict of interest||Colombel, Jean-Frédéric: No conflict of interest||Meuwis, Marie-Alice: No conflict of interest||Louis, Edouard: No conflict of interest

OP13 Ms. Jowett, Geraldine M: No conflict of interest||Ms. Read, Emily: No conflict of interest||Mr. Norman, Michael D: No conflict of interest||Ms. Arevalo, Patricia A: No conflict of interest||Dr. Vilà González, Marta: No conflict of interest||Dr. Roberts, Luke: No conflict of interest||Prof. Vallier, Ludovic: No conflict of interest||Prof. Curtis, Michael: No conflict of interest||Prof. Lord, Graham: No conflict of interest||Dr. Gentleman, Eileen: No conflict of interest||Dr. Neves, Joana F: No conflict of interest

OP14 Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion.||Dr. Verstockt, Sare: No conflict of interest||Prof. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda|||Prof. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

OP15 Pigneur Arnaud, Benedicte: No conflict of interest||Dr. Martinez-Vinson, Christine: No conflict of interest||Dr. Bourmaud, Aurélie: No conflict of interest||Dr. Swellen, Gastineau: No conflict of interest||Dr. Duclaux-Loras, Rémi: No conflict of interest||Prof. Hugot, Jean-Pierre: No conflict of interest||Dr. Roman, Céline: No conflict of interest||Dr. Dumant, Clementine: No conflict of interest||Dr. Spyckerelle, Claire: No conflict of interest||Dr. Guinard Samuel, Vincent: No conflict of interest||Dr. Willot, Stéphanie: No conflict of interest||Dr. Dupont, Claire: No conflict of interest||Dr. Breton, Anne: No conflict of interest||Dr. Caron, Nicolas: No conflict of interest||Dr. Chaillou, Emilie: No conflict of interest||Dr. Rebouissoux, Laurent: No conflict of interest||Dr. Triolo, Valérie: No conflict of interest||Dr. Bertrand, Valérie: No conflict of interest||Dr. Pages, Justine: No conflict of interest||Prof. Djamal-Dine, Djeddi: No conflict of interest||Dr. Bonneton, Marjorie: No conflict of interest||Dr. Uhlen, Stéphanie: No conflict of interest||Dr. Catteau, Natacha: No conflict of interest||Dr. Coopman, Stéphanie: No conflict of interest||Prof. Viala, Jérôme: No conflict of interest||Prof. Ruemmele, Frank M:|:|FMR has received grants and research support from Nestlé Nutrition Institute, AbbVie Inc., MSD, and Janssen; served as a member of advisory boards for Centocor (DEVELOP), AbbVie Inc. (CAPE and LEA), MSD France (SAC), Nestlé Nutrition Institute, Nestlé Health Science, Danone, Mead Johnson, Nutricia, Takeda, Celgene, Biogen, Shire, Pfizer, and Therakos; and has received payment and honorarium for lectures from AbbVie Inc., Danone, Nutricia, and Nestlé.

OP16 Dr. Berger, Tal: No conflict of interest||Miin Lee, Huey: No conflict of interest||Ramasamy Padmanaban, Lavenya: No conflict of interest||Wine, Eytan: No conflict of interest||Yerushalmi, Anat: No conflict of interest||Hojsak, Iva: No conflict of interest||Bronski, Jiri: No conflict of interest||Serban, Daniela: No conflict of interest||Yogev, Dotan: No conflict of interest||Ledder, Oren: No conflict of interest||Lionetti, Paolo: No conflict of interest||Scarrallo, Luca: No conflict of interest||Gasparetto, Marco: No conflict of interest||Croft, Nick: No conflict of interest||Miele, Erasmo: No conflict of interest||Staiano, Annamaria: No conflict of interest||Meredith, Joseph: No conflict of interest||Aloi, Marina: No conflict of interest||Alvisi, Patrizia: No conflict of interest||Urlep, Darja: No conflict of interest||Weiss, Batia: No conflict of interest||Knudsen, Mikkel: No conflict of interest||Matar, Manar: No conflict of interest||Manuel Navas-López, Víctor: No conflict of interest||Romano, Claudio: No conflict of interest||Dipasquale, Valeria: No conflict of interest||Norsa, Lorenzo: No conflict of interest||Kolho, Kaija-Leena: No conflict of interest||Shamir, Raanan: No conflict of interest||Dr. Shouval, Dror: No conflict of interest

OP17 Dr. ZHANG, Qian: No conflict of interest||Dr. Fachal, Laura: No conflict of interest||Ms. Shawky, Rasha: No conflict of interest||Dr. Parkes, Miles: No conflict of interest||Dr. Anderson, Carl: No conflict of interest||Dr. Raine, Tim: No conflict of interest

OP18 Meima - van Praag, Elise: No conflict of interest||Ms. van Rijn, Kyra: No conflict of interest||Ms. Snijder, Anne: No conflict of interest||Ms. Wasmann, Karin: No conflict of interest||Prof. Dr. Stoker, Jaap: No conflict of interest||Prof. Dr. D'Haens, Geert: No conflict of interest||Dr. Gecse, Krisztina: No conflict of interest||Gerhards, Michael: No conflict of interest||Jansen, Jeroen: No conflict of interest||Pronk, Apollo: No conflict of interest||van Tyl, Sebastiaan: No conflict of interest||Zimmerman, David: No conflict of interest||Bruin, Karlien: No conflict of interest||Prof. Dr. Spinelli, Antonino: No conflict of interest||Danese, Silvio: No conflict of interest||Dr. van der Bilt, Jarmila: No conflict of interest||Mundt, Marco: No conflict of interest||Prof. Dr. Bemelman, Willem: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest

OP19 Ms. Sarikaya, Melek: No conflict of interest||Ms. Zhao, Mirabella:|:|Travel fees from Takeda Pharma A/S, unrelated to this work.||Prof. Bendtsen, Flemming:|:|Personal fee and grants from Ferring A/S, all of which were unrelated to this study.||Dr. Burisch, Johan:|:|Personal fees from AbbVie, Janssen-Cilag, Celgene, MSD, Pfizer; grants and personal fees from Takeda, none of which related to this work.

OP20 Dr. Chaparro, Maria: No conflict of interest||Mrs. Garre, Ana: No conflict of interest||Dr. Núñez Ortiz , Andrea: No conflict of interest||Dr. Diz-Lois Palomares, María Teresa: No conflict of interest||Dr. Rodríguez, Cristina: No conflict of interest||Dr. Riestra, Sabino: No conflict of interest||Dr. Vela, Milagros: No conflict of interest||Dr. Benítez, José Manuel: No conflict of interest||Dr. Fernández Salgado, Estela: No conflict of interest||Dr. Sánchez Rodríguez, Eugenia: No conflict of interest||Dr. Hernández, Vicent: No conflict of interest||Dr. Ferreiro-Iglesias, Rocío: No conflict of interest||Dr. Ponferrada Díaz, Ángel: No conflict of interest||Dr. Barrio, Jesús: No conflict of interest||Dr. Huguet, José María: No conflict of interest||Dr. Arias, Lara: No conflict of interest||Dr. Martín-Arranz, María Dolores: No conflict of interest||Dr. Calvet, Xavier: No conflict of interest||Dr. Ginard, Daniel: No conflict of interest||Dr. Alonso-Abreu, Inmaculada: No conflict of interest||Dr. Fernández-Salazar, Luis: No conflict of interest||Dr. Varela Trastoy, Pilar: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Vera-Mendoza, Isabel: No conflict of interest||Dr. Vega, Pablo: No conflict of interest||Dr. Navarro, Pablo: No conflict of interest||Dr. Sierra, Mónica: No conflict of interest||Dr. Cabriada, José Luis: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest||Dr. Vicente, Raquel: No conflict of interest||Dr. Navarro-Llavat, Mercè: No conflict of interest||Dr. Echarri, Ana: No conflict of interest||Dr. Gomollón, Fernando: No conflict of interest||Dr. Guerra del Río, Elena: No conflict of interest||Dr. Casanova, María José: No conflict of interest||Dr. Spicakova, Katerina: No conflict of interest||Dr. Ortiz de Zarate, Jone: No conflict of interest||Dr. Alonso-Galán, Horacio: No conflict of interest||Dr. Barreiro-de Acosta, Manu: No conflict of interest||Dr. Gisbert, Javier P: No conflict of interest

OP21 Dr. Allocca, Mariangela: No conflict of interest||Dell’Avalle, Cecilia: No conflict of interest||Furfaro, Federica: No conflict of interest||Craviotto, Vincenzo: No conflict of interest||Zilli, Alessandra: No conflict of interest||D'Amico, Ferdinando: No conflict of interest||Peyrin-Biroulet, Laurent: No conflict of interest||Fiorino, Gionata: No conflict of interest||Danese, Silvio: No conflict of interest

OP22 Dr. Derikx, Lauranne: No conflict of interest||Dr. Siakavellas, Spyros:|:|Spyros Siakavellas has a support grant from the Greek Group for the study of IBD and speaker fees from Pfizer and Janssen.||Mrs. Derr, Lisa: No conflict of interest||Dr. Williams, Linda: No conflict of interest||Mr. Nikolas, Plevris:|:|Nikolas Plevris has speaker fees from Jannssen and takeda||Mr. Jenkinson, Philip: No conflict of interest||Mrs. Lucaciu, Laura: No conflict of interest||Mr. Constantine-Cooke, Nathan: No conflict of interest||Mrs. Covil, Kate: No conflict of interest||Mrs. Murdoch, Lauren: No conflict of interest||Dr. Jones, Gareth-Rhys: No conflict of interest||Prof. Lees, Charlie:|:|Professor Charlie Lees has received research support from Abbvie and Gilead, acted as a consultant to Abbvie, Janssen, Takeda, Pfizer, Galapagos, MSD, Hospira, Pharmacosmos, GSK, Gilead, Topivert, Vifor Pharma, Dr Falk, Oshi Health, Trellus Health and Iterative Scopes; he has received speaking fees and travel support from Pfizer, Janssen, Abbvie, Galapagos, MSD, Takeda, Shire, Ferring, Hospira, Warner-Chilcott and Dr Falk.

OP23 Prof. Vermeire, Séverine:|:|S Vermeire has received grants from AbbVie, J&J, Pfizer, and Takeda; and has received consulting and/or speaking fees from AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG.||Dr. Danese, Silvio:|:|S Danese has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, Nikkiso Europe GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma and Vifor.||Dr. Zhou, Wen:|:|W Zhou is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Pangan, Aileen:|:|A Pangan is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Greenbloom, Susan: No conflict of interest||Dr. D'Haens, Geert:|:|G D’Haens: consulting and/or lecture fees from AbbVie, ActoGeniX, AIM, Boehringer Ingelheim GmbH, Centocor, Chemo Centryx, Cosmo Technologies, Elan Pharmaceuticals, enGene, Dr Falk Pharma, Ferring, Galapagos, Giuliani SpA, Given Imaging, GlaxoSmithKline, Janssen Biologics, MSD, Neovacs, Novo Nordisk, Otsuka, PDL BioPharma, Pfizer, Receptos, Salix, SetPoint, Shire Pharmaceuticals, Schering-Plough, Takeda, Tillotts Pharma, UCB Pharma, Versant, and Vifor Pharma; research grants from AbbVie, Janssen, Given Imaging, MSD, Dr Falk Pharma, and PhotoPill; and speaking honoraria from AbbVie, Tillotts, Tramedico, Ferring, MSD, UCB Pharma, Norgine, and Shire.||Dr. Panes, Julian:|:|J Panés: consulting fees from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Genentech, GlaxoSmithKline, Janssen, Nestle, Origo, Pandion, Progenity, Pfizer, Robarts, Roche, Second Genome, Takeda, Theravance, and Wasserman; speaker fees from AbbVie, Biogen, Ferring, Janssen and Takeda; and research funding from AbbVie and Pfizer.||Dr. Juillerat, Pascal: No conflict of interest||Dr. Lindsay, James O:|:|JO Lindsay: research support for investigator led initiatives from AbbVie, Gilead, Pfizer, Shire and Takeda; consultancy/advisory board fees from AbbVie, Atlantic Healthcare, BMS, Celgene, Celtrion, Ferring, Gilead, GSK, Janssen, Lilly, MSD, Napp, Norgine, Pfizer, Roche, Shire, Takeda and Vifor Pharma; speaking fees and travel support from AbbVie, Ferring, Janssen, MSD, Napp, Norgine, Pfizer, Shire, Tillott’s, Takeda.||Dr. Loftus Jr, Edward V:|:|EV Loftus Jr: consulting fees from AbbVie, UCB, Janssen, Takeda, Celgene, Eli Lilly, Amgen, Pfizer, Celltrion Healthcare, Allergan, Bristol-Myers Squibb, Boehringer Ingelheim, Genentech, Gilead, Arena, Calibr, Iterative Scopes, Ono Pharma, and Sun Pharma; research support from AbbVie, UCB, Genentech, Janssen, Amgen, Pfizer, Takeda, Robarts Clinical Trials, Gilead, Celgene, Receptos, Birstol-Myers Squibb, and Theravance. ||Dr. Sandborn, William J:|:|WJ Sandborn: research grants from Abbvie, Abivax, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, Glaxo Smith Kline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seres Therapeutics, Shire, Takeda, Theravance Biopharma; consulting fees from Abbvie, Abivax, Admirx, Alfasigma, Alimentiv (previously Robarts Clinical Trials, owned by Alimentiv Health Trust), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB,

OP24 Prof. Dr. Danese, Silvio:|:|Silvio Danese has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, Nikkiso Europe GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma, and Vifor.||Dr. Vermeire , Séverine:|:|Séverine Vermeire has received grants from AbbVie, J&J, Pfizer, and Takeda and has received consulting and/or speaking fees from AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG.||Dr. Zhou, Wen:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Pangan, Aileen:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Siffledeen, Jesse:|:|Jesse Siffledeen has received consultancy and/or speaking honoraria from AbbVie, Janssen Pharmaceuticals, Allergan, Takeda, Ferring Pharmaceuticals, Shire, and Pfizer and educational grants from AbbVie.||Dr. Hébuterne, Xavier:|:|Xavier Hébuterne has received clinical research funding from AbbVie, Abivax, Alphasigma, Arena Pharmaceuticals, Celgene, Eli Lilly, Enterome, Gilead, Janssen, InDex Pharmaceuticals, Pfizer, Roche, Salix, Sangamo, Takeda, and Theravance; served on advisory boards for AbbVie, Arena Pharmaceuticals, Gilead, Janssen, Pfizer, Roche, and Takeda; and participated in lectures and educational activities for AbbVie, Amgen, Baxter, Fresenius Kabi, Janssen, MSD, Mylan, Nutricia, Pfizer, Tillots, and Takeda. ||Dr. Nakase, Hiroshi:|:|Hiroshi Nakase has received support from AbbVie GK, EA Pharma, Celgene, Daiichi Sankyo, Janssen Pharmaceutical K.K., JIMRO, Kissei, Kyorin, Mitsubishi Tanabe, Mochida, Nippon Kayaku, Pfizer, Takeda, and Zeria and grants for commissioned/joint research from Boehringer Ingelheim GmbH, Bristol-Myers Squibb, and Hoya Group Pentax Medical.||Dr. Higgins, Peter:|:|Peter D.R. Higgins has received consultancy support and research grants from AbbVie, Eli Lilly, and Pfizer.||Dr. Chen, Min-Hu:|:|Min-Hu Chen has received clinical research support from Janssen and Takeda; served on advisory boards for Boehringer Ingelheim and Janssen; and participated in educational activities for AbbVie, China Medical System, IPSEN, Janssen, and Takeda.||Dr. Sanchez-Gonzalez, Yuri:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Huang, Bidan:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Xie, Wangang:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Liu, John:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Weinreich, Michael:|:|Yuri Sanchez Gonzalez, Bidan Huang, Wangang Xie, John Liu, Aileen Pangan, Michael A. Weinreich, and Wen Zhou are AbbVie employees and may own AbbVie stock and/or options.||Dr. Pannaccione, Remo:|:|Remo Pannaccione has received consulting fees, speaker fees, and research support from AbbVie.

OP25 Prof. Peyrin-Biroulet, Laurent:|:|LPB reports personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, BMS, Boehringer Ingelheim, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Hikma, Index Pharmaceuticals, Inotrem, Janssen, Lilly, MSD, Mylan, Nestlé, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Theravance, Tillotts and Vifor; grants from AbbVie, MSD and Takeda; and stock options from CTM. ||Prof. Dr. Dotan, Iris:|:|ID reports personal fees from Abbott, AbbVie, Arena, Athos Therapeutics, Cambridge Healthcare, Celgene/BMS, Celltrion, Falk Pharma, Ferring, Galapagos, Genentech/Roche, Gilead, Integra Holdings, Janssen, Neopharm, Nestlé, Pfizer, Rafa Laboratories, Sublimity Therapeutics, Takeda, The Food Industry Association and Wild Biotech; and grants from Altman Research and Pfizer.||Prof. Hibi, Toshifumi:|:|TH reports grants from Otuska Holdings; grants and personal fees from AbbVie GK, JIMRO, Kyorin, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Takeda Pharmaceutical and Zeria Pharmaceutical; and personal fees from Aspen Japan K.K, BMS, Celltrion, EA Pharma, Eli Lilly, Ferring, Gilead Sciences, Janssen, Kissei Pharmaceutical, Nichi-Iko Pharmaceutical, Nippon Kayaku and Pfizer, outside the submitted work.||Ms. Taliadouros, Virginia:|:|VT is an employee and shareholder of Galapagos NV.||Ms. Oortwijn, Alessandra:|:|AO is an employee and shareholder of Galapagos NV. ||Ms. Zhao, Sally:|:|SZ is an employee and shareholder of Gilead Sciences, Inc. ||Ms. Zhang, Jie:|:|JZ is an employee and shareholder of Gilead Sciences, Inc. ||Mr. Hsieh, Jeremy:|:|JH is an employee and shareholder of Gilead Sciences, Inc. ||Prof. Feagan, Brian:|:|BF reports grants and personal fees from AbbVie, Amgen, AstraZeneca, BMS, Janssen Biotech/Centocor, JnJ/Janssen, Pfizer, Receptos and Takeda; personal fees from Ablynx, ActoGeniX, AdMIRx Inc., Akebia Therapeutics Inc., Allergan, Atlantic Pharma, Avaxia Biologics Inc., Avir Pharma, Baxter Healthcare Corporation, Biogen Idec, BiomX Israel, Boehringer Ingelheim, Boston Pharmaceuticals, Calypso Biotech, Celgene, Elan/Biogen, EnGene, Ferring, Galapagos, Genentech/Roche, gIcare Pharma, Gilead, Given Imaging, Gossamer Pharma, GSK, Inception IBD Inc., Ironwood, Japan Tobacco Company, Kyowa Hakko Kirin Co. Ltd., Lexicon, Lilly, Lycera Biotech, Merck, Mesoblast, Millennium, Nestlé, NextBiotix, Novartis, Novo Nordisk, ParImmune, Progenity, Prometheus Therapeutics & Diagnostics, Protagonist, Qu Biologics, Salix, Shire, Sienna Biologics, Sigmoid Pharma, Synergy Pharma, Teva Pharmaceuticals, TiGenix, Tillotts, UCB, Vertex, VHsquared, Vivelix Pharmaceuticals, Wyeth, Zealand and Zyngenia, outside the submitted work.

Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma; and stock or stock options from Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Prometheus Laboratories Progenity, Shoreline Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivreon Biosciences. Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock, stock options; Prometheus Laboratories – stock, stock options, consultant; Ventyx Biosciences – stock, stock options; Vimalan Biosciences – stock, stock options.||Dr. Reinisch, Walter: No conflict of interest||Dr. Sanchez Gonzalez, Yuri:|:|Y Sanchez Gonzalez is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Huang, Bidan:|:|B Huang is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Xie, Wangang:|:|W Xie is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Liu, John:|:|J Liu is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Weinreich, Michael A:|:|MA Weinreich is an AbbVie employees and may own AbbVie stock and/or options.||Dr. Panaccione, Remo:|:|R Panaccione has received consulting fees, speaker fees, and research support from AbbVie, Abbott, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Genentech, Gilead Sciences, Glaxo-Smith Kline, Janssen, Merck, Mylan, Oppilan Pharma, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Roche, Satisfai Health, Sandoz, Schering-Plough, Shire, Sublimity Therapeutics, Theravance Biopharma, UCB, and Takeda Pharmaceuticals.

OP26 Schreiber, Stefan Wolfgang:|:|SS has been a consultant for AbbVie, Allergan, Dr Falk Pharma, Ferring, Genentech, GlaxoSmithKline, Janssen, Merck, Pfizer, Shire, and Takeda.||Dr. Ferrante, Marc:|:|MF has been a consultant for AbbVie, Boehringer Ingelheim, Celltrion, Janssen, Lilly, Medtronic, Merck, Pfizer, Sandoz, Takeda, and Thermo Fisher has received research grants from Amgen, Biogen, Janssen, Pfizer, and Takeda and received speaker’s fees from AbbVie, Amgen, Biogen, Boehringer Ingelheim, Dr Falk Pharma, Ferring, Janssen, Lamepro BV, Merck, Mylan, Pfizer, Sandoz, Takeda, and Truvion Healthcare.||Dr. Panaccione, Remo:|:|RP has received consulting and/or speaker’s fees from AbbVie, Abbott, Alimentiv (Robarts Clinical Trials), ai4gi, Amgen, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan Pharmaceuticals, Ferring, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Lilly, Merck, Mylan, Oppilan, Pandion Therapeutics, Pfizer, Progenity, Protagonist Therapeutics, Roche, Satisfai, Sandoz, Schering-Plough, Shire, Sublimity Therapeutics, Takeda, Theravance, and UCB.||Dr. Colombel, Jean-Frederic:|:|J-FC has received research grants from AbbVie, Janssen, and Takeda has received payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb, Ferring, Shire, Takeda, and Tillots Pharma has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Enterome, Ferring, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, Inotrem, Janssen, Landos Biopharma, Lilly, LimmaTech Biologics (lmtbio), MedImmune, Merck, Novartis, Omass, Otsuka, Pfizer, Shire, Takeda, TiGenix, Viela Bio and holds stock options in Intestinal Biotech Development.||Dr. Hisamatsu, Tadakazu:|:|TH has received research grants from AbbVie, Alfresa Pharma, Daiichi Sankyo, EA Pharma, JIMRO, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda, and Zeria Pharmaceutical received consulting fees from AbbVie, Celgene, EA Pharma, Janssen, Nichi-Iko, and Pfizer and lecture fees from AbbVie, EA Pharma, Janssen, JIMRO, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Pfizer, and Takeda.||Dr. Lim, Allen:|:|AL has received research funding from AbbVie, Janssen, Lilly, and Takeda has served on advisory boards for AbbVie, Ferring, Janssen, and Takeda has been a speaker for AbbVie, Janssen, and Takeda and has been principal investigator for and owns stock in AbbVie.||Dr. Lindsay, James O:|:|JOL has received research support for investigator led initiatives from AbbVie, Gilead, Pfizer, Shire, and Takeda consulting/advisory board fees from AbbVie, Allergan (Warner Chilcott), Atlantic Healthcare, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, GlaxoSmithKline, Janssen, Lilly, Merck, Napp Pharmaceuticals, Norgine, Pfizer, Shire, Takeda, and Vifor Pharma speaking fees and travel support from AbbVie, Allergan (Warner Chilcott), Ferring, Janssen, Merck, Napp Pharmaceuticals, Norgine, Pfizer, Shire, Takeda, and Tillots Pharma.||Dr. Rubin, David T:|:|DTR has received grant support from Takeda and has served as a consultant for AbbVie, AbGenomics, Allergan, Arena Pharmaceuticals, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene/Syneos, Check-Cap, Dizal Pharmaceutical, GalenPharma/atlantica, Genentech/Roche, Gilead, Ichnos Sciences, InDex Pharmaceuticals, Iterative Scopes, Janssen, Lilly, Materia Prima Farmaceutica, Narrow River Management, Pfizer, Prometheus Biosciences, Reistone, Takeda, and TECHLAB.||Sandborn, William J:|:|WJS has received research grants from AbbVie, Amgen, Atlantic Healthcare, Genentech, Gilead, Janssen, Lilly, Pfizer, Prometheus Biosciences, Receptos (Celgene), and Takeda consulting fees from AbbVie, Allergan, Alimentiv (Robarts Clinical Trials), Amgen, Arena Pharmaceuticals, Avexegen, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus Pharmaceuticals, Cosmo Pharmaceuticals, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead, Gossamer Bio, Incyte, Janssen, Kyowa Kirin, Landos Biopharma, Lilly, Oppilan, Otsuka, Pfizer, Progenity, Prometheus Biosciences, Qualgen Therapeutics (Ritter Pharmaceuticals), Reistone, Seres Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Pharma, Sterna Biological, Sublimity Therapeutics, Takeda, Theravance, TiGenix, Tillotts Pharma, UCB, Ventyx Biosciences, Vimalan Biosciences, and Vivelix and has stock or stock options from BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan, Qualgen Therapeutics (Ritter Pharmaceuticals), Progenity, Prometheus Biosciences, Ventyx Biosciences, and Vimalan Biosciences. His spouse has received consulting fees from Iveric (Opthotech), Progenity and has stock or stock options in Escalier Biosciences, Iveric (Opthotech), Oppilan, Progenity, Prometheus Biosciences, Ventyx Biosciences, and is an employee of Oppilan, Escalier Biosciences, Prometheus Biosciences, Ventyx Biosciences, and Vimalan Biosciences.||Neimark, Ezequiel:|:|EN is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Song, Alexandra P:|:|APS is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Liao, Xiaomei:|:|XL is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Feng, Tian:|:|TF is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Berg, Sofie:|:|SB is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Wallace, Kori:|:|KW is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. D’Haens, Geert R:|:|GRD has received consulting and/or speaker’s fees from AbbVie, ActoGeniX, AIM ImmunoTech, Boehringer Ingelheim, Centocor, ChemoCentryx, Cosmo Pharmaceuticals, Dr Falk Pharma, Elan Pharmaceuticals, enGene, Ferring, Galapagos, Giuliani SpA, Given Imaging (Medtronic), GlaxoSmithKline, Janssen, Merck, Neovacs, Norgine, Novo Nordisk, Otsuka, PDL BioPharma, Pfizer, Receptos (Celgene), Salix, Schering-Plough, SetPoint Medical, Shire, Takeda, Tillotts Pharma, Tramedico, UCB, Versant Health, and Vifor Pharma and research grants from AbbVie, Dr Falk Pharma, Given Imaging (Medtronic), Janssen, Merck, and PhotoPill.

OP28

OP29 Bolte, Laura: No conflict of interest||Dr. Vich Vila, Arnau: No conflict of interest||Dr. Imhann, Floris:|:|FI received a speaker fee from AbbVie.||Dr. Collij, Valerie: No conflict of interest||Dr. Peters, Vera: No conflict of interest||Prof. Fu, Jingyuan: No conflict of interest||Dr. Kurilshikov, Alexander: No conflict of interest||Dr. Campmans-Kuijpers, Marjo:|:|MC received invited speaking fees from Takeda.||Prof. Dr. Dijkstra, Gerard:|:|GD reports speakers’ fees from Janssen Pharmaceuticals, Takeda and Pfizer.||Prof. Wijmenga, Cisca: No conflict of interest||Prof. Dr. Zhernakova, Alexandra: No conflict of interest||Prof. Dr. Weersma, Rinse:|:|RW acted as consultant for Takeda and received unrestricted research grants from Takeda and Johnson and Johnson pharmaceuticals and speaker fees from AbbVie, MSD, Olympus and AstraZeneca.

OP30 Dr. Haifer, Craig: No conflict of interest||Dr. Saikal, Aiasha: No conflict of interest||Dr. Paramsothy, Sudarshan: No conflict of interest||Dr. Borody, Thomas j:|:|Thomas J Borody has interest in Redhill Biopharma, Salix and Finch Therapeutics, ResMed and GSK; has interest in the Centre for Digestive Diseases, where faecal microbiota transplantation is a treatment option for patients, and has filed patents in this field||Dr. Ghaly, Simon: No conflict of interest||Prof. Kaakoush, Nadeem O: No conflict of interest||Prof. Leong, Rupert: No conflict of interest

Dr. Danese, Silvio:|:|Consulting fees from Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion Healthcare, Ferring, Gilead Sciences, Hospira, Inc., Janssen Research & Development, LLC., Johnson & Johnson Health Care Systems, Inc., Pfizer, Sandoz, UCB, Inc., Vifor International Inc.||Dr. Sandborn, William J:|:|Research grants from Atlantic Healthcare Limited, Amgen, Genentech, Gilead Sciences, AbbVie, Janssen Research & Development, LLC., Takeda, Lilly, Celgene/Receptos,Pfizer, Prometheus Laboratories (now Prometheus Biosciences); consulting fees from AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Avexegen Therapeutics, BeiGene, Boehringer Ingelheim, Celgene, Celltrion, Conatus, Cosmo, Escalier Biosciences, Ferring, Forbion, Genentech, Gilead Sciences, Gossamer Bio, Incyte, Janssen Research & Development, LLC., Kyowa Kirin Pharmaceutical Research, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pfizer, Progenity, Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories), Reistone, Ritter Pharmaceuticals, Robarts Clinical Trials (owned by Health Academic Research Trust, HART), Series Therapeutics, Shire, Sienna Biopharmaceuticals, Sigmoid Biotechnologies, Sterna Biologicals, Sublimity Therapeutics, Takeda, Theravance Biopharma, Tigenix, Tillotts Pharma, UCB Pharma, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals; and stock or stock options from BeiGene, Escalier Biosciences, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories), Progenity, Ritter Pharmaceuticals, Ventyx Biosciences, Vimalan Biosciences. Spouse: Iveric Bio - consultant, stock options; Progenity - consultant, stock; Oppilan Pharma - consultant, stock options; Escalier Biosciences – prior employee, stock options; Prometheus Biosciences (merger of Precision IBD and Prometheus Laboratories) - employee, stock options; Ventyx Biosciences – stock options; Vimalan Biosciences – stock options.||Dr. Feagan, Brian G:|:|Reports fees for serving on advisory boards from AbbVie, Allergan, Amgen, AstraZeneca, Avaxia Biologics, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Elan–Biogen, Ferring, Genentech–Roche, Janssen–Johnson &Johnson, Merck, Millennium, Nestlé, Novo Nordisk, Novartis, Pfizer, Prometheus, Protagonist, Receptos, Salix, Sigmoid Pharma, Takeda, Teva, TiGenix, Tillotts Pharma, and UCB Pharma, consulting fees from AbbVie, Actogenix, Akros, Albireo Pharma, Allergan, Amgen, AstraZeneca, Avaxia Biologics, Avir Pharma, Axcan, Baxter Healthcare, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Elan–Biogen, EnGene, Ferring, Genentech–Roche, GiCare Pharma, Gilead Sciences, Given Imaging, GlaxoSmithKline, Ironwood, Janssen Biotech–Centocor, Janssen–Johnson & Johnson, Kyowa Hakko Kirin, Eli Lilly, Merck, Mesoblast Pharma, Millennium, Nestlé, Novo Nordisk, Novartis, Pfizer, Prometheus, Protagonist, Receptos Salix, Sanofi, Shire, Sigmoid Pharma, Synergy Pharma, Takeda, Teva, TiGenix, Tillotts Pharma, UCB Pharma, Vertex, VHsquared, Wyeth, Zealand, and Zygenia, lecture fees from AbbVie, Janssen–Johnson & Johnson, Takeda, and UCB Pharma, and grant support from AbbVie, Amgen, AstraZeneca, Bristol- Meyers Squibb, Janssen Biotech–Centocor, Janssen–Johnson & Johnson, Pfizer, Receptos, Sanofi, and Takeda, and being a consultant to Robarts Clinical Trials.||Ms. Weisel, Kathleen:|:|Employees of Janssen Research & Development, LLC and own stock and/or stock options in JNJ||Dr. Gonzalez, Susana:|:|Employees of Janssen Research & Development, LLC and own stock and/or stock options in JNJ||Ms. Frustaci, Mary Ellen:|:|Employees of Janssen Research & Development, LLC and own stock and/or stock options in JNJ|||Mr. Yang, Zijiang:|:|Employees of Janssen Research & Development, LLC and own stock and/or stock options in JNJ|||Dr. Johanns, Jewel:|:|Employees of Janssen Research & Development, LLC and own stock and/or stock options in JNJ|||Dr. Germinaro, Matthew:|:|Employees of Janssen Research & Development, LLC and own stock and/or stock options in JNJ|||Dr. Afzali, Anita:|:|Consulting and speaker fees from AbbVie, Takeda, UCB, Janssen, Celgene, and Pfizer and has received research/education support from AbbVie, Janssen, Celgene, and Takeda|||Prof. Andrews, Jane M:|:|Consultant for Abbott, AbbVie, Allergan, Anatara, AstraZeneca, Bayer, Celegene, Ferring, Gilead, Hospira, Immunic, Janssen, MSD, Nestle, Pfizer, Shire, Takeda, and Vifor. |||Prof. D’Haens, Geert:|:|Investigator, Consultant, and Steering Committee Member for Janssen||Prof. Hisamatsu, Tadakazu:|:|Grant support from AbbVie, Daiichi-Sankyo, EA Pharma Co, Ltd. JIMRO, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmacuetical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc., Takeda Pharmaceutical Co., Ltd., consulting fees from EA Pharma Co, Ltd., Janssen Research & Development, LLC.,, and lecture fees from AbbVie, EA Pharma Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd||Dr. Panaccione, Remo:|:|Consulting fees from AbbVie, Janssen Research & Development, LLC., Takada California, Inc.|||Prof. Reinisch, Walter:|:|Investigator, Consultant, and Steering Committee Member for Janssen||Dr. Rubin, David T:|:|Research funding from Takeda, and has served as a consultant to Abbvie, Abgenomics, Allergan, Inc., Arena Pharmaceuticals, Biomica, Bristol-Myers Squibb, Dizal Pharmaceuticals, Ferring Pharmaceuticals, Inc., Genentech/Roche, Janssen Pharmaceuticals, Lilly, Mahana Therapeutics, Medtronic, Merck & Co., Inc, Napo Pharmaceuticals, Pfizer, Prometheus Laboratories, Shire, Takeda, Target PharmaSolutions, Inc and is a co-founder of Cornerstones Health, Inc ||Dr. Sands, Bruce E:|:|Personal fees from AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, grants and personal fees from Celgene, Akros Pharma, Arena Pharmaceuticals, Boehringer-Ingelheim, Forward Pharma, Hoffman-La RocheImmune Pharmaceuticals, Shire, Synergy Pharmaceuticals, Theravance Biopharma R&D, TiGenix, TopiVert Pharma, Receptos, Allergan, EnGene, Target PharmaSolutions, Lycera, Lyndra, Ironwood Pharmaceuticals, Salix, Vivelix Pharmaceuticals, UCB, Oppilan Pharmaceuticals, Gilead, Rheos Medicines, Seres Therapeutics, 4D Pharma, Capella Bioscience, Otsuka, Ferring, Protagonist Therapeutics, Palatin Technologies, Prometheus Laboratories. Personal fees and non-financial support from Janssen Research & Development, LLC., MedImmune, and Lilly. Grants, personal fees and non-financial support from Takeda and Pfizer|||Prof. Panes, Julian:|:|Consulting fees from AbbVie, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Genentech, GlaxoSmithKline, Janssen, MSD, Nestle, Oppilan, Progenity, Pfizer, Robarts, Roche, Second Genome, Takeda, Theravance, TiGenix, and Topivert; speaker fees from AbbVie, Biogen, Ferring, Janssen, MSD, Shire Pharmaceuticals, Takeda, and Tillotts; and research funding from AbbVie and MSD.

OP31 Bressler, Brian: No conflict of interest||Dr. Marshall, John K.: No conflict of interest||Dr. Atkinson, Ken: No conflict of interest||Dr. Sutcliffe, Simon: No conflict of interest||Mr. Pankovich, Jim: No conflict of interest||Mrs. Jones, Michelle: No conflict of interest||Dr. Kalyan, Shirin: No conflict of interest||Dr. Gunn, Hal: No conflict of interest

OP32 Ms. Verburgt, Charlotte: No conflict of interest||Ms. Dunn, Katherine: No conflict of interest||Mr. Bielawski, Joseph: No conflict of interest||Ms. Otley, Anthony: No conflict of interest||Heyman, Melvin: No conflict of interest||Sunseri, Withney: No conflict of interest||Mr. Shouval, Dror: No conflict of interest||Prof. Levine, Arie: No conflict of interest||Dr. de Meij, Tim: No conflict of interest||Mr. Hyams, Jeffrey: No conflict of interest||Mr. Denson, Lee: No conflict of interest||Mr. Kugathasan, Subra: No conflict of interest||Benninga, Marc: No conflict of interest||Prof. Dr. de Jonge, Wouter: No conflict of interest||Dr. Van Limbergen, Johan: No conflict of interest

OP33 Sandborn, William: No conflict of interest||Dr. Danese, Silvio: No conflict of interest||Dr. Leszczyszyn, Jaroslaw: No conflict of interest||Dr. Romatowski, Jacek: No conflict of interest||Dr. Altintas, Engin: No conflict of interest||Dr. Peeva, Elena: No conflict of interest||Dr. Vincent, Michael: No conflict of interest||Reddy, Padma: No conflict of interest||Banfield, Christopher: No conflict of interest||Banerjee, Anindita: No conflict of interest||Gale, Jeremy: No conflict of interest||Dr. Hung, Kenneth: No conflict of interest

OP34 Prof. Dr. Watanabe, Mamoru:|:|AbbVie GK., EA Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation., Mochida Pharmaceutical Co., Ltd., KYORIN Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Janssen Pharmaceutical K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Gilead Sciences, Miyarisan Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Celltrion Healthcare, Eli Lilly Japan K.K., ||Prof. Dr. Matsuoka, Katsuyoshi:|:|AbbVie GK., EA Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation., Mochida Pharmaceutical Co., Ltd., KYORIN Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co., Ltd., Astellas Pharma Inc., JIMRO Co., Ltd., Janssen Pharmaceutical K.K., Pfizer Japan Inc., Takeda Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Gilead Sciences, Miyarisan Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Celltrion Healthcare, Eli Lilly Japan K.K.||Dr. Ohmori, Toshihide:|:|Mochida Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corporation.,Takeda Pharmaceutical Co., Ltd., DAIICHI SANKYO Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Olympus Corporation., JIMRO Co., Ltd., KYORIN Pharmaceutical Co.,Ltd., EA Pharma Co., Ltd.||Dr. Nakajima, Koichi: No conflict of interest||Dr. Ishida, Tetsuya: No conflict of interest||Dr. Ishiguro , Yoh: No conflict of interest||Dr. Kanke, Kazunari: No conflict of interest||Prof. Dr. Kobayashi, Kiyonori: No conflict of interest||Prof. Dr. Hirai, Fumihito:|:|Abbvie GK, EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation., Takeda Pharmaceutical Co., Ltd.||Dr. Watanabe, Kenji:|:|Mitsubishi Tanabe Pharma Corporation., Takeda Pharmaceutical Co., Ltd., AbbVie GK., Ltd., EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Pfizer Japan Inc., KYORIN Pharmaceutical Co.,Ltd., Mochida Pharmaceutical Co., Ltd., Zeia Pharmaceutical Co., Ltd., JIMRO Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Asahi Kasei Medical Co., Ltd.||Prof. Dr. Hibi, Toshifumi:|:|Aspen, EA Pharma Co., Ltd, AbbVie GK, JIMRO Co., Ltd., Zeria Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation., KYORIN Pharmaceutical Co.,Ltd., Janssen Pharmaceutical K.K,, Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Gilead Sciences, Celltrion Healthcare Co., Ltd., Nippon Kayaku Co., Ltd., Kissei Pharmaceutical Co., Ltd., Ferring Pharmaceuticals Co.,Ltd., Eli Lilly Japan K.K., Pfizer Japan Inc., Nichi-Iko Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Bristol-Myers Squibb.

OP35

OP36 Dr. Bossuyt, Peter:|:|PB has received financial support for research from AbbVie, Amgen, Janssen, Mundipharma, Mylan, and Pfizer lecture fees from AbbVie, Janssen, Pfizer, and Takeda advisory board fees from Abbvie, Arena pharmaceuticals, Bristol-Myers Squibb, Hospira, Janssen, Merck, Mundipharma, Pentax Medical, Pfizer, PSI CRO, Roche, Sandoz, and Takeda.||Dr. Ferrante, Marc:|:|MF has been a consultant for AbbVie, Boehringer Ingelheim, Celltrion, Janssen, Lilly, Medtronic, Merck, Pfizer, Sandoz, Takeda, and Thermo Fisher has received research grants from AbbVie, Amgen, Biogen, Janssen, Pfizer, and Takeda and received speaker’s fees from AbbVie, Amgen, Biogen, Boehringer Ingelheim, Dr Falk Pharma, Ferring, Janssen, Lamepro BV, Merck, Mylan, Pfizer, Sandoz, Takeda, and Truvion.||Dr. Baert, Filip:|:|FB has been a consultant and/or speaker for AbbVie, Arena Pharmaceuticals, Celltrion, Dr Falk Pharma, Galapagos, Ferring, Janssen, Merck, Mundipharma, Pfizer, Takeda, and Vifor Pharma and has received research grants from AbbVie, Amgen, Chiesi, Ipsen, and Merck.||Dr. Danese, Silvio:|:|SD has received research grants from AbbVie, Alimentiv (Robarts Clinical Trials), Amgen, Genentech, Gilead, Janssen, Pfizer, Receptos (Celgene), Seres Therapeutics, Takeda, and UCB and has been a consultant for AbbVie, Allergan, Amgen, Bristol-Myers Squibb, Celgene, Celltrion, Janssen, Lilly, Pfizer, Takeda, and UCB.||Dr. Feagan, Brian G:|:|BGF has been a consultant and/or speaker for Abbott/AbbVie, AgomAb, Allakos, Allergan, AM Pharma (Ysios Capital), Amgen, Applied Molecular Transport, Aptevo, AstraZeneca, Atlantic Healthcare, BiomX, Boehringer Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Connect BioPharma, Disc Medicine, Everest Clinical Research, Exeliom (Nextbiotix), Galapagos, GalenPharma/atlantica, Genentech/Roche, Gilead, GlaxoSmithKline, Gossamer Bio, InDex Pharmaceuticals, Janssen, Kyowa Kirin, Leadiant, Lilly, Lument, Merck, Millennium Pharmaceuticals, Mylan, Nestlé, Origo Biopharma, Pandion Therapeutics, Par’Immune, Parvus Therapeutics, Pfizer, Prometheus Biosciences, Progenity, Protagonist Therapeutics, Qu Biologics, Rebiotix, Receptos (Celgene), Roche, Salix, Sandoz, Sanofi, Shire, Surrozen, Takeda, Tillotts Pharma, UCB, VHsquared, Viatris, and Zealand Pharma has received research grant/other financial support from AbbVie, Amgen, AstraZeneca/MedImmune, Atlantic Healthcare, Boehringer Ingelheim, Celgene, Celltech Therapeutics (UCB), Genentech/Roche, Gilead, GlaxoSmithKline, Janssen, Pfizer, Receptos (Celgene), Sanofi, Santarus, Takeda, Tillotts Pharma, and UCB has been a speaker for AbbVie, Janssen, Takeda, and Tillots Pharma has been a member of scientific advisory boards for AbbVie, Allergan, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Genentech/Roche, Janssen, Novartis, Origo Biopharma, Pfizer, Prometheus Biosciences, Protagonist Therapeutics, Takeda, and Tillotts Pharma has been a member of the board of directors for Alimentiv (Robarts Clinical Trials) and is a stockholder in Gossamer Bio.||Dr. Loftus Jr, Edward V:|:|EVL Jr has been a consultant for AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Calibr, Celgene, Celltrion, Genentech, Gilead, Iterative Scopes, Janssen, Lilly, Ono Pharmaceutical, Pfizer, Sun Pharma, Takeda, and UCB research support for Alimentiv (Robarts Clinical Trials), and has received research grants from AbbVie, Amgen, Bristol-Myers Squibb, Genentech, Gilead, Janssen, Pfizer, Receptos (Celgene), Takeda, Theravance, and UCB.||Dr. Panés, Julian:|:|JP has received research grants from AbbVie and Pfizer speaker’s fees from AbbVie, Ferring, Janssen, Pfizer, and Takeda and has been a consultant for AbbVie, Alfa Wasserman, Alimentiv (Robarts Clinical Trials), Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Ferring, Genentech, GlaxoSmithKline, GoodGut, Janssen, Merck, Nestlé, Origo Biopharma, Pfizer, Progenity, Roche, Takeda, and Theravance.||Dr. Peyrin-Biroulet, Laurent:|:|LP-B has received personal fees from AbbVie, Allergan, Alma Bio Therapeutics, Amgen, Arena, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Enterome, Ferring, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, Merck, Nestlé, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna Biological, Takeda, and

Danese, Silvio:|:|Silvio Danese reports consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc. and Vifor; and lecture fees from AbbVie, Amgen, Ferring Pharmaceuticals Inc., Gilead, Janssen, Mylan, Pfizer and Takeda.||Vermeire, Séverine:|:|Séverine Vermeire reports honoraria/consulting fees from AbbVie, Amgen, Arena, Celgene, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Hospira, Janssen, Lilly, MSD, Mundipharma, Pfizer Inc., Progenity, Second Genome, Shire and Takeda; and participation in company-sponsored speakers bureaux with AbbVie, Ferring, Hospira, Janssen, MSD, Pfizer, Takeda and Tillots. |Séverine Vermeire reports research grants from Abbvie, Galapagos, Johnson & Johnson, Pfizer and Takeda.||D’Haens, Geert:|:|Geert D’Haens has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamer Bio, Pfizer, Immunic, Johnson & Johnson, Kintai Therapeutics, Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint, Tillotts; and reports speaker fees from AbbVie, Biogen, Ferring, Johnson & Johnson, MSD, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millennium/Takeda, Tillotts and Vifor.||Panés, Julian:|:|Julian Panés reports consulting fees/honorarium from AbbVie, Arena, Boehringer Ingelheim, Celgene, Genentech/Roche, GlaxoSmithKline, Janssen, Origo, Pandion, Pfizer, Progenity, Takeda, Theravance and Wasserman; support for travel to meetings from AbbVie and Takeda during the conduct of the study; payment for lectures including service on speakers bureaux from Abbott, Janssen, Pfizer and Takeda; payment for development of educational presentations from Abbott, Janssen, Pfizer and Roche; and grants from AbbVie and Pfizer.||Dignass, Axel:|:|Axel Dignass reports fees for participation in review activities, such as data monitoring boards, statistical analysis, end point committees, and the like from Falk during the conduct of the study; consultancy fees from AbbVie, Amgen, Celgene/Bristol-Myers Squibb, Falk, Ferring, Fresenius Kabi, Gilead, Galapagos, Janssen, MSD, Pfizer, Pharmacosmos, Roche/Genentech, Sandoz/Hexal, Takeda, Tillotts and Vifor; payment from lectures including service on speakers bureaux from AbbVie, Falk Foundation, Ferring, Janssen, Med Update GmbH, MSD, Pfizer, Pharmacosmos, Streamed up, Takeda, Tillotts and Vifor; and payment for manuscript preparation from Falk Foundation, Pfizer, Takeda, Thieme, Tillotts and Uni-Med Verlag.|Axel Dignass reports payment for development of educational presentations from Ferring and Tillotts outside the submitted work.||Magro, Fernando:|:|Fernando Magro reports fees from lectures to AbbVie, Falk, Ferring, Hospira, Lab Vitoria, MSD, OM Pharma, PharmaKern, Schering Vifor and Takeda||Nazar, Maciej:|:|Maciej Nazar is an employee of Janssen-Cilag Polska Sp. z .o.o.||Le Bars, Manuela:|:|Manuela Le Bars is an employee of Janssen-Cilag and owner of RSU||Lahaye, Marjolein:|:|Marjolein Lahaye is an employee of Janssen-Cilag BV.||Ni, Lioudmila:|:|Lioudmila Ni is an employee of Janssen Cilag Russia. ||Bravatà, Ivana:|:|Ivana Bravatà is an employee of Janssen-Cilag.||Gaya, Daniel R.:|:|Daniel R. Gaya reports personal fees from AbbVie, Janssen and Takeda; and a travel grant from Vifor.||Peyrin-Biroulet, Laurent:|:|Laurent Peyrin-Biroulet reports personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, Lilly, MSD, Mylan, Nestlé, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Tillots and Vifor; grants from AbbVie, MSD and Takeda; and stock options from CTMA.

OP37

OP38 Dr. Al Bakir, Ibrahim: No conflict of interest||Dr. Curtius, Kit: No conflict of interest||Mr. Smith, Kane: No conflict of interest||Dr. Kopczynska, Maja: No conflict of interest||Dr. Moorghen, Morgan: No conflict of interest||Prof. Dr. Hart, Ailsa: No conflict of interest||Prof. Graham, Trevor: No conflict of interest

Pharmaceuticals, Janssen, Merck, Nestlé, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna Biological, Takeda, and Tillotts Pharma and grants from AbbVie, Merck, and Takeda. He also holds Clinical Trials Mobile Application (CTMA) stock options. ||Dr. Ran, Zhihua: No conflict of interest||Dr. Armuzzi, Alessandro:|:|AA has been a consultant or advisory board member for AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, Merck, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, and Takeda has received speaker’s fees from AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Ferring, Gilead, Janssen, Merck, Mitsubishi Tanabe Pharma, Nikkiso, Novartis, Pfizer, Roche, Samsung Bioepis, and Takeda and has received research grants from Merck, Pfizer, and Takeda.||Dr. D’Haens, Geert R:|:|GRD has received consulting and/or speaker’s fees from AbbVie, ActoGeniX, AIM ImmunoTech, Boehringer Ingelheim, Centocor, ChemoCentryx, Cosmo Pharmaceuticals, Dr Falk Pharma, Elan Pharmaceuticals, enGene, Ferring, Galapagos, Giuliani SpA, Given Imaging (Medtronic), GlaxoSmithKline, Janssen, Merck, Neovacs, Norgine, Novo Nordisk, Otsuka, PDL BioPharma, Pfizer, Receptos (Celgene), Salix, Schering-Plough, SetPoint Medical, Shire, Takeda, Tillotts Pharma, Tramedico, UCB, Versant Health, and Vifor Pharma and research grants from AbbVie, Dr Falk Pharma, Given Imaging (Medtronic), Janssen, Merck, and PhotoPill.||Dr. SONG, Alexandra: No conflict of interest||Dr. Neimark, Ezequiel:|:|EN is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Liao, Xiaomei:|:|XL is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Zhou, Qian:|:|QZ is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Berg, Sofie:|:|SB is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Wallace, Kori:|:|KW is a full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Dr. Panaccione, Remo:|:|RP has received consulting and/or speaker’s fees from AbbVie, Abbott, Alimentiv (Robarts Clinical Trials), Amgen, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Ferring, Galapagos, Genentech, Gilead, GlaxoSmithKline, Janssen, Lilly, Merck, Mylan, Oppilan, Pandion Therapeutics, Pfizer, Progenity, Protagonist Therapeutics, Roche, Satisfai, Sandoz, Schering-Plough, Shire, Sublimity Therapeutics, Takeda, Theravance, and UCB.

Prof. Dr. Danese, Silvio:|:|Has received lecture fees from AbbVie, Amgen, Ferring, Gilead, Janssen, Mylan, Pfizer and Takeda; and consulting fees from AbbVie, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring, Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity, Takeda, TiGenix, UCB and Vifor. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Hibi, Toshifumi:|:|Has received lecture fees from AbbVie GK, Aspen Japan K.K., Ferring, Gilead, Janssen, JIMRO, Mitsubishi Tanabe, Mochida, Pfizer and Takeda; advisory/consulting fees from AbbVie GK, Apo Plus Station, Bristol Myers Squibb, Celltrion, EA, Eli Lilly, Gilead, Janssen, Kyorin, Mitsubishi Tanabe, Nichi-Iko, Pfizer, Takeda and Zeria; and grants from AbbVie GK, EA, JIMRO, Otsuka and Zeria. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Ritter, Timothy E:|:|Has received fees from Gilead, AbbVie, Arena, Ferring, Genentech, Gossamer, Intercept, Janssen, Eli Lilly, Pfizer, Prometheus and Takeda. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Dinoso, Jason B:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Hsieh, Jeremy:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Yun, Chohee:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Zhang, Jie:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Mrs. Zhao, Sally:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Loftus Jr, Edward V:|:|Has received consulting fees from AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Calibr, Celgene, Celltrion, Eli Lilly, Genentech, Gilead, Iterative Scopes, Janssen, Ono, Pfizer, Sun, Takeda and UCB; and grants from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trials, Takeda, Theravance and UCB. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Rogler, Gerhard:|:|Has received consulting fees from Abbvie, Augurix, BMS, Boehringer Ingelheim, Calypso, Celgene, FALK, Ferring, Fisher, Genentech, Gilead, Janssen, MSD, Novartis, Pfizer, Phadia, Roche, UCB, Takeda, Tillotts, Vifor, Vital Solutions and Zeller; speaker fees from Abbvie, AstraZeneca, FALK, Janssen, MSD, Pfizer, Phadia, Takeda, Tillotts, UCB, Vifor and Zeller; and grants from AbbVie, Ardeypharm, Augurix, Calypso, FALK, Flamentera, MSD, Novartis, Pfizer, Roche, Takeda, Tillotts, UCB and Zeller. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.

OP39 Mr. Bourgonje, Arno R.: No conflict of interest||Mr. Hu, Shixian: No conflict of interest||Dr. Spekhorst, Lieke M.: No conflict of interest||Dr. Zhernakova, Daria V.: No conflict of interest||Dr. Vich Vila, Arnau: No conflict of interest||Ms. Li, Yanni: No conflict of interest||Dr. Voskuil, Michiel D.: No conflict of interest||Ms. van Berkel, Lisette A.: No conflict of interest||Dr. Bley Folly, Brenda: No conflict of interest||Mr. Charrout, Mohammed: No conflict of interest||Dr. Mahfouz, Ahmed: No conflict of interest||Prof. Reinders, Marcel J. T.: No conflict of interest||Ms. van Heck, Julia I. P.: No conflict of interest||Prof. Joosten, Leo A. B.: No conflict of interest||Dr. Visschedijk, Marijn C.: No conflict of interest||Dr. van Dullemen, Hendrik M.: No conflict of interest||Prof. Faber, Klaas Nico: No conflict of interest||Prof. Samsom, Janneke N.: No conflict of interest||Dr. Festen, Eleonora A. M.: No conflict of interest||Prof. Dijkstra, Gerard: No conflict of interest||Prof. Weersma, Rinse K.: No conflict of interest

OP40

DOP01 Dr. Chen, Baili: No conflict of interest||Dr. Zhang, Shenghong: No conflict of interest||Dr. Wang, Bangmao: No conflict of interest||Dr. Chen, Hong: No conflict of interest||Dr. Li, Yan: No conflict of interest||Dr. Cao, Qian: No conflict of interest||Dr. Zhong, Jie: No conflict of interest||Dr. Xie, Minjun: No conflict of interest||Dr. Ran, Zhihua: No conflict of interest||Dr. Tang, Tongyu: No conflict of interest||Ms. Yang, Ming:|:|Ming Yang is an employee and shareholder of I-Mab Biopharma. ||Dr. Guo, Taylor:|:|Taylor B. Guo is an employee and shareholder of I-Mab Biopharma. ||Ms. Xu, Beibei:|:|Beibei Xu is an employee of I-Mab Biopharma.||Ms. Cai, Zhiyu:|:|Zhiyu Cai is an employee of I-Mab Biopharma. ||Dr. Schreiber, Stefan:|:|Consultancies|AbbVie, AMT, Arena, BMS, Boehringer Ingelheim, Celltrion, Ferring, IMAB Biopharma, Janssen, Medimmune/AstraZeneca, MSD, Pfizer, Protagonist, Sanofi, Takeda, Theravance, UCB| |Paid Lectures|AbbVie, Celltrion, Ferring, Jansen, MSD, Pfizer, Takeda| |Grant Support: |none| |Paid Expertise: |none| |Vested Interests: |none||Chen, Minhu: No conflict of interest

DOP02 Dr. Dart, Robin:|:|Consulting: Gamma Delta Therapeutics, Takeda Funding: Adaptate Biotherapeutics Speaker fees: Janssen||Dr. Zlatareva, Iva: No conflict of interest||Dr. Irving, Peter:|:|Consultant and/or advisory board member: AbbVie, Warner Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson & Johnson, Shire, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira and Samsung Bioepis. Research Funding: MSD and Takeda||Prof. Hayday, Adrian:|:|Board member and equity holder in ImmunoQure, AG., and Gamma Delta Therapeutics, and is an equity holder in Adaptate Biotherapeutics

Danese, Silvio:|:|Silvio Danese reports consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc. and Vifor; and reports lecture fees from Abbvie, Amgen, Ferring Pharmaceuticals Inc., Gilead, Janssen, Mylan, Pfizer and Takeda.||Vermeire, Séverine:|:|Séverine Vermeire reports honoraria/consulting fees from AbbVie, Amgen, Arena, Celgene, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Hospira, Janssen, Lilly, MSD, Mundipharma, Pfizer Inc., Progenity, Second Genome, Shire and Takeda; participation in company-sponsored speakers bureaux with AbbVie, Ferring, Hospira, Janssen, MSD, Pfizer, Takeda and Tillots; and research grants from Abbvie, Galapagos, Johnson & Johnson, Pfizer and Takeda.||Dignass, Axel:|:|Axel Dignass reports fees for participation in review activities, such as data monitoring boards, statistical analysis, end point committees, and the like from Falk during the conduct of the study; consultancy fees from AbbVie, Amgen, Celgene/Bristol-Myers Squibb, Falk, Ferring, Fresenius Kabi, Gilead, Galapagos, Janssen, MSD, Pfizer, Pharmacosmos, Roche/Genentech, Sandoz/Hexal, Takeda, Tillotts and Vifor; payment from lectures including service on speakers bureaux from AbbVie, Falk Foundation, Ferring, Janssen, Med Update GmbH, MSD, Pfizer, Pharmacosmos, Streamed up, Takeda, Tillotts and Vifor; and payment for manuscript preparation from Falk Foundation, Pfizer, Takeda, Thieme, Tillotts and Uni-Med Verlag.|Axel Dignass reports payment for development of educational presentations from Ferring and Tillotts outside the submitted work.||Panés, Julian:|:|Julian Panés reports consulting fees/honorarium from AbbVie, Arena, Boehringer Ingelheim, Celgene, Genentech/Roche, GlaxoSmithKline, Janssen, Origo, Pandion, Pfizer, Progenity, Takeda, Theravance and Wasserman; support for travel to meetings from AbbVie and Takeda during the conduct of the study; payment for lectures including service on speakers bureaux from Abbott, Janssen, Pfizer and Takeda; payment for development of educational presentations from Abbott, Janssen, Pfizer and Roche; and grants from AbbVie and Pfizer.||D'Haens, Geert:|:|Geert D'Haens has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamer Bio, Pfizer, Immunic, Johnson & Johnson, Kintai Therapeutics, L Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint and Tillotts; Has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamerbio, Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint, Tillotts; and reports speaker fees from AbbVie, Biogen, Ferring, Johnson & Johnson, MSD, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millennium/Takeda, Tillotts and Vifor.||Magro, Fernando:|:|Professor Fernando Magro reports fees from lectures to AbbVie, Falk, Ferring, Hospira, Lab Vitoria, MSD, OM Pharma, PharmaKern, Schering Vifor and Takeda||Le Bars, Manuela:|:|Manuela Le Bars is an employee of Janssen-Cilag and owner of RSU||Nazar, Maciej:|:|Maciej Nazar is an employee of Janssen-Cilag Polska Sp. z .o.o.||Lahaye, Marjolein:|:|Marjolein Lahaye is an employee of Janssen-Cilag BV.||Ni, Lioudmila:|:|Lioudmila Ni is an employee of Janssen Cilag Russia. ||Bravatà, Ivana:|:|Ivana Bravatà is an employee of Janssen-Cilag.||Gaya, Daniel R.:|:|Daniel R. Gaya reports personal fees from AbbVie, Janssen and Takeda; and a travel grant from Vifor.||Peyrin-Biroulet, Laurent:|:|Laurent Peyrin-Biroulet reports personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, Lilly, MSD, Mylan, Nestlé, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Tillots and Vifor; grants from AbbVie, MSD and Takeda; and stock options from CTMA.

DOP03 Dr. Narula, Neeraj:|:|McMaster University Department of Medicine Internal Career Award and received honoraria from Janssen, Abbvie, Takeda, Pfizer, Merck, Sandoz, Novartis, and Ferring.||Ms. Wong, Emily: No conflict of interest||Dr. Colombel, Jean-Frederic:|:|Research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda,Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.||Dr. Riddell, Robert: No conflict of interest||Dr. Marshall, John:|:|Honoraria from Janssen, AbbVie, Allergan, Bristol-Meyer-Squibb, Ferring, Janssen, Lilly, Lupin, Merck, Pfizer, Pharmascience, Roche, Shire, Takeda and Teva.||Dr. Reinisch, Walter:|:|Speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult, |Consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC, |Advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC.||Dr. Dulai, Parambir:|:|Digestive Diseases Research Center grant NIH DK120515, a Research Scholar Award from the American Gastroenterology Association and received research support and consulting for Takeda, Abbvie, Janssen, Pfizer.

DOP04 Ms. UNIKEN VENEMA, Werna: No conflict of interest||Ms. Bangma, Amber: No conflict of interest||Dr. Van der Wijst, Monique: No conflict of interest||Dr. Kats-Ugurlu, Gursah: No conflict of interest||Dr. Bjork, Johannes: No conflict of interest||Dr. Vich Vila, Arnau: No conflict of interest||Prof. Dr. Weersma, Rinse: No conflict of interest||Dr. Festen, Eleonora: No conflict of interest

DOP05 Sandborn, William:|:|WJS reports: research grants from Abbvie, Abivax, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, Glaxo Smith Kline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seres Therapeutics, Shire, Takeda, Theravance Biopharma; consulting fees from Abbvie, Abivax, Admirx, Alfasigma, Alimentiv (previously Robarts Clinical Trials, owned by Alimentiv Health Trust), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma; and stock or stock options from Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Prometheus Laboratories Progenity, Shoreline Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivreon Biosciences. Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock, stock options; Prometheus Laboratories – stock, stock options, consultant; Ventyx Biosciences – stock, stock options; Vimalan Biosciences – stock, stock options.||Dr. Ding, Zhaoqing:|:|Employee, shareholder: Gossamer Bio, Inc.||Osterhout, Robin:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Feagan, Brian:|:|Grant/Research Support: AbbVie Inc., Amgen Inc., AstraZeneca/MedImmune Ltd., Atlantic Pharmaceuticals Ltd., Boehringer-Ingelheim, Celgene Corporation, Celltech, Genentech Inc/Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline (GSK), Janssen Research & Development LLC., Pfizer Inc., Receptos Inc. / Celgene International, Sanofi, Santarus Inc., Takeda Development Center Americas Inc., Tillotts Pharma AG, UCB. Consultant: Abbott/AbbVie, AgomAB Therapeutics, Allakos, Allergan, Amgen, Applied Molecular Transport Inc, Aptevo Therapeutics, Astra Zeneca, Atlantic Pharma, BioMx Israel, Boehringer-Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Connect BioPharma, Disc Medicine Inc., Everest Clinical Research Corp., Galapagos, Galen Atlantica, Genentech/Roche, Gilead, Gossamer Pharma, GSK, Hoffmann-LaRoche, Index Pharma, Janssen, Kyowa Kakko Kirin Co Ltd., Leadiant, Lilly, Lument AB, Merck, Millenium, Mylan, Nestles, Nextbiotix, Origo BioPharma, Pandion Therapeutics, ParImmune, Parvus Therapeutics Inc., Pfizer, Prometheus Therapeutics and Diagnostics, Progenity, Protagonist, Qu Biologics, Rebiotix, Receptos, Salix Pharma, Sandoz, Sanofi, Shire, Surrozen Inc., Takeda, Tillotts, UCB Pharma, VHsquared Ltd., Viatris, Ysios, Zealand Pharma. Speakers Bureau: AbbVie, Janssen, Takeda, Tillotts. Scientific advisory board: AbbVie, Allergan, Amgen, Astra Zeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Genentech/Roche, Janssen, Novartis, Origo BioPharma, Pfizer, Prometheus, Protagonist, Takeda, Tillotts Pharma. Board of Directors: Senior Scientific Director – Alimentiv Inc, London. Shareholder: Gossamer Bio, Inc.||Dr. Danese, Silvio: No conflict of interest||Dr. Jucov, Alina: No conflict of interest||Dr. Bhandari, Bal Raj: No conflict of interest||Dr. Raghupathi, Kartik:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Olson, Allan:|:|Employee, shareholder: Gossamer Bio, Inc.||Van Biene, Courtney:|:|Employee, shareholder: Gossamer Bio, Inc.||Ford, Julia:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Aranda, Richard:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Levesque, Barrett G.:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Bruey, Jean-Marie:|:|Employee, shareholder: Gossamer Bio, Inc.

DOP06 Dr. HERNANDEZ-ROCHA, Cristian: No conflict of interest||Dr. Turpin, Williams: No conflict of interest||Dr. Nayeri, Shadi: No conflict of interest||Borowski, Krzysztof: No conflict of interest||Stempak, Joanne: No conflict of interest||Dr. Conner, James: No conflict of interest||Dr. Silverberg, Mark S: No conflict of interest

DOP07 Dr. Modos, Dezso:|:|Dezso Modos worked as consultant for HEALX and IOTA Pharmaceuticals.||Dr. Brooks-Warburton, Johanne: No conflict of interest||Dr. Sudhakar, Padhmanand: No conflict of interest||Mr. Madgwick, Matthew:|:|Matthew Madgwick's PhD studentship is cofounded by BenevolentAI||Mr. Fazekas, David: No conflict of interest||Dr. Szalay-Beko, Mate: No conflict of interest||Dr. Thomas, John P.: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion.||Prof. Dr. Watson, Alastair: No conflict of interest||Dr. Tremelling, Mark: No conflict of interest||Dr. Parkes, Miles: No conflict of interest||Prof. Dr. Vermeire, Severine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Dr. Bender, Andreas:|:|Andreas Bender got research funding from AstraZeneca, GSK, Unilever, Lhassa, and consultant in HEALX.||Prof. Dr. Carding, Simon R.: No conflict of interest||Dr. Korcsmaros, Tamas:|:|Tamas Korcsmaros has research founded by BenevolentAI and Uniliver

DOP08 Dr. Alsoud, Dahham: No conflict of interest||Dr. Sudhakar, Padhmanand: No conflict of interest||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante , Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare|||Dr. Verstockt , Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm|||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

DOP09 Dr. Johnson, Travis: No conflict of interest||Dr. Steere, Boyd:|:|Employee and stockholder at Eli Lilly and Company||Dr. Zhang, Pengyue: No conflict of interest||Dr. Zang, Yong: No conflict of interest||Dr. Higgs, Richard:|:|Employee and shareholder of Eli Lilly and Company||Dr. Gottlieb, Klaus:|:|Employee and shareholder of Eli Lilly and Company||Dr. Reinisch, Walter:|:|Grant support and personal fees from Abbott Laboratories, AbbVie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnostik, and Merck Sharp & Dohme, and personal fees from Aptalis, Celltrion, Danone Austria, Elan, Ferring, Mitsubishi Tanabe Pharma Corporation, Otsuka, PDL BioPharma, Pharmacosmos, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult, Amgen, AM Pharma, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Covance, Galapagos, Genentech, Gilead Sciences, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson and Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millennium, Nestle, Novartis, Ocera, Pfizer, Procter & Gamble, Prometheus, Robarts Clinical Trial, Second Genome, SetPoint Medical, TiGenix, UCB, Zyngenia, and 4SC. ||Dr. Panés, Julian:|:|Consulting fees from AbbVie, Arena, Boehringer Ingelheim, Celgene, GoodGut, GSK, Janssen, MSD, Nestlé, Oppilan, Pfizer, Takeda, Theravance, and TiGenix, and unrestricted research grants from AbbVie and MSD.||Krishnan, Gary:|:|Employee and shareholder of Eli Lilly and Company

DOP10 Dr. Vaughan, Rose: No conflict of interest||Dr. Tjandra, Douglas: No conflict of interest||Dr. Patwardhan, Ashwin: No conflict of interest||Dr. Mingos, Nicholas: No conflict of interest||Prof. Gibson, Robert: No conflict of interest||Prof. Boussioutas, Alex: No conflict of interest||Dr. Christensen, Britt:|:|Britt Christensen has served as an advisory board member for Gilead. She has received speaking honoraria from AbbVie, Ferring, Janssen, Shire and Takeda. Her institution has received research grants and education grants from AbbVie, Janssen, Ferring, Pfizer and Takeda. She has received education grants from Pfizer and Takeda.

DOP11 Ms. Van Rijn, Kyra: No conflict of interest||Ms. Meima-van Praag, Elise: No conflict of interest||Prof. Dr. Bossuyt, Patrick: No conflict of interest||Prof. Dr. D'Haens, Geert: No conflict of interest||Dr. Horsthuis, Karin: No conflict of interest||Ms. Snijder, Harmanna: No conflict of interest||Dr. Tielbeek, Jeroen: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest||Prof. Dr. Stoker, Jaap: No conflict of interest

DOP12 Mr. Ma, Henry: No conflict of interest||Prof. Dr. Issac, Daniela Migliarese: No conflict of interest||Ms. Petrova, Alexandra: No conflict of interest||Ms. Almeida, Patricia: No conflict of interest||Ms. Parsons, Denise: No conflict of interest||Ms. Kuc, Anna: No conflict of interest||Prof. Dr. Carroll, Matthew Wyatt: No conflict of interest||Prof. Dr. Wine, Eytan: No conflict of interest||Prof. Dr. Huynh, Hien: No conflict of interest

DOP13 Dr. Byrne, Michael:|:|Satisfai Health Inc. - CEO and shareholder|ai4gi (JV with Satisfai Health) - Founder|Olympus America - Via ai4gi, Satisfai Health has a co-development with Olympus America.|Handzin Inc. - Advisor and shareholder.|||Dr. East, James:|:|Shareholder in Satisfai health||Dr. Iacucci, Marietta: No conflict of interest||Dr. Panaccione, Remo:|:|Shareholder in Satisfai Health Inc.||Dr. Kalapala, Rakesh: No conflict of interest||Dr. Duvvur, Nageshwar: No conflict of interest||Dr. Rughwani, Hardik: No conflict of interest||Dr. Singh, Aniruddha: No conflict of interest||Dr. Henkel, Milagros: No conflict of interest||Mr. Canaran, Lalit: No conflict of interest||Ms. Laage, Greta: No conflict of interest||Mr. St-Denis, Ludovic: No conflict of interest||Ms. Nikfal, Shima: No conflict of interest||Mr. Asselin, Jerome: No conflict of interest||Mr. Monsurate, Ryan: No conflict of interest||Mr. Cremonese, Enrico: No conflict of interest||Mr. Soudan, Florian: No conflict of interest||Dr. Travis, Simon:|:|Medical advisor to Satisfai Health Inc.

DOP14 Iacucci, Marietta: No conflict of interest||Nardone, Olga Maria: No conflict of interest||Ms. Jeffery, Louisa: No conflict of interest||Mr. Acharjee, Animesh: No conflict of interest||Dr. Zardo, Davide: No conflict of interest||Dr. Smith, Samuel CL: No conflict of interest||Mrs. Bazarova, Alina: No conflict of interest||Dr. Cannatelli, Rosanna: No conflict of interest||Dr. Shivaji, Uday N: No conflict of interest||Mr. Williams, John: No conflict of interest||Prof. Georgios, Gkoutos: No conflict of interest||Prof. Ghosh, Subrata: No conflict of interest

DOP15 Ms. Reijntjes, Maud: No conflict of interest||Dr. Heuthorst, Lianne: No conflict of interest||Dr. Gecse, Krisztina: No conflict of interest||Dr. Mookhoek, Aart: No conflict of interest||Prof. Dr. Bemelman, Willem: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest

DOP16 Dr. Miyoshi, Jun: No conflict of interest||Dr. Ozaki, Ryo: No conflict of interest||Ms. Yonezawa, Hiromi: No conflict of interest||Prof. Mori, Hideaki: No conflict of interest||Dr. Kawamura, Naohiro: No conflict of interest||Dr. Matsuura, Minoru: No conflict of interest||Prof. Hisamatsu, Tadakazu: No conflict of interest

DOP17 Mr. Bachour, Salam: No conflict of interest||Dr. Shah, Ravi: No conflict of interest||Mr. Lyu, Ruishen: No conflict of interest||Dr. Rieder, Florian: No conflict of interest||Dr. Cohen, Benjamin:|:|There are no conflicts of interest pertaining to this study, however Benjamin L. Cohen, M.D. receives the following financial support: Advisory Boards and Consultant for Abbvie, Celgene-Bristol Myers Squibb, Pfizer, Sublimity Therapeutics,Takeda, TARGET RWE; CME Companies: Cornerstones, Vindico; Speaking: Abbvie||Dr. Qazi, Taha: No conflict of interest||Dr. Lashner, Bret: No conflict of interest||Dr. Lipman, Jeremy: No conflict of interest||Dr. Regueiro, Miguel: No conflict of interest||Dr. Lightner, Amy:|:|There are no conflicts of interest to disclose pertaining to this study however Dr. Lightner serves as a consultant to Takeda. ||Dr. Holubar, Stefan: No conflict of interest||Dr. Click, Benjamin: No conflict of interest

DOP18 Dr. Golovics, Petra: No conflict of interest||Gonczi, Lorant: No conflict of interest||Dr. Reinglas, Jason: No conflict of interest||Dr. Verdon, Christine: No conflict of interest||Dr. Pundir, Sheetal: No conflict of interest||Dr. Afif, Waqqas: No conflict of interest||Dr. Wild, Gary: No conflict of interest||Prof. Dr. Bitton, Alain: No conflict of interest||Dr. Bessissow, Talat: No conflict of interest||Prof. Dr. Lakatos, Peter Laszlo: No conflict of interest

DOP19 Aldars-García, Laila: No conflict of interest||Dr. Gil-Redondo, Rubén: No conflict of interest||Dr. Embade, Nieves: No conflict of interest||Dr. Riestra, Sabino: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest||Dr. Rodríguez, Iago: No conflict of interest||Dr. Fernández, Luis: No conflict of interest||Dr. Ceballos, Daniel: No conflict of interest||Dr. Benítez, José Manuel: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest||Dr. Bastón-Rey, Iria: No conflict of interest||Dr. Algaba, Alicia: No conflict of interest||Dr. Casanova, María José: No conflict of interest||Dr. Lorente, Rufo: No conflict of interest||Dr. Ber, Yolanda: No conflict of interest||Dr. Royo, Vanesa: No conflict of interest||Dr. Esteve, María: No conflict of interest||Dr. Millet, Oscar: No conflict of interest||Dr. Gisbert*, Javier P.: No conflict of interest||Dr. Chaparro*, María: No conflict of interest

DOP20 Dr. Cusato, Jessica: No conflict of interest||Dr. Ribaldone, Davide Giuseppe: No conflict of interest||Dr. Bertani, Lorenzo: No conflict of interest||Dr. Antonucci, Miriam: No conflict of interest||Dr. Tomasello, Cristina: No conflict of interest||Dr. Caviglia, Gian Paolo: No conflict of interest||Mr. Dibetto, Simone: No conflict of interest||Dr. Mangia, Michela: No conflict of interest||Dr. Astegiano, Marco: No conflict of interest||Prof. D'Avolio, Antonio: No conflict of interest

DOP21 Mr. Lis-López, Lluís: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Ortiz-Masia, Dolores: No conflict of interest||Dr. Gisbert-Ferrándiz, Laura: No conflict of interest||Ms. Coll, Sandra: No conflict of interest||Dr. Calatayud, Sara: No conflict of interest||Dr. Barrachina, Maria Dolores: No conflict of interest||Dr. Cosín-Roger, Jesús: No conflict of interest

DOP22 Sudhakar, Padhmanand: No conflict of interest||Dr. Andrighetti, Tahila: No conflict of interest||Dr. Verstockt, Sare: No conflict of interest||Dr. Caenepeel, Clara: No conflict of interest||Prof. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare|||Prof. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda|||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion.||Prof. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

DOP23 Dr. Lewis, Amy: No conflict of interest||Dr. Pan-Castillo, Belen: No conflict of interest||Mr. Berti, Giulio: No conflict of interest||Dr. Felice, Carla: No conflict of interest||Dr. Gordon, Hannah: No conflict of interest||Dr. Gadhok, Radha: No conflict of interest||Dr. Minicozzi, Annamaria: No conflict of interest||Dr. Chinaleong , Joanne: No conflict of interest||Prof. Feakins, Roger: No conflict of interest||Prof. Lindsay, James: No conflict of interest||Prof. Silver, Andrew: No conflict of interest

DOP24 Ms. Becker, Marte: No conflict of interest||Ms. de Krijger, Manon: No conflict of interest||Prof. Dr. Bemelman, Willem: No conflict of interest||Prof. Dr. de Jonge, Wouter: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest||Dr. Wildenberg, Manon: No conflict of interest

DOP25 Dr. Pisani, Anthea: No conflict of interest||Dr. Rausch, Philipp: No conflict of interest||Dr. Ellul, Sarah: No conflict of interest||Dr. Bang, Corinna: No conflict of interest||Dr. Tabone, Trevor: No conflict of interest||Dr. Marantidis Cordina, Claire: No conflict of interest||Dr. Zahra, Graziella: No conflict of interest||Dr. Ellul, Pierre: No conflict of interest||Prof. Franke, Andre: No conflict of interest

DOP26 Afif, Waqqas:|:|Consulting: Abbvie, Amgen, Arena Pharmaceuticals, Dynacare, Janssen, Merck, Novartis, Pfizer, Sandoz, Takeda.||Dr. Marshall, John K:|:|Consulting: AbbVie, Allergan. Amgen, Bristol Myers Squibb, Ferring, Fresenius Kabi, Janssen, Lilly, Lupin, Merck, Novartis, Paladin, Pfizer, Pharmascience, Procter & Gamble, Roche, Sandoz, Shire, Takeda, Teva, Viatris||Dr. Kaidanovich-Beilin, Oksana:|:|Employee of Takeda Pharmaceuticals Inc.||Dr. Ward, Ryan:|:|Employee of Takeda Pharmaceuticals Inc. Canada||Dr. Seow, Cynthia:|:|Consulting: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience

DOP27 Mr. Gkikas, Konstantinos: No conflict of interest||Dr. Logan, Michael: No conflict of interest||Prof. Milling, Simon: No conflict of interest||Dr. Ijaz, Umer Z: No conflict of interest||Dr. Hansen, Richard:|:|RH has received speakers/consultancy fees or conference support from Nutricia, and 4D Pharma||Prof. Russell, Richard K:|:|RKR has received speaker's fees, travel support and/ or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson, Nutricia & 4D Pharma||Prof. Gerasimidis, Konstantinos:|:|K Gerasimidis has received research grants, speakers’ fees and had conference attendance paid by Nutricia/Nestle, Nutricia-Danone, Baxter, Abbott, and Dr Falk

DOP28 Dr. Sebepos-Rogers, Greg: No conflict of interest||Dr. Fragkos, Konstantinos: No conflict of interest||Dr. Shakweh, Eathar: No conflict of interest||Dr. Shah, Krishna: No conflict of interest||Dr. Lake, Luke: No conflict of interest||Dr. Balarajah, Sharmili: No conflict of interest||Dr. Chung, Yooyun: No conflict of interest||Dr. McGuire, Joshua: No conflict of interest||Mr. Al-Shakarchi, Nader: No conflict of interest||Ms. Khetan, Tanvi: No conflict of interest||Dr. Bottle, Juliet: No conflict of interest||Dr. Anandarajah, Cheran: No conflict of interest||Dr. Meade, Susanna: No conflict of interest||Dr. David, Lewis: No conflict of interest||Dr. Hicks, Lucy: No conflict of interest||Dr. Kok, Klaartje: No conflict of interest||Dr. Joshi, Neerav: No conflict of interest||Dr. Samaan, Mark: No conflict of interest||Dr. Patel, Kamal: No conflict of interest||Dr. Mehta, Shameer: No conflict of interest

DOP29 Dr. Akiyama, Shintaro: No conflict of interest||Dr. Cohen, Nathaniel: No conflict of interest||Dr. Traboulsi, Cindy: No conflict of interest||Ms. Rai, Victoria: No conflict of interest||Dr. Glick, Laura: No conflict of interest||Mr. Yi, Yangtian: No conflict of interest||Dr. Runde, Joseph: No conflict of interest||Prof. Dr. Cohen, Russell:|:|Russell Cohen is on the speaker’s bureau from AbbVie and Takeda. He is a consultant/advisor for AbbVie Laboratories, BM/celgene, Eli Lilly, Gilead Sciences, Janssen, Pfizer, Takeda, UCB Pharma. He has received clinical trial support/grants from Abbvie, BMS/Celgene, Boehringer Ingelheim, Crohn’s and Colitis Foundation of America, Genentech, Gilead Sciences, Hollister, Medimmune, Mesoblast Ltd., Osiris Therpeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres Therapeutics, Takeda Pharma, UCB Pharma. His wife is on the board of directors of Aerpio Theraoeutics, Novus Therapeutics, Vital Therapeutics, Inc, and NantKwest.||Dr. Skowron, Kinga: No conflict of interest||Prof. Dr. Hurst, Roger: No conflict of interest||Dr. Umanskiy, Konstantin: No conflict of interest||Dr. Shogan, Benjamin: No conflict of interest||Prof. Dr. Hyman, Neil: No conflict of interest||Ms. Rubin, Michele:|:|Michele Rubin has served as a consultant for Pfizer.||Dr. Dalal, Sushila:|:|Sushila Dalal has served as a consultant for Pfizer and is on the speaker’s bureau for AbbVie.||Dr. Sakuraba, Atsushi: No conflict of interest||Dr. Pekow, Joel:|:|Joel Pekow has received grant support from AbbVie and Takeda. He has served as a consultant for Veraste,. CVS Caremark and is on the advisory board for Takeda, Janssen and Pfizer.||Prof. Dr. Chang, Eugene:|:|Eugene Chang is the founder and chief medical officer of AVnovum Therapeutics.||Dr. Ollech, Jacob: No conflict of interest||Prof. Dr. Rubin, David: No conflict of interest

DOP30 Dr. sensi, bruno: No conflict of interest||Mr. Khan, Jim: No conflict of interest||Mr. Janindra, Warusavitarne: No conflict of interest||Dr. siragusa, leandro: No conflict of interest||Prof. panis, yves: No conflict of interest||Dr. frontali, alice: No conflict of interest||Dr. Stefan, Samuel: No conflict of interest||Dr. Bellato, vittoria: No conflict of interest||Prof. Dr. Espin Basany, Eloy: No conflict of interest||Dr. Marti-Gallostra, Marc: No conflict of interest||Dr. Frasson, Matteo: No conflict of interest||Prof. Dr. Garcia Granero, Eduardo: No conflict of interest||Prof. Dr. spinelli, antonino: No conflict of interest||Dr. carvello, michele: No conflict of interest||Prof. Sampietro, Gianluca: No conflict of interest||Prof. fichera, alessandro: No conflict of interest||Dr. Artigue, Michael: No conflict of interest||Prof. Dr. Zaghiyan, Karen: No conflict of interest||Dr. Adams, Evan: No conflict of interest||Prof. Dr. Konishi, Tsuyoshi: No conflict of interest||Prof. Dr. pellino, gianluca: No conflict of interest||Prof. Dr. Sica, Giuseppe: No conflict of interest

DOP31 Dr. Mañosa Ciria, Miriam:|:|I have received support for conference attendance, speaker fees, research support and consulting fees from Abvie, FAES Pharma, Ferring, Jannsen, MSD, Pfizer and Takeda||Dr. Calafat, Margalida: No conflict of interest||Dr. Ricart, Elena: No conflict of interest||Dr. Nos, Pilar: No conflict of interest||Dr. Iglesias, Eva: No conflict of interest||Dr. Riestra, Sabino: No conflict of interest||Dr. López-Sanroman, Antonio: No conflict of interest||Dr. Vera, Maribel: No conflict of interest||Dr. Guardiola, Jordi: No conflict of interest||Dr. Hernández, Vicent: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Carpio, Daniel: No conflict of interest||Dr. Mínguez, Miguel: No conflict of interest||Dr. Alba, Cristina: No conflict of interest||Dr. Martín-Arranz, Mª Dolores: No conflict of interest||Dr. Rodríguez, Esther: No conflict of interest||Dr. Gomollon, Fernando: No conflict of interest||Dr. Garcia-López, Santiago: No conflict of interest||Dr. Gutiérrez Casbas, Ana: No conflict of interest||Dr. Calvet, Xavier: No conflict of interest||Dr. González-Muñoza, Carlos: No conflict of interest||Dr. Barrio, Jesús: No conflict of interest||P Gisbert, Javier: No conflict of interest||Dr. Sicilia, Beatriz: No conflict of interest||Dr. Pérez-Calle, José Lázaro: No conflict of interest||Dr. Bujanda, Luis: No conflict of interest||Dr. Esteve, Maria: No conflict of interest||Dr. Ramos, Laura: No conflict of interest||Dr. Varela, Pilar: No conflict of interest||Dr. Sierra, Monica: No conflict of interest||Dr. Merino, Olga: No conflict of interest||Dr. Bermejo, Fernando: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Dr. Rodríguez, Antonio: No conflict of interest||Dr. Márquez, Lucia: No conflict of interest||Dr. Garcia-Bosch, Orlando: No conflict of interest||Dr. Cabriada, José Luis: No conflict of interest||Dr. Lorente, Rufo: No conflict of interest||Dr. Cañete, Fiorella: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest

DOP32 Dr. Rodríguez-Lago, Iago: No conflict of interest||Mrs. García Pérez, Cristina: No conflict of interest||Dr. Calafat, Margalida: No conflict of interest||Dr. Soto, María Pilar: No conflict of interest||Dr. Calvo, Marta: No conflict of interest||Dr. Sánchez Rodríguez, Eugenia: No conflict of interest||Dr. Caballol, Berta: No conflict of interest||Dr. Vela, Milagros: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Muñoz, Fernando: No conflict of interest||Dr. De Castro, Luisa: No conflict of interest||Dr. Calvet, Xavier: No conflict of interest||Dr. García-Alonso, Francisco Javier: No conflict of interest||Dr. Utrilla Fornals, Alejandra: No conflict of interest||Dr. Ferreiro-Iglesias, Rocío: No conflict of interest||Dr. González-Muñoza, Carlos: No conflict of interest||Dr. Chaparro, María: No conflict of interest||Dr. Luis, Bujanda: No conflict of interest||Dr. Sicilia, Beatriz: No conflict of interest||Dr. Alfambra, Erika: No conflict of interest||Dr. Rodriguez, Andrés: No conflict of interest||Dr. Pérez Fernández, Rubén: No conflict of interest||Dr. Rodríguez, Cristina: No conflict of interest||Dr. Almela, Pedro: No conflict of interest||Dr. Argüelles, Federico: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Tamarit-Sebastián, Sonsoles: No conflict of interest||Dr. Reygosa Castro, Cristina: No conflict of interest||Mrs. Jiménez, Laura: No conflict of interest||Dr. Marín-Jiménez, Ignacio: No conflict of interest||Dr. Alcaide, Noelia: No conflict of interest||Dr. Fernández-Salgado, Estela: No conflict of interest||Mrs. Iglesias Gómez, Águeda: No conflict of interest||Dr. Ponferrada, Ángel: No conflict of interest||Dr. Pajares, Ramón: No conflict of interest||Dr. Roncero, Óscar: No conflict of interest||Dr. Morales-Alvarado, Victor Jair: No conflict of interest||Dr. Cabriada, José Luis: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

DOP33 Dr. Rottoli, Matteo: No conflict of interest||Dr. Melina, Marica: No conflict of interest||Tanzanu, Marta: No conflict of interest||Romano, Angela: No conflict of interest||Belvedere, Angela: No conflict of interest||Parlanti, Daniele: No conflict of interest||Pezzuto, Anna Paola: No conflict of interest||Salice, Marco: No conflict of interest||Rizzello, Ferdinando: No conflict of interest||Prof. Gionchetti, Paolo: No conflict of interest||Prof. Poggioli, Gilberto: No conflict of interest

DOP34 Dr. Festa, Stefano: No conflict of interest||Dr. Scribano, Maria Lia: No conflict of interest||Dr. Aratari, Annalisa: No conflict of interest||Dr. Bezzio, Cristina: No conflict of interest||Prof. Dr. Principi, Mariabeatrice: No conflict of interest||Dr. Pugliese, Daniela: No conflict of interest||Prof. Dr. Ribaldone, Davide Giuseppe: No conflict of interest||Dr. Furfaro, Federica: No conflict of interest||Dr. Mocci, Giammarco: No conflict of interest||Dr. Spagnuolo, Rocco: No conflict of interest||Prof. Dr. Vernia, Piero: No conflict of interest||Dr. Costa, Francesco: No conflict of interest||Dr. Cosintino , Rocco: No conflict of interest||Dr. De Biasio, Fabiola: No conflict of interest||Dr. Saibeni, Simone: No conflict of interest||Prof. Dr. Armuzzi, Alessandro: No conflict of interest||Dr. Papi, Claudio: No conflict of interest

DOP35 Patel, Kamal Vijaykant:|:|KP has received honoraria for educational meetings and speaker fees from Abbvie, Janssen, Takeda, DrFalk and Ferring. KP has received Advisory Board fees from Abbvie and Janssen||Dr. Segal, Jonathan: No conflict of interest||Prof. Dr. Sebastian, Shaji:|:|SS holds research grants from Biogen, Takeda, AbbVie, Tillotts Pharma, Ferring and Biohit; served on the advisory boards of Takeda, AbbVie, Merck, Ferring, Pharmacocosmos, Warner Chilcott, Janssen, Falk Pharma, Biohit, TriGenix, Celgene and Tillots Pharma; and has received speaker fees from AbbVie, Biogen, AbbVie, Janssen, Merck, Warner Chilcott and Falk Pharma||Dr. Subramanian, Sreedhar:|:|SrS has received speaker fees from MSD, Actavis, Abbvie, Dr Falk pharmaceuticals, Shire and received educational grants from MSD, Abbvie, Actavis and is an advisory board member for Celltrion, Dr Falk pharmaceuticals and Vifor pharmaceuticals||Dr. Conley, Thomas: No conflict of interest||Dr. Gonzalez, Haidee: No conflict of interest||Dr. Kent, Alexandra:|:|AJK has served on the advisory boards for Abbvie, Janssen and BMS Celgene and has received speaker fees from Takeda, Pfizer and Janssen; and received travel/conference expenses from Tillotts, Janssen, Abbvie and Shield Therapeutics||Dr. Saifuddin, Aamir: No conflict of interest||Dr. Hicks, Lucy: No conflict of interest||Dr. Mehta, Shameer: No conflict of interest||Dr. Bhala, Neeraj: No conflict of interest||Prof. Dr. Brookes, Matthew:|:|MJB has received research grants from Vifor International, Pharmacosmos and Tillots Pharma; has received speaker fee from Abbvie and Vifor International; has been an advisory board member for Tillots Pharma, Vifor International; and received travel/conference expenses from Vifor International, Abbvie and Tillots Pharma||Dr. Lamb, Christopher:|:|CAL has received research support and/or has received fees for delivery of non-promotional education from: Genentech, Janssen, Takeda, Abbvie, Dr Falk, AstraZeneca, Eli Lilly, Orion, Pfizer, Roche, Sanofi Aventis, Ferring, UCB and Biogen||Dr. Kennedy, Nick:|:|NAK has served as a speaker and/or advisory board member for Allergan, Falk, Janssen, Mylan, Pharmacosmos, Takeda and Tillotts. He has had support to attend meetings from AbbVie, Falk, Janssen and Norgine. His department has received research funding from AbbVie, Celgene, Celtrion, MSD, Napp, Pfizer, Pharmacosmos and Takeda||Dr. Walker, Gareth:|:|GJW has served as a speaker and/or advisory board member for AbbVie, Falk and Janssen. He has had support to attend meetings from AbbVie, Falk, Janssen and Norgine. His department has received research funding from Tillotts

DOP36 Dr. Furfaro, Federica: No conflict of interest||Zilli , Alessandra: No conflict of interest||Craviotto, Vincenzo: No conflict of interest||Aratari , Annalisa: No conflict of interest||Bezzio, Cristina: No conflict of interest||Gilardi, Daniela: No conflict of interest||D'Amico, Ferdinando: No conflict of interest||Saibeni, Simone: No conflict of interest||Papi, Claudio: No conflict of interest||Peyrin-Biroulet, Laurent: No conflict of interest||Fiorino, Gionata: No conflict of interest||Danese, Silvio: No conflict of interest||Allocca, Mariangela: No conflict of interest

DOP37 Dr. Král, Jan: No conflict of interest||Dr. Nakov, Radislav: No conflict of interest||Dr. Lanska, Vera: No conflict of interest||Dr. Barberio, Brigida: No conflict of interest||Dr. Benech, Nicolas: No conflict of interest||Dr. Blesl, Andreas: No conflict of interest||Dr. Brunet, Eduard: No conflict of interest||Dr. Capela, Tiago Lima: No conflict of interest||Dr. Derikx, Lauranne A.A.P.: No conflict of interest||Dr. Dragoni, Gabriele: No conflict of interest||Dr. Eek, Aileen: No conflict of interest||Dr. Frias-Gomes , Catarina: No conflict of interest||Dr. Gîlcă-Blanariu , Georgiana-Emmanuela: No conflict of interest||Dr. Gilroy, Leah: No conflict of interest||Dr. Harvey, Philip R.: No conflict of interest||Dr. Kagramanova, Anna: No conflict of interest||Dr. Kani, Haluk Tarik: No conflict of interest||Dr. Konikoff, Tom: No conflict of interest||Dr. Lessing, Matthias: No conflict of interest||Dr. Madsen, Gorm Roager: No conflict of interest||Dr. Maksimaityte, Vaidota: No conflict of interest||Dr. Miasnikova, Maria: No conflict of interest||Dr. Mikolasevic, Ivana: No conflict of interest||Dr. Milivojevic, Vladimir: No conflict of interest||Dr. Noviello, Daniele: No conflict of interest||Dr. Oliinyk, Dmytro: No conflict of interest||Dr. Patai, Arpad: No conflict of interest||Dr. Protopapas, Adonis A.: No conflict of interest||Dr. Rodríguez-Lago, Iago: No conflict of interest||Dr. Schreiber, Philipp: No conflict of interest||Dr. Skuja, Vita: No conflict of interest||Dr. Tran, Florian: No conflict of interest||Dr. Truyens, Marie: No conflict of interest||Dr. Włodarczyk, Marcin: No conflict of interest||Dr. Zatorski, Hubert: No conflict of interest||Dr. Verstockt, Bram:|:|BV reports financial support for research from Pfizer; lecture fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R-Biopharm, Takeda and Truvion; consultancy fees from Janssen, Guidepont and Sandoz; all outside of the submitted work.||Dr. Segal, Jonathan P.:|:|JPS reports speaker fees from Takeda and Abbvie and Janssen; all outside of submitted work.

DOP38 Jiang, Jeanne:|:|Jeanne Jiang is an employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options from Takeda Pharmaceutical Company, Ltd.||Dr. Cazzetta, Susan E:|:|Susan Cazzetta is an employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options from Takeda Pharmaceutical Company, Ltd.||Dr. Athavale, Amod:|:|Amod Athavale is an employee of Trinity Partners, LLC. ||Ms. Kuharic, Maja:|:|Maja Kuharic is employed by the University of Illinois and supported by a Takeda Health Economics and Outcomes Research fellowship.||Dr. Fan, Tao:|:|Tao Fan is an employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options from Takeda Pharmaceutical Company, Ltd.||Ms. Silber, Abby:|:|Abby Silber is an employee of Trinity Partners, LLC.||Mr. Vijay, Abilash:|:|Vijay Abilash is an employee of Trinity Partners, LLC.||Ms. Hadker, Nandini:|:|Nandini Hadker is an employee of Trinity Partners, LLC.||Dr. Sharpe, Emily:|:|Emily Sharpe is an employee of Trinity Partners, LLC.||Dr. Nazarey, Pradeep P:|:|Pradeep Nazarey is an employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options from Takeda Pharmaceutical Company, Ltd.

DOP39 Dr. ATIA, Ohad: No conflict of interest||Dr. Yogev, Dotan: No conflict of interest||Ms. Friss, Chagit: No conflict of interest||Ms. Focht, Gili: No conflict of interest||Orlanski-Meyer, Esther: No conflict of interest||Magen Rimon, Ramit: No conflict of interest||Dr. Ledderman, Natan: No conflict of interest||Dr. Greenfeld, Shira: No conflict of interest||Prof. Kariv, Revital: No conflict of interest||Dr. Loewenberg Weisband, Yisca: No conflict of interest||Dr. Gabay, Hagit: No conflict of interest||Nevo, Daniel: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Gorelik, Yuri: No conflict of interest||Chowers, Yehuda: No conflict of interest||Prof. Dotan, Iris: No conflict of interest||Turner, Dan: No conflict of interest

DOP40 Dr. Zabana Abdo, Yamile: No conflict of interest||Dr. Marín-Jiménez, Ignacio: No conflict of interest||Dr. Rodríguez-Lago, Iago: No conflict of interest||Dr. Vera, Isabel: No conflict of interest||Dr. Martín, María Dolores: No conflict of interest||Dr. Guerra, Iván: No conflict of interest||Dr. Gisbert, Javier P: No conflict of interest||Dr. Mesonero, Francisco: No conflict of interest||Mrs. Benítez, Olga: No conflict of interest||Dr. Taxonera, Carlos: No conflict of interest||Dr. Ponferrada-Díaz, Ángel: No conflict of interest||Dr. Piqueras, Marta: No conflict of interest||Dr. Lucendo, Alfredo: No conflict of interest||Dr. Caballol, Berta: No conflict of interest||Dr. Mañosa, Míriam: No conflict of interest||Dr. Martínez-Montiel, Pilar: No conflict of interest||Dr. Bosca-Watts, Maia: No conflict of interest||Dr. Gordillo, Jordi: No conflict of interest||Dr. Bujanda, Luis: No conflict of interest||Dr. Manceñido, Noemí: No conflict of interest||Dr. Martínez-Pérez, Teresa: No conflict of interest||Dr. López, Alicia: No conflict of interest||Dr. Rodríguez, Cristina: No conflict of interest||Dr. García-López, Santiago: No conflict of interest||Dr. Vega, Pablo: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Melcarne, Luigi: No conflict of interest||Dr. Calvo, Marta: No conflict of interest||Dr. Iborra, Marisa: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Dr. Arias, Lara: No conflict of interest||Dr. Barrio, Jesús: No conflict of interest||Dr. Pérez, José Lázaro: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Pérez-Martínez, Isabel: No conflict of interest||Dr. Navarro-Llavat, Mercé: No conflict of interest||Dr. Hernández, Vicent: No conflict of interest||Dr. Argüelles-Arias, Federico: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Esteve, Maria: No conflict of interest

DOP41 Quaresma, Abel Botelho:|:|Abbvie, Janssen, Apsen||Prof. Damiao, Aderson Omar Mourao Cintra:|:|Abbvie, Janssen, Takeda, Pfizer||Prof. Coy, Claudio Saddy Rodrigues: No conflict of interest||Ms. Magro, Daniela Oliveira: No conflict of interest||Mr. Valverde, Douglas Andreas: No conflict of interest||Prof. Panaccione, Remo:|:|AbbVie, Amgen,|AstraZeneca, Axcan Pharma (now Aptalis), Biogen Idec,|Bristol- Myers Squibb, Centocor, ChemoCentryx, Eisai Medical|Research Inc., Elan Pharmaceuticals, Ferring, Genentech,|GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Millennium|Pharmaceuticals (now Takeda Oncology), Ocera Therapeutics|Inc., Otsuka America Pharmaceutical, Pfizer, Shire|Pharmaceuticals, Prometheus Laboratories, Schering- Plough|Corporation, Synta Pharmaceuticals Corp., Teva, UCB Pharma|and Warner Chilcott||Ms. Coward, Stephanie B: No conflict of interest||Prof. Ng, Siew C:|:|AbbVie, Ferring, Janssen, Menarini|and Takeda||Prof. Kaplan, Gilaad G: No conflict of interest||Prof. Kotze, Paulo Gustavo: No conflict of interest

DOP42 Dr. WENG, Meng-Tzu: No conflict of interest||Ms. Lin, Kuan-Lin: No conflict of interest||Prof. Chan, K Arnold: No conflict of interest||Prof. Wei, Shu-Chen: No conflict of interest

DOP43 Mr. Attauabi, Mohamed: No conflict of interest||Mr. Damsgaard Wewer, Mads: No conflict of interest||Prof. Dr. Bendtsen, Flemming: No conflict of interest||Prof. Dr. Seidelin, Jakob Benedict: No conflict of interest||Dr. Burisch, Johan: No conflict of interest

DOP44 Dr. Magen Rimon, Ramit: No conflict of interest||Dr. Atia, Ohad: No conflict of interest||Mrs. Friss, Chagit: No conflict of interest||Dr. Ledderman, Natan: No conflict of interest||Dr. Greenfeld, Shira: No conflict of interest||Prof. Kariv, Revital: No conflict of interest||Dr. Loewenberg Weisband, Yiska: No conflict of interest||Dr. Gabay, Chagit: No conflict of interest||Prof. Shaoul, Ron: No conflict of interest||Dr. Odes, Shmuel: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Prof. Dotan, Iris: No conflict of interest||Prof. Turner, Dan: No conflict of interest

DOP45 Dr. ATIA, Ohad: No conflict of interest||Prof. Yogev, Dotan: No conflict of interest||Ms. Chagit, Friss: No conflict of interest||Ms. Gili, Focht: No conflict of interest||Orlanski-Meyer, Esther: No conflict of interest||Dr. Magen Rimon, Ramit: No conflict of interest||Dr. Natan, Ledderman: No conflict of interest||Dr. Shira, Greenfeld: No conflict of interest||Prof. Kariv, Revital: No conflict of interest||Ms. Yisca, Loewenberg Weisband: No conflict of interest||Dr. Gabay, Hagit: No conflict of interest||Dr. Nevo, Daniel: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Dr. Gorelik, Yuri: No conflict of interest||Chowers, Yehuda: No conflict of interest||Prof. Iris, Dotan: No conflict of interest||Turner, Dan: No conflict of interest

DOP46 Dr. ATIA, Ohad: No conflict of interest||Ms. Friss, Chagit: No conflict of interest||Ms. Mendelovici, Adi: No conflict of interest||Shteyer, Eyal: No conflict of interest||Dr. Yogev, Dotan: No conflict of interest||Dr. Ledderman, Natan: No conflict of interest||Dr. Greenfeld, Shira: No conflict of interest||Kariv, Revital: No conflict of interest||Dr. Loewenberg Weisband, Yisca: No conflict of interest||Dr. Gabay, Hagit: No conflict of interest||Nevo, Daniel: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Prof. Dotan, Iris: No conflict of interest||Turner, Dan: No conflict of interest

DOP47 Dr. Bokemeyer, Bernd:|:|Dr. Bernd Bokemeyer has received consulting fees from: AbbVie, MSD, Shire, Ferring, Hospira, Takeda, Movetis, Shield Therapeutics, Pfizer, Biogen, Janssen, Hexal, and Celgene, outside the submitted work. Financial support for lectures and teaching from: AbbVie, Ferring, MSD, Merckle, Falk, HLR, Shield Therapeutics, Pfizer, Celltrion, Takeda, Janssen, and Mundipharma, outside the submitted work. Grant and financial support for research from AbbVie and Ferring, outside the submitted work.||Dr. Plachta-Danielzik, Sandra: No conflict of interest||Dr. Di Giuseppe, Romina: No conflict of interest||Dr. Mohl, Wolfgang: No conflict of interest||Prof. Dr. Teich, Niels: No conflict of interest||Prof. Dr. Hoffstadt, Martin: No conflict of interest||Dr. Schweitzer, Axel: No conflict of interest||Dr. von der Ohe, Manfred: No conflict of interest||Prof. Dr. Gauss, Annika: No conflict of interest||Prof. Dr. Atreya, Raja: No conflict of interest||Dr. Krause, Thomas: No conflict of interest||Prof. Dr. Blumenstein, Irina: No conflict of interest||Ms. Höchstödter, Jessica: No conflict of interest||Ms. Hartmann , Petra: No conflict of interest||Prof. Dr. Schreiber, Stefan:|:|Prod. Dr. Stefan Schreiber has received personal fees from Abbvie, Arena, BMS, Biogen, Celltrion, Celgene, IMAB, Gilead, MSD, Mylan, Pfizer, Fresenius, Janssen, Takeda, Theravance, provention Bio, from Protagonist, Falk, outside the submitted work.

DOP48 Dr. Huang, Zhongwen:|:|This study was sponsored by Takeda. Zhongwen Huang is an employee of Takeda and holds stock/stock options in Takeda. Medical writing support provided by Vardit, PhD, of Excel Medical Affairs, and funded by Takeda.||Dr. Ba, Yi:|:|This study was sponsored by Takeda. Yi Ba is an employee of Takeda and holds stock/stock options in Takeda. Medical writing support provided by Vardit, PhD, of Excel Medical Affairs, and funded by Takeda.||Dr. Kamble, Pravin:|:|This study was sponsored by Takeda. Kamble Pravin is an employee of Takeda and holds stock/stock options in Takeda. Medical writing support provided by Vardit, PhD, of Excel Medical Affairs, and funded by Takeda.||Wang, Song:|:|This study was sponsored by Takeda. Song Wang is an employee of Takeda and holds stock/stock options in Takeda. Medical writing support provided by Vardit, PhD, of Excel Medical Affairs, and funded by Takeda.

DOP49 Dr. Pugliese, Daniela:|:|Speaker fees and/or advisory board from AbbVie, MSD, Takeda and Janssen, Pfizer.||Dr. Privitera, Giuseppe:|:|Consultancy fees from Alphasigma and speaker fees from Janssen.||Prof. Armuzzi, Alessandro:|:|Consultant/ Advisory board: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, Merck, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, and Takeda Speaker fees: AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Ferring, Gilead, Janssen, Merck, Mitsubishi Tanabe Pharma, Nikkiso, Novartis, Pfizer, Roche, Samsung Bioepis, and Takeda Research funding: Merck, Pfizer, and Takeda.

DOP50 Dr. Ledder, Oren: No conflict of interest||Mrs. Lujan, Rona: No conflict of interest||Dr. Orlanski-Meyer, Esther: No conflict of interest||Mrs. Friss, Chagit: No conflict of interest||Dr. Loewenberg Weisband, Yiska: No conflict of interest||Dr. Greenfeld, Shira: No conflict of interest||Dr. Kariv, Revital: No conflict of interest||Dr. Lederman, Natan: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Mrs. Focht, Gili: No conflict of interest||Dr. Yanai, Henit: No conflict of interest||Dr. Ollech, Yakov: No conflict of interest||Prof. Dotan, Iris: No conflict of interest||Prof. Turner, Dan: No conflict of interest

DOP51 Mr. Thomas, Pepijn: No conflict of interest||Ms. Smits, Lisa: No conflict of interest||Mr. Te Groen, Maarten: No conflict of interest||Dr. West, Rachel:|:|RW has participated in advisory boards, or as a speaker, or consultant for the following companies: Abbvie, Janssen. ||Dr. Russel, Maurice: No conflict of interest||Mr. Jansen, Jeroen:|:|JJ has served on advisory boards, or as speaker, or consultant for Abbvie, Amgen, Ferring, Fresenius, Janssen, MSD, Pfizer, Takeda.||Dr. Römkens, Tessa:|:|TR has served as speaker, or consultant for Ferring, Janssen, Takeda. ||Dr. Hoentjen, Frank:|:|FH has served on advisory boards, or as speaker, or consultant for Abbvie, Celgene, Janssen Cilag, MSD, Takeda, Celltrion, Teva, Sandoz, and Dr Falk, and has received unrestricted grants from Dr Falk, Janssen-Cilag, Abbvie.

DOP52 Dr. Chaparro, Maria: No conflict of interest||Ms. García Donday, María: No conflict of interest||Dr. Calviño Suarez, Cristina: No conflict of interest||Dr. Rubio, Saioa: No conflict of interest||Dr. Figueira, Montserrat: No conflict of interest||Dr. Pérez Martínez, Isabel: No conflict of interest||Leo Carnerero, Eduardo: No conflict of interest||Dr. Rodríguez Lago, Iago: No conflict of interest||Dr. Ruiz Cerulla, Alexandra: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest||Dr. López Serrano, Pilar: No conflict of interest||Dr. Ramírez de la Piscina Urraca, Patricia: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Suarez Ferrer, Cristina: No conflict of interest||Dr. Alfambra Cabrejas, Erika: No conflict of interest||Dr. Armesto, Rubén: No conflict of interest||Dr. Diz-Lois Palomares, María Teresa: No conflict of interest||Dr. Guerra, Iván: No conflict of interest||Dr. Vázquez Morón, Juan María: No conflict of interest||Dr. Casanova, María José: No conflict of interest||Dr. Hervías Cruz, Daniel: No conflict of interest||Dr. Huguet, Jose María: No conflict of interest||Dr. de Jorge Turrión, Miguel Ángel: No conflict of interest||Dr. Marín Pedrosa, Sandra: No conflict of interest||Dr. Molina Arriero, Gema: No conflict of interest||Dr. Ramos, Laura: No conflict of interest||Dr. Zúñiga de Mora-Figueroa, Beatriz: No conflict of interest||Dr. Camargo Camero, Raquel: No conflict of interest||Dr. Fernández-Clotet, Agnes: No conflict of interest||Dr. Gutiérrez Casbas, Ana: No conflict of interest||Dr. Martínez Montiel, Pilar: No conflict of interest||Dr. Rodríguez Insa, Raúl: No conflict of interest||Dr. Sendra Rumbeu, Pau: No conflict of interest||Dr. Tardillo Marín, Carlos: No conflict of interest||Dr. Vicente Lidón, Raquel: No conflict of interest||Dr. Arias García, Lara: No conflict of interest||Dr. Bujanda, Luis: No conflict of interest||Dr. Lucendo, Alfredo J: No conflict of interest||Dr. Manceñido Marcos, Noemí: No conflict of interest||Dr. Gisbert, Javier P.: No conflict of interest

DOP53 Dubinsky, Marla C:|:|reports consulting for Arena, AbbVie, Bristol Myers Squibb, Celgene, Janssen, Pfizer, and Takeda||Dr. Mahadevan, Uma:|:|reports consulting for BMS, Pfizer, Takeda, Janssen, ABbvie, Gilead, and Prometheus||Dr. Charles, Lorna:|:|employee of Bristol Myers Squibb Company.||Dr. Afsari, Sonia:|:|employee of Bristol Myers Squibb Company.||Ms. Henry, Alyssa:|:|employee of Bristol Myers Squibb Company.||Prof. Dr. Comi, Giancarlo:|:|reports compensation for consulting and/or speaking activities from Almirall, Biogen, Celgene Corporation, EXCEMED, Forward Pharma, Genzyme, Merck, Novartis, Roche, Sanofi, and Teva.||Prof. Dr. Selmaj, Krzysztof:|:|reports consulting for Biogen, Celgene, Genzyme, Merck, Novartis, Ono Pharma, Roche, Synthon, and Teva.||Prof. Dr. van der Woude, C. Janneke:|:|reports compensation from Pfizer, Falk, AbbVie, Celltrion, Tramedico, and Takeda

DOP54 Mr. Rezazadeh Ardabili, Ashkan: No conflict of interest||Dr. Jeuring, Steven F G: No conflict of interest||Dr. Mujagic, Zlatan: No conflict of interest||Dr. Romberg-Camps, Mariëlle J L: No conflict of interest||Dr. van Bodegraven, Ad A:|:|AvB has served as speaker, adviser and/or principal investigator for AbbVie, Arandal, Arena, Celgene, Ferring, Janssen, MSD, Pfizer, Roche, Takeda, TEVA, and received research grants from TEVA, Eurostars funding, ZonMW, all outside the submitted work. ||Prof. Dr. Jonkers, Daisy M A E:|:|DJ reports grants from Top Knowledge Institute (Well on Wheat), grants from Horizon 2020 DISCOvERIE, grants from NWO-CCC Partnership program (Carbokinetics), all outside the submitted work.||Dr. Pierik, Marie J:|:|MP reports grants and non-financial support from Falk Pharma, grants from European commission, grants from ZONMW (Dutch national research fund), grants and non-financial support from Takeda, grants and non-financial support from Johnson and Johnson, grants and non-financial support from Abbvie, non-financial support from Ferring, non-financial support from Immunodiagnostics, non-financial support from MSD, all outside the submitted work.

DOP55 Mr. Rezazadeh Ardabili, Ashkan: No conflict of interest||Mr. Goudkade, Danny: No conflict of interest||Mr. Wintjens, Dion S J: No conflict of interest||Dr. Romberg-Camps, Mariëlle J L: No conflict of interest||Dr. Winkens, Bjorn: No conflict of interest||Dr. Pierik, Marie J:|:|MP reports grants and non-financial support from Falk Pharma, grants from European commission, grants from ZONMW (Dutch national research fund), grants and non-financial support from Takeda, grants and non-financial support from Johnson and Johnson, grants and non-financial support from Abbvie, non-financial support from Ferring, non-financial support from Immunodiagnostics, non-financial support from MSD, all outside the submitted work. ||Prof. Dr. Grabsch, Heike I: No conflict of interest||Prof. Dr. Jonkers, Daisy M A E:|:|DJ reports grants from Top Knowledge Institute (Well on Wheat), grants from Horizon 2020 DISCOvERIE, grants from NWO-CCC Partnership program (Carbokinetics), all outside the submitted work.

DOP57 Mr. Maruszczak, Maciej:|:|Maruszczak Maciej is an employees of Parexel International. Parexel International received funding from Takeda Pharmaceuticals Inc. to conduct analysis of this study.||Mr. Genenz, Ken:|:|Ken Genenz is a salaried employee of Takeda Pharmaceuticals.||Ms. Turkstra, Erika:|:|Erika Turkstra is an employees of Parexel International. Parexel International received funding from Takeda Pharmaceuticals Inc. to conduct analysis of this study.||Ms. Fenu, Elisabetta:|:|Elisabetta Fenu is a salaried employee of Takeda Pharmaceuticals.||Dr. Hantsbarger, Gary:|:|Gary Hantsbarger is a salaried employee of Takeda Pharmaceuticals.||Dr. Gilaberte, Inmaculada:|:|Inmaculada Gilaberte is a salaried employee of Takeda Pharmaceuticals.||Ms. Karki, Chitra:|:|Chitra Karki is a salaried employee of Takeda Pharmaceuticals.||Dr. Panes, Julian:|:|Julian Panes received personal fees from AbbVie, Boehringer Ingelheim, Celgene, Galapagos, Genentech, GSK, Immunic Therapeutics, Janssen, MSD, Nestlé, Novartis, Origo Pharmaceuticals, Pandion Therapeutics, Pfizer, Progenity, Roche, Takeda Pharmaceuticals, Theravance Biopharma, TiGenix and Wasserman

DOP58 Dr. GREYWOODE, Ruby: No conflict of interest||Dr. Petralia, Francesca: No conflict of interest||Dr. Ullman, Thomas: No conflict of interest||Dr. Colombel, Jean-Frederic:|:|research grants from AbbVie, Janssen Pharmaceuticals and Takeda; has received payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb Company, Ferring Pharmaceuticals, Shire, Takeda and Tillots; has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen Pharmaceuticals, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development.||Dr. Ungaro, Ryan:|:|advisory board member or consultant for AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, and Takeda; research support from AbbVie, Boehringer Ingelheim, and Pfizer

DOP59 Lee, Scott D.:|:|Personal fees: AbbVie, AbGenomics, Applied Molecular Transport, Arena, Boehringer Ingelheim, Bridge Biotherapeutics, Bristol-Myers Squibb, Celgene, Celltrion, Cornerstones Health, Eli Lilly, Janssen, KCRN Research, Salix, Samsung Bioepis, Takeda, UCB||Allegretti, Jessica R.:|:|Grants: Merck|Personal fees: Artugen, Baccain, Celgene, Finch Therapeutics, Iterative Scopes, Janssen, Morphic, Pandion, Pfizer Inc||Steinwurz, Flavio:|:|Personal fees: AbbVie, Eurofarma, Ferring, Janssen, Pfizer Inc, Sandoz, Takeda, UCB||Connelly, Susan B.:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Paulissen, Jerome:|:|Other: Employee: Syneos Health (paid contractor to Pfizer Inc)||Gecse, Krisztina B.:|:|Grants: Celltrion, Pfizer Inc|Personal fees: AbbVie, Arena, Celltrion, Ferring, Galapagos, Gilead, Immunic, Janssen, Novartis, Pfizer Inc, Roche, Samsung Bioepis, Takeda, Tillotts

DOP60 Mantzaris, Gerassimos:|:|Research Grants: AbbVie, Genesis, MSD, and Takeda. Advisor/Speaker: AbbVie, Aenorasis, MSD, Falk Pharma, Ferring, Hospira, Janssen, MYLAN, Pfizer, Takeda, and Vianex||Dr. Yarur, Andres:|:|Advisory board: Takeda, Prometheus laboratories, Arena and Bristol Myers||Dr. Wang, Song:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Adsul, Shashi:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Kamble, Pravin:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Luo, Michelle:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Guerin, Annie:|:|Employee of Analysis Group, who were contracted by Takeda to perform this analysis||Dr. Billmyer, Emma:|:|Employee of Analysis Group, who were contracted by Takeda to perform this analysis||Dr. Nguyen, Ha:|:|Employee of Analysis Group, who were contracted by Takeda to perform this analysis||Dr. Bressler, Brian:|:|Advisor/Speaker: Ferring, Janssen, Abbvie, Takeda, Pfizer, Novartis, BMS, Merck. Advisor: Alimentiv, Gilead, Iterative Scopes, AMT, Celgene, Microbiome Insights, Merck, Amgen, Pendopharm, Genentech, BMS, Allergan, Protagonist, Fresenius Kabi, Mylan. Research support: Janssen, Abbvie, GSK, BMS, Amgen, Genentech, Merck, BI, Qu Biologic, Celgene, Alvine. Stock Options: Qu Biologic

DOP61 Sandborn, William J:|:|Grants: AbbVie, Abivax, Arena, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, Janssen, Pfizer Inc, Prometheus Biosciences, Seres, Shire, Takeda, Theravance Biopharma|Personal fees: AbbVie, Abivax, Admirx, Alfasigma, Alimentiv (previously Robarts Clinical Trials, owned by Alimentiv Health Trust), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Eli Lilly, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), InDex Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer Inc, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma|Other: Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock, stock options; Prometheus Laboratories – stock, stock options, consultant; Ventyx Biosciences – stock, stock options; Vimalan Biosciences – stock, stock options||Dubinsky, Marla C.:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Torres, Joana:|:|Grants: AbbVie, Janssen|Personal fees: Arena, Galapagos, Gilead, Janssen, Pfizer Inc||Vermeire, Séverine:|:|Grants: AbbVie, Janssen, MSD, Pfizer Inc, Takeda|Personal fees: AbbVie, Abivax, Arena, Celgene, Eli Lilly, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Hospira, Janssen, MSD, Mundipharma, Pfizer Inc, Progenity, Second Genome, Shire, Takeda, Tillotts||Kotze, Paulo G.:|:|Personal fees: AbbVie, Janssen, Pfizer Inc, Takeda, UCB||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Paulissen, Jerome:|:|Other: Employee: Syneos Health (paid contractor to Pfizer Inc)||Mundayat, Rajiv:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Gardiner, Sean:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Kulisek, Nicole:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||D’Haens, Geert R.:|:|Personal fees: AbbVie, Ablynx, Allergan, Amakem, Amgen, AM Pharma, Arena, AstraZeneca, Avaxia, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronics, Dr. Falk Pharma, Echo Pharmaceuticals, Eli Lilly, Engene, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Gossamer Bio, Hospira, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Nextbiotics, Norgine, Novo Nordisk, Otsuka, Pfizer Inc, Photopill, Progenity, Prometheus Laboratories/Nestlé, Protagonist, Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestlé, SetPoint Medical, Shire, Teva, TiGenix, Tillotts, TopiVert, Versant, Vifor

DOP62 Dr. Chanchlani, Neil: No conflict of interest||Dr. Lin, Simeng:|:|Dr. Lin reports non-financial support from Pfizer, non-financial support from Ferring.||Dr. Thomas, Amanda: No conflict of interest||Dr. Hamilton, Ben: No conflict of interest||Ms. Nice, Rachel: No conflict of interest||Dr. Chee, Desmond:|:|Dr. Chee reports non-financial support from Ferring, personal fees and non-financial support from Pfizer, outside the submitted work||Dr. Kennedy, Nicholas:|:|Dr. Kennedy reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik; grants and non-financial support from AbbVie, grants and personal fees from Celltrion, personal fees and non-financial support from Janssen, personal fees from Takeda, personal fees and non-financial support from Dr Falk. ||Dr. Goodhand, James:|:|Dr. Goodhand reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik.||Prof. Ahmad, Tariq:|:|Dr. Ahmad reports grants and non-financial support from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik,; personal fees from Biogen inc, grants and personal fees from Celltrion Healthcare, personal fees and non-financial support from Immundiagnostik, personal fees from Takeda, personal fees from ARENA, personal fees from Gilead, personal fees from Adcock Ingram Healthcare, personal fees from Pfizer, personal fees from Genentech, non-financial support from Tillotts.

DOP63 Dr. Zittan, Eran: No conflict of interest||Prof. Steinhart, A. Hillary: No conflict of interest||Mrs. Aran, Hila: No conflict of interest||Mrs. Milgrom, Raquel: No conflict of interest||Dr. Koifman, Eduard: No conflict of interest||Prof. Gralnek, Ian M.: No conflict of interest||Prof. Zelber-Sagi, Shira: No conflict of interest||Prof. Silverberg, Mark S.: No conflict of interest

DOP64 Ms. Ouboter, Laura: No conflict of interest||Dr. Barnhoorn, Marieke: No conflict of interest||Ms. Plug, Léonie: No conflict of interest||Dr. van Pel, Melissa: No conflict of interest||Prof. Zwaginga, Jaap-Jan: No conflict of interest||Dr. Roelen, Dave: No conflict of interest||Dr. Pascutti, Fernanda: No conflict of interest||Prof. Koning, Frits: No conflict of interest||Dr. Hawinkels, Lucas: No conflict of interest||Prof. Verspaget, Hein: No conflict of interest||Dr. van der Meulen - de Jong, Andrea: No conflict of interest

DOP65 Dr. Yanai, Henit:|:|Institutional research grants from Pfizer; Consulting fees from Abbvie, Ferring, Janssen, Neopharm Ltd., Pfizer, Takeda; Honoraria for lectures from Abbvie, Janssen, Pfizer, Takeda; Participation on a Data Safety Monitoring Board or Advisory Board from Abbvie, Neopharm Ltd., Pfizer, Takeda. ||Prof. Dr. Levine , Arie:|:|This study was supported by a research grant from Nestle Health Science.|AL was supported by research grants from the Azrieli Foundation and Nestle Health.|AL reports grants from Nestle Health Science, Janssen, Abbvie;  advisory boards, travel, speaker fees from  Takeda, Nestle Health, Celgene, Megapharm; and a licensing and consulting agreement with IP with Nestle Health to develop new products. ||Dr. Hirsch , Ayal: No conflict of interest||Mrs. Sigall Boneh , Rotem:|:|received consultancy and speaker’s fees from Nestle Health Science and Megapharm; travel grant from Nestle Health.||Prof. Dr. Kopylov , Uri:|:|report consulting fees from Abbvie, Jannsen, Takeda, MSD, Pfizer, Takeda, Medtronic; honoraria for lectures from Abbvie Jannsen Takeda MSD Pfizer Takeda Medtronic; Leadership or fiduciary role from Takeda; research grants from Takeda Jannsen Medtronic. ||Dr. Banai Eran, Hagar: No conflict of interest||Dr. Cohen, Nathaniel Aviv: No conflict of interest||Dr. Ron, Yulia: No conflict of interest||Dr. Goren , Idan:|:|received research grants from Pfizer, travel grants from ECCO and IOIBD. ||Dr. Leibovitzh, Haim: No conflict of interest||Wardi , Joram: No conflict of interest||Dr. Zittan, Eran:|:|received research support and consulting fees from Janssen, Abbvie, Takeda, Neopharm, and Pfizer. ||Dr. Ziv-Baran , Tomer: No conflict of interest||Mrs. Abramas, Lee: No conflict of interest||Mrs. Fliss-Isakov , Naomi: No conflict of interest||Mrs. Raykhel, Barbara: No conflict of interest||Mrs. Pfeffer Gik , Tamar: No conflict of interest||Prof. Dr. Dotan , Iris:|:|reports institutional research grants from Altman and Pfizer; consulting fees from Arena, Gilead, Cambridge Healthcare, Wild bio, Food industries organization, Integra Holdings; honoraria for lectures from Janssen, Abbvie, Takeda, Pfizer, Genentech/Roche, Arena, Neopharm, Celltrion, Rafa Laboratories, Ferring, Falk Pharma, Nestle, Celgene/BMS, Abbott; Participation on a Data Safety Monitoring Board or Advisory Board from spare consortium Janssen, Abbvie, Takeda, Pfizer, Genentech/Roche, Arena, Neopharm, Gilead, Galapagos, Celltrion, Sublimity, Wild bio, Athos therapeutics, Food industries organization, Celgene/BMS, Abbott. ||Prof. Dr. Maharshak, Nitsan:|:|reports grants or contracts from Takeda, Abbott, Israel Scientific Foundation, Abbvie, Pfizer, and Janssen; consulting fees from BiomX; honoraria for lectures from Abbvie, Ferring, Janssen, Pfizer, and Takeda; participation on a Data Safety Monitoring Board or Advisory Board from Neopharm, Pfizer, Takeda, and BiomX.

DOP66 Pidoux, Maya: No conflict of interest||Dr. Logan, Michael: No conflict of interest||Prof. Milling, Simon:|:|SM has participated in medical board meetings with Pfizer||Dr. Ijaz, Umer Zeeshan: No conflict of interest||Dr. Hansen, Richard:|:|RH had received speakers/consultancy fees or conference support from Nutricia and 4D Pharma||Prof. Dr. Russell, Richard. K:|:|RKR has received speaker’s fees, travel support, and/or participated in medical board meetings with Nestle, MSD Immunology, AbbVie, Dr Falk, Takeda, Napp, Mead Johnson, Nutricia & 4D Pharma||Prof. Gerasimidis, Konstantinos:|:|KG received research grants, speakers’ fees and had conference attendance paid by Nutricia, Nestle, Abbott, Baxter and Dr Falk

DOP67 Prof. Dr. Kim, Eun Soo: No conflict of interest||Prof. Dr. Park, Dong Il: No conflict of interest||Prof. Dr. Kim, Hyo Jong: No conflict of interest||Prof. Dr. Lee, Yoo Jin: No conflict of interest||Prof. Dr. Koo, Ja Seol: No conflict of interest||Prof. Dr. Kim, Eun Sun: No conflict of interest||Prof. Dr. Yoon, Hyuk: No conflict of interest||Dr. Lee, Ji Hyun: No conflict of interest||Prof. Dr. Kim, Ji Won: No conflict of interest||Prof. Dr. Shin, Sung Jae: No conflict of interest||Prof. Dr. Kim, Hyung Wook: No conflict of interest||Prof. Dr. Kim, Hyun-Soo: No conflict of interest||Prof. Dr. Park, Young Sook: No conflict of interest||Prof. Dr. Kim, You Sun: No conflict of interest||Prof. Dr. Kim, Tae Oh: No conflict of interest||Prof. Dr. Lee, Jun: No conflict of interest||Prof. Dr. Choi, Chang Hwan: No conflict of interest||Prof. Dr. Han, Dong Soo: No conflict of interest||Prof. Dr. Chun, Jaeyoung: No conflict of interest||Prof. Dr. Kim, Hyun Soo: No conflict of interest

DOP68 Mrs. Ostromohov, Gaiana: No conflict of interest||Dr. Fiebelman, Morin: No conflict of interest||Dr. Hirsch, Ayal: No conflict of interest||Dr. Ron, Yulia: No conflict of interest||Dr. Aviv Cohen , Nathaniel: No conflict of interest||Prof. Kariv , Revital: No conflict of interest||Dr. Deutsch, Liat: No conflict of interest||Dr. Anbar, Ronit: No conflict of interest||Prof. Maharshak, Nitsan: No conflict of interest||Dr. Fliss Isakov, Naomi: No conflict of interest

DOP69 Mr. Eaton, Kiefer:|:|employee of CRG-EVERSANA, Burlington, ON, Canada. ||Ms. Duperrouzel, Corinne:|:|employee of CRG-EVERSANA, Burlington, ON, Canada.||Mr. Bhandari, Parash:|:|employee of CRG-EVERSANA, Burlington, ON, Canada.||Ms. Craigie, Samantha:|:|employee of CRG-EVERSANA, Burlington, ON, Canada.||Dr. Bonner, Ashley:|:|employee of CRG-EVERSANA, Burlington, ON, Canada.||Dr. Cameron, Chris:|:|an employee and shareholder of CRG-EVERSANA, Sydney, NS, Canada. ||Dr. Tencer, Tom:|:|employee and shareholder of Bristol Myers Squibb, Princeton, NJ, USA||Mr. Kumar, Jinender:|:|employee and shareholders of Bristol Myers Squibb, Princeton, NJ, USA

DOP70 Mr. YANG, Shaopeng: No conflict of interest||Ms. Liang, Xiaonan: No conflict of interest||Ms. Liu, Airu: No conflict of interest||Prof. Zhang, Xiaolan: No conflict of interest

DOP71 Mrs. VENTIN-HOLMBERG, Rebecka: No conflict of interest||Mr. Höyhtyä, Miikka: No conflict of interest||Mr. Saqib, Shahzad: No conflict of interest||Dr. Korpela, Katri: No conflict of interest||Nikkonen, Anne: No conflict of interest||Dr. Salonen, Anne: No conflict of interest||Prof. de Vos, Willem M.: No conflict of interest||Dr. Kolho, Kaija-Leena: No conflict of interest

DOP72 Mr. Jenkinson, Philip: No conflict of interest||Dr. Plevris, Nikolas:|:|Consulancy fees for Jannssen and Takeda||Dr. Lyons, Mathew: No conflict of interest||Dr. Siakavellas, Spyros: No conflict of interest||Dr. Arnott, Ian:|:|IDA has received consultancy fees from Vifor and travel support from Takeda and Dr Falk||Dr. Jones, Gareth-Rhys: No conflict of interest||Prof. Watson, Angus: No conflict of interest||Prof. Lees, Charlie:|:|CWL has received research support from Gilead, Oshi Health and AbbVie, consultancy fees from AbbVie, Pfizer, Dr Falk, Hospira, MSD, Gilead, Pharmacosmos, Takeda and Vifor, and speaker fees and travel support from AbbVie, Pfizer, Ferring, Hospira, and Takeda.

DOP73 Dr. GORELIK, Yuri: No conflict of interest||Mr. Freilich, Shay: No conflict of interest||Dr. Gerassy-Vainberg, Shiran: No conflict of interest||Ms. Blatt, Alexandra: No conflict of interest||Dr. Pressman, Sigal: No conflict of interest||Ms. Focht, Gili: No conflict of interest||Ms. Friss, Chagit: No conflict of interest||Dr. Loewenberg Weisband, Yisca: No conflict of interest||Prof. Greenfeld, Shira: No conflict of interest||Dr. Kariv, Revital: No conflict of interest||Dr. Ledderman, Natan: No conflict of interest||Prof. Iris, Dotan: No conflict of interest||Prof. Kashi, Yechezkel: No conflict of interest||Prof. Turner, Dan: No conflict of interest||Prof. Chowers, Yehuda: No conflict of interest

DOP74 Mr. Kutschera, Maximilian: No conflict of interest||Dr. Primas, Christian:|:|Christian Primas has served as a speaker/consultant/advisory board member for Abbvie, MSD, Takeda, Roche Janssen, Merck, Ferring, Astro Pharma.||Dr. Reinisch, Sieglinde:|:|Sieglinde Reinisch has served as a speaker for Abbvie, MSD, Takeda, Janssen, and Ferring.||Prof. Novacek, Gottfried:|:|Gottfried Novacek has served as a speaker/consultant/advisory board member for Abbvie, MSD, Takeda, Janssen, Sandoz, Pfizer, Gilead, Astro Pharma, Falk Pharma GmbH, Ferring, Vifor.||Kim, Sung Hyun: No conflict of interest||Lee, Sun Hee: No conflict of interest||Lee , Joon Ho: No conflict of interest||Prof. Reinisch, Walter:|:|Walter Reinisch has served||as a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult,|as a consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Intrinsic Imaging, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC,|as an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC, and|has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik, MSD||Mould, Diane R.: No conflict of interest

DOP75 Mr. Mahmoud, Remi: No conflict of interest||Mr. Schultheiss, Johannes: No conflict of interest||Mr. Louwers, Jonas: No conflict of interest||Mr. van der Kaaij, Michiel: No conflict of interest||Mr. van Hellemondt, Boris: No conflict of interest||Dr. Mahmmod, Nofel: No conflict of interest||Dr. van Boeckel, Petra: No conflict of interest||Dr. Jharap, Bindia: No conflict of interest||Dr. Fidder, Herma: No conflict of interest||Prof. Dr. Oldenburg, Bas: No conflict of interest

DOP76 Ms. Funez-dePagnier, Gabriela: No conflict of interest||Dr. Lima, Svetlana: No conflict of interest||Ms. Duenas-Bianchi, Lucia: No conflict of interest||Mr. Lai, Daniel: No conflict of interest||Dr. Ahmed, Waseem: No conflict of interest||Dr. Battat, Robert: No conflict of interest||Prof. Dr. Scherl, Ellen: No conflict of interest||Dr. Lukin, Dana: No conflict of interest||Dr. Longman, Randy: No conflict of interest

DOP77 Dr. Richter, Vered: No conflict of interest||Dr. Bermont, Anton: No conflict of interest||Dr. Cohen, Daniel L: No conflict of interest||Prof. Broide, Efrat: No conflict of interest||Prof. Shirin, Haim: No conflict of interest

DOP78 Prof. Dr. Feakins, Roger M.: No conflict of interest

DOP79 Dr. Albshesh, Ahmad: No conflict of interest||Prof. Dr. Eder, Piotr: No conflict of interest||Prof. Dr. Ribaldone , Davide Giuseppe: No conflict of interest||Prof. Dr. Oldenburg, Bas: No conflict of interest||Dr. De Boer, Nanne K.: No conflict of interest||Dr. Mantzaris, Gerassimos J.: No conflict of interest||Prof. Savarino, Edoardo Vincenzo: No conflict of interest||Dr. Dragoni , Gabriele: No conflict of interest||Dr. Weisshof, Roni: No conflict of interest||Dr. Truyens, Marie: No conflict of interest||Dr. Festa, Stefano: No conflict of interest||Dr. Maillard, Michel H: No conflict of interest||Dr. Capirchio , Lena: No conflict of interest||Dr. Filip, Rafal: No conflict of interest||Prof. Kopylov, Uri: No conflict of interest

DOP80 Dr. Saraiva, Miguel: No conflict of interest||Dr. Ribeiro, Tiago: No conflict of interest||Afonso, João: No conflict of interest||Dr. Cardoso, Hélder: No conflict of interest||Prof. Ferreira, João: No conflict of interest||Dr. Andrade, Patrícia: No conflict of interest||Prof. Parente, Marco: No conflict of interest||Prof. Jorge, Renato: No conflict of interest||Prof. Lopes, Susana: No conflict of interest||Prof. Dr. Macedo, Guilherme: No conflict of interest

DOP81 Dr. Bossuyt, Peter:|:|PB has received financial support for research from AbbVie, Mundipharma, Pfizer, Janssen, Amgen and Mylan; lecture fees from AbbVie, Takeda, Pfizer and Janssen; advisory board fees from Abbvie, Arena pharmaceuticals, BMS, Takeda, Hospira, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz, Galapagos, PSI-CRO and Pentax.|||Dr. Baert, Didier: No conflict of interest||Dr. Baert, Filip:|:|FB has received grant/research support from AbbVie, Amgen, Janssen, and Takeda; honoraria from AbbVie, Amgen, Arena, Celgene, Ferring, Fresenius Kabi, Janssen, Merck Sharp & Dohme, Pfizer, and Takeda; and was on speaker bureaus for AbbVie, Ferring, Janssen, Merck Sharp & Dohme, Pfizer, and Takeda|||Hoefkens, Eveline: No conflict of interest||Huys, Inge: No conflict of interest||Lembrechts, Nikki: No conflict of interest||De Jonckere, Evva: No conflict of interest||Prof. Dr. Dewint, Pieter:|:|PDW has received financial support for research from Biogen, Mundipharma; lecture fees from Biogen, Janssen; advisory board fees from Janssen, Sandoz |||Dr. Pouillon, Lieven:|:|LP has received advisory board fees from Janssen-Cilag, Sandoz and Takeda; presentation fees from AbbVie and Ferring; and personal fees (travel support) from AbbVie, Ferring, Norgine and Takeda.

DOP82 Prof. Dr. Loftus, Jr, Edward:|:|Has received consulting fees from AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Calibr, Celgene, Celltrion, Eli Lilly, Genentech, Gilead, Iterative Scopes, Janssen, Ono, Pfizer, Sun, Takeda and UCB; and grants from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trials, Takeda, Theravance and UCB. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Vermeire, Severine:|:|Has received grants from AbbVie, Johnson & Johnson, Pfizer, and Takeda; and consulting and/or speaking fees from AbbVie, Arena, Avaxia, Boehringer Ingelheim, Celgene, Dr. Falk, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, ProDigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance and Tillotts. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Feagan, Brian:|:|BF has received grants/consulting fees from AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Janssen/Centocor, Johnson & Johnson/Janssen, Pfizer, Receptos and Takeda; consulting fees from Ablynx, ActoGeniX, AdMIRx, Akebia, Allergan, Atlantic, Avaxia, Avir, Baxter, Biogen Idec, BiomX, Boehringer Ingelheim, Boston, Calypso, Celgene, Elan/Biogen, enGene, Ferring, Galapagos, Genentech/Roche, gIcare, Gilead, Given Imaging, Gossamer, GSK, Inception IBD, Ironwood, Japan Tobacco Company, Kyowa Hakko Kirin, Lexicon, Eli Lilly, Lycera, Merck, Mesoblast, Millennium, Nestlé, NextBiotix, Novartis, Novo Nordisk, Par’Immune, Progenity, Prometheus, Protagonist, Qu, Salix, Shire, Sienna, Sigmoid, Synergy, Teva, TiGenix, Tillotts, UCB, Vertex, VHsquared, Vivelix, Wyeth, Zealand and Zyngenia; and is Senior Scientific Director of Alimentiv. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Yun, Chohee:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Hsieh, Jeremy:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Ms. Liu, Xiaopeng:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Mrs. Zhao, Sally:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Moerch, Ulrik:|:|Is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Sandborn, William J:|:|Has received grants from AbbVie, Abivax, Arena, Boehringer Ingelheim, Celgene, Genentech, Gilead, GlaxoSmithKline, Janssen, Eli Lilly, Pfizer, Prometheus, Seres, Shire, Takeda and Theravance; consulting fees from AbbVie, Abivax, AdMIRx, Alfasigma, Alimentiv, Alivio, Allakos, Amgen, Applied Molecular Transport, Arena, Bausch/Salix, BeiGene, Bellatrix, Boehringer Ingelheim, Boston, Bristol Myers Squibb, Celgene, Celltrion, Celularity, Cosmo, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead, Glenmark, Gossamer Bio, Immunic (Vital Therapies), Index, Intact, Janssen, Kyverna, Landos, Eli Lilly, Oppilan, Otsuka, Pandion, Pfizer, Progenity, Prometheus, Protagonist, Provention, Reistone, Seres, Shanghai Pharma Biotherapeutics, Shire, Shoreline, Sublimity, Surrozen, Takeda, Theravance, Thetis, Tillotts, UCB, Vedanta, Ventyx, Vimalan, Vivelix, Vivreon and Zealand; and stock or stock options from Allakos, BeiGene, Gossamer, Oppilan, Prometheus, Progenity, Shoreline, Ventyx, Vimalan and Vivreon. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Hibi, Toshifumi:|:|Has received lecture fees from AbbVie GK, Aspen Japan K.K., Ferring, Gilead, Janssen, JIMRO, Mitsubishi Tanabe, Mochida, Pfizer and Takeda; advisory/consulting fees from AbbVie GK, Apo Plus Station, Bristol Myers Squibb, Celltrion, EA, Eli Lilly, Gilead, Janssen, Kyorin, Mitsubishi Tanabe, Nichi-Iko, Pfizer, Takeda and Zeria; and grants from AbbVie GK, EA, JIMRO, Otsuka and Zeria. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Michael Molloy-Bland, PhD of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.

DOP83 Abreu, Maria Teresa:|:|Grant support from Prometheus Bioscience, Takeda, and Pfizer; consulting fees from Janssen Research & Development, LLC., Prometheus Bioscience, Takeda, Focus Medical Communications, Pfizer, Boehringer Ingelheim Pharmaceuticals, Gilead, Imedex, Cornerstone Health, Inc, Landos Biophama, UCB Biopharma SRL, Eli Lilly, and Cosmo Biopharma.||Danese, Silvio:|:|Consulting fees from Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion Healthcare, Ferring, Gilead Sciences, Hospira, Inc., Janssen Research & Development, LLC., Johnson & Johnson Health Care Systems, Inc., Pfizer, Sandoz, UCB, Inc., Vifor International Inc.||Dr. Sandborn, William J:|:|Grants from Abbvie, Abivax, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, Glaxo Smith Kline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seres Therapeutics, Shire, Takeda, Theravance Biopharma; consulting fees from Abbvie, Abivax, Admirx, Alfasigma, Alimentiv (Robarts Clinical Trials, owned by Health Academic Research Trust [HART]), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer,|Progenity, Prometheus Biosciences, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma; and stock or stock options from Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Progenity, Shoreline Biosciences, Ventyx Biosciences, Vimalan Biosciences. Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock options; Ventyx Biosciences – stock options; Vimalan Biosciences – stock options.||Dr. Miao, Ye:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Tikhonov, Ilia:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Zhang, Hongyan:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Panaccione, Remo:|:|Consulting fees from AbbVie, Janssen Research & Development, LLC., Takada California, Inc.||Dr. Hisamatsu, Tadakazu:|:|Grant support from AbbVie, Daiichi-Sankyo, EA Pharma Co, Ltd. JIMRO, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmacuetical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc., Takeda Pharmaceutical Co., Ltd., consulting fees from EA Pharma Co, Ltd., Janssen Research & Development, LLC.,, and lecture fees from AbbVie, EA Pharma Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd.||Dr. Scherl, Ellen J:|:|Grant support from AbbVie, AstraZeneca, Crohn’s and Colitis Foundation, Janssen Research & Development, LLC., New York Crohn’s Foundation, Pfizer, UCB, Genentech, Seres Therapeutics, and Celgene; consulting fees: AbbVie, Abgenomics, Crohn’s and Colitis Foundation, Evidera, GI Health Foundation, Janssen, Protagonist, Seres, Takeda Stock: Gilead; speaker fees from GI Health Foundation, Prime Therapeutics.||Dr. Leong, Rupert W:|:|Grant support from NHMRC, GESA, Janssen, Shire, Endochoice, Ferring; and consulting fees from Janssen Research & Development, LLC. Aspen, AbbVie, Celgene, Ferring, Pfizer, Hospira, Novartis, Dr Falk Pharma, MSD, Takeda.||Dr. Rowbotham, David S:|:|Grant support from NIL, consulting fees from NIL, lecture fees from AbbVie; Janssen Research & Development, LLC., Baxter; Pharmaco; bioCSL; Given imaging; Emerge Health, and has served on the advisory board of AbbVie; Janssen Research & Development, LLC.; Baxter; Pharmaco; Hospira.||Dr. Arasaradnam, Ramesh P:|:|Grant support and consulting fees from Janssen Research & Development, LLC.||Dr. Afif, Waqqas:|:|Grant support from Janssen Research & Development, LLC.||Dr. Peyrin-Biroulet, Laurent:|:|Personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals , Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine ; Mylan, Lilly, Fresenius Kabi, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera, Theravance; grants from Abbvie, MSD, Takeda; stock options: CTMA.||Dr. Sands, Bruce E:|:|Reports personal fees from AbbVie, personal fees from Amgen, personal fees from|AstraZeneca, personal fees from Bristol-Myers Squibb, grants and personal fees from Celgene, personal fees and non-financial support from Janssen Research & Development, LLC., personal fees and nonfinancial support from MedImmune, grants, personal fees and non-financial support from Takeda, personal fees from Akros Pharma, personal fees from Arena Pharmaceuticals, personal fees from Boehringer-Ingelheim, personal fees from Forward Pharma, personal fees from Immune Pharmaceuticals, personal fees and non-financial support from Lilly, personal fees from Shire, personal fees from Synergy Pharmaceuticals, personal fees from Theravance Biopharma R&D, personal fees from TiGenix, personal fees from TopiVert Pharma, personal fees from Receptos, personal fees from Allergan, personal fees from EnGene, personal fees from Target PharmaSolutions, personal fees from Lycera, personal fees from Lyndra, personal fees from Ironwood Pharmaceuticals, personal fees from Salix, personal fees from Vivelix Pharmaceuticals, personal fees from UCB, personal fees from Oppilan Pharmaceuticals,personal|fees from Gilead, personal fees from Rheos Medicines, personal fees from Seres Therapeutics, personal fees from 4D Pharma, personal fees from Capella Bioscience, personal fees from Otsuka , personal fees from Ferring, personal fees from Protagonist Therapeutics, personal fees from Palatin Technologies, grants, personal fees and non-financial support from Pfizer, personal fees from Hoffman-La Roche, personal fees from Prometheus Laboratories.||Dr. Marano, Colleen:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.

DOP84

DOP85 Dr. Vavricka, Stephan R.:|:|Grants: Abbott, Falk, Ferring, Janssen, MSD, Pfizer Inc, Sanofi-Aventis, Takeda, Tillotts, UCB, Vifor|Personal fees: Abbott, Falk, Ferring, Janssen, MSD, Pfizer Inc, Sanofi-Aventis, Takeda, Tillotts, UCB, Vifor||Dr. Greuter, Thomas:|:|Grants: Novartis|Personal fees: Dr. Falk Pharma, Sanofi-Aventis, Vifor||Dr. Cohen, Benjamin L.:|:|Personal fees: AbbVie, Bristol-Myers Squibb, Celgene, Cornerstones, Pfizer Inc, Sublimity Therapeutics, Target RWE, Vindico||Reinisch, Walter:|:|Grants: Abbott Laboratories, AbbVie, Aesca, Centocor, Falk Pharma GMbH, Immundiagnostik, MSD|Personal fees: 4SC, Abbott Laboratories, AbbVie, Aesca, Amgen, AM Pharma, AOP Orphan, Aptalis, Arena, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cellerix, Celltrion, Centocor, ChemoCentryx, Covance, Danone, Austria, Elan, Eli Lilly, Ernst & Young, Falk Pharma GMbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Immundiagnostik, InDex, Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, MedAhead, MedImmune, Millennium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestlé, Novartis, Ocera, Otsuka, Parexel, PDL, Pfizer Inc, Pharmacosmos, Philip Morris Institute, PLS Education, Proctor & Gamble, Prometheus, Laboratories, Protagonist, Provention, Robarts Clinical Trials, Roland, Berger GmBH, Sandoz, Schering-Plough, Second Genome, Seres, Therapeutics, SetPoint Medical, Shire, Sigmoid, Takeda, Therakos, TiGenix, UCB, Vifor, Yakult, Zealand, Zyngenia||Steinwurz, Flavio:|:|Personal fees: AbbVie, Eurofarma, Ferring, Janssen, Pfizer Inc, Sandoz, Takeda, UCB||Fellmann, Marc:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Guo, Xiang:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Paulissen, Jerome:|:|Other: Employee: Syneos Health (paid contractor to Pfizer Inc)||Dr. Peyrin-Biroulet, Laurent:|:|Grants: AbbVie, MSD, Takeda|Personal fees: AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, Boehinger Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, CTMA, Eli Lilly, Enterome, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Hikma, InDex Pharmaceuticals, Inotrem, Janssen, MSD, Mylan, Nestlé, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer Inc, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Theravance, Tillotts, Vifor

D'Haens, Geert:|:|Research support: AbbVie, Bühlmann Laboratories, Dr Falk Pharma, Ferring, GlaxoSmithKline, Johnson & Johnson, Medtronics, Merck Sharp & Dohme, Millennium/Takeda, PhotoPill, Prometheus, Alimentiv and Setpoint; lecture fees: AbbVie, Biogen, Dr Falk Pharma, Ferring, Giuliani, Johnson & Johnson, Merck Sharp & Dohme, Millennium/Takeda, Norgine, Otsuka, Shire, Tillotts, UCB and Vifor; consulting fees: AbbVie, Ablynx, ActoGeniX, Amakem, Amgen, AM-Pharma, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene/Receptos, Celltrion, Cosmo, Elan, enGene, Ferring, Galapagos, Gilead, GlaxoSmithKline, Hospira/Pfizer, Immunic, Johnson & Johnson, Lycera, Medimetrics, Medtronics, Merck Sharp & Dohme, Millennium/Takeda, Mitsubishi Pharma, Mundipharma, Novo Nordisk, Otsuka, PDL, Prometheus, Protagonist, Salix, Samsung Bioepis, Sandoz, Setpoint, Shire, Teva, TiGenix, Tillotts, TopiVert, UCB, Versant and Vifor; directorship at Alimentiv. |This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Baert, Filip:|:|Grant/research support: AbbVie, Amgen, Janssen and Takeda; honoraria from AbbVie, Amgen, Arena, Celgene, Celltrion, Ferring, Fresenius Kabi, Janssen, Merck Sharp & Dohme, Pfizer, Sandoz, and Takeda; speaker bureau for AbbVie, Ferring, Janssen, Merck Sharp & Dohme, Pfizer and Takeda. |This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Danese, Silvio:|:|Lecture fees: AbbVie, Allergan, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Hospira, Johnson & Johnson, Merck, Merck Sharp & Dohme, Mundipharma, Pfizer, Sandoz, Takeda, TiGenix, UCB and Vifor; consulting fees: AbbVie, Allergan, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Hospira, Johnson & Johnson, Merck, Merck Sharp & Dohme, Mundipharma, Pfizer, Sandoz, Takeda, TiGenix, UCB and Vifor.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Kobayashi, Taku:|:|Research support: AbbVie, Alfresa, Asahi Kasei Medical, EA Pharma, Kyorin, Mochida, Nippon Kayaku, Otsuka, Thermo Fisher Scientific and Zeria; Consulting fees: AbbVie, Alfresa, CovidienÐ, Eli Lilly, Ferring, Janssen, Kyorin, Mochida, Nippon Kayaku, Pfizer, Takeda and Thermo Fisher Scientific; lecture fees: AbbVie, Ajinomoto Bio-Pharma, Alfresa, Asahi Kasei Medical, Astellas, Celltrion, EA Pharma, Eisai, Gilead, Janssen, JIMRO, Kyorin, Mitsubishi Tanabe Pharma, Mochida, Nippon Kayaku, Takeda and Zeria.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Loftus Jr., Edward V.:|:|Research support from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trials, Takeda, Theravance Biopharma and UCB; consulting fees from AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Calibr, Celgene, Celltrion, Eli Lilly, Genentech, Gilead, Iterative Scopes, Janssen, Ono Pharma, Pfizer, Sun Pharma, Takeda and UCB; is a shareholder of Exact Sciences; and served as a medical editor for Healio/SLACK.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Sandborn, William J.:|:|WJS has received research grants from Abbvie, Abivax, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, Glaxo Smith Kline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seres Therapeutics, Shire, Takeda, and Theravance Biopharma; consulting fees from Abbvie, Abivax, Admirx, Alfasigma, Alimentiv (previously Robarts Clinical Trials, owned by Alimentiv Health Trust), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer, Progenity, Prometheus Biosciences, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, and Zealand Pharma; and holds stock/stock options in Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Progenity, Shoreline Biosciences, Ventyx Biosciences, Vimalan Biosciences, and Vivreon Biosciences; spouse of WJS reports consulting for Iveric Bio and Oppilan Pharma; and holds stock/stock options in Iveric Bio, Oppilan Pharma, Progenity, Prometheus Biosciences, Ventyx Biosciences and Vimalan Biosciences; employee of Prometheus Biosciences.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Dornic, Quentin:|:|Employee of Cytel subcontracted to Takeda.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Lindner, Dirk:|:|Employee of Takeda and holds stock/stock options in Takeda.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Kisfalvi, Krisztina:|:|Employee of Takeda and holds stock/stock options in Takeda. |This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Marins, Ed G.:|:|Employee of Takeda and holds stock/stock options in Takeda.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Vermeire, Séverine:|:|Research support: AbbVie, Johnson & Johnson, Pfizer and Takeda; lecture fees: AbbVie, Centocor, Ferring, Genentech/Roche, Hospira, Johnson & Johnson, Merck Sharp & Dohme, Pfizer, Takeda and Tillotts; consulting fees: AbbVie, Abivax, Celgene, Celltrion, Centocor, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Hospira, Johnson & Johnson, Merck Sharp & Dohme, Mundipharma, Pfizer, ProDigest, Prometheus, Second Genome, Takeda and Tillotts.|This study was sponsored by Takeda. Medical writing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.

DOP86

DOP87 Dr. D'Amico, Ferdinando: No conflict of interest||Dr. Fiorino, Gionata: No conflict of interest||Mrs. Massarini, Eugenia: No conflict of interest||Dr. Solitano, Virginia: No conflict of interest||Dr. Guillo, Lucas: No conflict of interest||Dr. Allocca, Mariangela: No conflict of interest||Dr. Furfaro, Federica: No conflict of interest||Dr. Zilli, Alessandra: No conflict of interest||Dr. Bonovas, Stefanos: No conflict of interest||Prof. Dr. Peyrin-Biroulet, Laurent: No conflict of interest||Prof. Dr. Danese, Silvio: No conflict of interest

DOP88 Peyrin-Biroulet, Laurent:|:|Consultant and/or speaker: AbbVie, Amgen, Biogen, Biogaran, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Forward Pharma, Genentech, HAC-Pharma, Hospira, Index, Janssen, Lilly, Lycera, Merck, Mitsubishi, Norgine, Pfizer, Pharmacosmos, Pilège, Samsung Bioepis, Soz, Takeda, Therakos, Tillotts, UCB, Vifor. ||Louis, Edouard:|:|Research grant: Janssen, Pfizer, and Takeda; educational grant: AbbVie, Janssen, MSD, and Takeda; speaker fees: AbbVie, Falk, Ferring, Hospira, Janssen, MSD, Pfizer, and Takeda; advisory board: AbbVie, Celgene, Ferring, Hospira, Janssen, MSD, Pfizer, and Takeda, Galapagos, Gilead, Arena; consultant: AbbVie.||Ghosh, Subrata:|:|Steering committee member for Pfizer, Janssen, AbbVie, BMS, Celgene, Boehringer-Ingelheim; speaker honorarium from AbbVie, Janssen, Takeda, Shield, Ferring, Falk Pharma.||Lee, Scott D:|:|Consultant; Applied Molecular Transport, Arena, Boehringer Ingelheim, Bridge Biotherapeutics, Bristol-Myers Squibb, Celgene, Celltrion Healthcare, Cornerstones Health, Eli Lilly and Company, Janssen, KCRN Research, Samsung Bioepis, UCB; research grants: AbbVie, AbGenomics, Arena, Celgene, Janssen, Salix, Takeda, UCB.||Griffith, Jenny:|:|Full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Wallace, Kori:|:|Full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Berg, Sofie:|:|Full-time employee of AbbVie, and may hold AbbVie stock or stock options.||Loftus Jr, Edward V:|:|Consultant: AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Calibr, Celgene, Celltrion Healthcare, Eli Lilly, Genentech, Gilead, Iterative Scopes, Janssen, Ono Pharma, Pfizer, Sun Pharma, Takeda, UCB; research grants: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trials, Takeda, Theravance, UCB.

Dr. Scherl, Ellen J:|:|Grant support from AbbVie, AstraZeneca, Crohn’s and Colitis Foundation, Janssen Research & Development, LLC., New York Crohn’s Foundation, Pfizer, UCB, Genentech, Seres Therapeutics, and Celgene; consulting fees: AbbVie, Abgenomics, Crohn’s and Colitis Foundation, Evidera, GI Health Foundation, Janssen, Protagonist, Seres, Takeda Stock: Gilead; speaker fees from GI Health Foundation, Prime Therapeutics.||Dr. Rowbotham, David S.:|:|Grant support from NIL, consulting fees from NIL, lecture fees from AbbVie; Janssen Research & Development, LLC., Baxter; Pharmaco; bioCSL; Given imaging; Emerge Health, and has served on the advisory board of AbbVie; Janssen Research & Development, LLC.; Baxter; Pharmaco; Hospira.||Danese, Silvio:|:|Consulting fees from Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion Healthcare, Ferring, Gilead Sciences, Hospira, Inc., Janssen Research & Development, LLC., Johnson & Johnson Health Care Systems, Inc., Pfizer, Sandoz, UCB, Inc., Vifor International Inc.||Dr. Sandborn, William J.:|:|Grants from Abbvie, Abivax, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, Glaxo Smith Kline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seres Therapeutics, Shire, Takeda, Theravance Biopharma; consulting fees from Abbvie, Abivax, Admirx, Alfasigma, Alimentiv (Robarts Clinical Trials, owned by Health Academic Research Trust [HART]), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer, Progenity, Prometheus Biosciences, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma; and stock or stock options from Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Progenity, Shoreline Biosciences, Ventyx Biosciences, Vimalan Biosciences. Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock options; Ventyx Biosciences – stock options; Vimalan Biosciences – stock options.||Dr. Miao, Ye:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Zhang, Hongyan:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Abreu, Maria T.:|:|Grant support from Prometheus Bioscience, Takeda, and Pfizer; consulting fees from Janssen Research & Development, LLC., Prometheus Bioscience, Takeda, Focus Medical Communications, Pfizer, Boehringer Ingelheim Pharmaceuticals, Gilead, Imedex, Cornerstone Health, Inc, Landos Biophama, UCB Biopharma SRL, Eli Lilly, and Cosmo Biopharma.||Dr. Panaccione, Remo:|:|Consulting fees from AbbVie, Janssen Research & Development, LLC., Takeda California, Inc.||Dr. Afif, Waqqas:|:|Grant support from Janssen Research & Development, LLC.||Dr. Hisamatsu, Tadakazu:|:|Grant support from AbbVie, Daiichi-Sankyo, EA Pharma Co, Ltd. JIMRO, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmacuetical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc., Takeda Pharmaceutical Co., Ltd., consulting fees from EA Pharma Co, Ltd., Janssen Research & Development, LLC.,, and lecture fees from AbbVie, EA Pharma Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd.||Dr. Leong, Rupert W.:|:|Grant support from NHMRC, GESA, Janssen, Shire, Endochoice, Ferring; and consulting fees from Janssen Research & Development, LLC. Aspen, AbbVie, Celgene, Ferring, Pfizer, Hospira, Novartis, Dr Falk Pharma, MSD, Takeda.||Dr. Arasaradnam, Ramesh P.:|:|Grant support and consulting fees from Janssen Research & Development, LLC.||Dr. Sands, Bruce E.:|:|Reports personal fees from AbbVie, personal fees from Amgen, personal fees from AstraZeneca, personal fees from Bristol-Myers Squibb, grants and personal fees from Celgene, personal fees and non-financial support from Janssen Research & Development, LLC., personal fees and nonfinancial support from MedImmune, grants, personal fees and non-financial support from Takeda, personal fees from Akros Pharma, personal fees from Arena Pharmaceuticals, personal fees from Boehringer-Ingelheim, personal fees from Forward Pharma, personal fees from Immune Pharmaceuticals, personal fees and non-financial support from Lilly, personal fees from Shire, personal fees from Synergy Pharmaceuticals, personal fees from Theravance Biopharma R&D, personal fees from TiGenix, personal fees from TopiVert Pharma, personal fees from Receptos, personal fees from Allergan, personal fees from EnGene, personal fees from Target PharmaSolutions, personal fees from Lycera, personal fees from Lyndra, personal fees from Ironwood Pharmaceuticals, personal fees from Salix, personal fees from Vivelix Pharmaceuticals, personal fees from UCB, personal fees from Oppilan Pharmaceuticals, personal fees from Gilead, personal fees from Rheos Medicines, personal fees from Seres Therapeutics, personal fees from 4D Pharma, personal fees from Capella Bioscience, personal fees from Otsuka , personal fees from Ferring, personal fees from Protagonist Therapeutics, personal fees from Palatin Technologies, grants, personal fees and non-financial support from Pfizer, personal fees from Hoffman-La Roche, personal fees from Prometheus Laboratories.||Dr. Marano, Colleen:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.

DOP89 Zoller, Heinz:|:|Heinz Zoller has received grants from and has consulted for Pharmacosmos, and Vifor. ||Dr. Wolf, Myles:|:|Myles Wolf has received personal consulting fees from Pharmacosmos.||Dr. Blumenstein, Irina:|:|Irina Blumenstein has received consultant and speaker fees from Pharmacosmos.|||Dr. Primas, Christian: No conflict of interest||Prof. Dr. Lindgren, Stefan: No conflict of interest||Dr. Thomsen, Lars Lykke:|:|Lars Lykke Thomsen is a full-time employee of Pharmacosmos.||Prof. Dr. Reinisch, Walter:|:|Walter Reinisch has received consultancy fees from: Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Intrinsic Imaging, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Quell Tx, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC.||Prof. Iqbal, Tariq:|:|Tariq Iqbal has received speaker fees from Pharmacosmos, and Vifor.

DOP90 Dr. Ricciuto, Amanda: No conflict of interest||Dr. Lamb, Christopher: No conflict of interest||Dr. Benchimol, Eric I.: No conflict of interest||Dr. Walker, Gareth: No conflict of interest||Dr. Kennedy, Nicholas: No conflict of interest||Ms. Kuenzig, M. Ellen: No conflict of interest||Dr. Kaplan, Gilaad: No conflict of interest||Dr. Griffiths, Anne M.: No conflict of interest||Dr. Reinisch, Walter: No conflict of interest||Dr. Sebastian, Shaji: No conflict of interest

N01 Dr. Farrell, Dawn:|:|This study was funded by a N-ECCO research grant||Dr. Bager, Palle: No conflict of interest||Ms. Bredin, Fran: No conflict of interest||Ms. Cairnes, Vida: No conflict of interest||Ms. Forry, Mary: No conflict of interest||Ms. Gilham, Ellie: No conflict of interest||Ms. Godwin, Nuala: No conflict of interest||Ms. Herdmangrant, Rosaleen: No conflict of interest||Ms. Ni Dhalaigh, Doireann: No conflict of interest||Mr. O' Shea, Tadhg: No conflict of interest||Ms. Sugrue, Kathleen: No conflict of interest

N02 Ms. Asnong, Katrien: No conflict of interest||Ms. Hoefkens, Eveline: No conflict of interest||Mrs. Lembrechts, Nikki: No conflict of interest||Ms. Van de Schoot, Ils: No conflict of interest||Dr. Pouillon, Lieven:|:|Lieven Pouillon received advisory board fees from Janssen-Cilag, Sandoz and Takeda; presentation fees from AbbVie and Ferring; and personal fees (congress support) from AbbVie, Ferring, Norgine and Takeda.||Dr. Bossuyt, Peter:|:|Peter Bossuyt has received financial support for research from AbbVie, Mundipharma, Pfizer, Janssen, Amgen and Mylan; lecture fees from AbbVie, Takeda, Pfizer and Janssen; advisory board fees from Abbvie, Arena pharmaceuticals, BMS, Takeda, Hospira, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz, Galapagos, PSI-CRO and Pentax.

N03 Ms. Geens, Patricia: No conflict of interest||Mrs. De Dycker, Els: No conflict of interest||Mrs. Paps, Ariane: No conflict of interest||Mrs. Lambrechts, Tessy: No conflict of interest||Prof. Dr. Sabino, João: No conflict of interest||Prof. Dr. Ferrante, Marc: No conflict of interest||Prof. Dr. Vermeire, Séverine: No conflict of interest

N04 Dr. Dibley, Lesley: No conflict of interest||Dr. Kemp, Karen: No conflict of interest||Ms. Duncan, Julie: No conflict of interest||Mrs. Mason, Isobel: No conflict of interest||Mrs. Lisa, Younge: No conflict of interest

N05 Ms. Iizawa, Masami:|:|Masami Iizawa is an employee of Takeda Pharmaceutical Company Limited.|This review (collaborative research) was funded by Takeda. ||Ms. Hirose, Lisa:|:|Lisa Hirose is an employee of Takeda Pharmaceutical Company Limited. |This review (collaborative research) was funded by Takeda. ||Ms. Tairaka, Ai:|:|Ai Tairaka is an employee of Takeda Pharmaceutical Company Limited.|This review (collaborative research) was funded by Takeda. ||Prof. Maya, Nunotani:|:|This review (collaborative research) was funded by Takeda. |Maya Nunotani received an advisory fee on protocol from Takeda Pharmaceutical Company.

N06 Ms. Dewitte, Goedele: No conflict of interest||Dr. Geldof, Jeroen: No conflict of interest||Dr. Truyens, Marie: No conflict of interest||Prof. Dr. Lobaton, Triana: No conflict of interest

N07 Ms. THAPWONG, Parichat: No conflict of interest||Prof. Norton, Christine: No conflict of interest||Mrs. Terry, Helen: No conflict of interest||Dr. Czuber-Dochan, Wladyslawa: No conflict of interest

N08 Ms. Takahashi, Miho: No conflict of interest||Prof. Nunotani, Maya: No conflict of interest||Prof. Dr. Aoyama, Nobuo: No conflict of interest

N09 Mrs. Fourie, Simona: No conflict of interest||Prof. Norton , Christine: No conflict of interest||Prof. Jackson, Debra: No conflict of interest||Dr. Czuber-Dochan , Wladyslawa: No conflict of interest

N10 Mrs. Breiteneicher, Simone: No conflict of interest||Mrs. Le Thi, Thu Giang: No conflict of interest||Dr. Klucker, Elisabeth: No conflict of interest||Dr. Schwerd, Tobias: No conflict of interest||Mrs. Csollarova, Katarina: No conflict of interest||Dr. Neuhaus, Lukas: No conflict of interest||Prof. Dr. Koletzko, Sibylle: No conflict of interest||Dr. Török, Helga: No conflict of interest||Dr. Koletzko, Leandra: No conflict of interest

N11 Dr. Martinato, Matteo: No conflict of interest||Dr. Comoretto, Rosanna Irene: No conflict of interest||Dr. Zampieri, Amanda: No conflict of interest||Dr. Monaco, Eleonora: No conflict of interest||Dr. Barberio, Brigida: No conflict of interest||Dr. Azzolina, Danila: No conflict of interest||Prof. Savarino, Edoardo: No conflict of interest||Prof. Gregori, Dario: No conflict of interest

N12 Mrs. Fourie, Simona: No conflict of interest||Dr. Czuber-Dochan, Wladyslawa: No conflict of interest||Prof. Jackson, Debra: No conflict of interest||Prof. Norton, Christine: No conflict of interest

N13 Prof. Dr. Rohatinsky, Noelle: No conflict of interest||Ms. Russell, Brooke: No conflict of interest||Mr. Boyd, Ian: No conflict of interest||Ms. Dickson, Alyssa: No conflict of interest||Dr. Fowler, Sharyle: No conflict of interest||Prof. Dr. Peña-Sánchez, Juan Nicolás: No conflict of interest||Ms. Quintin, Carol-Lynne: No conflict of interest||Prof. Dr. Risling, Tracie: No conflict of interest||Ms. Wicks, Kendall: No conflict of interest||Mr. Wicks, Mike: No conflict of interest

N14 Ms. Walsh, Catherine: No conflict of interest

N15 Ms. GARZIA STAFRACE, Naomi: No conflict of interest

N16 Ms. Barnes, Heather: No conflict of interest||Mrs. Fourie, Simona: No conflict of interest

N17 Ms. Conmy, Caroline: No conflict of interest

N18 Mrs. HERRERIAS, Giedre: No conflict of interest||Mrs. Ribeiro, Jaqueline Ribeiro: No conflict of interest||Mr. Beraldo, Rodrigo Fedatto: No conflict of interest||Prof. Dr. Hossne, Rogerio Saad-: No conflict of interest||Prof. Dr. Baima, Julio Pinheiro: No conflict of interest||Prof. Dr. Sassaki, Lígia Yukie: No conflict of interest

P001 Dr. Serena, Carolina: No conflict of interest||Ms. Monfort-Ferre, Diandra: No conflict of interest||Dr. Bautista, Michelle: No conflict of interest||Dr. Menacho, Margarita: No conflict of interest||Dr. Martí, Marc: No conflict of interest||Dr. Espin, Eloy: No conflict of interest||Prof. Dr. Vendrell, Joan: No conflict of interest||Dr. Fernández-Veledo, Sonia: No conflict of interest

P002 Dr. Lamb, Christopher Andrew:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group||Ms. Doyle, Jennifer:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group||Dr. Hulme, Gillian:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Mrs. Cooke, Kate:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group||Ms. Au-Yeung, Amelia:|:|Employee of Genentech Inc.||Dr. Ojeda-Garcia, Juan:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Mr. Fuller, Andrew:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Dr. McDonald, David:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Dr. Mansfield, John C:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Prof. Kirby, John A:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Dr. McBride, Jacqueline:|:|Employee of Genentech Inc, a member of the Roche Group.||Dr. Speight, R Alexander:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.||Dr. O’Gorman, William:|:|Employee of Genentech Inc, a member of the Roche Group.||Dr. Filby, Andrew:|:|This work was supported by a research grant from Genentech Inc, a member of the Roche Group.

P003 Mr. GERBETH, Lorenz: No conflict of interest||Dr. Glauben, Rainer: No conflict of interest||Prof. Dr. Siegmund, Britta: No conflict of interest

P004 Ms. Kornilova, Polina: No conflict of interest||Mrs. Potari-Gul, Lejla:|:|Getting support from Unilever.||Dr. Modos, Dezso:|:|Dezso Modos worked as a consultant for HEALX and IOTA Pharmaceuticals.||Mr. Madgwick, Matthew:|:|Getting support from BenevolentAI.||Dr. Haerty, Wilfried: No conflict of interest||Dr. Korcsmaros, Tamas:|:|Getting support from Unilever and BenevolentAI.

P005 Dr. Thomas, John P: No conflict of interest||Mr. Olbei, Marton: No conflict of interest||Dr. Hautefort, Isabelle: No conflict of interest||Dr. Modos, Dezso: No conflict of interest||Dr. Korcsmaros, Tamas:|:|Tamas Korcsamros co-supervise a PhD student from Unilever and Benevolent AI.

P006 Mr. Vich Vila, Arnau: No conflict of interest||Hu, Shixian: No conflict of interest||Andreu-Sánchez, Sergio: No conflict of interest||Dr. Collij, Valerie: No conflict of interest||Jansen, Dianne: No conflict of interest||Ruigrok, Renate: No conflict of interest||Dr. Abu-Ali, Galeb: No conflict of interest||Dr. Parkinson, John: No conflict of interest||Dr. Al Garawi, Amal: No conflict of interest||Schneider, Jessica: No conflict of interest||Dr. Kurilshikov, Alexander: No conflict of interest||Dr. Björk, Johannes: No conflict of interest||Dr. Gacesa, Ranko: No conflict of interest||Prof. Fu, Jingyuan: No conflict of interest||Prof. Zhernakova, Alexandra: No conflict of interest||Prof. Dr. Weersma, Rinse K: No conflict of interest

P007 Ms. RODGER, Beverley: No conflict of interest||Dr. Hoti, Inva: No conflict of interest||Dr. Gordon, Hannah: No conflict of interest||Prof. Dr. Lindsay, James: No conflict of interest||Dr. Stagg, Andrew: No conflict of interest

P008 Ms. Letizia, Marilena: No conflict of interest||Kaufmann, Ulrike: No conflict of interest||Gerbeth, Lorenz: No conflict of interest||Sand, Annegret: No conflict of interest||Brunkhorst, Max: No conflict of interest||Wang, Yinhu: No conflict of interest||Böttcher, Chotima: No conflict of interest||Schlickeiser, Stephan: No conflict of interest||Fernández-Zapata, Maria Camila: No conflict of interest||Kunkel, Desirée: No conflict of interest||Siegmund, Britta: No conflict of interest||Feske, Stefan: No conflict of interest||Weidinger, Carl: No conflict of interest

P009 Mrs. Abbas Egbariya, Haya: No conflict of interest||Mrs. Braun, Tzipi: No conflict of interest||Mr. Hadar , Rotem: No conflict of interest||Prof. Gal-Mor, Ohad: No conflict of interest||Prof. Shental, Noam: No conflict of interest||Dr. Haberman, Yael: No conflict of interest||Dr. Amir, Amnon: No conflict of interest

P010 Dr. Gong, Wenbin: No conflict of interest||Dr. Liu, Peizhao: No conflict of interest||Prof. Ren, Jianan: No conflict of interest

P011 Dr. Werner, Lael: No conflict of interest||Weiss, Batya: No conflict of interest||Shamir, Raanan: No conflict of interest||Dr. Shouval, Dror: No conflict of interest

P012 Ms. Heredia, Maud: No conflict of interest||Dr. Costes, Léa: No conflict of interest||Dr. Tindemans, Irma: No conflict of interest||Dr. Aardoom, Martine: No conflict of interest||Dr. Klomberg, Renz: No conflict of interest||Mr. Kemos, Polychronis: No conflict of interest||Dr. Joosse, Maria (Linda): No conflict of interest||Mrs. van Haaften, Daniëlle: No conflict of interest||Mr. Tuk, Bastiaan: No conflict of interest||Prof. Dr. Ruemmele, Frank: No conflict of interest||Prof. Dr. Croft, Nick: No conflict of interest||Prof. Dr. Escher, Johanna: No conflict of interest||Dr. de Ridder, Lissy: No conflict of interest||Dr. Samsom, Janneke: No conflict of interest

P013 Dr. Vieujean, Sophie: No conflict of interest||Dr. Hu, Shurong: No conflict of interest||Dr. Bequet, Emeline: No conflict of interest||Ms. Salée, Catherine: No conflict of interest||Ms. Massot, Charlotte: No conflict of interest||Dr. Bletard, Noëlla: No conflict of interest||Mr. Pierre, Nicolas: No conflict of interest||Ms. Quesada Calvo, Florence: No conflict of interest||Mr. Baiwir, Dominique: No conflict of interest||Mr. Mazzucchelli, Gabriel: No conflict of interest||Mr. De Pauw, Edwin: No conflict of interest||Dr. Coimbra Marques, Carla: No conflict of interest||Prof. Dr. Delvenne, Philippe: No conflict of interest||Prof. Dr. Edouard, Louis: No conflict of interest||Mrs. Meuwis, Marie-Alice: No conflict of interest

P014 Ms. Levhar, Nina: No conflict of interest||Hadar, Rotem: No conflict of interest||Braun, Tzipi: No conflict of interest||Efroni, Gilat: No conflict of interest||Abramovich, Ifat: No conflict of interest||Gottlieb, Eyal: No conflict of interest||Sosnovski, Katya: No conflict of interest||Abass, Haya: No conflict of interest||Berger, Tal: No conflict of interest||Granot, Maya: No conflict of interest||Neuman, Sandra: No conflict of interest||Selinger, Limor: No conflict of interest||Picard, Orit: No conflict of interest||Yavzuri, Miri: No conflict of interest||Dr. Lahat, Adi: No conflict of interest||Prof. Eliakim, Rami: No conflict of interest||Dr. Weiss, Batia: No conflict of interest||Prof. Kopylov, Uri: No conflict of interest||Prof. Ben-Horin, Shomron: No conflict of interest||Amir, Amnon: No conflict of interest||Dr. Haberman, Yael: No conflict of interest

P015 Mr. MANNA, Subhakankha: No conflict of interest||Dr. Sehn, Maximillian: No conflict of interest||Ms. Cardoso da Silva, Danielle: No conflict of interest||Dr. Elezkurtaj, Sefer: No conflict of interest||Ms. Cineus, Roodline: No conflict of interest||Prof. Dr. Hegazy, Ahmed: No conflict of interest||Prof. Dr. Siegmund, Britta: No conflict of interest||Dr. Weixler, Benjamin: No conflict of interest||Prof. Dr. Hummel, Michael: No conflict of interest||Dr. Gröne, Jörn: No conflict of interest||Dr. Schumann, Michael: No conflict of interest

P016 Dr. XIE, Liqin: No conflict of interest||Dr. Baribault, Helene: No conflict of interest||Dr. Lu, Chenggang: No conflict of interest||Dr. Handa, Priya: No conflict of interest||Dr. Newman, Maureen: No conflict of interest||Mr. Le, Lucas: No conflict of interest||Ms. Liu, Angela: No conflict of interest||Mr. Mutha, Devin: No conflict of interest||Mrs. Deshmukh, Shalaka: No conflict of interest||Mrs. Shah, Darshini: No conflict of interest||Mrs. Tun, Christine: No conflict of interest||Mr. Le, Tiep: No conflict of interest||Dr. Fletcher, Russell: No conflict of interest||Dr. Chen, Hui: No conflict of interest||Dr. Ye, Jay: No conflict of interest||Dr. Tibbitts, Jay: No conflict of interest||Dr. Srinivasan, Usha: No conflict of interest||Dr. Li, Yang: No conflict of interest||Dr. Vanhove, Geertrui: No conflict of interest||Dr. Yeh, Wen-Chen: No conflict of interest

P017 Dr. Haberman Ziv, Yael: No conflict of interest||Dr. Iqbal, Najeeha T: No conflict of interest||Braun, Tzipi: No conflict of interest||Dexheimer, Phillip J.: No conflict of interest||Hadar, Rotem: No conflict of interest||Rahman, Najeeb: No conflict of interest||Dr. Syed, Sana: No conflict of interest||Dr. Moskaluk, Chrisk: No conflict of interest||Dr. Moore, Sean R: No conflict of interest||Dr. Ali, Syed Asad: No conflict of interest||Dr. Denson, Lee A: No conflict of interest

P018 Ms. Garrido Trigo, Alba: No conflict of interest||Ms. Corraliza, Ana M.: No conflict of interest||Ms. Melón-Ardanaz, Elisa: No conflict of interest||Ms. Veny, Marisol: No conflict of interest||Dr. Ordás, Ingrid: No conflict of interest||Dr. Ricart, Elena: No conflict of interest||Ms. Masamunt, Maria Carme: No conflict of interest||Dr. Panès, Julià: No conflict of interest||Mr. Hemberg, Martin: No conflict of interest||Ms. Mereu, Elisabetta: No conflict of interest||Mr. Heyn, Holger: No conflict of interest||Ms. Azucena, Salas: No conflict of interest

P019 Ms. Jongsma, Myrthe: No conflict of interest||Dr. Costes, Lea M.M.: No conflict of interest||Dr. Tindemans, Irma: No conflict of interest||Dr. Cozijnsen, Martinus A.: No conflict of interest||Mrs. Raatgeep, Rolien H.C.: No conflict of interest||Ms. van Pieterson, Merel: No conflict of interest||Dr. Li, Yunlei: No conflict of interest||Prof. Escher, Johanna C.: No conflict of interest||Dr. de Ridder, Lissy: No conflict of interest||Dr. Samsom, Janneke N.: No conflict of interest

P020 Mrs. POTARI-GUL, Lejla:|:|Getting support from Unilever.||Dr. Modos, Dezso:|:|Dezso Modos worked as a consultant for HEALX and IOTA Pharmaceuticals.||Dr. Turei, Denes: No conflict of interest||Dr. Valdeolivas, Alberto: No conflict of interest||Mr. Madgwick, Matthew:|:|Getting support from BenevolentAI.||Prof. Dr. Saez-Rodriguez, Julio:|:|Receives funding from GSK and Sanofi and consultant fees from Travere Therapeutics.||Dr. Korcsmaros, Tamas:|:|Getting support from Unilever and BenevolentAI.

P021 Ms. Heredia, Maud: No conflict of interest||Mr. Charrout, Mohammed: No conflict of interest||Mr. Klomberg, Renz: No conflict of interest||Ms. Aardoom, Martine: No conflict of interest||Ms. Jongsma, Maria: No conflict of interest||Mr. Kemos, Polychronis: No conflict of interest||Mrs. van Haaften, Daniëlle: No conflict of interest||Mr. Tuk, Bastiaan: No conflict of interest||Mrs. van Berkel, Lisette: No conflict of interest||Dr. Bley Folly, Brenda: No conflict of interest||Dr. Mahfouz, Ahmed: No conflict of interest||Prof. Dr. Reinders, Marcel: No conflict of interest||Prof. Dr. Ruemmele, Frank: No conflict of interest||Prof. Dr. Croft, Nick: No conflict of interest||Prof. Dr. Escher, Johanna: No conflict of interest||Dr. de Ridder, Lissy: No conflict of interest||Dr. Samsom, Janneke: No conflict of interest

P022 Mr. SUAU, Roger: No conflict of interest||Mr. Garcia-Jaraquemada, Arce: No conflict of interest||Dr. Lorén, Violeta: No conflict of interest||Ms. Torres, Paola: No conflict of interest||Ms. Jou, Eva: No conflict of interest||Ms. Llaves, Mariona: No conflict of interest||Dr. Aterido, Adrià: No conflict of interest||Dr. Julià, Toni: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Lozano, Juan José: No conflict of interest||Prof. Dr. Domènech, Eugeni: No conflict of interest||Dr. Mañosa, Miriam: No conflict of interest||Prof. Dr. Manyé, Josep: No conflict of interest

P023 Dr. XIE, Liqin: No conflict of interest||Dr. Handa, Priya: No conflict of interest||Mrs. Tun, Christine: No conflict of interest||Ms. Liu, Angela: No conflict of interest||Dr. Lu, Chenggang: No conflict of interest||Dr. Baribault, Helene: No conflict of interest||Dr. Newman, Maureen: No conflict of interest||Mr. Le, Lucas: No conflict of interest||Mrs. Shah, Darshini: No conflict of interest||Mrs. Deshmukh, Shalaka: No conflict of interest||Mr. Mutha, Devin: No conflict of interest||Mr. Le, Tiep: No conflict of interest||Dr. Fletcher, Russell: No conflict of interest||Dr. Chen, Hui: No conflict of interest||Dr. Ye, Jay: No conflict of interest||Dr. Tibbitts, Jay: No conflict of interest||Dr. Srinivasan, Usha: No conflict of interest||Dr. Li, Yang: No conflict of interest||Dr. Vanhove, Geertrui: No conflict of interest||Dr. Yeh, Wen-Chen: No conflict of interest

P024 Dr. Sugimoto, Shinya: No conflict of interest||Prof. Kobayashi, Eiji: No conflict of interest||Dr. Fujii, Masayuki: No conflict of interest||Ms. Ohta, Yuki: No conflict of interest||Dr. Ishikawa, Keiko: No conflict of interest||Dr. Nanki, Kosaku: No conflict of interest||Prof. Hakamata, Yoji: No conflict of interest||Prof. Kanai, Takanori: No conflict of interest||Prof. Sato, Toshiro: No conflict of interest

P025 LIU, Beibei: No conflict of interest||Ms. Spalinger, Marianne: No conflict of interest||Ms. Perez , Laura Garcia: No conflict of interest||Mr. Machicote, Andres: No conflict of interest||Prof. Gagliani, Nicola: No conflict of interest||Prof. Dr. Scharl, Michael: No conflict of interest||Prof. Dr. Huber, Samuel: No conflict of interest

P026 Ms. Ilan, Karny: No conflict of interest||Mr. Motro, Yair: No conflict of interest||Mrs. Nemirovsky, Anna: No conflict of interest||Ms. Lerner, Livnat: No conflict of interest||Dr. Schwartz, Doron: No conflict of interest||Ms. Goren, Ganit: No conflict of interest||Mr. Sergienko, Ruslan: No conflict of interest||Prof. Greenberg, Dan: No conflict of interest||Prof. Slonim-Nevo , Vered: No conflict of interest||Prof. Sarid, Orly: No conflict of interest||Prof. Friger, Michael: No conflict of interest||Dr. Regev, Shirley: No conflict of interest||Prof. Dr. Odes, Selwyn (Shmuel): No conflict of interest||Prof. Moran-Gilad , Jacob: No conflict of interest||Prof. Monsonego, Alon: No conflict of interest

P027 Ms. Arnauts, Kaline: No conflict of interest||Ms. Lapierre, Cynthia: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm||Dr. Verstockt, Sare: No conflict of interest||Dr. Sudhakar, Padhmanand: No conflict of interest||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Prof. Dr. Verfaillie, Catherine: No conflict of interest||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare

P028 Dr. Gisbert-Ferrandiz, Laura: No conflict of interest||Mr. Llau, Jorge: No conflict of interest||Dr. Cosin-Roger, Jesús: No conflict of interest||Ms. Coll, Sandra: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Ortiz-Masia, Dolores: No conflict of interest||Dr. Hinojosa, Joaquin: No conflict of interest||Dr. Calatayud, Sara: No conflict of interest||Prof. Dr. Barrachina, Maria Dolores: No conflict of interest

P029 Dr. LIU, Xueqing: No conflict of interest||Ms. Milik, Angelica:|:|Employee and shareholder of Metacrine||Mr. O'Connell, Robert:|:|Employee of Bolder Biopath||Ms. White, Julie:|:|Employee of Bolder Biopath||Dr. Wagner, Brandee:|:|Employee and shareholder of Metacrine

P030 Ms. Bauset, Cristina: No conflict of interest||Mr. Lis-López, Lluís: No conflict of interest||Dr. Ortiz-Masia, Dolores: No conflict of interest||Dr. Gisbert-Ferrándiz, Laura: No conflict of interest||Ms. Coll, Sandra: No conflict of interest||Dr. Calatayud, Sara: No conflict of interest||Dr. Barrachina, Maria Dolores: No conflict of interest||Dr. Cosín-Roger, Jesús: No conflict of interest

P031 Dr. Su, Jingling: No conflict of interest||Dr. Xie, Chenxi: No conflict of interest||Prof. Dr. Hu, yiqun: No conflict of interest||Prof. Dr. Huang, Qingwen: No conflict of interest||Prof. Dr. Shi, Huaxiu: No conflict of interest||Prof. Dr. Wang, Lin: No conflict of interest||Prof. Dr. Ren, Jianlin: No conflict of interest

P032 Mrs. Rahman, Shafaque: No conflict of interest||Mr. Elfiky, Ahmed: No conflict of interest||Ms. H.P. van Hamersveld, Patricia: No conflict of interest||Mrs. Verseijden, Caroline: No conflict of interest||Mr. Welting, Olaf: No conflict of interest||Mr. L Meijer, Sybren: No conflict of interest||Mr. B.M. Hakvoort, Theodorus: No conflict of interest||Mr. J. de Jonge, Wouter: No conflict of interest||Mrs. E.M. Heinsbroek, Sigrid: No conflict of interest

P033 Dr. Gordon, Hannah: No conflict of interest||Dr. Rodger, Beverley: No conflict of interest||Dr. Hoti, Inva: No conflict of interest||Prof. Lindsay, James O.: No conflict of interest||Dr. Stagg, Andrew: No conflict of interest

P034 Dotti, Isabella: No conflict of interest||Dr. Sulpice, Eric: No conflict of interest||Dr. Nougarède, Adrien: No conflict of interest||Dr. Jary, Dorothée: No conflict of interest||Dr. Clément, Flora: No conflict of interest||Dr. Gidrol, Xavier: No conflict of interest||Dr. Navarro, Fabrice: No conflict of interest||Dr. Salas, Azucena: No conflict of interest

P035 Mrs. Muñoz-Villafranca, Carmen: No conflict of interest||Mr. Aresti Goiriena, Unai: No conflict of interest||Ispizua, Nahia: No conflict of interest||Ms. Irigoyen Muñoz, Maria: No conflict of interest||Mrs. Rivera Garcia, Natalia Andrea: No conflict of interest||Mrs. Ortiz de Zárate, Jone: No conflict of interest||Ms. Arreba Gonzalez , Paz: No conflict of interest||Mr. Calderón García, Ángel José: No conflict of interest

P036 Ms. INČIŪRAITĖ, Rūta: No conflict of interest||Dr. Juzėnas, Simonas: No conflict of interest||Dr. Ramonaitė, Rima: No conflict of interest||Dr. Skiecevičienė, Jurgita: No conflict of interest

P037 JONES, Jp:|:|Employee and shareholder of Morphic||Dr. Lee, Dooyoung:|:|Employee and shareholder of Morphic||Dr. Smukste, Inese:|:|Employee and shareholder of Morphic||Dr. Cui, Dan:|:|Employee and shareholder of Morphic||Dr. Bursavich, Matthew G.:|:|Employee and shareholder of Morphic||Dr. Troast, Dawn:|:|Employee and shareholder of Morphic||Dr. Zhong, Cheng:|:|Employee and shareholder of Morphic||Dr. Wong , Jamie E.:|:|Employee and shareholder of Morphic||Dr. Mangada, Maloy M.:|:|Employee and shareholder of Morphic||Dr. Bain, Gerard:|:|Employee and shareholder of Morphic||Dr. Lippa, Blaise:|:|Employee and shareholder of Morphic||Dr. Ray, Adrian S.:|:|Employee and shareholder of Morphic||Dr. Rogers, Bruce N.:|:|Employee and shareholder of Morphic

P038 Dr. Machicote, Andres: No conflict of interest||Dr. Pelczar, Penelope: No conflict of interest||Nawrocki , Mikolaj: No conflict of interest||Dr. Fazio, Antonella: No conflict of interest||Liu , Beibei: No conflict of interest||Kopplin, Lydia: No conflict of interest||Wende, Marie: No conflict of interest||Dr. Indenbirken, Daniela: No conflict of interest||Prof. Pabst, Oliver: No conflict of interest||Prof. Strowig, Till: No conflict of interest||Prof. Gagliani, Nicola: No conflict of interest||Prof. Huber, Samuel: No conflict of interest

P039 Prof. Dr. Iakovlev, Alexey Alexandrovich: No conflict of interest||Volkov, Alexander: No conflict of interest||Prof. Dr. Tarasova, Galina: No conflict of interest||Dr. Zubova, Anna: No conflict of interest

P040 ZHANG, Yu: No conflict of interest||Mr. WANG, Chaohui: No conflict of interest||Ms. Yao, Lingya:|:|sss||Mrs. Li, Mengjie: No conflict of interest||Prof. Dr. Jin, Jin: No conflict of interest||Prof. Dr. Cao, Qian: No conflict of interest

P041 Mrs. BENSHOSHAN, Marina: No conflict of interest||Ms. Sosnovski, Katya E: No conflict of interest||Mrs. Braun, Tzipi: No conflict of interest||Dr. Amir, Amnon: No conflict of interest||Prof. Anikster, Yair: No conflict of interest||Haberman Ziv, Yael: No conflict of interest

P042 Tarasova, Galina: No conflict of interest||Dr. Dobaeva, Natalia: No conflict of interest||Prof. Dr. Iakovlev, Aleksei: No conflict of interest||Dr. Volkov, Alexander: No conflict of interest

P043 Ms. COLL, Sandra: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Cosín-Roger, Jesús: No conflict of interest||Dr. Ortiz-Masià, Dolores: No conflict of interest||Dr. Gisbert-Ferrándiz, Laura: No conflict of interest||Dr. Barrachina, Dolores: No conflict of interest||Dr. Calatayud, Sara: No conflict of interest

P044 Dr. Akiror, Sarah: No conflict of interest||Dr. Acharjee, Animesh: No conflict of interest||Dr. Jeffery, Louisa: No conflict of interest||Dr. Shivaji, Uday Nagesh: No conflict of interest||Zardo, Davide: No conflict of interest||Dr. Gkoutos, Georgios: No conflict of interest||Prof. Ghosh, Subrata: No conflict of interest||Dr. Iacucci, Marietta: No conflict of interest

P045 Kokkotis, Georgios: No conflict of interest||Ms. Tarapatzi, Gesthimani: No conflict of interest||Dr. Drygiannakis, Ioannis: No conflict of interest||Dr. Filidou, Eirini: No conflict of interest||Mr. Kandilogiannakis, Leonidas: No conflict of interest||Dr. Arvanitidis, Konstantinos: No conflict of interest||Dr. Valatas, Vassilis: No conflict of interest||Prof. Dr. Koutroubakis, Ioannis: No conflict of interest||Prof. Dr. Vradelis, Stergios: No conflict of interest||Prof. Dr. Kolios, George: No conflict of interest||Prof. Dr. Bamias, Giorgos: No conflict of interest

P046 Ms. MOLNÁR, Tünde: No conflict of interest||Jójárt, Boldizsár: No conflict of interest||Dr. Resál, Tamás: No conflict of interest||Dr. Szántó, Kata: No conflict of interest||Dr. Kata, Diána: No conflict of interest||Dr. Földesi, Imre: No conflict of interest||Prof. Dr. Molnár, Tamás: No conflict of interest||Dr. Maléth, József: No conflict of interest||Dr. Farkas, Klaudia: No conflict of interest

P047 Mrs. Quiniou, Gaelle: No conflict of interest||Mrs. Dinet, Oceane: No conflict of interest||Mrs. Cervantes, ornella: No conflict of interest||Mrs. Verdet, Malorie: No conflict of interest||Prof. Boschetti, Gilles: No conflict of interest||Dr. Viret, Christophe: No conflict of interest||Prof. Nancey, Stephane: No conflict of interest||Prof. Faure, Mathias: No conflict of interest||Dr. ROZIERES, Aurore: No conflict of interest

P048 Dr. Agrawal, Manasi:|:|MA receives research support from the Dickler Family Fund, New York Community Trust and the Helmsley Charitable Trust Fund for SECURE-IBD.||Dr. Tarassishin, Leonid: No conflict of interest||Ms. Rendon, Alexa: No conflict of interest||Ms. Hillenbrand, Christen: No conflict of interest||Dr. Debebe, Anketse: No conflict of interest||Ms. White, Sierra: No conflict of interest||Ms. Eisele, Caroline: No conflict of interest||Ms. Hawkins, Kelly: No conflict of interest||Dr. Kim, Eun Soo: No conflict of interest||Ms. Thjømøe, Anne:|:|Employee of Calpro AS||Ms. Mørk, Einar:|:|Employee of Calpro AS||Dr. Chen, Ching-Lynn: No conflict of interest||Dr. Kornbluth, Asher: No conflict of interest||Dr. George, James: No conflict of interest||Dr. Legnani, Peter: No conflict of interest||Dr. Maser, Elana: No conflict of interest||Dr. Stone , Joanne: No conflict of interest||Dr. Dubinsky, Marla: No conflict of interest||Dr. Sabino, Joao:|:|Speaker fees: Abbvie, and Takeda Speaker’s fees: Abbvie, and Takeda.|Consultancy fees: Janssen.||Dr. Torres, Joana: No conflict of interest||Prof. Dr. Colombel, Jean-Frederic:|:|JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.||Prof. Dr. Peter, Inga: No conflict of interest||Dr. Hu, Jianzhong: No conflict of interest

P049 Mr. Kandilogiannakis, Leonidas: No conflict of interest||Dr. Filidou, Eirini: No conflict of interest||Dr. Drygiannakis, Ioannis: No conflict of interest||Ms. Tarapatzi, Gesthimani: No conflict of interest||Dr. Arvanitidis, Konstantinos: No conflict of interest||Prof. Dr. Bamias, Giorgos: No conflict of interest||Dr. Valatas, Vassilis: No conflict of interest||Dr. Paspaliaris, Vasilis: No conflict of interest||Prof. Dr. Kolios, George: No conflict of interest

P050 Ms. Montfort-Ferré, Diandra: No conflict of interest||Dr. Serena, Carolina: No conflict of interest||Dr. Millan, Monica: No conflict of interest||Mr. Boronat-Toscano, Albert: No conflict of interest||Dr. Maymó-Masip, Elsa: No conflict of interest||Dr. Caro, Aleidis: No conflict of interest||Dr. Espina, Beatriz: No conflict of interest||Prof. Dr. Vendrell, Joan: No conflict of interest||Dr. Fernández-Veledo, Sonia: No conflict of interest

P051 Mr. Jorge, Marín-Aracil: No conflict of interest||Prof. Dr. Barrachina, Maria Dolores: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Gisbert-Ferrándiz, Laura: No conflict of interest||Dr. Cosin-Roger, Jesus: No conflict of interest||Ms. Coll, Sandra: No conflict of interest||Prof. Dr. Calatayud, Sara: No conflict of interest||Dr. López-Serrano, Antonio: No conflict of interest||Prof. Dr. Ortiz-Masiá, Dolores: No conflict of interest

P052 Mr. Harder, Brandon: No conflict of interest||Dr. Casavant, Ellen: No conflict of interest||Dr. McBride, Jacqueline: No conflict of interest||Dr. Park, Kun Tae: No conflict of interest||Dr. Mathews, W. Rodney: No conflict of interest||Dr. Anania, Veronica G.: No conflict of interest||Dr. Lekkerkerker, Annemarie: No conflict of interest

P053 Ms. KHUSNUTDINOVA, Dilyara: No conflict of interest||Ms. Markelova, Maria: No conflict of interest||Ms. Siniagina, Maria: No conflict of interest||Ms. Boulygina, Eugenia: No conflict of interest||Mr. Abdulkhakov, Sayar: No conflict of interest||Ms. Grigoryeva, Tatyana: No conflict of interest

P054 Dr. Xu, Mengque: No conflict of interest||Ms. Shen, Yuqin: No conflict of interest||Ms. Cen, Mengsha: No conflict of interest

P055 Mrs. Nemirovsky, Anna: No conflict of interest||Ms. Ilan, Karny: No conflict of interest||Ms. Lerner, Livnat: No conflict of interest||Ms. Cohen-Lavi , Liel: No conflict of interest||Dr. Schwartz, Doron: No conflict of interest||Ms. Goren, Ganit: No conflict of interest||Mr. Sergienko, Ruslan: No conflict of interest||Prof. Greenberg, Dan: No conflict of interest||Prof. Slonim-Nevo , Vered: No conflict of interest||Prof. Sarid, Orly: No conflict of interest||Prof. Dr. Friger, Michael: No conflict of interest||Dr. Regev, Shirley: No conflict of interest||Prof. Dr. Odes, Selwyn (Shmuel): No conflict of interest||Prof. Hertz, Tomer: No conflict of interest||Prof. Monsonego, Alon: No conflict of interest

P056 Ms. COLL, Sandra: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Cosín-Roger, Jesús: No conflict of interest||Dr. Ortiz-Masià, Dolores: No conflict of interest||Dr. Gisbert-Ferrándiz, Laura: No conflict of interest||Dr. Navarro-Vicente, Fran: No conflict of interest||Dr. Barrachina, Dolores: No conflict of interest||Dr. Calatayud, Sara: No conflict of interest

P057 Mr. WANG, Chaohui:|:|basic science||Ms. Yao, Lingya:|:|basic science||Dr. Zhang, yu: No conflict of interest||Prof. Cao, qian:|:|basic science

P058 Dr. Park, Jihye: No conflict of interest||Dr. Daeun , Jeong: No conflict of interest||Prof. Youn Wook , Chung: No conflict of interest||Prof. Jae Hee , Cheon: No conflict of interest||Prof. Ji-Hwan , Ryu: No conflict of interest

P059 Taylor Meadows, Kristen:|:|Employee, shareholder: Gossamer Bio, Inc.||Murphy, Susan:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Levesque, Barrett G.:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Carter, Laura L.:|:|Employee, shareholder: Gossamer Bio, Inc.||Dr. Salter-Cid, Luisa:|:|Employee, shareholder: Gossamer Bio, Inc.

P060 Ms. O CONNELL, Lauren: No conflict of interest||Ms. Olli, Kristine: No conflict of interest||Dr. Wilkinson, Cinthia: No conflict of interest||Dr. Collins, Colm: No conflict of interest||Dr. Jedlicka, Paul: No conflict of interest||Dr. Aherne, Carol: No conflict of interest

P061 Mr. Wiese, Jakob Johann: No conflict of interest||Mr. Fascì , Alberto: No conflict of interest||Ms. Kühl, Anja A.: No conflict of interest||Ms. Siegmund, Britta: No conflict of interest||Mrs. Prüß, Magdalena Sarah: No conflict of interest||Mr. Schumann, Michael: No conflict of interest

P062 Dr. Alsoud, Dahham: No conflict of interest||Dr. Verstockt, Sare: No conflict of interest||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda|||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare|||Dr. Noor, Nurulamin: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm|||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

P063 Ms. JACOBS, Inge: No conflict of interest||Mr. Creyns, Brecht: No conflict of interest||Dr. Dragoni, Gabriele: No conflict of interest||Mr. Cremer, Jonathan: No conflict of interest||Dr. Bislenghi, Gabriele: No conflict of interest||Prof. Dr. D'Hoore, Andre: No conflict of interest||Mr. Ke, Bo-jun: No conflict of interest||Prof. Matteoli, Gianluca: No conflict of interest||Prof. Dr. De Hertogh, Gert: No conflict of interest||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Dr. Joao, Guedelha Sabino:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Breynaert, Christine: No conflict of interest||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm||Prof. Dr. Vanuytsel, tim:|:|Financial support for research: Danone and MyHealth|Consultant and advisory board member: Baxter, Dr. Falk Pharma, Takeda, Tramedico, Truvion, VectivBio and Zealand Pharma|Speakers fees: Abbott, Dr. Falk Pharma, Fresenius Kabi, Kyowa Kirin and Menarini, Takeda and Will Pharma

P064 Ms. COQUANT, Garance: No conflict of interest||Dr. Aguanno, Doriane: No conflict of interest||Dr. Peyrottes, Agathe: No conflict of interest||Mr. Brot, Loic: No conflict of interest||Ms. Belloir, Christine: No conflict of interest||Dr. Briand, Loic: No conflict of interest||Dr. Grill, Jean-Pierre: No conflict of interest||Dr. Thenet, Sophie: No conflict of interest||Dr. De Sordi, Luisa: No conflict of interest||Prof. Seksik, Philippe:|:|P.S. reports consulting fees from Abbvie, Takeda, Merck-MSD, Pfizer, Astellas, Janssen and Biocodex and grants from Biocodex and Janssen. These COIs are unrelated to the current presentation.

P065 Dr. Agrawal, Manasi:|:|MA receives research support from the Dickler Family Fund, New York Community Trust and the Helmsley Charitable Trust Fund for SECURE-IBD.||Dr. Tarassishin, Leonid: No conflict of interest||Ms. Rendon, Alexa: No conflict of interest||Dr. Debebe, Anketse: No conflict of interest||Ms. Hillenbrand, Christen: No conflict of interest||Ms. White, Sierra: No conflict of interest||Ms. Eisele, Caroline: No conflict of interest||Ms. Hawkins, Kelly: No conflict of interest||Dr. Chen, Ching-Lynn: No conflict of interest||Dr. Kornbluth, Asher: No conflict of interest||Dr. George, James: No conflict of interest||Dr. Legnani, Peter: No conflict of interest||Dr. Maser, Elana: No conflict of interest||Dr. Stone, Joanne: No conflict of interest||Dr. Dubinsky, Marla: No conflict of interest||Dr. Sabino, Joao:|:|Speaker fees: Abbvie, and Takeda Speaker’s fees: Abbvie, and Takeda.|Consultancy fees: Janssen.||Dr. Torres, Joana: No conflict of interest||Prof. Dr. Colombel, Jean-Frederic:|:|JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.||Prof. Dr. Peter, Inga: No conflict of interest||Dr. Hu, Jianzhong: No conflict of interest

P066 Dr. Yokoyama, Yoshihiro: No conflict of interest||Dr. Yamakawa, Tsukasa: No conflict of interest||Dr. Hayashi, Yuki: No conflict of interest||Dr. Kazama, Tomoe: No conflict of interest||Dr. Hirayama, Daisuke: No conflict of interest||Prof. Dr. Nakase, Hiroshi:|:|Hiroshi Nakase has received support from AbbVie GK., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co.,Ltd., Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical K.K, Takeda Pharmaceutical Co.,Ltd., Pfizer Inc, Celgene Corporation., EA Pharma Co.,Ltd., Zeria Pharmaceutical CO.,Ltd., Mochida Pharmaceutical Co.,Ltd., Nippon Kayaku Co.,Ltd., Daiichi Sankyo Company, Limited., JIMRO Co.,Ltd., as well as grants for commissioned/joint research from Hoya Group Pentax Medical, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company.

P067 Ms. Tarapatzi, Gesthimani: No conflict of interest||Dr. Filidou, Eirini: No conflict of interest||Mr. Kandilogiannakis, Leonidas: No conflict of interest||Dr. Arvanitidis, Konstantinos: No conflict of interest||Prof. Dr. Vradelis, Stergios: No conflict of interest||Dr. Kotzampassi, Katerina: No conflict of interest||Prof. Dr. Kolios, George: No conflict of interest

P068 Dr. HORNSBY, Eve: No conflict of interest||Dr. Yadon, Adam N.: No conflict of interest||Dr. Clarke, Astrid: No conflict of interest||Dr. Grant, Ethan: No conflict of interest||Prof. Lindsay, James O.:|:|Has received honoraria for consulting with Gilead and Galapagos as part of an advisory board||Dr. Stagg, Andy J.:|:|The work is funded by an investigator initiated research grant from Gilead.

P069 Dr. Gutierrez Becker, Benjamin: No conflict of interest||Dr. Giuffrida, Enrica: No conflict of interest||Dr. Mangia, Michela: No conflict of interest||Dr. Arcadu, Filippo: No conflict of interest||Mrs. Whitehill, Victoria: No conflict of interest||Mr. Guaraglia, David:|:|CTO of Virgo Surgical Video Solutions||Mr. Schwartz, Matthew:|:|CEO of Virgo Surgical Video Solutions||Mr. Sabouni, Ryon:|:|Works at Virgo Surgical Video Solutions||Dr. Prunotto, Marco:|:|Former employee of Roche|Head of Translational Research at Galapagos|||Dr. Oh, Young: No conflict of interest||Dr. Daperno, Marco: No conflict of interest

P070 Dr. MURRAY, Clare: No conflict of interest||Dr. Cooper, Nicky: No conflict of interest||Dr. Lucas, Cathy L: No conflict of interest||Dr. Manso, Ana Sousa: No conflict of interest||Dr. Ray, Nick C: No conflict of interest||Dr. Worthington, Jenny: No conflict of interest||Dr. Fox, J Craig: No conflict of interest

P071 Dr. Jones, Fiona: No conflict of interest||Prof. Doherty, Glen: No conflict of interest||Dr. McNamee, Eoin: No conflict of interest

P072 Dr. Colombo, Giorgia: No conflict of interest||Dr. Ribaldone, Davide Giuseppe: No conflict of interest||Dr. Caviglia, Gian Paolo: No conflict of interest||Prof. Genazzani, Armando: No conflict of interest||Dr. Travelli, Cristina: No conflict of interest

P073 Dr. Gisbert-Ferrandiz, Laura: No conflict of interest||Ms. Queralt, Marta: No conflict of interest||Dr. Cosín-Roger, Jesús: No conflict of interest||Ms. Coll, Sandra: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Ortiz-Masia, Dolores: No conflict of interest||Mr. Llau, Jorge: No conflict of interest||Dr. Navarro-Vicente, Francisco: No conflict of interest||Dr. Calatayud, Sara: No conflict of interest||Prof. Barrachina, Maria Dolores: No conflict of interest

P074 Mr. OWEN, John: No conflict of interest

P075 Ms. ATANASOVA, Konstantina: No conflict of interest||Mr. Lotter, Tobias: No conflict of interest||Dr. Reindl, Wolfgang: No conflict of interest||Prof. Dr. Lis, Stefanie: No conflict of interest

P076 Ms. Creoli, Mara: No conflict of interest||Dr. Strisciuglio, Caterina: No conflict of interest||Dr. Vitale, Alessandra: No conflict of interest||Ms. Oglio, Franca: No conflict of interest||Dr. Paino, Salvatore: No conflict of interest||Prof. Dr. Luongo, Livio: No conflict of interest||Dr. Tortora, Chiara: No conflict of interest||Dr. Argenziano, Maura: No conflict of interest||Ms. Di Paola, Alessandra: No conflict of interest||Dr. Maione, Sabatino: No conflict of interest||Prof. Dr. Rossi, Francesca: No conflict of interest

P077 Ms. Folan, Anne-Mairead: No conflict of interest||Prof. Jones, Georgina: No conflict of interest||Dr. Baker, Daniel: No conflict of interest||Dr. Brown, Steven: No conflict of interest||Dr. Lee, Matthew: No conflict of interest||Prof. Lobo, Alan:|:|AL is a consultant, advisory board member or received lecture fees for MSD, Janssen, Pfizer, Takeda Pharma, AbbVie, Dr Falk, Shield Pharmaceuticals and Vifor Pharma. All other authors have no conflicts of interest to declare.

P078 Notararigo, Sara: No conflict of interest||Dr. Bravo, Susana: No conflict of interest||Dr. Martin-Pastor, Manuel: No conflict of interest||Dr. Baston-Rey, Iria: No conflict of interest||Dr. Quiroga-Castiñeira, Adriano: No conflict of interest||Prof. Dominguez-Munoz, J. Enrique: No conflict of interest||Dr. Domínguez Medina, Eduardo: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

P079 Dr. Felice, Carla: No conflict of interest||Lewis, Amy: No conflict of interest||Prof. Armuzzi, Alessandro: No conflict of interest||Prof. Lindsay, James O: No conflict of interest||Prof. Silver, Andrew: No conflict of interest

P080 Magro, Fernando:|:|FM has received honoraria from Janssen for participation in expert panels.||Portela, Francisco:|:|FP has received honoraria from Janssen for participation in expert panels.||Lago, Paula:|:|PL has received honoraria from Janssen for participation in expert panels.||Chagas, Cristina:|:|CC has received honoraria from Janssen for participation in expert panels.||Moreira, Francisco:|:|FM is an employee of IQVIA Portugal and was contracted by Janssen Portugal for the development of this project.||Mr. Pereira, Fábio:|:|FP is an employee of IQVIA Portugal and was contracted by Janssen Portugal for the development of this project.||Rodrigues, Bernardo:|:|BR is an employee of Janssen Portugal.||Pedrosa, Hugo:|:|HP is an employee of IQVIA Portugal and was contracted by Janssen Portugal for the development of this project.||Correia, Luís:|:|LC has received honoraria from Janssen for participation in advisory boards.

P081 Dr. Pascoal, Lívia Bitencourt: No conflict of interest||Ms. Palma, Bruna Biazon: No conflict of interest||Dr. Chaim, Fábio Henrique: No conflict of interest||Ms. Nogueira, Guilherme: No conflict of interest||Ms. Rodrigues, Bruno Lima: No conflict of interest||Prof. Dr. Ayrizono, Maria Lourdes Setsuko: No conflict of interest||Prof. Dr. Velloso, Lício Augusto: No conflict of interest||Prof. Dr. Leal, Raquel Franco: No conflict of interest

P082 Ms. Deleu, Sara: No conflict of interest||Ms. Arnauts, Kaline: No conflict of interest||Dr. Machiels, Kathleen:|:|Pfizer Medical advisor employee in inflammation and immunology since 5/01/2021.||Dr. Huys, Geert R.B.: No conflict of interest||Prof. Dr. Thevelein, Johan:|:|VIB and KU Leuven have submitted a patent application (15 Sept. 2017; EP 17191252.0.) based on the possible beneficial effect of S. boulardii produced acetic acid for its commercial use as probiotic.||Prof. Dr. Raes, Jeroen:|:|Financial support for research: Danone, Nestle, MRM health, Prodigest, Janssen Pharmaceuticals, Cargill, Beneo|Consulting and/or speaking fees: Yakult, Tsumura, Dr Falk Pharma, GSK, MRM health, Biofortis, Ferring, Merck, Nutricia, Takeda, Janssen Pharmaceuticals|||Prof. Dr. Vermeire, Severine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

P083 Ms. Heuthorst, Lianne: No conflict of interest||Dr. Mookhoek, Aart: No conflict of interest||Dr. Wildenberg, Manon: No conflict of interest||Prof. Dr. D'Haens, Geert: No conflict of interest||Prof. Dr. Bemelman, Willem: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest

P084 Dr. McDonagh, Padraic: No conflict of interest||Ms. O'Connell, Fiona: No conflict of interest||Dr. O'Connell, Jim: No conflict of interest||Ms. Argue, Ruth: No conflict of interest||Dr. Corcoran, Roisin: No conflict of interest||Kevans, David: No conflict of interest||Prof. O'Sullivan, Jacintha: No conflict of interest

P085 Dr. LU, Chenggang: No conflict of interest||Ms. Shah, Darshini: No conflict of interest||Ms. Wijnands, Anouk: No conflict of interest||Prof. Dr. Oldenburg, Bastiaan: No conflict of interest||Dr. Yeh, Wen-Chen: No conflict of interest||Dr. Vanhove, Geertrui: No conflict of interest||Dr. Li, Yang: No conflict of interest

P086 Dr. Martin-Hernández, David: No conflict of interest||Mr. Robledo Montaña, Javier: No conflict of interest||Ms. López-Gutiérrez, Irene: No conflict of interest||Ms. González-Prieto, Marta: No conflict of interest||Mr. González Bris, Álvaro: No conflict of interest||Ms. Ulecia-Morón, Cristina: No conflict of interest||MacDowell, Karina: No conflict of interest||Tendilla-Beltrán, Hiram: No conflict of interest||Ms. Moreno, Beatriz: No conflict of interest||Ms. Calleja-Rodríguez, Natalia: No conflict of interest||Dr. Rodríguez-Mascarenhas, Sandra: No conflict of interest||Dr. Caso, Javier R: No conflict of interest||Dr. García-Bueno, Borja: No conflict of interest||Dr. Marín-Jiménez, Ignacio: No conflict of interest||Prof. Leza, Juan C: No conflict of interest||Dr. Menchen Viso, Luis Alberto: No conflict of interest

P087 Dr. Hazel, Karl: No conflict of interest||Dr. McGinley, Natalia: No conflict of interest||Dr. O'Toole, Aoibhlinn: No conflict of interest||Dr. Keely, Stephen: No conflict of interest

P088 FACANALI, Marcio: No conflict of interest||Dr. Bortolozzo Graciolli Facanali, Carolina: No conflict of interest||Dr. Rodrigues Boarini, Lucas:|:|has served as a speaker from Abbvie.||Prof. Dr. Vaz Safatle Ribeiro, Adriana: No conflict of interest||Prof. Dr. Sobrado, Carlos Walter:|:|has served as a speaker from Janssen, Takeda and Abbvie.

P089 Mr. Marín-Aracil, Jorge: No conflict of interest||Prof. Dr. Barrachina , Maria Dolores: No conflict of interest||Ms. Bauset, Cristina: No conflict of interest||Dr. Cosin-Roger, Jesus: No conflict of interest||Ms. Coll, Sandra: No conflict of interest||Prof. Dr. Calatayud, Sara: No conflict of interest||Dr. Antonio, López-Serrano: No conflict of interest||Prof. Dr. Ortiz-Masiá, Dolores: No conflict of interest

P090 Ms. Akimenko, Elena: No conflict of interest||Mr. Bjerrum, Jacob Tveiten: No conflict of interest||Ms. Allin, Kristine H: No conflict of interest||Mr. Iversen, Aske Thorn: No conflict of interest||Prof. Dr. Jess, Tine: No conflict of interest

P091 Dr. ANTOLIN-FONTES, Beatriz: No conflict of interest||Borsi, Andras: No conflict of interest||Nissinen, Riikka: No conflict of interest||Bravatà, Ivana: No conflict of interest||Barthelmes, Jennifer Norma: No conflict of interest||Le Bars, Manuela: No conflict of interest||Lee, Jennifer: No conflict of interest||Maywald, Ulf: No conflict of interest||Prof. Dr. Bokemeyer, Bernd: No conflict of interest||Prof. Dr. Wilke, Thomas: No conflict of interest||Dr. Ghiani, Marco: No conflict of interest

P092 Mr. Noguier, Guillaume:|:|Theradiag's employee||Mr. Montaillier, Christophe:|:|Theradiag's employee||Mr. Daviere, Simon: No conflict of interest||Yang, Ying:|:|Theradiag's employee||Colombeau, Lilian:|:|Theradiag's employee||Mr. Parussini, Ermis:|:|Theradiag's employee

P093 Dr. MILO, Francesco: No conflict of interest||Dr. Romeo, Erminia Francesca: No conflict of interest||Dr. Rea, Francesca: No conflict of interest||Dr. Grimaldi Capitello, Teresa: No conflict of interest||Dr. De Angelis, Paola: No conflict of interest||Dr. Tabarini, Paola: No conflict of interest

P094 Dr. Burneikis, Dominykas: No conflict of interest||Dr. Liska, David: No conflict of interest||Dr. Lipman, Jeremy: No conflict of interest||Dr. Valente, Michael: No conflict of interest||Dr. Gorgun, Emre: No conflict of interest||Dr. Kessler, Hermann: No conflict of interest||Dr. Hull, Tracy: No conflict of interest||Dr. Sklow, Bradford: No conflict of interest||Dr. Steele, Scott: No conflict of interest||Dr. Lightner, Amy: No conflict of interest||Dr. Holubar, Stefan: No conflict of interest

P095 Ms. Verstockt, Sare: No conflict of interest||Mrs. Glorieus, Elien: No conflict of interest||Ms. Ukunda, Christella: No conflict of interest||Ms. Barbaraci, Morgane: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm|||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda|||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare|||Dr. Geldof, Jeroen: No conflict of interest||Prof. Dr. De Vos, Martine: No conflict of interest||Prof. Dr. Laukens, Debby: No conflict of interest||Prof. Dr. Cleynen, Isabelle: No conflict of interest||Dr. Vandermeulen, Liv: No conflict of interest||Prof. Dr. Lobatón, Triana: No conflict of interest||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

P096 Dr. Viazis, Nikolaos: No conflict of interest||Ms. Mountaki, Aikaterini: No conflict of interest||Mr. Koustenis, Kanellos: No conflict of interest||Mr. Veretanos, Christos: No conflict of interest||Mr. Arvanitis, Konstantinos: No conflict of interest||Ms. Georgiadi, Tereza: No conflict of interest||Mr. Karampekos, George: No conflict of interest||Dr. Manolakis, Anastasios: No conflict of interest||Dr. Archavlis, Emmanouil: No conflict of interest||Dr. Christidou, Angeliki: No conflict of interest||Dr. Mela, Maria: No conflict of interest||Dr. Mantzaris, Gerasimos: No conflict of interest

P097 Ms. Asscher, Vera: No conflict of interest||Ms. Waars, Sanne: No conflict of interest||Mr. Fens, Jesse: No conflict of interest||Ms. Wieland, Monse: No conflict of interest||Dr. van der Meulen-de Jong, Andrea: No conflict of interest||Dr. Stuyt, Rogier: No conflict of interest||Ms. Baven-Pronk, Martine: No conflict of interest||Dr. van der Marel, Sander: No conflict of interest||Dr. Jacobs, Rutger: No conflict of interest||Dr. Haans, Jeoffrey: No conflict of interest||Dr. Van Deudekom, Floor: No conflict of interest||Dr. Mooijaart, Simon: No conflict of interest||Dr. Maljaars, Jeroen: No conflict of interest

P099 Dr. Kani, Haluk Tarik: No conflict of interest||Dr. Ergenc, Ilkay: No conflict of interest||Mr. Polat, Gorkem: No conflict of interest||Dr. Ozen Alahdab, Yesim: No conflict of interest||Dr. Temizel, Alptekin: No conflict of interest||Prof. Dr. Atug, Ozlen: No conflict of interest

P100 Dr. Gupta, Vipin: No conflict of interest||Dr. Hartery, Karen: No conflict of interest||Dr. Oxford IBD Cohort Investigators, Investigators: No conflict of interest||Dr. Bassett, Paul: No conflict of interest||Dr. Culver, Emma: No conflict of interest||Prof. East, James: No conflict of interest

P101 Dr. Ollech, Jacob: No conflict of interest||Dr. Bannon, Lian: No conflict of interest||Prof. Maharshak, Nitzan: No conflict of interest||Prof. Tulchinsky, Hagit: No conflict of interest||Dr. Yanai, Henit: No conflict of interest||Prof. Dotan, Iris: No conflict of interest

P102 Mr. Attauabi, Mohamed: No conflict of interest||Dr. Poulsen, Anja: No conflict of interest||Dr. Kajbæk Verner-Andersen, Marianne: No conflict of interest||Dr. Rosager Hansen, Malte: No conflict of interest||Dr. Pedersen, Natalia: No conflict of interest||Dr. Pilegaard Prahm, August: No conflict of interest||Dr. Berg Lødrup, Anders: No conflict of interest||Prof. Dr. Haderselv, Kent: No conflict of interest||Dr. Larsen, Lone: No conflict of interest||Prof. Dr. Jess, Tine: No conflict of interest||Dr. Glerup, Henning: No conflict of interest||Dr. Molazahi, Akbar: No conflict of interest||Dr. Mathiassen Oppfeldt, Asser: No conflict of interest||Prof. Dr. Dahlerup, Jens Frederik: No conflict of interest||Prof. Dr. Lodberg Hvas, Christian: No conflict of interest||Dr. Neumann, Anders: No conflict of interest||Dr. Wase, Abdel: No conflict of interest||Dr. Dam Jensen, Michael: No conflict of interest||Dr. Nathan, Torben: No conflict of interest||Dr. Jensen, Søren: No conflict of interest||Dr. Theede, Klaus: No conflict of interest||Dr. Kiszka-Kanowitz, Marianne: No conflict of interest||Prof. Dr. Benedict Seidelin, Jakob: No conflict of interest||Dr. Burisch, Johan: No conflict of interest

P103 Ms. Pulley, Jennifer:|:|Roche employee/shareholder||Ms. Galloway, Deanna:|:|Roche employee/shareholder||Dr. Oh, Young:|:|Genentech employee/shareholder||Mr. Devine, Jacob:|:|Genentech employee/shareholder||Dr. Petrek, Hannah:|:|Genentech employee/shareholder||Dr. Khavarian, Alysha:|:|Genentech employee/shareholder||Ms. Matsui, Alison:|:|Genentech employee/shareholder

P104 Dr. Mesonero Gismero, Francisco: No conflict of interest||Zabana, Yamile: No conflict of interest||Fernández-Clotet, Agnès: No conflict of interest||Sola, Ana: No conflict of interest||Caballol, Berta: No conflict of interest||Leo, Eduardo: No conflict of interest||García, Maria José: No conflict of interest||Bertoletti, Federico: No conflict of interest||Alejandro, Mínguez: No conflict of interest||Suris, Gerard: No conflict of interest||Casis, Begoña: No conflict of interest||Ferreiro-Iglesias, Rocío: No conflict of interest||Calafat, Margalida: No conflict of interest||Jiménez, Itxaso: No conflict of interest||Miranda-Bautista, José: No conflict of interest||Lamuela, Luis Javier: No conflict of interest||Fajardo, Ingrid: No conflict of interest||Torrealba, Leyanira: No conflict of interest||Nájera, Rodrigo: No conflict of interest||Sáiz, Rosa María: No conflict of interest||González, Irene: No conflict of interest||Vicuña, Miren: No conflict of interest||García-Morales, Natalia: No conflict of interest||Gutiérrez, Ana: No conflict of interest||López-García, Alicia: No conflict of interest||Benítez, José Manuel: No conflict of interest||Rubín de Célix, Cristina: No conflict of interest||Tejido, Coral: No conflict of interest||Brunet, Eduard: No conflict of interest||Bastón, Iria: No conflict of interest||Rodríguez-Lago, Iago: No conflict of interest||Baltar, Ruth: No conflict of interest||Huguet, José María: No conflict of interest||Hermida, Benito: No conflict of interest||Caballero-Mateos, Antonio: No conflict of interest||Sánchez-Guillén, Luis: No conflict of interest||Bouhmidi, Abdel: No conflict of interest||Pajares, Ramón: No conflict of interest||López-Sanromán, Antonio: No conflict of interest||Barreiro-de Acosta, Manuel: No conflict of interest

P105 Dr. Marshall, Jack: No conflict of interest||Dr. Rowse, Georgina: No conflict of interest||Mrs. Hollobone, Sarah: No conflict of interest||Mr. Afhim, Sam: No conflict of interest||Dr. Oliver, Phillip: No conflict of interest

P106 Dr. Martin Arranz, Eduardo: No conflict of interest||Dr. Suarez Ferrer, Cristina: No conflict of interest||Ms. García Ramirez, Laura: No conflict of interest||Dr. Sanchez Azofra, María: No conflict of interest||Dr. Rueda García, Jose Luis: No conflict of interest||Dr. Poza Cordón, Joaquín: No conflict of interest||Dr. Martín Arranz, María Dolores: No conflict of interest

P107 Mr. Miquel Cusachs, Josep Oriol: No conflict of interest||Dr. Bahí Saavedra, Anna: No conflict of interest||Dr. Vila Currius, Mireia: No conflict of interest||Dr. Lliròs Dupre, Marc: No conflict of interest||Dr. Leal Validivieso, Carles: No conflict of interest||Dr. Aldeguer Manté, Xavier: No conflict of interest

P109 Dr. Kabir, Misha: No conflict of interest||Dr. Curtius, Kit: No conflict of interest||Dr. Kalia, Parul: No conflict of interest||Dr. Al Bakir, Ibrahim: No conflict of interest||Dr. Choi, Chang-Ho Ryan: No conflict of interest||Dr. Hartono, Juanda L: No conflict of interest||Prof. East, James E: No conflict of interest||Prof. Lindsay, James O: No conflict of interest||Dr. Vega, Roser: No conflict of interest||Prof. Thomas-Gibson, Siwan: No conflict of interest||Prof. Graham, Trevor A: No conflict of interest||Prof. Hart, Ailsa: No conflict of interest||Dr. Wilson, Ana: No conflict of interest

P110 Dr. Dotson, Jennifer: No conflict of interest||Dr. Hunter, Theresa:|:|Employee and shareholder at Eli Lilly and Company||Lukanova, Rina: No conflict of interest||Dr. Crandall, Wallace:|:|Employee and shareholder at Eli Lilly and Company ||Komocsar, Wendy:|:|Employee and shareholder at Eli Lilly and Company||Larkin, Amy:|:|Employee and shareholder at Eli Lilly and Company ||Meakin, Sophie: No conflict of interest||Dr. Otley, Anthony: No conflict of interest

P111 Mr. BACHOUR, Salam: No conflict of interest||Dr. Shah, Ravi S.: No conflict of interest||Mr. Lyu, Ruishen: No conflict of interest||Dr. Nakamura, Takahiro: No conflict of interest||Dr. Shen, Michael: No conflict of interest||Dr. Li, Terry: No conflict of interest||Dr. Rieder, Florian: No conflict of interest||Dr. Cohen, Benjamin:|:|There are no conflicts of interest for this study however Benjamin L. Cohen, M.D. receives the following financial support: Advisory Boards and Consultant for Abbvie, Celgene-Bristol Myers Squibb, Pfizer, Sublimity Therapeutics,Takeda, TARGET RWE; CME Companies: Cornerstones, Vindico; Speaking: Abbvie||Dr. Qazi, Taha: No conflict of interest||Dr. Lashner, Bret: No conflict of interest||Dr. Achkar, Jean Paul: No conflict of interest||Dr. Philpott, Jessica:|:|There are no conflicts of interest pertaining to this study however Dr. Philpott serves on the speakers board for Abbvie||Dr. Lightner, Amy:|:|There are no conflicts of interest pertaining to this study however Dr. Lightner serves as a consultant for Takeda||Dr. Holubar, Stefan: No conflict of interest||Dr. Regueiro, Miguel: No conflict of interest||Dr. Dane, Bari: No conflict of interest||Dr. Baker, Mark:|:|There are no conflicts of interests for the purpose of this study, however Dr. Baker disclose Siemens Healthineers to the institution in the form of salary support, hardware and software in investigating lower exposure CTE in the evaluation of patients with Crohn’s disease.||Dr. Axelrad, Jordan: No conflict of interest||Dr. Click, Benjamin: No conflict of interest

P112 Dr. Martins Figueiredo, Luisa: No conflict of interest||Dr. Correia, Fábio: No conflict of interest||Dr. Rafael, Maria Ana: No conflict of interest||Dr. Lourenço, Luis: No conflict of interest||Dr. Oliveira, Ana Maria: No conflict of interest||Dr. C. Branco, Joana: No conflict of interest||Dr. Santos, Liliana: No conflict of interest||Dr. Martins, Alexandra: No conflict of interest

P113 Dr. Ribeiro, Tiago: No conflict of interest||Dr. Mascarenhas Saraiva, Miguel: No conflict of interest||Afonso, João: No conflict of interest||Dr. Cardoso, Hélder: No conflict of interest||Prof. Dr. Ferreira, João: No conflict of interest||Andrade, Patrícia: No conflict of interest||Prof. Dr. Jorge, Renato: No conflict of interest||Prof. Lopes, Susana: No conflict of interest||Prof. Dr. Macedo, Guilherme: No conflict of interest

P114 Mr. KLOMBERG, Renz: No conflict of interest||Mr. Kemos, Polychronis: No conflict of interest||Ms. Aardoom, Martine: No conflict of interest||Mr. Rizopoulos, Dimitris: No conflict of interest||Prof. Dr. Croft, Nick: No conflict of interest||Dr. de Ridder, Lissy: No conflict of interest||Mr. Neyt, Mattias: No conflict of interest

P115 Mr. Bresteau, Clément: No conflict of interest||Prof. Amiot, Aurélien:|:|Honoraria from Abbvie, Hospira, Takeda, Gilead, Biocodex, Janssen, Tillotts, Ferring, Pfizer and MSD||Dr. Kirchgesner, Julien: No conflict of interest||Dr. de’Angelis, Nicola: No conflict of interest||Prof. Lefevre, Jérémie H.:|:|Honoraria from Takeda||Prof. Bouhnik, Yoram:|:|Honoraria from Abbvie, Biogaran, Boehringer Ingelheim, Celgene, Ferring, Gilead, Hospira, Janssen, Mayoly-Spindler, MSD, Norgine, Pfizer, Roche, Samsung Bioepis, Sandoz, Sanofi, Shire, Takeda, UCB||Prof. Panis, Yves: No conflict of interest||Prof. Beaugerie, Laurent:|:|Honoraria from Janssen, Pfizer, Allergan, AbbVie, Janssen, MSD, Ferring Pharmaceuticals, Mayoly-Spindler, Takeda and Tillotts, and research support from Abbott, Ferring Pharmaceuticals, Hospira-Pfizer, Janssen, MSD, Takeda and Tillotts||Prof. Allez, Matthieu:|:|Honoraria from Abbvie, MSD, Janssen, Takeda, Pfizer, Novartis, Ferring, Tillotts, Celgene and Genentech/Roche||Prof. Brouquet, Antoine:|:|Speaker fees from Takeda, Merck-Serono, Abbvie, Roche, Amgen and Janssen-Cilag and invitation to scientific meeting from Biom’up, Roche, Win’up surgical system and Intuitive surgical||Prof. Carbonnel, Franck:|:|Honoraria from Amgen, BMS, Celltrion, Enterome, Ferring, Janssen, Medtronic, Pfizer, Pharmacosmos, Roche and Tillotts as well as lecture fees from Abbvie, Astra, BMS, Ferring, Janssen, MSD, Pfizer, Pileje, and Takeda||Dr. Meyer, Antoine: No conflict of interest

P116 Dr. McCurdy, Jeffrey:|:|Jeffrey McCurdy has received speaker/consultancy fees from AbbVie, Janssen, Pfizer and Takeda.||Mr. Crooks, Patrick:|:|Patrick Crooks is a salaried employee of IQVIA. His company received a fee from Takeda to design and conduct this research.||Dr. Gwaltney, Chad:|:|Chad Gwaltney received consulting fees from IQVIA to design and conduct this research.||Dr. Krupnick, Robert:|:|Robert Krupnick is a salaried employee of IQVIA. His company received a fee from Takeda to design and conduct this research.||Dr. Cadogan, Kathy-Ann:|:|Kathy-Ann Cadogan is a salaried employee of Takeda Pharmaceuticals USA, Inc.||Dr. Gonzalez, Sandra:|:|Sandra Gonzalez is a salaried employee of Takeda Pharmaceuticals USA, Inc.||Ms. Karki, Chitra:|:|Chitra Karki is a salaried employee of Takeda Pharmaceuticals USA, Inc.

P117 Dr. Siakavellas, Spyridon:|:|Support grant from the Greek Group for the study of IBD and speaker fees received from Pfizer and Janssen.||Dr. Derikx, Lauranne: No conflict of interest||Ms. Derr, Lisa: No conflict of interest||Dr. Williams, Linda: No conflict of interest||Dr. Plevris, Nikolas:|:|Has received consultancy fees from Takeda and speaker fees and/or travel support from Abbvie, Takeda,Norgine, Ferring, and Janssen. ||Mr. Jenkinson, Phil: No conflict of interest||Dr. Laura, Lucaciu: No conflict of interest||Mr. Constantine-Cooke, Nathan: No conflict of interest||Ms. Covil, Kate: No conflict of interest||Ms. Murdoch, Lauren: No conflict of interest||Dr. Jones, Gareth-Rhys: No conflict of interest||Prof. Lees, Charlie:|:|Professor Charlie Lees has received research support from Abbvie and Gilead, acted as a consultant to Abbvie, Janssen, Takeda, Pfizer, Galapagos, MSD, Hospira, Pharmacosmos, GSK, Gilead, Topivert, Vifor Pharma, Dr Falk, Oshi Health, Trellus Health and Iterative Scopes; he has received speaking fees and travel support from Pfizer, Janssen, Abbvie, Galapagos, MSD, Takeda, Shire, Ferring, Hospira, Warner-Chilcott and Dr Falk.

P118 Prof. YAO, Jiayin: No conflict of interest||Prof. Hu, Bang: No conflict of interest||Wang, Huashe: No conflict of interest||Zhi, Min: No conflict of interest

P119 Dr. Chavannes, Mallory: No conflict of interest||Dr. Hart, Lara: No conflict of interest||Dr. Afif, Waqqas: No conflict of interest||Dr. Lakatos, Peter: No conflict of interest||Dr. Bitton, Alain: No conflict of interest||Dr. Bressler, Brian: No conflict of interest||Dr. Bessissow, Talat: No conflict of interest

P120 Dr. Roa, Iñigo: No conflict of interest||Dr. Merino, Olga: No conflict of interest||Dr. Gómez Irwin, Laura: No conflict of interest||Dr. Arosa, Miriam: No conflict of interest||Dr. García González, José María: No conflict of interest||Dr. Ituarte, Ricardo: No conflict of interest||Dr. Méndez, Tomás Ángel: No conflict of interest||Dr. Cortón, Leire: No conflict of interest||Castelo, Susana: No conflict of interest||Dr. Suárez, María Jesús: No conflict of interest

P121 Serghini, Meriem: No conflict of interest||Dr. Ben Youssef, Hela: No conflict of interest||Dr. Laabidi, Asma: No conflict of interest||Dr. Ben Mustapha, Nadia: No conflict of interest||Dr. Hafi, marwa: No conflict of interest||Prof. Dr. fekih, monia: No conflict of interest||Prof. Dr. Boubaker, Jalel: No conflict of interest

P122 Dr. Levartovsky, Asaf: No conflict of interest||Mr. Barash, Yiftach: No conflict of interest||Prof. Ben-Horin, Shomron: No conflict of interest||Mrs. Ungar, Bella: No conflict of interest||Mr. Klang, Eyal: No conflict of interest||Ms. Soffer, Shelly: No conflict of interest||Prof. Amitai, Marianne M.: No conflict of interest||Prof. Kopylov, Uri: No conflict of interest

P123 Bourgonje, Arno R.: No conflict of interest||Ms. Alexdottir, Marta: No conflict of interest||Ms. Loveikyte, Roberta: No conflict of interest||Ms. Bay-Jensen, Anne-Christine: No conflict of interest||Dr. van Dullemen, Hendrik M.: No conflict of interest||Dr. Visschedijk, Marijn C.: No conflict of interest||Dr. Festen, Eleonora A. M.: No conflict of interest||Prof. Weersma, Rinse K.: No conflict of interest||Prof. Karsdal, Morten A.: No conflict of interest||Prof. Faber, Klaas Nico: No conflict of interest||Dr. Mortensen, Joachim H.: No conflict of interest||Prof. Dijkstra, Gerard: No conflict of interest

P124 Dr. Festa, Stefano: No conflict of interest||Dr. Zerboni, Giulia: No conflict of interest||Dr. Derikx, Lauranne: No conflict of interest||Dr. Ribaldone, Davide Giuseppe: No conflict of interest||Dr. Dragoni, Gabriele: No conflict of interest||Dr. Buskens, Christianne J: No conflict of interest||Prof. Dr. Nieveen van Dijkum, Els: No conflict of interest||Dr. Pugliese, Daniela: No conflict of interest||Dr. Panzuto, Francesco: No conflict of interest||Dr. Krela-Kaźmierczak, Iwona: No conflict of interest||Dr. Reiss, Hilla: No conflict of interest||Dr. Shitrit, Ariella Bar-Gil: No conflict of interest||Dr. Chaparro, Maria: No conflict of interest||Prof. Dr. Gisbert, Javier P: No conflict of interest||Dr. Kopylov, Uri: No conflict of interest||Dr. Teich, Niels: No conflict of interest||Dr. Vainer, Elez: No conflict of interest||Prof. Dr. Nagtegaal, Iris: No conflict of interest||Dr. Hoentjen, Frank: No conflict of interest||Dr. Garcia, Maria Jose: No conflict of interest||Dr. Filip, Rafal: No conflict of interest||Dr. Foteinogiannopoulou, Kalliopi: No conflict of interest||Prof. Dr. Koutroubakis, Ioannis: No conflict of interest||Dr. Argollo, Marjorie: No conflict of interest||Dr. van Wanrooij, Roy: No conflict of interest||Dr. Laja, Hendrik: No conflict of interest||Dr. Truyens, Marie: No conflict of interest||Prof. Dr. Lobaton Ortega, Triana: No conflict of interest||Dr. Molnar, Tamas: No conflict of interest||Prof. Savarino, Edoardo: No conflict of interest||Dr. Aratari, Annalisa: No conflict of interest||Dr. Papi, Claudio: No conflict of interest||Dr. Goren, Idan: No conflict of interest

P125 Dr. Pujol Muncunill, Gemma: No conflict of interest||Dr. Monleon-Getino, Antonio: No conflict of interest||Dr. Méndez-Viera, Javier: No conflict of interest||Mrs. Álvarez-Carnero, Laura: No conflict of interest||Dr. Martin de Carpi, Javier: No conflict of interest

P126 Dr. Kakkadasam Ramaswamy, Pradeep: No conflict of interest||Dr. Subhaharan, Deloshaan: No conflict of interest||Dr. Edwards, John: No conflict of interest||Dr. Willmann, Laura: No conflict of interest||Dr. Shukla, Dheeraj: No conflict of interest||Dr. Moattar, Hadi: No conflict of interest||Dr. Bhullar, Maneesha: No conflict of interest||Dr. Dorrington, Alexander: No conflict of interest||Dr. Ishaq, Naveed: No conflict of interest||Dr. McIvor, Carolyn: No conflict of interest||Dr. Mohsen, Waled: No conflict of interest

P127 Dr. PALOMINO PÉREZ, Laura María: No conflict of interest||Dr. Velasco Rodríguez-Belvis, Marta: No conflict of interest||Dr. León Falconi, José Luis: No conflict of interest||Dr. Sánchez Fernández-Bravo, Carmen: No conflict of interest||Dr. Vazquez Gómez, Julio Alberto: No conflict of interest||Dr. Muñoz Codoceo, Rosa Ana: No conflict of interest

P128 Dr. Luber, Raphael:|:|RPL has received educational grants from Ferring, Pfizer and Vifor Pharma. ||Dr. Duff, Alexa:|:|AD has received speaker fees from Janssen and Takeda. ||Dr. Pavlidis, Polychronis: No conflict of interest||Dr. Honap, Sailish:|:|SH has served as speaker for Janssen, Pfizer and Takeda. ||Dr. Meade, Susanna:|:|SM has received speaker fees from Dr Falk Pharma. ||Dr. Ray, Shuvra: No conflict of interest||Dr. Anderson, Simon: No conflict of interest||Dr. Mawdsley, Joel: No conflict of interest||Dr. Samaan, Mark:|:|MAS served as a speaker, a consultant and/or an advisory board member for Sandoz, Janssen, Takeda, MSD, Falk, Samsung Bioepis. ||Dr. Irving, Peter:|:|PMI has served as a speaker, a consultant and/or an advisory board member for Abbvie, Warner Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, and has received research funding from MSD, Takeda.

P129 Ms. Wakeman, Ruth: No conflict of interest||Ms. Ainley, Rachel: No conflict of interest||Dr. Arnott, Ian D: No conflict of interest||Dr. Barrett, Kevin J: No conflict of interest||Mr. Bell, Graham: No conflict of interest||Ms. Berry, Sarah: No conflict of interest||Dr. Bhatnagar, Gauraang: No conflict of interest||Mr. Blackwell, Jonathan: No conflict of interest||Dr. Bloom, Stuart: No conflict of interest||Ms. Bramwell, Caroline: No conflict of interest||Dr. Brookes, Matthew James: No conflict of interest||Mr. Burman, Andy: No conflict of interest||Ms. Cairnes, Vida: No conflict of interest||Ms. Crook, Kay: No conflict of interest||Ms. Dobson, Liz: No conflict of interest||Dr. Epstein, Jenny: No conflict of interest||Prof. Faiz, Omar: No conflict of interest||Prof. Feakins, Roger: No conflict of interest||Ms. Fletcher, Melissa: No conflict of interest||Ms. Garrick, Vikki: No conflict of interest||Ms. Glatter, Jackie: No conflict of interest||Dr. Hawthorne, Antony Barney: No conflict of interest||Ms. Keetarut, Katie: No conflict of interest||Dr. Lamb, Christopher A: No conflict of interest||Ms. Lee, Margaret: No conflict of interest||Ms. Meade, Uchu: No conflict of interest||Dr. Muhammed, Rafeeq: No conflict of interest||Dr. Murdock, Andrew: No conflict of interest||Prof. Nevill, Alan M: No conflict of interest||Mr. Parekh, Amit: No conflict of interest||Dr. Rochford, Andrew: No conflict of interest||Dr. Rowse, Georgina: No conflict of interest||Prof. Sagar, Peter: No conflict of interest||Ms. St.Clair-Jones, Anja: No conflict of interest||Mr. Segal, Jonathan: No conflict of interest||Dr. Selinger, Christian Philipp: No conflict of interest||Ms. Sleet, Sarah: No conflict of interest||Prof. Taylor, Stuart: No conflict of interest||Ms. Winsor, Gemma: No conflict of interest||Ms. Younge, Lisa: No conflict of interest

P130 Dr. Dionigi, Beatrice: No conflict of interest||Dr. Lavaryk, Olga: No conflict of interest||Dr. Lightner, Amy: No conflict of interest||Dr. Holubar, Stefan: No conflict of interest||Dr. Hull, Tracy: No conflict of interest

P131 Dr. Lu, Cathy: No conflict of interest||Ms. Filyk, Alexis: No conflict of interest||Ms. Mainoli, Barbara: No conflict of interest||Mr. de Almeida, Luiz: No conflict of interest||Dr. Novak, Kerri: No conflict of interest||Dr. Panaccione, Remo: No conflict of interest||Dr. Hirota, Simon: No conflict of interest||Dr. Dufour, Antoine: No conflict of interest

P132 Dr. Truffi, Marta: No conflict of interest||Dr. Morasso, Carlo: No conflict of interest||Mrs. Albasini, Sara: No conflict of interest||Dr. Malovini, Alberto: No conflict of interest||Prof. Bellazzi, Riccardo: No conflict of interest||Mrs. Piccotti, Francesca: No conflict of interest||Mr. Caldarone, Alessandro: No conflict of interest||Dr. Sorrentino, Luca: No conflict of interest||Dr. Mazzucchelli, Serena: No conflict of interest||Dr. Sampietro, Gianluca: No conflict of interest||Dr. Colombo, Francesco: No conflict of interest||Prof. Ardizzone, Sandro: No conflict of interest||Prof. Corsi, Fabio: No conflict of interest

P133 Dr. SORIANO, Alessandra: No conflict of interest||Dr. Bertolini, Elena: No conflict of interest||Dr. Bertani, Angela: No conflict of interest||Dr. Beltrami, Marina: No conflict of interest||Prof. Macchioni, Pierluigi: No conflict of interest

P134 Dr. Freitas, Marta: No conflict of interest||Dr. Macedo Silva, Vítor: No conflict of interest||Dr. Arieira, Cátia: No conflict of interest||Dr. Cúrdia Gonçalves, Tiago: No conflict of interest||Dr. Dias de Castro, Francisca: No conflict of interest||Dr. Leite, Sílvia: No conflict of interest||Dr. Moreira, Maria João: No conflict of interest||Prof. Dr. Cotter, José: No conflict of interest

P135 Dr. Yokoo, Takashi: No conflict of interest||Dr. Yoshikawa, Shyusaku: No conflict of interest||Dr. Masuda, Tsutomu: No conflict of interest||Dr. Terauchi, Seiji: No conflict of interest||Dr. Uchida, Hideki: No conflict of interest||Dr. Nakao, Takeshi: No conflict of interest||Dr. Yamaoka, Kentarou: No conflict of interest||Dr. Inagaki, Mizumi: No conflict of interest||Dr. Okamoto, Kouhei: No conflict of interest||Dr. Shibata, Yusuke: No conflict of interest||Dr. Higashio, Tsubasa: No conflict of interest||Dr. Inatsugi, Naoki: No conflict of interest

P136 Dr. Viola, Anna: No conflict of interest||Giambò, Federica: No conflict of interest||Dr. Chiappetta, MIchele Francesco: No conflict of interest||Dr. Costantino, Giuseppe: No conflict of interest||Prof. Pallio, Socrate: No conflict of interest||Prof. Navarra, Giuseppe: No conflict of interest||Prof. Alibrandi, Angela: No conflict of interest||Prof. Fries, Walter: No conflict of interest

P137 Mr. HAGENDORN, Erik:|:|Erik Hagendorn is an employee of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.||Mr. Karsen, Samuel:|:|Samuel Karsen is an employee of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.||Dr. Pai, Rish: No conflict of interest||Dr. Jairath, Vipul: No conflict of interest||Mrs. Knight, Heather:|:|Heather Knight is an employee of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.||Dr. Schwartz, Annette:|:|Annette Schwartz is an employee of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.||Mr. Laroux, Stephen:|:|Stephen Laroux is an employee of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.||Dr. Butler, James:|:|James Butler was an employee of AbbVie at the time of the study. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.||Dr. Dunstan, Robert:|:|Robert Dunstan is an employee of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.

P138 Dr. MACEDO SILVA, Vítor: No conflict of interest||Dr. Freitas, Marta: No conflict of interest||Dr. Xavier, Sofia: No conflict of interest||Dr. Cúrdia Gonçalves, Tiago: No conflict of interest||Dr. Boal Carvalho, Pedro: No conflict of interest||Dr. Dias de Castro, Francisca: No conflict of interest||Dr. Rosa, Bruno: No conflict of interest||Moreira, Maria João: No conflict of interest||Prof. Dr. Cotter, José: No conflict of interest

P139 Dr. Cohen, Nathaniel Aviv: No conflict of interest||Dr. Kliper, Efrat: No conflict of interest||Dr. Zamstein, Noa: No conflict of interest||Dr. Ziv-Baran, Tomer: No conflict of interest||Dr. Ben Tov, Amir: No conflict of interest||Prof. Kariv, Revital: No conflict of interest

P140 Ms. BEVERS, Nanja: No conflict of interest||Ms. Aliu, Arta: No conflict of interest||Mr. Rezazadeh Ardabili , Ashkan: No conflict of interest||Dr. Winkens, Bjorn: No conflict of interest||Dr. Raijkmakers, Maarten: No conflict of interest||Dr. van de Vijver, Els: No conflict of interest||Prof. Dr. Swinkels, Dorine: No conflict of interest||Dr. Pierik, Marieke: No conflict of interest||Dr. van Rheenen, Patrick: No conflict of interest

P141 Dragoni, Gabriele: No conflict of interest||Dr. Innocenti, Tommaso: No conflict of interest||Dr. Lynch, Erica Nicola: No conflict of interest||Dr. Fiorini, Cecilia: No conflict of interest||Dr. Parisio, Laura: No conflict of interest||Dr. Roselli, Jenny: No conflict of interest||Dr. Bagnoli, Siro: No conflict of interest||Dr. Macrì, Giuseppe: No conflict of interest||Dr. Rogai, Francesca: No conflict of interest||Prof. Dr. Milani, Stefano: No conflict of interest||Prof. Dr. Galli, Andrea: No conflict of interest||Dr. Milla, Monica: No conflict of interest

P142 Dr. KURIAKOSE KUZHIYANJAL, Anish John: No conflict of interest||Dr. Nigam, Gaurav B.: No conflict of interest||Mr. Antoniou, Georgios A: No conflict of interest||Prof. Dr. Cross, Raymond K: No conflict of interest||Prof. Dr. Farraye, Francis A.: No conflict of interest||Prof. Dr. Limdi, Jimmy K.: No conflict of interest

P143 Dr. Sempere Robles, Laura: No conflict of interest||Dr. Bernabeu, Purificación: No conflict of interest||Mr. Cameo, José: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest||Dr. García, Gloria: No conflict of interest||Dr. García, Mariana Fe: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest||Prof. Zapater, Pedro: No conflict of interest||Prof. Ruiz-Cantero, María Teresa: No conflict of interest||Prof. van-der Hofstadt , Carlos: No conflict of interest

P144 Dr. Weintraub, Yael: No conflict of interest||Prof. Dr. Cohen, Shlomi: No conflict of interest||Mrs. Chapnik, Nava: No conflict of interest||Dr. Anafy, Adi: No conflict of interest||Dr. Yerushalmy-Feler, Anat: No conflict of interest||Dr. Ben-Tov , Amir: No conflict of interest||Prof. Dr. Dotan, Iris: No conflict of interest||Prof. Dr. Riva, Tauman: No conflict of interest||Prof. Froy, Oren: No conflict of interest

P145 Dr. Rottoli, Matteo: No conflict of interest||Pellino, Gianluca: No conflict of interest||Tanzanu, Marta: No conflict of interest||Baldi, Caterina: No conflict of interest||Frontali, Alice: No conflict of interest||Carvello, Michele: No conflict of interest||Foppa, Caterina: No conflict of interest||Kontovounisios, Christos: No conflict of interest||Tekkis, Paris: No conflict of interest||Colombo, Francesco: No conflict of interest||Sancho-Muriel, Jorge: No conflict of interest||Matteo, Frasson: No conflict of interest||Danelli, Piergiorgio: No conflict of interest||Celentano, Valerio: No conflict of interest||Spinelli, Antonino: No conflict of interest||Panis, Yves: No conflict of interest||Sampietro, Gianluca: No conflict of interest||Poggioli, Gilberto: No conflict of interest

P146 Dr. Zittan, Eran: No conflict of interest||Prof. Steinhart, A. Hillary: No conflict of interest||Mrs. Aran, Hila: No conflict of interest||Mrs. Milgrom, Raquel: No conflict of interest||Dr. Koifman, Eduard: No conflict of interest||Prof. Gralnek, Ian M.: No conflict of interest||Prof. Zelber-Sagi, Shira: No conflict of interest||Prof. Silverberg, Mark S.: No conflict of interest

P147 Dr. EINDOR, Adi: No conflict of interest||Meleady, Laura: No conflict of interest||Jacobson, Kevan: No conflict of interest

P148 Dr. de Sousa Magalhães, Rui: No conflict of interest||Dr. Lima Capela, Tiago: No conflict of interest||Dr. Rosa, Bruno: No conflict of interest||Dr. Moreira, Maria João: No conflict of interest||Prof. Cotter, José: No conflict of interest

P149 Dr. SHIN, Minsoo: No conflict of interest||Dr. Lim, Jin Gyu: No conflict of interest||Dr. Kim, Min Soo: No conflict of interest||Dr. Moon, Soo Young: No conflict of interest||Dr. Hahn, Jong Woo: No conflict of interest||Dr. Kim, Do Hyun: No conflict of interest||Dr. Moon, Jin Soo: No conflict of interest||Dr. Ko, Jae Sung: No conflict of interest

P150 Shin, Seungyong: No conflict of interest||Dr. Choi, Chang Won: No conflict of interest||Dr. Moon, Jung Min: No conflict of interest||Prof. Kim, Hee Sung: No conflict of interest||Prof. Choi, Chang Hwan: No conflict of interest

P151 Dr. PALOMINO PÉREZ, Laura María: No conflict of interest||Dr. Velasco Rodríguez-Belvis, Marta: No conflict of interest||Dr. Sirvent Cerdá, Sara Inmaculada: No conflict of interest||Dr. Vazquez Gómez , Julio Alberto: No conflict of interest||Dr. Muñoz Codoceo, Rosa Ana: No conflict of interest

P152 Dr. Morão, Bárbara: No conflict of interest||Dr. Nascimento, Catarina: No conflict of interest||Dr. Frias Gomes, Catarina: No conflict of interest||Dr. Gonçalves, Tiago: No conflict of interest||Dr. Castro, Francisca: No conflict of interest||Dr. Moreira, Maria João: No conflict of interest||Dr. Cotter, José: No conflict of interest||Dr. Pereira, Flávio: No conflict of interest||Dr. Caldeira, Ana: No conflict of interest||Dr. Sousa, Rui: No conflict of interest||Dr. Coelho, Rosa: No conflict of interest||Dr. Macedo, Guilherme: No conflict of interest||Dr. Macedo, Cláudia: No conflict of interest||Dr. Ferreira, Margarida: No conflict of interest||Dr. Cravo, Marília: No conflict of interest||Dr. Glória, Luísa: No conflict of interest||Dr. Torres, Joana: No conflict of interest||Dr. Palmela, Carolina: No conflict of interest

P153 Louis, Edouard:|:|Research grants from Janssen, Pfizer and Takeda; educational grants from AbbVie, Janssen and Takeda; speaker fees from AbbVie, Celgene, Falk, Ferring, Janssen, Pfizer, Roche and Takeda; consultancy to AbbVie, Arena, Celgene, Eli Lilly, Ferring, Galapagos, Gilead, Janssen and Takeda.||Siegel, Corey A.:|:|Consultancy to AbbVie, BMS, Janssen, Lilly, Pfizer, Prometheus and Takeda; speaker for CME activities for AbbVie, BMS, Pfizer and Takeda; grants from AbbVie, Janssen, Pfizer and Takeda.||Mrs. James, Barbara:|:|Employee of AbbVie and may own stock or options.||Heidenreich, Sebastian:|:|Employees of Evidera, a business unit of PPD. Evidera received funding for conducting the work outlined in this presentation. Sebastian Heidenreich is a minority stockholder of PPD as part of his employment.||Krucien, Nicolas:|:|Employees of Evidera, a business unit of PPD. Evidera received funding for conducting the work outlined in this presentation. ||Ghosh, Subrata:|:|Steering committee member for AbbVie, Boehringer Ingelheim, Celgene and Janssen, advisory committee member for AbbVie; speaker fees from AbbVie, Janssen, Pfizer and Takeda; consultancy to Boehringer Ingelheim, Celgene, Eli Lilly, Gilead and Roche.

P154 Dr. Siakavellas, Spyridon:|:|Support grant from the Greek Group for the study of IBD and speaker fees received from Pfizer and Janssen.||Dr. Derikx, Lauranne: No conflict of interest||Ms. Derr, Lisa: No conflict of interest||Dr. Williams, Linda: No conflict of interest||Dr. Plevris, Nikolas:|:|Consultancy fees from Takeda and speaker fees and/or travel support from Abbvie, Takeda,Norgine, Ferring, and Janssen.||Mr. Jenkinson, Phil: No conflict of interest||Dr. Lucaciu, Laura: No conflict of interest||Mr. Constantine-Cooke, Nathan: No conflict of interest||Ms. Covil, Kate: No conflict of interest||Ms. Murdoch, Lauren: No conflict of interest||Dr. Jones, Gareth-Rhys: No conflict of interest||Prof. Lees, Charlie:|:|Professor Charlie Lees has received research support from Abbvie and Gilead, acted as a consultant to Abbvie, Janssen, Takeda, Pfizer, Galapagos, MSD, Hospira, Pharmacosmos, GSK, Gilead, Topivert, Vifor Pharma, Dr Falk, Oshi Health, Trellus Health and Iterative Scopes; he has received speaking fees and travel support from Pfizer, Janssen, Abbvie, Galapagos, MSD, Takeda, Shire, Ferring, Hospira, Warner-Chilcott and Dr Falk.

P155 Wijnands, Anouk M.: No conflict of interest||Mr. te Groen, Maarten: No conflict of interest||Ms. Peters, Yonne: No conflict of interest||Prof. Dr. Kaptein, Ad A.: No conflict of interest||Prof. Dr. Oldenburg, Bas: No conflict of interest||Dr. Hoentjen, Frank: No conflict of interest||Dr. Lutgens, Maurice W.M.D.: No conflict of interest

P156 Dr. Vicente Lidon, Raquel:|:|Support for travel for meetings to support study|Payment for writing or reviewing the manuscript||Dr. García, Santiago:|:|Consulting|Support for travel for meetings to support study|Payment for writing or reviewing the manuscript||Ms. Corsino, Pilar:|:|Support for travel for meetings to support study||Dr. Boudet, José Miguel:|:|Support for travel for meetings to support study||Dr. Sierra, Eva María:|:|Support for travel for meetings to support study||Dr. García, Paula:|:|Support for travel for meetings to support study||Dr. Sanz, Patricia:|:|Support for travel for meetings to support study||Dr. Gomollón, Fernando:|:|Consulting|Support for travel for meetings to support study|Payment for writing or reviewing the manuscript

P157 Dr. KIM, Jung Min: No conflict of interest||Dr. Rim, John Hoon: No conflict of interest||Ms. Kim, Da Hye: No conflict of interest||Mrs. Kim, Hye-Youn: No conflict of interest||Prof. Choi, Sung Kyoung: No conflict of interest||Dr. Kim, Dong Yun: No conflict of interest||Mr. Choi, Yo Jun: No conflict of interest||Ms. Yu, Seyoung: No conflict of interest||Prof. Dr. Gee, Heon Yung: No conflict of interest||Prof. Dr. Cheon, Jae Hee: No conflict of interest

P158 Ms. KURTEVA, Elena: No conflict of interest||Ms. Rendo, Giulia: No conflict of interest||Ms. Ahmad, Tania: No conflict of interest||Mr. Watson, Tom: No conflict of interest||Mr. Jones, Kelsey: No conflict of interest||Mr. Gaynor, Edward: No conflict of interest||Ms. Kiparissi, Fevronia: No conflict of interest

P159 Prof. Dr. Yarur, Andres: No conflict of interest||Mrs. Alexandra, Bruss: No conflict of interest||Dr. Beniwal-Patel, Poonam: No conflict of interest||Dr. Stein, Daniel: No conflict of interest||Ms. Nunez, Lizbeth: No conflict of interest||Mr. Berens, Brandon: No conflict of interest||Dr. Shaina, Sekhri: No conflict of interest||Dr. Parakkal , Deepak: No conflict of interest||Prof. Dr. Shaker, Joseph: No conflict of interest||Dr. Jenna, Sarvaideo: No conflict of interest

P160 Mrs. HASSINE, Amani: No conflict of interest||Dr. Akkari, Imen: No conflict of interest||Dr. Mrabet, Soumaya: No conflict of interest||Dr. Ben Jazia, Elhem: No conflict of interest

P161 Dr. FERRETTI, Francesca: No conflict of interest||Dr. Monico, Maria Camilla: No conflict of interest||Dr. Cannatelli, Rosanna: No conflict of interest||Dr. Lenti, Marco Vincenzo: No conflict of interest||Prof. Di Sabatino, Antonio: No conflict of interest||Dr. Carmagnola, Stefania: No conflict of interest||Dr. Conforti, Francesco: No conflict of interest||Dr. Pastorelli, Luca: No conflict of interest||Prof. Caprioli, Flavio: No conflict of interest||Dr. Bezzio, Cristina: No conflict of interest||Dr. Saibeni, Simone: No conflict of interest||Dr. Mazza, Stefano: No conflict of interest||Prof. Vecchi, Maurizio: No conflict of interest||Prof. Maconi, Giovanni: No conflict of interest||Prof. Ardizzone, Sandro: No conflict of interest

P162 Dr. Revés, Joana: No conflict of interest||Dr. Frias Gomes, Catarina: No conflict of interest||Prof. Dr. Ellul, Pierre: No conflict of interest||Dr. Callé, Catarina: No conflict of interest||Ms. Almeida, Alexandra: No conflict of interest||Prof. Dr. Burisch, Johan: No conflict of interest||Buhagiar, Tiffany: No conflict of interest||Attard, Abigail: No conflict of interest||Lo, Bobby: No conflict of interest||Ungaro, Ryan: No conflict of interest||Morão, Bárbara: No conflict of interest||Gouveia, Catarina: No conflict of interest||Branco , Joana: No conflict of interest||Rodrigues, Jaime: No conflict of interest||Teixeira, Cristina: No conflict of interest||Castro, Francisca: No conflict of interest||Nunes, Gonçalo: No conflict of interest||Brito, Mariana: No conflict of interest||Antunes, Marília: No conflict of interest||Torres, Joana: No conflict of interest||Borralho, Paula: No conflict of interest

P163 Mrs. Paulides, Emma: No conflict of interest||Dr. Pasma, Annelieke: No conflict of interest||Dr. Erler, Nicole S.: No conflict of interest||Mrs. van Eijk, Rachel L.A.: No conflict of interest||Dr. de Vries, Annemarie C.: No conflict of interest||Prof. Dr. van der Woude, Christien Janneke: No conflict of interest

P164 Dr. Vernero, Marta: No conflict of interest||Dr. Ribaldone , Davide Giuseppe: No conflict of interest||Dr. Giudici , Gabriele: No conflict of interest||Dr. Stalla , Francesco Maria: No conflict of interest||Dr. Dutto , Camilla: No conflict of interest||Prof. Bugianesi , Elisabetta: No conflict of interest||Prof. Saracco, Giorgio Maria: No conflict of interest||Dr. Caviglia , Gian Paolo: No conflict of interest||Dr. Astegiano, Marco: No conflict of interest

P165 Mr. Pehrsson, Martin: No conflict of interest||Dr. E. Godskesen, Line: No conflict of interest||Dr. Bay-Jensen, Anne-Christine:|:|Shareholder in Nordic Bioscience A/S||Prof. Dr. Asser Karsdal, Morten:|:|Shareholder in Nordic Bioscience A/S||Prof. Dr. Krag, Aleksander: No conflict of interest||Prof. Dr. Kjeldsen, Jens: No conflict of interest||Dr. Høg Mortensen, Joachim:|:|Employed at Nordic Bioscience A/S

P166 Dr. Jayasooriya, Nishani: No conflict of interest||Prof. Dr. Saxena, Sonia: No conflict of interest||Dr. Blackwell, Jonathan: No conflict of interest||Prof. Petersen , Irene: No conflict of interest||Prof. Bottle, Alex: No conflict of interest||Dr. Creese, Hanna: No conflict of interest||Prof. Dr. Pollok, Richard: No conflict of interest

P167 Dr. Rodríguez, Andrés: No conflict of interest||Dr. Herreros, Belen: No conflict of interest||Dr. Muñoz, Roser: No conflict of interest||Dr. Sempere, Laura: No conflict of interest||Dr. Bernal, Lorena: No conflict of interest||Dr. Hurtado, Ana: No conflict of interest||Dr. Orts, Beatriz: No conflict of interest||Dr. Zapater, Pedro: No conflict of interest||Dr. Moreno, Oscar: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest

P168 Dr. Reindl, Wolfgang: No conflict of interest||Dr. Wuestenberg, Torsten: No conflict of interest||Ms. Knoedler, Laura: No conflict of interest||Prof. Dr. Ebert, Matthias: No conflict of interest||Mr. Wirbel, Jakob: No conflict of interest||Dr. Zeller, Georg: No conflict of interest||Dr. Thomann, Anne: No conflict of interest

P169 Dr. Cenni, Sabrina: No conflict of interest||Dr. Russo , Giuseppina: No conflict of interest||Dr. De Nigiris, Angelica: No conflict of interest||Dr. Casertano, Marianna: No conflict of interest||Dr. Pacella, Daniela: No conflict of interest||Prof. Miele, Erasmo: No conflict of interest||Dr. Martinelli, Massimo: No conflict of interest||Prof. Staiano, Annamaria: No conflict of interest||Dr. Strisciuglio, Caterina: No conflict of interest

P170 Prof. Dr. Park, Jae Jun: No conflict of interest||Prof. Dr. Jung, Yunho: No conflict of interest||Prof. Dr. Na, Soo-Young: No conflict of interest||Prof. Dr. Lee, Yoo Jin: No conflict of interest||Prof. Dr. Kim, Jong Wook: No conflict of interest||Prof. Dr. Kim, Nam-Hoon: No conflict of interest

P171 Calviño Suárez, Cristina: No conflict of interest||Dr. Dos-Santos, Raquel: No conflict of interest||Dr. Baston-Rey, Iria: No conflict of interest||Dr. Montero, Fernando J: No conflict of interest||Dr. Ferreiro-Iglesias, Rocio: No conflict of interest||Dr. Marin-Jimenez, Ignacio: No conflict of interest||Dr. Gonzalez, Carlos M: No conflict of interest||Dr. Perez-Pampin, Eva: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

P172 Matsuoka, Katsuyoshi:|:|Received research grant from Janssen Pharmaceutical K.K related to this study. Research grants not related to this study from AbbVie, EA Pharma, Mitsubishi Tanabe Pharma, Mochida, Kyorin, KisseiJIMRO, Pfizer, Nippon Kayaku. Lecture/consulting fees from AbbVie, EA Pharma, Mitsubishi Tanabe Pharma, Mochida, Kyorin, Kissei, Astellas Pharma, JIMRO, Janssen, Pfizer, Takeda, Zeria, Gilead Sciences, Miyarisan, Nippon Kayaku, Celltrion Healthcare, Eli Lilly. ||Dr. Fujii, Toshimitsu:|:|Received research grant from Janssen Pharmaceutical K.K related to this study. Received fees for promotional material from AbbVie, Ajinomoto Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, EA Pharma, Janssen Pharma, Kissei pharma, Kyorin Pharma, Kyowa Hakko Kirin, Mitsubishi-Tanabe Pharma, Mochida Pharma, Nichiiko, Nippon Kayaku, Takeda Pharmaceutical Co. Ltd, Zeria Pharma. Received commercial research funding from AbbVie GK, Alfresa Corporation, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Celgene Corporation, EA Pharma Co. Ltd, Eisai Co. Ltd, Eli Lilly and Company, Gilead Sciences, Janssen Pharmaceutical K.K., Kissei pharmaceutical Co. Ltd, Takeda Pharmaceutical Co. Ltd.||Prof. Dr. Okamoto, Ryuichi:|:|Received research grant from Janssen Pharmaceutical K.K related to this study. Received scholarship grant: Mitsubishi Tanabe Pharma, Zeria, MOCHIDA Pharmaceutical Co.,Ltd., Takeda Pharmaceutical Co.,Ltd.||Dr. Yamada, Akihiro:|:|Received personal fees (honoraria) form Janssen Pharmaceutical K.K. related to this study.||Dr. Kunisaki, Reiko:|:|Received speakers, advisory and consultancy fees from AbbVie GK, Astellas Pharm Inc, EA Pharma Co, Ltd, Janssen Pharmaceuticals, K.K. Kissei Pharmaceutical Co, Ltd, Kyorin Pharmaceutical Co, Ltd, Kyowa Hakko Kirin Co, Ltd, Nippon Kayaku Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharma Co Ltd, and Zeria Pharmaceutical Co Ltd and has received research funding from AbbVie GK, Ajinomoto Co, Inc, EA Pharma Co, Ltd, Janssen Pharmaceuticals, K.K. Kissei Pharmaceutical Co, Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharma Co Ltd, Zeria Pharmaceutical Co Ltd, Eli Lilly and Company, and Pfizer Inc.||Dr. Matsuura, Minoru:|:|Received personal fees from Mitsubishi Tanabe Pharma Corporation. ,AbbVie GK.,Takeda Pharmaceutical Co.,Ltd. Janssen Pharmaceutical K.K., KYORIN Pharmaceutical Co.,Ltd., MOCHIDA Pharmaceutical Co.,Ltd., Mylan EPD G.K., aspen JAPAN, Nippon Kayaku Co.,Ltd., JIMRO, EA Pharma Co.,Ltd., KISSEI PHARMACEUTICAL CO., LTD. Received grant from Mitsubishi Tanabe Pharma Corporation., AbbVie GK., KYORIN Pharmaceutical Co.,Ltd., MOCHIDA Pharmaceutical Co.,Ltd., Nippon Kayaku Co.,Ltd., JIMRO, EA Pharma Co.,Ltd., AYUMI Pharmaceutical Co.,Ltd. Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Watanabe, Kenji:|:|Received research grants from Janssen Pharmaceutical K.K, EA Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd., and Scholarship grants from Mitsubishi Tanabe Pharma Corporation; AbbVie Japan Co., Ltd.; EA Pharma Co., Ltd.,and honoraria from Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceutical Co., Ltd.; AbbVie Japan Co., Ltd.; EA Pharma Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Kyorin Pharmaceutical Co.; Mochida Pharmaceutical Co., Ltd., and Endowed chair from AbbVie Japan Co., Ltd.; EA Pharma Co., Ltd.; Zeia Pharmaceutical Co.. Ltd.; Kyorin Pharmaceutical Co.; Mitsubishi Tanabe Pharma Corporation; JIMRO Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Asahi Kasei Medical Co., Ltd; Mochida Pharmaceutical Co., Ltd. ||Dr. Shiga, Hisashi:|:|Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Takatsu, Noritaka:|:|Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Bamba, Shigeki:|:|Received lecture fees from AbbVie GK, Mitsubishi Tanabe Pharma Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Janssen, Mochida Pharmaceutical, and EA Pharma Co., Ltd., and research support from AbbVie GK. Received research grant from Janssen Pharmaceutical K.K related to this study.||Dr. Mikami, Yohei:|:|Received research grant from Janssen Pharmaceutical K.K related to this study|||Dr. Yamamoto, Takayuki:|:|Received research grant from Janssen Pharmaceutical K.K related to this study|||Dr. Shimoyama, Takahiro:|:|Received research grant from Janssen Pharmaceutical K.K related to this study|||Dr. Motoya, Satoshi:|:|Received lecture fees from Mitsubishi Tanabe Pharma Co., Ltd., AbbVie GK, Mochida Pharmaceutical, Takeba Pharamaceutical, Janssen, and research support from Pfizer Japan Inc., AbbVie GK, EA Pharma Co., Janssen and Takeba Pharamaceutical. Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Torisu, Takehiro:|:|Received grants from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co., AbbVie GK., Zeria Pharmaceutical Co., Ltd., Janssen Pharmaceutical K. K and MOCHIDA PHARMACEUTICAL CO., LTD.||Dr. Kobayashi, Taku:|:|Received personal fees from Alfresa Pharma, Covidien, Eli Lilly, Ferring Pharmaceuticals, Janssen, Kyorin Pharmaceutical Co., Ltd, Mochida Pharmaceutical, Nippon Kayaku, Pfizer, Takeda Pharmaceutical, Thermo Scientific, Abbvie GK, Ajinomoto Pharma, Astellas, Celltrion, EA Pharma Co., Ltd, Mochida Pharmaceutical, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma , ZERIA, Gilead Sciences, JIMRO Co., Ltd, grants from Abbvie GK, EA Pharma Co., Ltd, Otsuka Holdings Co., Ltd, ZERIA, Kyorin Pharmaceutical Co., Ltd, Mochida Pharmaceutical, EA Pharma Co., Ltd, Thermo Fisher Scientific, Alfresa Pharma, Nippon Kayaku||Prof. Dr. Ohmiya, Naoki:|:| Received lecture fees from EA Pharma Co., Ltd, commissioned/joint research from Abbvie GK, Daiichi Sankyo Company, Limited., grants from Bristol-Myers Squibb Company, Takeba Pharamaceutical, Eli Lilly,Mitsubishi Tanabe Pharma Co., Ltd, Nippon Kayaku Co., Ltd. Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Saruta, Masayuki:|:|Received honoraria from Abbvie GK, Janssen Pharma K.K., Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co.,Ltd., Zeria Pharmaceutical Co.,Ltd., Takeda Pharmaceutical Co.,Ltd., Kissei Pharmaceutical Co.,Ltd., Pfizer Japan Inc. Received fees for promotional materials from EA Pharma Co.,Ltd; Scholarship Donations from EA Pharma Co.,Ltd, Zeria Pharmaceutical Co.,Ltd., Mochida Pharmaceutical Co.,Ltd., Otsuka Pharmaceutical Co., Ltd. Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Matsuda, Koichiro:|:|Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Matsumoto, Takayuki:|:|Shareholder: Tanabe Mitsubishi, Abbvie, EA Pharma, Jansen Pharmaceutical, Kyorin Pharamaceutical, Mochida Pharamaceutical, Takeba Pharamaceutical. Received research grant from Janssen Pharmaceutical K.K related to this study||Prof. Dr. Nakase, Hiroshi:|:|Received research support from AbbVie GK., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co.,Ltd., Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical K.K, Takeda Pharmaceutical Co.,Ltd., Pfizer Inc, Celgene Corporation., EA Pharma Co.,Ltd., Zeria Pharmaceutical CO.,Ltd., Mochida Pharmaceutical Co.,Ltd., Nippon Kayaku Co.,Ltd., Daiichi Sankyo Company, Limited., JIMRO Co.,Ltd., as well as grants for commissioned/joint research from Hoya Group Pentax Medical, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company. Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Maemoto, Atsuo:|:|Received research grant from Janssen Pharmaceutical K.K related to this study||Dr. Shinzaki, Shinichiro:|:|Received speaker fees from Abbvie Inc, Aspen Japan Co., Ltd., EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., JIMRO Co., Ltd., Mitsubishi-Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Pharmaceuticals K.K., Takeda Pharmaceutical Co.,Ltd., Zeria Pharmaceutical Co., Ltd. Received research grant form Sekisui Medical Co., Ltd. Received advisory fees from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co.,Ltd.||Dr. Murata, Yoko:|:|Employee of Janssen Pharmaceutical K.K.||Mr. Yoshigoe, Shinichi:|:|Employee of Janssen Pharmaceutical K.K.||Dr. Sasaki, Ayako:|:|Employee of Janssen Pharmaceutical K. K.||Mr. Yajima, Tsutomu:|:|Employee of Janssen Pharmaceutical K.K.||Prof. Dr. Hisamatsu, Tadakazu:|:|Tadakazu Hisamatsu has received research grants from Alfresa Pharma Co. Ltd., EA pharma Co. Ltd., Mitsubishi Tanabe Pharma Corporation, AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., and received consulting fees from EA pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd. , and received lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc.

P173 Rodríguez, Andrés: No conflict of interest||Dr. Herreros, Belen: No conflict of interest||Muñoz, Roser: No conflict of interest||Dr. Sempere, Laura: No conflict of interest||Sirera, Paula: No conflict of interest||Dr. González-Bueno, Victoria: No conflict of interest||Dr. Torregrosa, María Eugenia: No conflict of interest||Dr. Alfayate, Rocio: No conflict of interest||Orts, Beatriz: No conflict of interest||Prof. Dr. Zapater, Pedro: No conflict of interest||Tejedo, Dolores: No conflict of interest||Prof. Dr. Moreno-Pérez, Oscar: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest

P174 Dr. COOPER, Jared: No conflict of interest||Danois, Karen: No conflict of interest||Dr. Koro, Konstantin: No conflict of interest||Dr. Wilson, Stephanie: No conflict of interest||Dr. Medellin, Alexandra: No conflict of interest||Dr. Ma, Christopher: No conflict of interest||Dr. Novak, Kerri: No conflict of interest||Dr. Seow, Cynthia: No conflict of interest||Dr. Kaplan, Gilaad: No conflict of interest||Dr. Panaccione, Remo: No conflict of interest||Dr. Lu, Cathy: No conflict of interest

P175 Dr. Yzet, Clara:|:|takeda, janseen, abbvie||Dr. Brazier, Franck: No conflict of interest||Dr. Sebbagh, Virginie: No conflict of interest||Dr. Vanelslander, Pierre: No conflict of interest||Dr. Dejour, Valérie: No conflict of interest||Mrs. David, Blanche: No conflict of interest||Prof. Dr. Nguyen-Khac, Eric: No conflict of interest||Mr. Diouf, Momar: No conflict of interest||Prof. Dr. Fumery, Mathurin:|:|Takeda, pfizer, Jansen, Abbvie, Amgen, Gilead

P176 Ms. WICKRAMASEKERA, Nyantara: No conflict of interest||Shackley, Phil: No conflict of interest||Coates, Elizabeth: No conflict of interest||Barr, Amy: No conflict of interest||Lee, Matthew: No conflict of interest||Blackwell, Sue: No conflict of interest||Bedford, Hugh: No conflict of interest||Dames, Nicola: No conflict of interest||Prof. Sebastian, Shaji: No conflict of interest||Prof. Probert, Christopher: No conflict of interest||Prof. Lobo, Alan: No conflict of interest

P177 Dr. Jacob Broder , Brodersen: No conflict of interest||Mrs. Karina Winther, Andersen: No conflict of interest||Dr. JENSEN, Michael Dam: No conflict of interest

P178 Dr. BUSACCA, Anita: No conflict of interest||Dr. Sinagra, Emanuele: No conflict of interest||Dr. Guida, Laura: No conflict of interest||Dr. Carrozza, Lucio: No conflict of interest||Dr. Melodia, Miriana: No conflict of interest||Dr. Maida, Marcello: No conflict of interest||Dr. Battaglia, Salvatore: No conflict of interest||Dr. Celsa, Ciro: No conflict of interest||Prof. Cammà, Calogero: No conflict of interest||Dr. Cappello, Maria: No conflict of interest

P179 Prof. Dr. Hisamatsu, Tadakazu:|:|COI: This study was conducted as a collaborative research and funded by Takeda Pharmaceutical Company. Hisamatsu Tadakazu has received advisory fee from Takeda for scientific advice about this research. Annabelle Yoon is an employee of Takeda.|COI of Tadakazu Hisamatsu is,|Joint Research: Alfresa Pharma Co. Ltd., EA pharma Co. Ltd., |Grant support: Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd.|Consulting fee: EA pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd. |Lecture fee: Mitsubishi Tanabe Pharma Corporation, AbbVie GK, EA pharma Co. Ltd., Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc.|||Mrs. Yoon, Annabelle:|:|This study was conducted as a collaborative research and funded by Takeda Pharmaceutical Company. Hisamatsu Tadakazu has received advisory fee from Takeda for scientific advice about this research. Annabelle Yoon is an employee of Takeda.

P180 Dr. Gibbons, Eimear: No conflict of interest||Dr. Hayes, Thomas: No conflict of interest||Dr. Shahzad, Chuhadry Khurum: No conflict of interest||Dr. Hussain, Abid: No conflict of interest||Dr. Hall, Barry: No conflict of interest||Dr. Smyth, Clare: No conflict of interest||Prof. Farrell, Richard: No conflict of interest||Dr. Kelly, Orlaith: No conflict of interest

P181 Dr. Chee, Desmond: No conflict of interest||Ms. Nice, Rachel: No conflict of interest||Dr. Hamilton, Ben: No conflict of interest||Mr. Jones, Edward: No conflict of interest||Ms. Hawkins, Sarah: No conflict of interest||Ms. Redstone, Clare: No conflict of interest||Ms. Cairnes, Vida: No conflict of interest||Dr. Pohl, Keith: No conflict of interest||Dr. Chanchlani, Neil: No conflict of interest||Dr. Lin, Simeng:|:|Dr. Chee reports non-financial support from Ferring, personal fees and non-financial support from Pfizer, outside the submitted work.||Dr. Kennedy, Nick:|:|Dr. Kennedy reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; grants and non-financial support from AbbVie, grants and personal fees from Celltrion, personal fees and non-financial support from Janssen, personal fees from Takeda, personal fees and non-financial support from Dr Falk, outside the submitted work.||Dr. Ahmad, Tariq:|:|Dr. Ahmad reports grants and non-financial support from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; personal fees from Biogen inc, grants and personal fees from Celltrion Healthcare, personal fees and non-financial support from Immundiagnostik, personal fees from Takeda, personal fees from ARENA, personal fees from Gilead, personal fees from Adcock Ingram Healthcare, personal fees from Pfizer, personal fees from Genentech, non-financial support from Tillotts , outside the submitted work.||Dr. Goodhand, James:|:|Dr. Goodhand reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study.||Dr. McDonald, Timothy: No conflict of interest

P182 Dr. Chavannes, Mallory: No conflict of interest||Dr. Hart, Lara: No conflict of interest||Dr. Dillman, Jonathan R: No conflict of interest||Dr. Marachelian, Araz: No conflict of interest||Dr. Polk, D Brent: No conflict of interest

P183 Dr. Gatti, Simona: No conflict of interest||Dr. vallorani, martina: No conflict of interest||Dr. zoppi, elisabetta: No conflict of interest||Dr. palego, giulia: No conflict of interest||Dr. aloi, marina: No conflict of interest||Dr. bramuzzo, matteo: No conflict of interest||Dr. felici, enrico: No conflict of interest||Dr. zuin, giovanna: No conflict of interest||Dr. borali, elena: No conflict of interest||Dr. catassi, giulia: No conflict of interest||Dr. grazian, federica: No conflict of interest||Dr. quagliarella, alessandra: No conflict of interest||Prof. catassi, carlo: No conflict of interest

P184 Mrs. Van Lingen, Emilie: No conflict of interest||Dr. Tushuizen, Maarten: No conflict of interest||Mr. Steenhuis, Maarten: No conflict of interest||Ms. van Deynen, Tamina: No conflict of interest||Ms. Martens, Juul: No conflict of interest||Ms. Diaz-Infante Morales, Daniela: No conflict of interest||Dr. van der Meulen-de Jong, Andrea: No conflict of interest||Dr. Molendijk, Ilse: No conflict of interest||Dr. van der Marel, Sander: No conflict of interest||Dr. Maljaars, Jeroen: No conflict of interest

P185 Dr. Hernandez Camba, Alejandro: No conflict of interest||Dr. Ramos, Laura: No conflict of interest||Dr. Madrid Álvarez, M. Blanca: No conflict of interest||Dr. Pérez-Méndez, Lina: No conflict of interest||Dr. Nos, Pilar: No conflict of interest||Dr. Hernández, Vicente: No conflict of interest||Dr. Guerra, Ivan: No conflict of interest||Dr. Jimenez, Nuria: No conflict of interest||Dr. Lorente, Rufo: No conflict of interest||Dr. Sierra-Ausín, Mónica: No conflict of interest||Dr. Ginard, Daniel: No conflict of interest||Dr. Varela, Pilar: No conflict of interest||Dr. Arranz, Laura: No conflict of interest||Dr. Cabello Tapia, María José: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Barreiro, Manuel: No conflict of interest

P186 Dr. Dahmani, Wafa: No conflict of interest||Dr. Sahar, Nasr: No conflict of interest||Dr. Aya, Hammami: No conflict of interest||Dr. Nour, Elleuch: No conflict of interest||Dr. Wafa, Ben Ameur: No conflict of interest||Dr. Aida, Ben Slama: No conflict of interest||Dr. Ahlem, Brahem: No conflict of interest||Dr. Mehdi, Ksiaa: No conflict of interest||Dr. Hanene, Jaziri: No conflict of interest||Dr. Ali, Jmaa: No conflict of interest

P187 Dr. Wolf, Douglas C:|:|Consulting and/or Participation in Advisory Boards for AbbVie, Corrona, Eli Lilly, Janssen, Pfizer, Prometheus, Takeda, UCB||Dr. Naegeli, April N:|:|Eli Lilly and Company, employee/stock||Dr. Moore, Page C:|:|Corrona, LLC, employee||Dr. Janak, Jud C:|:|Corrona, LLC, employee||Dr. Crabtree, Margaux M:|:|Corrona, LLC, employee||Dr. Shan, Mingyang:|:|Eli Lilly and Company, employee/stock||Dr. Hunter, Theresa M:|:|Eli Lilly and Company, employee/stock||Dr. Sontag, Angelina:|:|Eli Lilly and Company, employee/stock||Dr. Cross, Raymond K:|:|Consulting and/or Participation in Advisory Boards for AbbVie, Bristol Myers Squibb, LabCorp, Janssen, Pfizer, Samsung Bioepis, and Takeda

P188 Dr. AFONSO, Joao: No conflict of interest||Dr. Mascarenhas, Miguel: No conflict of interest||Dr. Ribeiro, Tiago: No conflict of interest||Dr. Cardoso, Hélder: No conflict of interest||Dr. Ferreira, João: No conflict of interest||Dr. Andrade, Patrícia: No conflict of interest||Prof. Dr. Jorge, Renato: No conflict of interest||Prof. Dr. Lopes, Susana: No conflict of interest||Prof. Dr. Macedo, Guilherme: No conflict of interest

P190 CHARAN, Mahima: No conflict of interest||Dr. Maclaren, Laura: No conflict of interest||Dr. Bryant, Cameron: No conflict of interest||Ms. Wade, Katherine: No conflict of interest||Mrs. Johnson, Heather: No conflict of interest||Dr. McLaughlin, Simon: No conflict of interest

P191 Dr. Koureta, Evgenia: No conflict of interest||Dr. TAMPAKI, Maria: No conflict of interest||Dr. Voulgaris, Theodoros: No conflict of interest||Dr. Laoudi, Efrosini: No conflict of interest||Dr. Karatzas, Panteleimon: No conflict of interest||Prof. Dr. Papatheodoridis, Georgios: No conflict of interest

P192 Prof. Knyazev, Oleg: No conflict of interest||Lishchinskaia, Albina: No conflict of interest||Kagramanova, Anna: No conflict of interest||Ms. Zvyaglova, Mariya: No conflict of interest||Dr. Noskova, Karina: No conflict of interest||Mr. Kulakov, Dmitriy: No conflict of interest||Prof. Parfenov, Asfold: No conflict of interest

P193 Dr. Domislović, Viktor: No conflict of interest||Dr. Hrabric Sonje, Kristina: No conflict of interest||Prof. Dr. Brinar, Marko: No conflict of interest||Prof. Dr. Cukovic-Cavka, Silvija: No conflict of interest||Dr. Turk, Niksa: No conflict of interest||Dr. Grgic, Dora: No conflict of interest||Prof. Dr. Sjekavica, Ivica: No conflict of interest||Prof. Dr. Krznaric, Zeljko: No conflict of interest

P194 Mrs. Vinni, Eleni: No conflict of interest||Dr. Karaivazoglou, Katerina: No conflict of interest||Mrs. Lourida, Theoni: No conflict of interest||Mrs. Kalogeropoulou, Maria: No conflict of interest||Mrs. Tourkochristou, Evanthia: No conflict of interest||Mr. Tsounis, Efthymios: No conflict of interest||Mrs. Lampropoulou, Efi: No conflict of interest||Dr. Theocharis, Georgios: No conflict of interest||Prof. Thomopoulos, Konstantinos: No conflict of interest||Prof. Gourzis, Philippos: No conflict of interest||Prof. Triantos, Christos: No conflict of interest

P195 Dr. Mingazov, Airat: No conflict of interest||Prof. Achkasov, Sergey: No conflict of interest||Dr. Vardanyan, Armen: No conflict of interest||Dr. Baranova, Tatiana: No conflict of interest

P196 Dr. CAPELA, Tiago: No conflict of interest||Dr. Macedo Silva, Vitor: No conflict of interest||Dr. Freitas, Marta: No conflict of interest||Dr. Cúrdia Gonçalves, Tiago: No conflict of interest||Dr. Dias de Castro, Francisca: No conflict of interest||Dr. Moreira, Maria João: No conflict of interest||Prof. Dr. Cotter, José: No conflict of interest

P197 Dr. Ruban, Maya: No conflict of interest||Prof. Cohen, Shlomi: No conflict of interest||Dr. Yerushalmy-Feler, Anat: No conflict of interest

P198 Dr. Byrne, Michael:|:|Satisfai Health Inc. - CEO and shareholder|ai4gi (JV with Satisfai Health) - Founder|Olympus America - Via ai4gi, Satisfai Health has a co-development with Olympus America.|Handzin Inc. - Advisor and shareholder.|||Dr. East, James:|:|A shareholder in Satisfai Health Inc.||Dr. Iacucci, Marietta: No conflict of interest||Dr. Travis, Simon:|:|Advisor to Satisfai Health Inc.||Dr. Kalapala, Rakesh: No conflict of interest||Dr. Duvvur, Nageshwar: No conflict of interest||Dr. Rughwani, Hardik: No conflict of interest||Dr. Singh, Aniruddha: No conflict of interest||Mr. Monsurate, Ryan: No conflict of interest||Mr. Soudan, Florian: No conflict of interest||Ms. Laage, Greta: No conflict of interest||Mr. Cremonese, Enrico: No conflict of interest||Mr. Canaran, Lalit: No conflict of interest||Mr. St-Denis, Ludovic: No conflict of interest||Ms. Nikfal, Shima: No conflict of interest||Mr. Asselin, Jerome: No conflict of interest||Dr. Henkel, Milagros: No conflict of interest||Dr. Panaccione, Remo:|:|Shareholder in Satisfai Health Inc.

P199 Ms. Wu, Tingting: No conflict of interest||Ms. Huang, Lingjie: No conflict of interest||Prof. Dr. Cao, Qian: No conflict of interest

P200 Mr. HMIMASS, Saber: No conflict of interest||Mrs. benelbarhdadi, imane: No conflict of interest||Mrs. lagdali, nawal: No conflict of interest||Mr. borahma, mohamed: No conflict of interest||Mrs. ajana, fatima zohra: No conflict of interest

P201 Mrs. HASSINE, Amani: No conflict of interest||Dr. Akkari, Imen: No conflict of interest||Dr. Mrabet, Soumaya: No conflict of interest||Dr. Ben Jazia, Elhem: No conflict of interest

P202 Ms. LUQUE CARMONA, Ana María: No conflict of interest||Dr. Rojas Feria, María: No conflict of interest||Mrs. De la Cruz Ramirez, María Dolores: No conflict of interest||Mr. Trigo Salado, Claudio: No conflict of interest||Mr. Herrera Justiniano, José Manuel: No conflict of interest||Mr. Leo Carnerero, Eduardo: No conflict of interest

P203 Mrs. HASSINE, Amani: No conflict of interest||Dr. Hammami, Aya: No conflict of interest||Dr. Ben Ameur, Wafa: No conflict of interest||Dr. Dahmani, Wafa: No conflict of interest||Dr. Elleuch, Nour: No conflict of interest||Dr. Jaziri, Hanen: No conflict of interest||Prof. Ben Slama, Aida: No conflict of interest||Prof. Braham, Ahlem: No conflict of interest||Prof. Ksiaa, Mehdi: No conflict of interest||Dr. Bannour, Rania: No conflict of interest||Prof. Dr. Jmaa, Ali: No conflict of interest

P204 Dr. Park, Jihye: No conflict of interest||Prof. Hyuk, Yoon: No conflict of interest

P205 Ms. Sabbah, Mariam: No conflict of interest||Ms. Jlassi, Houssaina: No conflict of interest||Ms. Bellil, Nawel: No conflict of interest||Ms. Trad, Dorra: No conflict of interest||Ms. Ouakaa, Asma: No conflict of interest||Ms. Bibani, Norsaf: No conflict of interest||Ms. Gargouri, Dalila: No conflict of interest

P206 Dr. SETHURAMAN, Aruna: No conflict of interest||Dr. Kontaki, Eleni: No conflict of interest||Dr. Gaynor, Edward: No conflict of interest||Dr. Jones, Kelsey: No conflict of interest||Dr. Cherian, Abraham: No conflict of interest||Dr. Zamvar, Veena: No conflict of interest||Dr. Kiparissi, Fevronia: No conflict of interest

P207 Dr. Johnsen, Kay-Martin: No conflict of interest||Dr. Mona, Dixon Gundersen: No conflict of interest||Prof. Florholmen, Jon: No conflict of interest||Prof. Goll, Rasmus: No conflict of interest

P208 Dr. Dahmani, Wafa: No conflict of interest||Dr. Sahar, Nasr: No conflict of interest||Dr. Ay, Hammami: No conflict of interest||Dr. Nour, Elleuch: No conflict of interest||Dr. Wafa, Ben Ameur: No conflict of interest||Prof. Aida, Ben Slama: No conflict of interest||Dr. Ahlem, Brahem: No conflict of interest||Dr. Mehdi, Ksiaa: No conflict of interest||Dr. Hanene, Jaziri: No conflict of interest||Prof. Ali, Jmaa: No conflict of interest

P209 Mrs. HASSINE, Amani: No conflict of interest||Dr. Hammami, Aya: No conflict of interest||Prof. Dr. Braham, Ahlem: No conflict of interest||Dr. Jaziri, Hanen: No conflict of interest||Prof. Dr. Jmaa, Ali: No conflict of interest

P210 Dr. Rodríguez-Lago, Iago: No conflict of interest||Mr. Agirre, Urko: No conflict of interest||Dr. Intxaurza, Nekane: No conflict of interest||Dr. Cantero, David: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Dr. Cabriada, José Luis: No conflict of interest

P211 Ms. SPIGARELLI DE RÁBAGO, Isabel: No conflict of interest||Ms. Suárez Ferrer, Cristina: No conflict of interest||Mr. Poza Cordón, Joaquín: No conflict of interest||Mr. Martín Arranz, Eduardo: No conflict of interest||Ms. Sánchez Azofra, María: No conflict of interest||Mr. Rueda García, Jose Luis: No conflict of interest||Ms. Suarez Cabredo, Carolina Georgina: No conflict of interest||Ms. Hernández Pérez, María: No conflict of interest||Ms. Martín Arranz, María Dolores: No conflict of interest

P212 Dr. Hrabric Sonje, Kristina: No conflict of interest||Dr. Domislović, Viktor: No conflict of interest||Prof. Dr. Brinar, Marko: No conflict of interest||Prof. Dr. Cukovic-Cavka, Silvija: No conflict of interest||Turk, Niksa: No conflict of interest||Grgic, Dora: No conflict of interest||Prof. Dr. Sjekavica, Ivica: No conflict of interest||Prof. Dr. Krznaric, Zeljko: No conflict of interest

P213 Mrs. Paulides, Emma: No conflict of interest||Mrs. Cornelissen, Demi: No conflict of interest||Prof. Dr. van der Woude, Christien Janneke: No conflict of interest

P214 Dr. CASERTANO, Marianna: No conflict of interest||Dr. Cenni, Sabrina: No conflict of interest||Dr. Caprio, Angela Maria: No conflict of interest||Dr. Oglio, Franca: No conflict of interest||Dr. Pacella, Daniela: No conflict of interest||Dr. Miele, Erasmo: No conflict of interest||Dr. Martinelli, Massimo: No conflict of interest||Prof. Dr. Staiano, Annamaria: No conflict of interest||Dr. Strisciuglio, Caterina: No conflict of interest

P215 Grova, Mauro: No conflict of interest||Dr. Crispino, Federica: No conflict of interest||Dr. Maida, Marcello: No conflict of interest||Dr. Renna, Sara:|:|Sara Renna served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, MSD and Takeda Pharmaceuticals ||Dr. Mocciaro, Filippo:|:|Filippo Mocciaro served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, Janssen, Pfizer and Takeda Pharmaceuticals. ||Dr. Casà, Angelo: No conflict of interest||Dr. Rizzuto, Giulia: No conflict of interest||Dr. Scimeca, Daniela: No conflict of interest||Dr. Di Mitri, Roberto: No conflict of interest||Dr. Macaluso, Fabio Salvatore:|:|Fabio Salvatore Macaluso served as an advisory board member and/or received lecture grants from AbbVie, Biogen, MSD, and Takeda Pharmaceuticals. ||Dr. Orlando, Ambrogio:|:|Ambrogio Orlando served as an advisory board member for AbbVie, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals.

P216 Dr. Lorenzon, Greta: No conflict of interest||Dr. Marsilio, Ilaria: No conflict of interest||Dr. Maniero, Daria: No conflict of interest||Dr. Rigo, Alessandra: No conflict of interest||Dr. Barberio, Brigida: No conflict of interest||Dr. Zingone, Fabiana: No conflict of interest||Dr. Bahur, Bayda:|:| full-time employee of ProciseDx Inc, and hold options to purchase shares||Dr. Bray , Kurtis R.:|:|full-time employee of ProciseDx Inc, hold options to purchase shares||Prof. Savarino, Edoardo Vincenzo: No conflict of interest

P217 Dr. Fadeeva, Nina: No conflict of interest||Prof. Dr. Knyazev, Oleg: No conflict of interest||Prof. Dr. Parfenov, Asfold: No conflict of interest||Dr. Kagramanova, Anna: No conflict of interest||Dr. Lishinskaya, Albina: No conflict of interest||Ms. Babayan, Anait: No conflict of interest||Dr. Danilov, Mikhail: No conflict of interest||Mr. Dolgopyatov, Igor: No conflict of interest

P218 Mrs. HASSINE, Amani: No conflict of interest||Dr. Akkari, Imen: No conflict of interest||Dr. Mrabet, Soumaya: No conflict of interest||Dr. Ben Jazia, Elhem: No conflict of interest

P219 Ms. RASMAGINA, Irina: No conflict of interest||Prof. Bakulin, Igor: No conflict of interest||Mrs. Mariya, Skalinskaya: No conflict of interest

P220 Carlson, Sean: No conflict of interest||Dr. Harrow, Paul: No conflict of interest||Dr. McCartney, Sara: No conflict of interest

P221 Dr. Kunovsky, Lumir: No conflict of interest||Dr. Marek, Filip: No conflict of interest||Prof. Dr. Kala, Zdenek: No conflict of interest||Dr. Ivanecka, Dominika: No conflict of interest||Dr. Iesalnieks, Igors: No conflict of interest

P222 Dr. Yerushalmy-Feler, Anat: No conflict of interest||Prof. Cohen, Shlomi: No conflict of interest

P223 Dr. Doherty, Jayne: No conflict of interest||Dr. Brennan, Shane: No conflict of interest||Dr. Dinneen, Kate: No conflict of interest||Dr. Muldoon, Cian: No conflict of interest||Prof. Mc Kiernan, Susan: No conflict of interest||Dr. Dunne, Cara: No conflict of interest||Dr. Mac Carthy, Finbar: No conflict of interest||Dr. Hartery, Karen: No conflict of interest||Dr. Ciara, Ryan: No conflict of interest||Prof. Kevans, David: No conflict of interest

P224 Prof. Arias-Loste, María Teresa: No conflict of interest||Ms. Salcines, Leticia: No conflict of interest||Dr. Rodriguez-Duque, Juan Carlos: No conflict of interest||Dr. García García, María José: No conflict of interest||Prof. Iruzubieta, Paula: No conflict of interest||Dr. Rivas, Coral: No conflict of interest||Dr. Castro, Beatriz: No conflict of interest||Prof. Rivero, Montserrat: No conflict of interest||Prof. Crespo, Javier: No conflict of interest

P225 Dr. Sahar, Nasr: No conflict of interest||Dahmani, Wafa: No conflict of interest||Dr. Nour, Elleuch: No conflict of interest||Dr. Aya, Hammami: No conflict of interest||Dr. Wafa, Ben Ameur: No conflict of interest||Dr. Aida, Ben Slama: No conflict of interest||Dr. Salem, Ajmi: No conflict of interest||Dr. Ahlem, Brahem: No conflict of interest||Dr. Mehdi, Ksiaa: No conflict of interest||Dr. Hanene, Jaziri: No conflict of interest||Dr. Ali, Jmaa: No conflict of interest

P226 Ms. BEN FARHAT, Fatma: No conflict of interest||Dr. Sabbah, Mariem: No conflict of interest||Ms. Ben Abid, Mariem: No conflict of interest||Dr. Bibani, Norsaf: No conflict of interest||Dr. Bellil, Nawel: No conflict of interest||Dr. Aoun, Karim: No conflict of interest||Dr. Bouratbine, Aida: No conflict of interest||Dr. Gargouri, Dalila: No conflict of interest

P227 Dr. Sahar, Nasr: No conflict of interest||Dr. Dahmani, Wafa: No conflict of interest||Dr. Nour, Elleuch: No conflict of interest||Dr. Aya, Hammami: No conflict of interest||Dr. Wafa, Ben Ameur: No conflict of interest||Prof. Aida, Ben Slama: No conflict of interest||Prof. Ahlem, Brahem: No conflict of interest||Prof. Mehdi, Ksiaa: No conflict of interest||Dr. Hanene, Jaziri: No conflict of interest||Prof. Ali, Jmaa: No conflict of interest

P228 Ms. Ruiterkamp, Marit: No conflict of interest||Ms. Arkenbosch, Jeanine: No conflict of interest||Dr. van Ruler, Oddeke: No conflict of interest||Dr. van der Marel, Sander: No conflict of interest||Dr. van Dongen, Koen: No conflict of interest||Dr. Maljaars, P. W. Jeroen: No conflict of interest||Dr. Hoentjen, Frank: No conflict of interest||Dr. West, Rachel: No conflict of interest||Dr. Jharap, Bindia: No conflict of interest||Prof. Dr. Dijkstra, Gerard: No conflict of interest||Dr. Campmans-Kuijpers, Marjo: No conflict of interest||Mrs. Jansen, Sita: No conflict of interest||Mrs. Romberg-Camps, Mariëlle: No conflict of interest||Prof. Dr. Stassen, Laurents: No conflict of interest||Prof. Dr. van der Woude, C. Janneke: No conflict of interest||Dr. de Vries, Annemarie: No conflict of interest

P229 Dr. Afonso, Joana:|:|Employee of BÜHLMANN Laboratories AG||Dr. Ricken, Benjamin:|:|Employee of BÜHLMANN Laboratories AG||Dr. Schuster, Thomas:|:|Employee of BÜHLMANN Laboratories AG||Dr. Guschin, Dmitrii:|:|Employee of BÜHLMANN Laboratories AG||Mr. Schneider, Michael:|:|Employee of BÜHLMANN Laboratories AG

P230 Dr. Tanaka, Makoto: No conflict of interest||Dr. Kawakami, Aki: No conflict of interest||Ms. Sakagami, Kayoko: No conflict of interest||Ms. Terai, Tomoko: No conflict of interest||Dr. Ito, Hiroaki: No conflict of interest

P231 Ms. Jlassi, Houssaina: No conflict of interest||Ms. Sabbah, Mariam: No conflict of interest||Ms. Bellil, Nawel: No conflict of interest||Ms. Trad, Dorra: No conflict of interest||Ms. Ouakaa, Asma: No conflict of interest||Ms. Bibani, Norsaf: No conflict of interest||Ms. Gargouri, Dalila: No conflict of interest

P232 Dr. Kaazan, Patricia: No conflict of interest||Dr. li, tracy: No conflict of interest||seow, warren: No conflict of interest||bednarz, jana: No conflict of interest||Mr. pipicella, Joseph: No conflict of interest||Dr. Ng, Watson: No conflict of interest||Dr. Wiiliams , Astrid-Jane: No conflict of interest||Prof. Connor , Susan: No conflict of interest||Prof. Dr. Andrews, Jane: No conflict of interest

P233 Mrs. HASSINE, Amani: No conflict of interest||Dr. Hamami, Aya: No conflict of interest||Dr. Dahmani, Wafa: No conflict of interest||Dr. Ben Ameur, Wafa: No conflict of interest||Dr. Elleuch, Nour: No conflict of interest||Prof. Braham, Ahlem: No conflict of interest||Dr. Bannour, Rania: No conflict of interest||Dr. Jaziri, Hanen: No conflict of interest||Prof. Dr. Jmaa, Ali: No conflict of interest

P234 Dr. Muñoz-Villafranca, Carmen: No conflict of interest||Dr. IRABIEN, Martin: No conflict of interest||Dr. Hernandez-Aretxabaleta, Nerea: No conflict of interest||Dr. Arreba, Paz: No conflict of interest||Dr. Ortiz de Zárate, Jone: No conflict of interest||Dr. Garcia-Gomez, Carmen: No conflict of interest||Mr. Aresti, Unai: No conflict of interest||Mrs. Bilbao, Amaia: No conflict of interest||Dr. Irigoyen, Maria: No conflict of interest||Dr. Garcia-Vivar, Maria Luz: No conflict of interest

P235 Dr. FACANALI, Carolina: No conflict of interest||Prof. Dr. Sousa Freitas Queiroz, Natalia:|:|has served as a speaker and advisory board member of Janssen, Takeda and Abbvie.||Dr. Facanali, Marcio Roberto: No conflict of interest||Dr. Rodrigues Boarini, Lucas:|:|has served as a speaker from Abbvie||Dr. Amuratti Gonçalves, José Luiz: No conflict of interest||Prof. Dr. Rodrigues Borba, Marcelo:|:|reports reciving travel grants support from Janssen||Prof. Dr. Nahas, Sergio Carlos: No conflict of interest||Prof. Dr. Sobrado, Carlos Walter:|:|has served as a speaker from Janssen, Takeda and Abbvie.

P236 Klaus, Jochen: No conflict of interest||Kretschmer, Monika: No conflict of interest||Schulte, Lucas: No conflict of interest||Kaltenbach, Tanja: No conflict of interest||Rauschek, Lena: No conflict of interest||Ms. Sularz, Melanie: No conflict of interest

P237 Dr. Junior, Romulo Silva Freire: No conflict of interest||Dr. Carvalho, Matheus Ferreira: No conflict of interest||Dr. Silva, Jessica Calheiros: No conflict of interest||Dr. Barros, Luisa Leite: No conflict of interest||Dr. Azevedo, Matheus Freitas Cardoso: No conflict of interest||Dr. Carlos, Alexandre de Souza: No conflict of interest||Dr. Oba, Jane: No conflict of interest||Dr. Hashimoto, Cláudio Lyoiti: No conflict of interest||Prof. Cançado, Eduardo Luiz Rachid: No conflict of interest||Dr. Damiao, Aderson Omar Moura Cintra: No conflict of interest||Dr. Sipahi, Aytan Miranda: No conflict of interest

P238 Dr. Biscanin, Alen: No conflict of interest||Dr. Tomasic, Vedran: No conflict of interest||Dr. Dorosulic, Zdravko: No conflict of interest||Dr. Kralj, Dominik: No conflict of interest||Dr. Lerotic, Ivan: No conflict of interest||Dr. Cacic, Petra: No conflict of interest||Dr. Ogresta, Doris: No conflict of interest||Dr. Hrabar, Davor: No conflict of interest

P239 Dr. Mahmood, Tariq: No conflict of interest||Dr. Muhammad, Qasim: No conflict of interest

P240 Dr. Miettinen, Johanna:|:|Provision of writing assistance||Prof. Vuolteenaho, Olli: No conflict of interest||Ms. Hedberg, Pirjo: No conflict of interest

P241 Dr. Luber, Raphael:|:|RPL has received educational grants from Ferring, Pfizer and Vifor Pharma. ||Dr. Petri, Bianca: No conflict of interest||Dr. Griffin, Nyree: No conflict of interest||Dr. Irving, Peter:|:|PMI has served as a speaker, a consultant and/or an advisory board member for Abbvie, Warner Chilcott, Ferring, Falk Pharma, Takeda, MSD, Johnson and Johnson, Shire, Vifor Pharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, and has received research funding from MSD, Takeda.

P242 Samarasinghe, Muditha: No conflict of interest||Chariah, Florence: No conflict of interest||Dr. Desilva, Chinthaka: No conflict of interest||Dr. Koutsoumpas, Andreas: No conflict of interest

P243 Prof. Knyazev, Oleg: No conflict of interest||Ms. Kagramanova, Anna: No conflict of interest||Lishchinskaya, Albina: No conflict of interest||Li, Irina: No conflict of interest||Dr. Noskova, Karina: No conflict of interest||Ms. Fadeeva, Nina: No conflict of interest||Subbotin, Valeriy: No conflict of interest||Demchenko, Alexandra: No conflict of interest||Babayan, Anait: No conflict of interest||Zvyaglova, Mariya: No conflict of interest||Kulakov, Dmitriy: No conflict of interest

P244 Ms. WICKRAMASEKERA, Nyantara: No conflict of interest||Dr. Shackley, Phil: No conflict of interest||Dr. Coates, Elizabeth: No conflict of interest||Ms. Barr, Amy: No conflict of interest||Mr. Lee, Matt: No conflict of interest||Ms. Blackwell, Sue: No conflict of interest||Mr. Bedford, Hugh: No conflict of interest||Ms. Dames, Nicola: No conflict of interest||Prof. Probert, Christopher: No conflict of interest||Prof. Sebastian, Shaji: No conflict of interest||Prof. Lobo, Alan: No conflict of interest

P245 Dr. HAMDI, Sara: No conflict of interest||Dr. Ben Ameur, Wafa: No conflict of interest||Dr. Hammami, aya: No conflict of interest||Dr. Elleuch, Nour: No conflict of interest||Dr. Dahmani, Wafa: No conflict of interest||Dr. Ben Slama, Aida: No conflict of interest||Dr. Ksiaa, Mehdi: No conflict of interest||Dr. Braham, Ahlem: No conflict of interest||Dr. Ajmi, Salem: No conflict of interest||Dr. Jaziri, Hanen: No conflict of interest||Dr. Jmaa, Ali: No conflict of interest

P246 Dr. Chee, Desmond:|:|Dr. Chee reports non-financial support from Ferring, personal fees and non-financial support from Pfizer, outside the submitted work.||Dr. Hamilton, Ben: No conflict of interest||Ms. Cairnes, Vida: No conflict of interest||Dr. Lin, Simeng:|:|Dr. Lin reports non-financial support from Pfizer, non-financial support from Ferring, outside the submitted work.||Dr. Chanchlani, Neil: No conflict of interest||Dr. Ahmad, Tariq:|:|Dr. Ahmad reports grants and non-financial support from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; personal fees from Biogen inc, grants and personal fees from Celltrion Healthcare, personal fees and non-financial support from Immundiagnostik, personal fees from Takeda, personal fees from ARENA, personal fees from Gilead, personal fees from Adcock Ingram Healthcare, personal fees from Pfizer, personal fees from Genentech, non-financial support from Tillotts , outside the submitted work.||Dr. Goodhand, James:|:|Dr. Goodhand reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study.||Dr. Kennedy, Nick:|:|Dr. Kennedy reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; grants and non-financial support from AbbVie, grants and personal fees from Celltrion, personal fees and non-financial support from Janssen, personal fees from Takeda, personal fees and non-financial support from Dr Falk, outside the submitted work.

P247 Dr. Hernandez Camba, Alejandro: No conflict of interest||Dr. Carrillo-Palau, Marta: No conflict of interest||Dr. Ramos, Laura: No conflict of interest||Dr. Hernández Alvarez-Buylla, Noemi: No conflict of interest||Dr. Alonso-Abreu, Inmaculada: No conflict of interest||Dr. Hernández, Anjara: No conflict of interest||Dr. Vela, Milagros: No conflict of interest||Dr. Arranz, Laura: No conflict of interest||Dr. Hernández-Guerra, Manuel: No conflict of interest||Dr. González-Gay, Miguel A.: No conflict of interest||Dr. Ferraz- Amaro, Ivan: No conflict of interest

P248 Dr. VÁZQUEZ GÓMEZ, Julio Alberto: No conflict of interest||Dr. Velasco Rodríguez-Belvís, Marta: No conflict of interest||Dr. Palomino Pérez, Laura María: No conflict of interest||Ms. Sánchez Llorente, Paula: No conflict of interest||Mrs. Aguilar Ladrón de Guevara, Carmen: No conflict of interest||Dr. Muñoz Codoceo, Rosa Ana: No conflict of interest

P249 Mrs. HASSINE, Amani: No conflict of interest||Dr. Hammami, Aya: No conflict of interest||Dr. Jaziri, Hanen: No conflict of interest||Dr. Elleuch, Nour: No conflict of interest||Dr. Ksiaa, Mehdi: No conflict of interest||Dr. Ben Slama, Aida: No conflict of interest||Prof. Jmaa, Ali: No conflict of interest

P250 Prof. Broide, Efrat: No conflict of interest||Dr. Richter, Vered: No conflict of interest||Dr. Mari, Amir: No conflict of interest||Dr. Khoury, Tawifik: No conflict of interest||Prof. Shirin, Haim: No conflict of interest||Dr. Naftali, Timna: No conflict of interest

P251 Serghini, Meriem: No conflict of interest||Ms. Ben Youssef, Hela: No conflict of interest||Prof. baccouche , hela: No conflict of interest||Dr. hafi, maroua: No conflict of interest||Dr. labidy, asma: No conflict of interest||Dr. ben mustapha, nadia: No conflict of interest||Prof. Dr. fekih, monia: No conflict of interest||Prof. Dr. boubaker, jalel: No conflict of interest

P252 Mrs. HASSINE, Amani: No conflict of interest||Dr. Hammami, Aya: No conflict of interest||Dr. Ben Ameur, Wafa: No conflict of interest||Dr. Dahmani, Wafa: No conflict of interest||Dr. Elleuch, Nour: No conflict of interest||Prof. Ben Slama, Aida: No conflict of interest||Prof. Braham, Ahlem: No conflict of interest||Prof. Ksiaa, Mehdi: No conflict of interest||Dr. Bannour, Rania: No conflict of interest||Dr. Jaziri, Hanen: No conflict of interest||Prof. Dr. Jmaa, Ali: No conflict of interest

P253 Newton, Louise:|:|This study was funded by Eli Lilly and Company.||Guobyte, Aiste:|:|This study was funded by Eli Lilly and Company.||McFadden, Shehan:|:|This study was funded by Eli Lilly and Company.||Symonds, Tara:|:|This study was funded by Eli Lilly and Company.||Delbecque, Laure:|:|This study was funded by Eli Lilly and Company.||Donaldson , Jill:|:|This study was funded by Eli Lilly and Company.||Naegeli, April:|:|This study was funded by Eli Lilly and Company

P254 Dr. Flores, Cristina: No conflict of interest||Dr. Petry, Roberta: No conflict of interest||Dr. Bortolin Fonseca, Carla: No conflict of interest||Dr. Dos Santos Harlacher, Luciana: No conflict of interest

P255 Dr. Crispino, Federica: No conflict of interest||Dr. Grova, Mauro: No conflict of interest||Dr. Maida, Marcello: No conflict of interest||Dr. Renna, Sara:|:|Sara Renna served as an advisory board member for AbbVie, Janssen and MSD Pharmaceuticals, and received lecture grants from AbbVie, Janssen, MSD and Takeda Pharmaceuticals. ||Dr. Casà, Angelo: No conflict of interest||Dr. Rizzo, Giulia: No conflict of interest||Dr. Macaluso, Fabio Salvatore:|:|Fabio Salvatore Macaluso served as an advisory board member and/or received lecture grants from AbbVie, Biogen, Janssen, MSD, Pfizer, Samsung Bioepis, and Takeda Pharmaceuticals.||Dr. Orlando, Ambrogio:|:|Ambrogio Orlando served as an advisory board member for AbbVie, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals.

P256 Dr. Sambuelli, Alicia: No conflict of interest||Dr. Gil , Anibal: No conflict of interest||Dr. Negreira , Silvia: No conflict of interest||Dr. Tirado , Pablo: No conflict of interest||Dr. Huernos, Sergio: No conflict of interest||Dr. Goncalves , Silvina: No conflict of interest||Prof. Dr. Lakatos , Peter: No conflict of interest

P257 Dr. PALOMINO PÉREZ, Laura María: No conflict of interest||Dr. Velasco Rodríguez-Belvis , Marta: No conflict of interest||Dr. Cañedo Villaroya, Elvira: No conflict of interest||Dr. Vazquez Gómez, Julio Alberto: No conflict of interest||Dr. Muñoz Codoceo, Rosa Ana: No conflict of interest

P258 Dr. Hazel, Karl: No conflict of interest||Dr. Glynn, Emily: No conflict of interest||Dr. Boland, Karen: No conflict of interest||Dr. O'Toole, Aoibhlinn: No conflict of interest

P259 Mr. Murphy, Christopher:|:|Shareholder||Dr. Stevens, Chris:|:|Consulting fees||Ms. Hershberger, Ellie:|:|Consulting fees||Ms. Quintas, Megan:|:|shareholder||Mr. Miller, Benjamin:|:|shareholder||Mr. Ghahramani, Parviz:|:|consulting, fees for participation in review activities

P260 Dr. Sands, Bruce E.:|:|Grants: Arena, Theravance Biopharma R&D|Personal fees: Abivax SA, Arena, Bacainn Therapeutics, Boehringer Ingeleim, Boston Pharmaceuticals, Celltrion, Cowen Services Company, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, InDex Pharmaceuticals, Inotrem, Ironwood Pharmaceuticals, Janssen Biotech, Janssen Pharmaceutica NV, Kallyope, Pfizer Inc, Prometheus Biosciences, Protagonist Therapeutics, Surrozen, Takeda, Takeda (China) International, Takeda Distribudora, Target RWE, USWM Enterprises, Viela Bio||Dr. Cohen, Russell D.:|:|Personal fees: AbbVie, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, Gilead, Janssen, Pfizer Inc, Roche, Takeda, UCB|Other (clinical trials – Principal Investigator): AbbVie, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Crohn’s & Colitis Foundation of America, Genentech, Gilead, Hollister, MedImmune, Mesoblast Ltd., Osiris Therpeutics, Pfizer Inc, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres, Takeda, UCB||Dr. Ha, Christina:|:|Grants: Pfizer Inc|Personal fees: AbbVie, Genentech, InDex Pharmaceuticals, Janssen, Pfizer Inc, Takeda||Dr. Reinisch, Walter:|:|Grants: Abbott Laboratories, AbbVie, Aesca, Centocor, Falk Pharma GMbH, Immundiagnostik, MSD|Personal fees: 4SC, Abbott Laboratories, AbbVie, Aesca, Amgen, AM Pharma, AOP Orphan, Aptalis, Arena, Astellas, AstraZeneca, Avaxia, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Cellerix, Celltrion, Centocor, ChemoCentryx, Covance, Danone, Austria, Elan, Eli Lilly, Ernst & Young, Falk Pharma GMbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Immundiagnostik, InDex, Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, MedAhead, MedImmune, Millennium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestlé, Novartis, Ocera, Otsuka, Parexel, PDL, Pfizer Inc, Pharmacosmos, Philip Morris Institute, PLS Education, Proctor & Gamble, Prometheus, Laboratories, Protagonist, Provention, Robarts Clinical Trials, Roland, Berger GmBH, Sandoz, Schering-Plough, Second Genome, Seres, Therapeutics, SetPoint Medical, Shire, Sigmoid, Takeda, Therakos, TiGenix, UCB, Vifor, Yakult, Zealand, Zyngenia||Dr. Salese, Leonardo:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Dr. Mundayat, Rajiv:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Dr. Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Dr. Panés, Julian:|:|Grants: AbbVie, Pfizer Inc|Personal fees: AbbVie, Arena, Biogen, Boehringer Ingelheim, Celgene, Genentech, Gilead, GlaxoSmithKline, GoodGut, Immunic, Janssen, MSD, Nestlé, Origo, Pfizer Inc, Progenity, Robarts Clinical Trials, Roche, Takeda, Theravance, Wasserman

P261 Dr. Dalal, Rahul: No conflict of interest||Dr. Esckilsen, Scott: No conflict of interest||Dr. Barnes, Edward:|:|Dr. Barnes has served as a consultant for AbbVie, Gilead, Pfizer, Takeda, and Target RWE.||Mr. Pruce, Jordan: No conflict of interest||Ms. Marcus, Jenna: No conflict of interest||Dr. Allegretti, Jessica:|:|Dr. Allegretti serves as a consultant for Takeda, Janssen, Pfizer, Pandion, Servatus, Finch Therapeutics, Iterative Scopes and Artugen and has grant support from Merck.

P262 Mr. Casas Deza, Diego: No conflict of interest||Lamuela Calvo, Luis Javier: No conflict of interest||Arbonés Mainar, Jose Miguel: No conflict of interest||Ricart, Elena: No conflict of interest||Gisbert, Javier P.: No conflict of interest||Rivero Tirado, Montserrat: No conflict of interest||Sanchez Rodríguez, Eugenia: No conflict of interest||Sicilia, Beatriz: No conflict of interest||Gutierrez Casbas, Ana: No conflict of interest||Merino Ochoa, Olga: No conflict of interest||Márquez, Lucia: No conflict of interest||Laredo de la Torre, Viviana: No conflict of interest||Martin Arranz, Maria Dolores: No conflict of interest||Lopez Serrano, Pilar: No conflict of interest||Riestra Menéndez, Sabino: No conflict of interest||Gonzalez Muñoza, Carlos: No conflict of interest||de Castro Parga, Luisa: No conflict of interest||Calvo Moya, Marta: No conflict of interest||Garcia Alonso, Javier: No conflict of interest||Esteve, María: No conflict of interest||Iborra Colomino, Marisa: No conflict of interest||Dura Gil, Miguel: No conflict of interest||Barreiro de Acosta, Manuel: No conflict of interest||Lorente Poyatos, Rufo: No conflict of interest||Manceñido, Noemí: No conflict of interest||Caballo, Berta: No conflict of interest||Calafat, Margalida: No conflict of interest||Rodríguez Lago, Iago: No conflict of interest||Guardiola Capo, Jordi: No conflict of interest||Morales Alvarado, Victor Jair: No conflict of interest||Tardillo, Carlos: No conflict of interest||Bujanda, Luis: No conflict of interest||Muñoz Nuñez, Jose Fernando: No conflict of interest||Ber Nieto, Yolanda: No conflict of interest||Bermejo, Fernando: No conflict of interest||Chaparro, María: No conflict of interest||Almela, Pedro: No conflict of interest||Navarro, Mercé: No conflict of interest||Domènech, Eugeni: No conflict of interest||García López, Santiago: No conflict of interest

P263 Chaparro, Maria: No conflict of interest||Bastón Rey, Iria: No conflict of interest||Fernández-Salgado, Estela: No conflict of interest||González García, Javier: No conflict of interest||Ramos, Laura: No conflict of interest||Diz-Lois Palomares, María Teresa: No conflict of interest||Argüelles, Federico: No conflict of interest||Iglesias Flores, Eva: No conflict of interest||Cabelo, Mercedes: No conflict of interest||Rubio Iturria, Saioa: No conflict of interest||Núñez Ortiz, Andrea: No conflict of interest||Charro, Mara: No conflict of interest||Ginard, Daniel: No conflict of interest||Dueñas Sadornil, Carmen: No conflict of interest||Merino Ochoa, Olga: No conflict of interest||David, Busquets: No conflict of interest||Iyo, Eduardo: No conflict of interest||Gutiérrez Casbas, Ana: No conflict of interest||Ramírez de la Piscina, Patricia: No conflict of interest||Boscá-Watts, Marta Maia: No conflict of interest||Arroyo, Maite: No conflict of interest||García, María José: No conflict of interest||Hinojosa, Esther: No conflict of interest||Gordillo, Jordi: No conflict of interest||Martínez Montiel, Pilar: No conflict of interest||Velayos Jiménez, Benito: No conflict of interest||Quílez Ivorra, Cristina: No conflict of interest||Vázque morón, Juan María: No conflict of interest||Huguet, Jose María: No conflict of interest||González Lama, Yago: No conflict of interest||Muñagorri Santos, Ana Isabel: No conflict of interest||Amo, Víctor Manuel: No conflict of interest||Martín Arranz, María Dolores: No conflict of interest||Bermejo, Fernando: No conflict of interest||Martínez Cadilla, Jesús: No conflict of interest||Fradejas Salazar, Paola: No conflict of interest||Novella, Cynthia: No conflict of interest||Vispo, Eugenia: No conflict of interest||Barreiro-de Acosta, Manuel: No conflict of interest||P. Gisbert, Javier: No conflict of interest

P264 Dr. Suris Marin, Gerard: No conflict of interest||Dr. Santacana, Eugènia: No conflict of interest||Dr. Padullés, Nuria: No conflict of interest||Dr. Padró, Ariadna: No conflict of interest||Dr. Serra, Katja: No conflict of interest||Dr. Ruiz, Alexandra: No conflict of interest||Dr. Blat, Rosa: No conflict of interest||Dr. Arajol, Claudia: No conflict of interest||Ms. Sanchez, Elena: No conflict of interest||Dr. Berrozpe, Ana: No conflict of interest||Dr. Rodríguez-Alonso, Lorena:|:|Dra Rodríguez-Alonso has served as a speaker and a consultant from MSD,Abbvie,Takeda,Janssen,Pfizer and Ferring||Dr. Rodríguez-Moranta, Francisco:|:|Conference and advisory: MSD,Jansen,Takeda,Abbvie,Pfizer||Dr. Guardiola, Jordi:|:|Dr.Guardiola has served as a speaker,a consultant, an advisory member for or has received research fundung from Roche,MSD,Abbvie,Kern P^harma,Takeda,Janssen,Pfizer,Ferring,Chiesi and GE Healthcare

P266 Dr. Truyens, Marie: No conflict of interest||Ms. De Galan, Cara: No conflict of interest||Prof. Dr. Peeters, Harald: No conflict of interest||Dr. Mesonero Gismero, Francisco: No conflict of interest||Dr. Elorza, Ainara: No conflict of interest||Dr. Torres, Paola: No conflict of interest||Dr. Vandermeulen, Liv: No conflict of interest||Dr. Jauregui Amezaga, Aranzazu: No conflict of interest||Dr. Ferreiro-Iglesias, Rocio: No conflict of interest||Dr. Holvoet, Tom: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Peries Reverter, Laia: No conflict of interest||Dr. Geldof, Jeroen: No conflict of interest||Dr. Varkas, Gaëlle: No conflict of interest||Prof. Dr. De Vos, Martine: No conflict of interest||Prof. Dr. Lobaton, Triana: No conflict of interest

P267 Dr. Huang, Zhongwen:|:|Zhongwen Huang is an employee of Takeda and holds Takeda stock or stock options.||Dr. Ba, Yi:|:|Yi Ba is an employee of Takeda and holds Takeda stock or stock options.||Dr. Kamble, Pravin:|:|Pravin Kamble is an employee of Takeda and holds Takeda stock or stock options||Wang, Song:|:|Song Wang is an employee of Takeda and holds Takeda stock or stock options.

P268 Ms. Heuthorst, Lianne: No conflict of interest||Dr. Wasmann, Karin: No conflict of interest||Ms. Reijntjes, Maud: No conflict of interest||Dr. Hompes, Roel: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest||Prof. Dr. Bemelman, Willem: No conflict of interest

P269 Mr. Thomas, Pepijn: No conflict of interest||Mr. Den Broeder, Nathan: No conflict of interest||Dr. West, Rachel:|:|RW has participated in advisory boards, or as a speaker, or consultant for the following companies: Abbvie, Janssen. ||Dr. Russel, Maurice: No conflict of interest||Mr. Jansen, Jeroen:|:|JJ has served on advisory boards, or as speaker, or consultant for Abbvie, Amgen, Ferring, Fresenius, Janssen, MSD, Pfizer, Takeda.||Dr. Römkens, Tessa:|:|TR has served as speaker, or consultant for Ferring, Janssen, Takeda. ||Dr. Hoentjen, Frank:|:|FH has served on advisory boards, or as speaker, or consultant for Abbvie, Celgene, Janssen Cilag, MSD, Takeda, Celltrion, Teva, Sandoz, and Dr Falk, and has received unrestricted grants from Dr Falk, Janssen-Cilag, Abbvie.

P270 Prof. Knyazev, Oleg: No conflict of interest||Kagramanova, Anna Valeryevna: No conflict of interest||Ms. Lishchinskaya, Albina: No conflict of interest||Ms. li, Irina: No conflict of interest||Ms. Shkurko, Tatyana: No conflict of interest||Mr. Kulakov, Dmitriy: No conflict of interest||Ms. Babayan, Anait: No conflict of interest||Ms. Zvyaglova, Mariya: No conflict of interest||Dr. Zhulina, Elena: No conflict of interest||Prof. Parfenov, Asfold: No conflict of interest

P271 Danese, Silvio:|:|Consulting fees from AbbVie, Allergan, Amgen,|AstraZeneca, Biogen, Boehringer Ingelheim, Celgene,|Celltrion, Ferring, Gilead, Hospira, Janssen, Johnson & Johnson, MSD, Mundipharma, Pfizer, Roche, Sandoz, Takeda, TiGenix, UCB, and Vifor, and advisory board fees from Arena|||Dr. Schreiber, Stefan:|:|Advisory board fees from AbbVie, Arena, BMS, Biogen,|Celltrion, Celgene, IMAB, Gilead, MSD, Mylan, Pfizer, Fresenius, Janssen, Takeda, Theravance, Provention Bio, Protagonist, and Falk|||Dr. Loftus Jr., Edward:|:|Grant support and consulting fees from Takeda, Janssen,|AbbVie, UCB, Pfizer, Amgen, Genentech, Gilead, Seres|Therapeutics, and Celgene/Receptos, grant support, consulting|fees, and fees for serving on a steering committee from Gilead,|consulting fees and fees for serving on a data and safety monitoring board from Eli Lilly, consulting fees from Celltrion|Healthcare, Bristol-Myers Squibb, Boehringer Ingelheim, Allergan, CVS Caremark, and Napo Pharmaceuticals, grant support from MedImmune and Robarts Clinical Trials, and fees for serving on a data and safety monitoring board from Mesoblast|||Dr. Colombel, Jean-Frédéric:|:|Grant support, consulting fees, advisory board|fees, and lecture fees from AbbVie, Janssen, and Takeda, consulting fees, advisory board fees, and lecture fees from Amgen, Ferring, Shire, and Allergan, consulting fees and advisory board fees from Arena, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enterome, Genentech, Ipsen, Landos, MedImmune, Merck, Novartis, Pfizer, TiGenix and Viela, and stock options in Intestinal Biotech Development and Genfit|||Dr. Peyrin-Biroulet, Laurent:|:|Grant support, consulting fees, lecture fees, and advisory|board fees from AbbVie, Takeda, and MSD, consulting fees, lecture fees, and advisory board fees from Janssen, Ferring, Tillots, Celltrion, Pfizer, and Roche, consulting fees and advisory board fees from Genentech, Pharmacosmos, Sandoz, Celgene, Allergan, Arena, Gilead, and Amgen, consulting fees from Boehringer Ingelheim, Index Pharmaceuticals, and Alma, consulting fees and lecture fees from Biogen and Samsung Bioepis, advisory board fees from Sterna, Nestle, and Enterome, lecture fees from Hikma, and stock options in CT-SCOUT|||Dr. Agboton, Christian:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Lindner, Dirk:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Lirio, Richard:|:|Employee of the study sponsor, Takeda Pharmaceuticals and holds Takeda stock or stock options||Dr. Sands, Bruce:|:|Consulting fees from 4D Pharma, AbbVie, Amgen, AstraZeneca, Capella Bioscience, Celltrion Healthcare, EnGene, Ferring, Janssen Global Services, Lyndra, MedImmune, Oppilan Pharma, Otsuka America Pharmaceutical, Palatin Technologies, Progenity, Prometheus Laboratories, Protagonist Therapeutics, Rheos Medicines, Seres Therapeutics, Sienna Biopharmaceuticals, Synergy Pharmaceuticals, TiGenix,|UCB, Valeant Pharmaceuticals North America, and Vivelix Pharmaceuticals, consulting fees and advisory board fees from Allergan, Arena Pharmaceuticals, Boehringer Ingelheim, Eli Lilly and Company, F. Hoffmann–La Roche, and Shire, grant support and advisory board fees from Celgene Corporation, advisory board fees from Ironwood Pharmaceuticals and Target PharmaSolutions, grant support, consulting fees, and advisory board fees from Janssen Biotech, grant support, consulting fees, advisory board fees, and lecture fees from Pfizer, grant support and consulting fees from Theravance Biopharma, and consulting fees and lecture fees from Gilead Sciences

P272 Dr. Uzzan, Mathieu: No conflict of interest||Dr. Bresteau, Clément: No conflict of interest||Dr. Laharie, David:|:|counseling, boards, transports or fees from Abbvie, Biogaran, Biogen, Ferring, Gilead, HAC-pharma, Janssen, MSD, Novartis, Pfizer, Prometheus, Roche, Takeda, Theradiag, Tillots.||Dr. Stefanescu, Carmen: No conflict of interest||Dr. Carbonnel, Franck: No conflict of interest||Dr. Serrero, Mélanie:|:|boarding or lecture fees from Abbvie, Amgen, Celltrion, Ferring, Janssen, Pfizer, MSD, Takeda, Tillots||Dr. Viennot, Stéphanie: No conflict of interest||Dr. Nachury, Maria:|:|Abbvie, Adacyte, Amgen, Arena, Biogen, CTMA, Ferring, Janssen, Mayoli-Spindler, MSD, Pfizer, Takeda||Dr. Amiot, Aurélien:|:|Aurelien Amiot has received consulting fees from Abbvie, Hospira, Takeda, Gilead and Biocodex as well as lecture fees and travel accommodations from Abbvie, Janssen, Biocodex, Hospira, Ferring, Takeda and MSD. This author has also received advisory board fees from Gilead, Takeda and Abbvie. ||Dr. Altwegg, Romain:|:|Romain Altwegg received board or lectures fees from Abbvie, Janssen, Pfizer, Amgen, Biogen, Takeda||Dr. Picon, Laurence:|:|Abbvie, Amgen, MSD, Pfizer, Takeda||Dr. Nahon, Stéphane:|:|Janssen, Pfizer, Takeda, MSD, Gilead, Ferring||Dr. Vuitton, Lucine:|:|LV : has received fees from Abbvie, Amgen, Ferring, Gilead, Mayoli, MSD, Pfizer, Janssen and Takeda||Dr. Ah Soune, Philippe: No conflict of interest||Dr. Kirchgesner, Julien: No conflict of interest||Dr. Peyrin-Biroulet, Laurent: No conflict of interest||Dr. Bouhnik, Yoram: No conflict of interest

P273 Prof. Knyazev, Oleg: No conflict of interest||Kagramanova, Anna Valeryevna: No conflict of interest||Dr. Lishchinskaya, Albina: No conflict of interest||Dr. Li, Irina: No conflict of interest||Shkurko, Tatyana: No conflict of interest||Dr. Veselov, Aleksey: No conflict of interest||Dr. Fadeeva, Nina: No conflict of interest||Dr. Zhulina, Elena: No conflict of interest||Prof. Dr. Parfenov, Asfold: No conflict of interest

P274 Mr. JENSEN, Kristoffer: No conflict of interest||Jensen, Camilla B: No conflict of interest||Wennerström, Christina:|:|Janssen Cilag is a medical company having biologics against IBD in its portfolio.||Sommer, Karen Jytte:|:|Janssen Cilag is a medical company having biologics against IBD in its portfolio.||Burisch, Johan: No conflict of interest||Petersen, Janne: No conflict of interest

P275 Dr. Lichtenstein, Lev: No conflict of interest||Dr. Koslowsky, Benjamin: No conflict of interest||Dr. Avni-Biron, Irit: No conflict of interest||Dr. Ovadia, Baruch: No conflict of interest||Dr. Ben-Bassat, Ofer: No conflict of interest||Dr. Naftali, Timna: No conflict of interest||Prof. Dr. Kopylov, Uri: No conflict of interest||Dr. Haberman, Yael: No conflict of interest||Dr. Banai Eran, Hagar: No conflict of interest||Prof. Dr. Eliakim, Rami: No conflict of interest||Dr. Lahat-Zok, Adi: No conflict of interest||Dr. Hirsch, Ayal: No conflict of interest||Dr. Zittan, Eran: No conflict of interest||Prof. Dr. Maharshak, Nitsan: No conflict of interest||Dr. Waterman, Matti: No conflict of interest||Prof. Dr. Israeli, Eran: No conflict of interest||Dr. Goren, Idan: No conflict of interest||Dr. Ollech, Jacob E.: No conflict of interest||Dr. Yanai, Henit: No conflict of interest||Dr. Ungar, Bella: No conflict of interest||Prof. Dr. Avidan, Benjamin: No conflict of interest||Dr. Ben Hur, Dana: No conflict of interest||Dr. Melamud, Bernardo: No conflict of interest||Dr. Segol, Ori: No conflict of interest||Dr. Shalem, Zippora: No conflict of interest||Prof. Dr. Dotan, Iris: No conflict of interest||Prof. Dr. Odes, Selwyn H.: No conflict of interest||Prof. Dr. Ben-Horin, Shomron: No conflict of interest||Dr. Snir, Yf'at: No conflict of interest||Dr. Milgrom, Yael: No conflict of interest||Prof. Dr. Broide, Efrat: No conflict of interest||Prof. Dr. Goldin, Eran: No conflict of interest||Dr. Delgado, Shmuel: No conflict of interest||Dr. Ron, Yulia: No conflict of interest||Dr. Cohen, Nathaniel Aviv: No conflict of interest||Dr. Maoz, Eran: No conflict of interest||Dr. Zborovski, Maya: No conflict of interest||Dr. Odeh, Safwat: No conflict of interest||Dr. Abu Freha, Naim: No conflict of interest||Prof. Dr. Bar-Gil Shitrit, Ariella: No conflict of interest

P276 Mr. Pérez Galindo, Pablo:|:|Personal Fees: Consulting, support for travel for meetings to support study.||Gisbert, Javier P.: No conflict of interest||Carrillo-Palau, Marta: No conflict of interest||Bertoletti, Federico: No conflict of interest||González-Vivó, María: No conflict of interest||Ferrer, Juan Angel: No conflict of interest||Pajares, Ramón: No conflict of interest||Merino, Olga: No conflict of interest||Castaño, Andrés: No conflict of interest||Chaparro, María: No conflict of interest||Calvo, Marta: No conflict of interest||Barreiro-de-Acosta, Manuel: No conflict of interest||Rodríguez, Andrés: No conflict of interest||Lorente, Rufo H.: No conflict of interest||Algaba, Alicia: No conflict of interest||Riado, Daniel: No conflict of interest||Vela, Milagros: No conflict of interest||De-la-Maza, Saioa: No conflict of interest||Llaó, Jordina: No conflict of interest||Vega, Pablo: No conflict of interest||Utrilla, Alejandra: No conflict of interest||Almela, Pedro: No conflict of interest||Carpio, Daniel: No conflict of interest

P277 Ms. Guberna Blanco, Laura: No conflict of interest||Nyssen, Olga Pérez: No conflict of interest||Chaparro, María: No conflict of interest||Dr. Gisbert, Javier Pérez:|:|Dr. Gisbert has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Hospira, Pfizer, Kern Pharma, Biogen, Takeda, Janssen, Roche, Sandoz, Celgene, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical, and Vifor Pharma.

P278 Bourgonje, Arno R.: No conflict of interest||Ms. Alexdottir, Marta: No conflict of interest||Ms. Loveikyte, Roberta: No conflict of interest||Ms. Bay-Jensen, Anne-Christine: No conflict of interest||Dr. van Dullemen, Hendrik M.: No conflict of interest||Dr. Visschedijk, Marijn C.: No conflict of interest||Dr. Festen, Eleonora A. M.: No conflict of interest||Prof. Weersma, Rinse K.: No conflict of interest||Prof. Karsdal, Morten A.: No conflict of interest||Prof. Faber, Klaas Nico: No conflict of interest||Dr. Mortensen, Joachim H.: No conflict of interest||Prof. Dijkstra, Gerard: No conflict of interest

P279 Dr. Bokemeyer, Bernd: No conflict of interest||Mr. Kaiser, Carsten: No conflict of interest||Dr. Primas, Christian: No conflict of interest||Prof. Dr. Novacek, Gottfried: No conflict of interest||Dr. Biedermann, Luc: No conflict of interest||Prof. Dr. Seibold, Frank: No conflict of interest||Dr. Tappe, Ulrich: No conflict of interest||Prof. Dr. Bettenworth, Dominik: No conflict of interest||Dr. Graw, Jan: No conflict of interest||Mrs. Hartmann, Petra: No conflict of interest||Dr. Plachta-Danielzik, Sandra: No conflict of interest||Prof. Dr. Schultz, Carsten: No conflict of interest

P280 Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Lobaton, Triana:|:|Consultancy fee: Janssen, Sandoz and Biogen|Financial support for research: Abbvie, Mylan, MSD, Mundipharma, Biogen, Janssen, Pfizer and Takeda |Speaker fees: Ferring, Abbvie, Janssen, MSD, Takeda and Sandoz||Dr. Dreesen, Erwin:|:|Speakers fees: Janssen||Ms. Hoefkens, Eveline: No conflict of interest||Mrs. Fierens, Liselotte: No conflict of interest||Dr. Liefferinckx, Claire:|:|Financial support for research: FNRS post-doctoral fellow, Fonds Erasme (Erasme hospital, Belgium)|Consultancy fees: Abbvie, Takeda|Speakers fees: Sandoz, Janssen

P281 Dr. Deprez, Nele: No conflict of interest||Dr. De Somer, Thomas: No conflict of interest||Dr. Baert, Didier: No conflict of interest||Dr. Deceuninck, Mieke: No conflict of interest||Dr. Huys, Inge: No conflict of interest||Dr. Mattens, Veerle: No conflict of interest||Dr. Sterckx, An: No conflict of interest||Dr. Vanden Branden, Stijn: No conflict of interest||Dr. Vanderstraeten, Erik: No conflict of interest||Dr. Vandervoort, Jo: No conflict of interest||Ms. Vanheddegem, Nina: No conflict of interest||Prof. Dewint, Pieter:|:|PDW has received financial support for research from Biogen, Mundipharma; lecture fees from Biogen, Janssen; advisory board fees from Janssen, Sandoz, Samsung Bioepis

P282 Ms. Guo, Angela: No conflict of interest||Mr. Ross, Cameron: No conflict of interest||Dr. Chande, Nilesh: No conflict of interest||Dr. Gregor, Jamie: No conflict of interest||Dr. Ponich, Terry: No conflict of interest||Dr. Beaton, Melanie: No conflict of interest||Dr. Khanna, Reena: No conflict of interest||Dr. Kim, Richard: No conflict of interest||Dr. Wilson, Aze: No conflict of interest

P283 Mr. de Voogd, Floris: No conflict of interest||Ms. Van Wassenaer, Elsa: No conflict of interest||Dr. Mookhoek, Aart: No conflict of interest||Mr. Bots, Steven: No conflict of interest||Ms. Van Gennep, Sara: No conflict of interest||Dr. Duijvestein, Marjolijn: No conflict of interest||Prof. Dr. Ponsioen, Cyriel: No conflict of interest||Dr. Löwenberg, Mark: No conflict of interest||Prof. Dr. D'Haens, Geert: No conflict of interest||Dr. Gecse, Krisztina: No conflict of interest

P284 Dr. Thunberg, Joel: No conflict of interest||Dr. Björkqvist, Olle: No conflict of interest||Dr. Olén, Ola:|:|Dr Olén has been PI for studies financed by grants from Pfizer, Takeda, Ferring, and Janssen.||Prof. Ludvigsson, Jonas F.:|:|Jonas L coordinates a study from Swibreg which has received funding from Janssen||Dr. Eriksson, Carl:|:|CE has served as a speaker, a consultant or an advisory board member for Takeda, Janssen Cilag, Pfizer, Abbvie, and has received research funding from the Regional Agreement on Medical Training and Clinical Research between Region Örebro County and Örebro University: ALF.||Prof. Halfvarson, Jonas:|:|Dr. Halfvarson reports personal fees from Abbvie, grants and personal fees from Janssen, grants and personal fees from MSD, personal fees from Pfizer, personal fees from Vifor Pharma, grants and personal fees from Takeda, personal fees from Tillotts Pharma, personal fees from Celgene, personal fees from Sandoz, personal fees from Shire, personal fees from Ferring, personal fees from Prometheus Laboratories Inc., non-financial support from Olink Proteomics, personal fees from Thermo Fisher Scientific, personal fees from Celltrion , personal fees from Novartis, personal fees from Aqilion

P285 Dr. Weisshof, Roni:|:|RW received advisory board fees from Janssen and AMAG Pharmaceuticals; and presentation fees from Takeda, AbbVie, and Janssen.||Vavricka, Stephan:|:|SV received consultant fees, unrestricted research grants and speaker fees from Abbott, Celtrion, Ferring, MSD, Pfizer, Sanofi-Aventis, Takeda, Tillots, UCB, Vifor and Falk Pharma.||Pouillon , Lieven:|:|LP received advisory board fees from Janssen-Cilag, Sandoz and Takeda; presentation fees from AbbVie and Ferring; and personal fees (congress support) from AbbVie, Ferring, Norgine and Takeda. ||Braegger, Fiona:|:|FB is an employee of Takeda.||Roset, Montserrat:|:|MR is an employee of IQVIA.||Bent-Ennakhil, Nawal:|:|NB is an employee of Takeda and owns stock.||Ferrante, Marc:|:|MF received research grants from AbbVie, Amgen, Biogen, Janssen, Pfizer and Takeda; was a speaker for AbbVie, Amgen, Biogen, Boehringer Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare; and was a consultant to AbbVie, Boehringer-Ingelheim, Celltrion, Janssen, Eli Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher.

P286 Ms. Straatmijer, Tessa: No conflict of interest||Dr. Biemans, Vince B.C.: No conflict of interest||Dr. Hoentjen, Frank:|:|Frank Hoentjen has served on advisory boards, or as|speaker or consultant for Abbvie, Celgene, Janssen-Cilag, MSD,|Takeda, Celltrion, Teva, Sandoz and Dr Falk, and has received unrestricted grants from Dr Falk, Janssen-Cilag, Abbvie.||Dr. de Boer, Nanne K.H.:|:| Nanne K.H. de Boer has served as a speaker for AbbVie,|Takeda and MSD. He has served as consultant and principal investigator for Takeda and TEVA Pharma B.V. He has received (unrestricted) research grants from Dr. Falk and Takeda. ||Mr. Bodelier, Alexander GL:|:|Alexander|G.L. Bodelier has served as speaker and/or participant in advisory|board for: Abbvie, Merck Sharp & Dohme, Takeda, Vifor Pharma,|Mundipharma. ||Prof. Dr. Dijkstra, Gerard:|:|G. Dijkstra: has unrestricted research grants from Abbvie and Takeda. Advisory boards for|Mundipharma and Pharmacosmos. Received speaker’s fees from Abbvie, Takeda and Janssen|Pharmaceuticals.||Ms. van Dop, Willemijn: No conflict of interest||Dr. Haans, Jeoffrey J.L.:|:|Jeoffrey J.L. Haans reports personal fees from advisory board for Takeda Nederland B.V.,|personal fees from advisory board for Lamepro B.V.||Mr. Jansen, Jeroen M.:|:|Jeroen M. Jansen has served on advisory boards,|or as speaker or consultant for Abbvie, Amgen, Ferring, Fresenius,|Janssen, MSD, Pfizer, Takeda. ||Dr. Maljaars, P.W. Jeroen:|:|P.W. Jeroen|Maljaars has served as a speaker and an advisory board member for|Abbvie, Takeda and Janssen-Cilag.||Dr. van der Marel, Sander: No conflict of interest||Dr. Oldenburg, Bas:|:|B. Oldenburg: speaker: Ferring, MSD and Abbvie. Advisory boards: Ferring, MSD, Abbvie, Takeda,|Pfizer and Janssen. Research Grants: Abbvie, Ferring, Takeda, Pfizer, MSD and Dr Falk.||Prof. Ponsioen, Cyriel Y:|:|Cyriel Ponsioen received grant support from Takeda, served in advisory boards for Takeda and AbbVie, and received speaker’s fees from Takeda, AbbVie, and Dr Falk Pharma. ||Dr. Visschedijk, Marijn C.: No conflict of interest||Dr. de Vries , Annemarie C.:|:|A.C. de Vries: has participated in advisory board and/or received financial compensation from the|following companies: Janssen, Takeda, Abbvie and Tramedico||Dr. West, Rachel:|:| Rachel L. West has participated in|advisory board and/or received financial compensation from the|following companies: Jansen and Abbvie. ||Prof. van der Woude, C. Janneke:|:|CJ van der Woude: has served on advisory boards and/or received financial compensation from the|following companies: MSD, FALK Benelux, Abbott laboratories, Mundipharma Pharmaceuticals,|Janssen, Takeda and Ferring during the last 3 years. ||Dr. Pierik, Marieke:|:|MJ Pierik has served on advisory boards, or as speaker or consultant for Abbvie, Janssen-Cilag, MSD,|Takeda, Ferring, Dr Falk and Sandoz and has received unrestricted grants from, Janssen-Cilag, Abbvie|and Takeda outside the submitted work.|||Dr. Duijvestein, Marjolijn:|:|MD reports advisory fees from Echo Pharma and Robarts Clinical Trials, Inc., speaker fees from Janssen, Merck & Co., Inc., Pfizer, Takeda and Tillotts Pharma, and nonfinancial support from Dr. Falk Pharm.||Dr. van der Meulen- de Jong, Andrea E:|:|AE van der Meulen—de Jong has served on advisory boards, or as speaker or consultant for Takeda,|Tramedico and AbbVie, and has received grants from Takeda.

P288 Dr. Macaluso, Fabio Salvatore:|:|Fabio Salvatore Macaluso served as an advisory board member and/or received lecture grants from AbbVie, Biogen, Janssen, MSD, Pfizer, Samsung Bioepis, and Takeda Pharmaceuticals. ||Dr. Cappello, Maria:|:|Maria Cappello served as an advisory board member for AbbVie, MSD, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Chiesi, and Takeda Pharmaceuticals. ||Dr. Crispino, Federica: No conflict of interest||Dr. Grova, Mauro: No conflict of interest||Dr. Privitera, Antonino Carlo: No conflict of interest||Dr. Piccillo, Giovita: No conflict of interest||Dr. Magnano, Antonio: No conflict of interest||Dr. Ferracane, Concetta: No conflict of interest||Dr. Belluardo, Nunzio: No conflict of interest||Dr. Giangreco, Emiliano: No conflict of interest||Prof. Fries, Walter:|:|Walter Fries served as an advisory board member and/or received lecture grants from AbbVie, Biogen, MSD, Pfizer, Mundipharma, Zambon, Janssen, Sandoz, and Takeda Pharmaceuticals. ||Dr. Viola, Anna: No conflict of interest||Dr. Di Mitri, Roberto: No conflict of interest||Dr. Mocciaro, Filippo: No conflict of interest||Dr. Camilleri, Salvatore: No conflict of interest||Dr. Garufi, Serena: No conflict of interest||Dr. Renna, Sara:|:|Sara Renna served as an advisory board member for AbbVie and MSD Pharmaceuticals, and received lecture grants from AbbVie, Janssen, MSD and Takeda Pharmaceuticals. ||Dr. Casà, Angelo: No conflict of interest||Dr. Maida, Marcello: No conflict of interest||Dr. Orlando, Ambrogio:|:|Ambrogio Orlando served as an advisory board member for AbbVie, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals.

P289 Prof. Dr. Bouhnik, Yoram:|:|Consulting for Abbvie, Amgen, Biogaran, Biogen, Boehringer Ingelheim, Celltrion, Ferring, Fresenius Kabi, Gilead, Hospira, Janssen, Lilly, Mayoli Spindler, Merck, MSD, Norgine, Pfizer, Roche, Sandoz, Sanofi, Shire, Takeda, Tillotts, UCB and travel supports from Abbvie, MSD, Ferring, Takeda, Hospira, Janssen||Prof. Dr. Nancey, Stéphane:|:|Counseling, boards, support for travel or fees from Takeda, Abbvie, Janssen, Pfizer, Tillots, Novartis, Biogen, Amgen, Sandoz, HAC-Pharma, MSD.||Dr. Assing, Maryse:|:|Employee of Pfizer||Dr. Mammar, Nadir:|:|Employee of Pfizer||Prof. Dr. Laharie, David:|:|Counseling, boards, supports for travel or fees from Abbvie, Biogaran, Biogen, Ferring, HAC-pharma, Janssen, MSD, Novartis, Pfizer, Prometheus, Roche, Takeda, Theradiag, Tillots

P290 Ungaro, Ryan:|:|Ryan Ungaro has served as an advisory board member or consultant for Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, and Takeda; research support from AbbVie, Boehringer Ingelheim, and Pfizer. This study was sponsored by Takeda. Medical writing support provided by Milena Wagner, PhD, of Excel Medical Affairs, and funded by Takeda.||Kadali, Harisha:|:|Harisha Kadali is an employee of Takeda and holds Takeda stock or stock options. This study was sponsored by Takeda. Medical writing support provided by Milena Wagner, PhD, of Excel Medical Affairs, and funded by Takeda.||Zhang, Wenwen:|:|Wenwen Zhang is an employee of Takeda and holds Takeda stock or stock options. This study was sponsored by Takeda. Medical writing support provided by Milena Wagner, PhD, of Excel Medical Affairs, and funded by Takeda.||Adsul, Shashi:|:|Shashi Adsul is an employee of Takeda and holds Takeda stock or stock options. This study was sponsored by Takeda. Medical writing support provided by Milena Wagner, PhD, of Excel Medical Affairs, and funded by Takeda.||Reinisch, Walter:|:|Walter Reinisch is a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, and Yakult; is a consultant for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millennium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Takeda, Therakos, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC; is an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC; and has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik, and MSD. This study was sponsored by Takeda. Medical writing support provided by Milena Wagner, PhD, of Excel Medical Affairs, and funded by Takeda.

P291 Lee, Caroline:|:|Employee of Arena Pharmaceuticals, Inc.||Tang, Yong:|:|Employee of Arena Pharmaceuticals, Inc.||Schroeder, Cassandra:|:|Employee of Arena Pharmaceuticals, Inc.||Zhang, Jinkun:|:|Employee of Arena Pharmaceuticals, Inc.||Nguyen-Cleary, Thai:|:|Employee of Arena Pharmaceuticals, Inc.||Mullin, Susan:|:|Employee of Arena Pharmaceuticals, Inc.||Ma, Michael:|:|Employee of Arena Pharmaceuticals, Inc.||Lyon, Naomi:|:|Employee of Arena Pharmaceuticals, Inc.||Grundy, John:|:|Employee of Arena Pharmaceuticals, Inc.

P292 Ms. Sleutjes, Jasmijn: No conflict of interest||Dr. Roeters van Lennep, Jeanine E.: No conflict of interest||Prof. Boersma, Eric: No conflict of interest||Dr. de Vries, Annemarie C.:|:|MLDS, Tramedico (research funding), Jansen, Takeda, Abbvie (advisory board)||Prof. Dr. van der Woude, C. Janneke:|:|Celltrion, Abbvie, Takeda (advisory board)

P293 Dr. Vieujean, Sophie: No conflict of interest||Dr. Loly, Jean-Philippe: No conflict of interest||Ms. Boutaffala, Layla: No conflict of interest||Prof. Dr. Pariente, Benjamin: No conflict of interest||Prof. Dr. Reenaers, Catherine: No conflict of interest||Mrs. Briquet, Alexandra: No conflict of interest||Mrs. Lechanteur, Chantal: No conflict of interest||Prof. Dr. Beguin, Yves: No conflict of interest||Prof. Dr. Louis, Edouard: No conflict of interest

P294 Dr. Posch, Maximilian: No conflict of interest||Dr. Tanase, Raisa: No conflict of interest||Dr. Maisaia, Konstantine: No conflict of interest||Dr. Jucov, Alina: No conflict of interest||Dr. Geier, Christian: No conflict of interest||Dr. Hotson, Drew:|:|Shareholder||Mr. Hamdy, Omar: No conflict of interest||Dr. Whitney, J. Andrew:|:|Shareholder||Dr. Garovoy, Marvin:|:|Shareholder||Dr. Kanwar, Bittoo:|:|Shareholder||Dr. Schreiber, Stefan: No conflict of interest

P295 Dr. Maniero, Daria: No conflict of interest||Dr. Lorenzon, Greta: No conflict of interest||Dr. Marsilio, Ilaria: No conflict of interest||Dr. Rigo, Alessandra: No conflict of interest||Dr. Cardin, Romilda: No conflict of interest||Dr. Facchin, Sonia: No conflict of interest||Dr. Barberio, Brigida: No conflict of interest||Dr. D'Incà, Renata: No conflict of interest||Dr. Zingone, Fabiana: No conflict of interest||Dr. Bahur, Bayda:|:|full-time employee of ProciseDx Inc, and hold options to purchase shares.||Dr. Bray, Kurtis R.:|:|full-time employee of ProciseDx Inc, and hold options to purchase shares||Savarino, Edoardo Vincenzo: No conflict of interest

P296 Dr. Mak, Joyce Wing Yan: No conflict of interest||Mr. Yuen, Nobel Tsz Kin: No conflict of interest||Mr. Yip, Terry Cheuk Fung: No conflict of interest||Mr. Lam, Ray Hon Man: No conflict of interest||Mr. Lam, Brian Kin Hang: No conflict of interest||Prof. Chan, Francis Ka Leung: No conflict of interest||Prof. Ng , Siew Chien: No conflict of interest

P297 ANGULO MCGRATH, Isabela: No conflict of interest||Mr. Bracho González, Manuel: No conflict of interest||Mr. Ocaña Ledesma, Alejandro: No conflict of interest||Dr. Olmedo Martín, Raul Vicente: No conflict of interest

P298 Dr. ROSIOU, Konstantina: No conflict of interest||Dr. Ong Ming San, Elaine: No conflict of interest||Dr. Kumar, Aditi: No conflict of interest||Dr. Esquivel, Kim: No conflict of interest||Dr. Almas, Saima: No conflict of interest||Dr. Stokes, Daniel: No conflict of interest||Dr. Ng, Tze: No conflict of interest||Dr. Jayasooriya, Nishani: No conflict of interest||Mr. Ranasinghe, Ian: No conflict of interest||Prof. Pollok, Richard: No conflict of interest||Dr. Brookes, Matthew:|:|MJB has received grants and travel expenses from Vifor International and Tillots Pharma, outside of the submitted work.||Dr. Selinger, Christian P:|:|CPS has received unrestricted research grants from Warner Chilcott, Janssen and AbbVie, has provided consultancy to Warner Chilcott, Dr Falk, AbbVie, Takeda, Fresenius Kabi and Janssen, and had speaker arrangements with Warner Chilcott, Dr Falk, AbbVie, MSD, Pfizer and Takeda.

P299 Mr. Schultheiss, Johannes: No conflict of interest||Mr. Mahmoud, Remi: No conflict of interest||Mr. Louwers, Jonas: No conflict of interest||Mr. van der Kaaij, Michiel: No conflict of interest||Mr. van Hellemondt, Boris: No conflict of interest||Dr. van Boeckel, Petra: No conflict of interest||Dr. Mahmmod, Nofel: No conflict of interest||Dr. Jharap, Bindia: No conflict of interest||Dr. Fidder, Herma: No conflict of interest||Prof. Dr. Oldenburg, Bas: No conflict of interest

P300 Dr. Schulberg, Julien: No conflict of interest||Dr. Wright, Emily: No conflict of interest||Dr. Holt, Bronte: No conflict of interest||Dr. Sutherland, Tom: No conflict of interest||Ms. Ross, Alyson: No conflict of interest||Dr. Hamilton, Amy: No conflict of interest||Dr. Vogrin, Sara: No conflict of interest||Dr. Miller, Ashley: No conflict of interest||Dr. Connell, William: No conflict of interest||Dr. Lust, Mark: No conflict of interest||Dr. Ding, Nik: No conflict of interest||Dr. Moore, Gregory: No conflict of interest||Dr. Bell, Sally: No conflict of interest||Dr. Shelton, Edward: No conflict of interest||Dr. Christensen, Britt: No conflict of interest||Dr. De Cruz, Peter: No conflict of interest||Dr. Rong, Yuwei: No conflict of interest||Prof. Dr. Kamm, Michael: No conflict of interest

P301

P302 Dr. LI WAI SUEN, Christopher:|:|CFDLWS is supported by an NHMRC Postgraduate Scholarship.|CFLDWS has received research grants from the Robert C Bulley Charitable Foundation and the St Vincent's Hospital (Melbourne) Research Endowment Fund.||Ms. Morris, Rachel: No conflict of interest||Dr. Choy, Matthew:|:|MCC has served as a speaker for DiaSorin, has received research funding from Janssen, and has received educational support from Ferring, Shire, Janssen, AbbVie, Takeda and Orphan. |MCC is supported by a Gandel Philanthropy Major Grant.||Dr. Nigro, Julie: No conflict of interest||Prof. Visvanathan, Kumar:|:|KV has been on advisory boards of Gilead and Qiagen and has received institutional research grants from Gilead and Qiagen and Roche.||Prof. De Cruz, Peter:|:|PDC has served as a speaker, a consultant and an advisory board member for Ferring, Shire, Janssen, AbbVie, Takeda and Baxter.|PDC is supported by a NHMRC Early Career Fellowship and has received research funding from Janssen, AbbVie, Takeda, Shire, Ferring and Baxter.

Danese, Silvio:|:|Silvio Danese reports consultancy fees from AbbVie, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring Pharmaceuticals Inc., Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity Therapeutics, Takeda, TiGenix, UCB Inc. and Vifor; and lecture fees from AbbVie, Amgen, Ferring Pharmaceuticals Inc., Gilead, Janssen, Mylan, Pfizer and Takeda||Vermeire, Séverine:|:|Séverine Vermeire reports honoraria/consulting fees from AbbVie, Amgen, Arena, Celgene, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Hospira, Janssen, Lilly, MSD, Mundipharma, Pfizer Inc., Progenity, Second Genome, Shire and Takeda; participation in company-sponsored speakers bureaux with AbbVie, Ferring, Hospira, Janssen, MSD, Pfizer, Takeda and Tillots; and research grants from Abbvie, Galapagos, Johnson & Johnson, Pfizer and Takeda. ||D'Haens, Geert:|:|Geert D’Haens has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamer Bio, Pfizer, Immunic, Johnson & Johnson, Kintai Therapeutics, Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint and Tillotts; and reports speaker fees from AbbVie, Biogen, Ferring, Johnson & Johnson, MSD, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millennium/Takeda, Tillotts and Vifor. ||Panés, Julian:|:|Julian Panés reports consulting fees/honorarium from AbbVie, Arena, Boehringer Ingelheim, Celgene, Genentech/Roche, GlaxoSmithKline, Janssen, Origo, Pandion, Pfizer, Progenity, Takeda, Theravance and Wasserman. |Julian Panés reports support for travel to meetings from AbbVie and Takeda during the conduct of the study; payment for lectures including service on speakers bureaux from Abbott, Janssen, Pfizer and Takeda; payment for development of educational presentations from Abbott, Janssen, Pfizer and Roche; and grants from AbbVie and Pfizer.||Dignass, Axel:|:|Axel Dignass reports fees for participation in review activities, such as data monitoring boards, statistical analysis, end point committees, and the like from Falk during the conduct of the study.|Axel Dignass reports consultancy fees from AbbVie, Amgen, Celgene/Bristol-Myers Squibb, Falk, Ferring, Fresenius Kabi, Gilead, Galapagos, Janssen, MSD, Pfizer, Pharmacosmos, Roche/Genentech, Sandoz/Hexal, Takeda, Tillotts and Vifor; payment from lectures including service on speakers bureaux from AbbVie, Falk Foundation, Ferring, Janssen, Med Update GmbH, MSD, Pfizer, Pharmacosmos, Streamed up, Takeda, Tillotts and Vifor; payment for manuscript preparation from Falk Foundation, Pfizer, Takeda, Thieme, Tillotts and Uni-Med Verlag; and payment for development of educational presentations from Ferring and Tillotts outside the submitted work.||Magro, Fernando:|:|Fernando Magro reports fees from lectures to AbbVie, Falk, Ferring, Hospira, Lab Vitoria, MSD, OM Pharma, PharmaKern, Schering Vifor and Takeda||Nazar, Maciej:|:|Maciej Nazar is an employee of Janssen-Cilag Polska Sp. z .o.o.||Le Bars, Manuela:|:|Manuela Le Bars is an employee of Janssen-Cilag and owner of RSU||Lahaye, Marjolein:|:|Marjolein Lahaye is an employee of Janssen-Cilag BV.||Ni, Lioudmila:|:|Lioudmilla Ni is an employee of Janssen Cilag Russia.||Bravatà, Ivana:|:|Ivana Bravatà is an employee of Janssen-Cilag.||Gaya, Daniel R.:|:|Daniel R. Gaya reports personal fees from AbbVie, Janssen and Takeda; and a travel grant from Vifor.||Peyrin-Biroulet, Laurent:|:|Laurent Peyrin-Biroulet reports personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, Lilly, MSD, Mylan, Nestlé, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Takeda, Tillots and Vifor; grants from AbbVie, MSD and Takeda; and stock options from CTMA.

P303 Dr. Podmanicky, Dusan: No conflict of interest||Dr. Jezberova, Michaela: No conflict of interest||Dr. Lucenicova, Jana: No conflict of interest||Dr. Bak, Vladimir: No conflict of interest||Dr. Kadleckova, Barbora: No conflict of interest||Dr. Zelinkova, Zuzana: No conflict of interest

P304 Ms. Kantasiripitak, Wannee:|:|Conference registration fee: AbbVie||Dr. van Hoeve, Karen:|:|KvH reports having received a research grant from Mundipharma Comm. VA and Celltrion Healthcare Co and has also received research grants by the IBD Patient’s Association Flanders (CCV VZW)||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Vermeire, Severine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Prof. Dr. Hoffman, Ilse: No conflict of interest||Prof. Dr. Declerck, Paul: No conflict of interest||Dr. Thomas, Debby: No conflict of interest||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Dr. Dreesen, Erwin:|:|Postdoctoral research fellow of the Research Foundation – Flanders (FWO), Belgium (grant number 12X9420N) |Consultancy fees: argenx and Janssen (all honoraria/fees paid to the University)|Registration fee: AbbVie

P305 Dr. Macaluso, FabioSalvatore: No conflict of interest||Prof. Fries, Walter: No conflict of interest||Dr. Renna, Sara: No conflict of interest||Dr. Viola, Anna: No conflict of interest||Dr. Muscianisi, Marco: No conflict of interest||Dr. Cappello, Maria: No conflict of interest||Dr. Guida, Laura: No conflict of interest||Dr. Siringo, Sebastiano: No conflict of interest||Dr. Camilleri, Salvatore: No conflict of interest||Dr. Garufi, Serena: No conflict of interest||Dr. Privitera, Antonino Carlo: No conflict of interest||Dr. Belluardo, Nunzio: No conflict of interest||Dr. Giangreco, Emiliano: No conflict of interest||Dr. Bertolami, Carmelo: No conflict of interest||Dr. Vassallo, Roberto: No conflict of interest||Dr. Rizzuto, Giulia: No conflict of interest||Dr. Orlando, Rosalba: No conflict of interest||Dr. Ventimiglia, Marco: No conflict of interest||Dr. Orlando, Ambrogio: No conflict of interest

P306 Dr. RAY, Adrian:|:|Employee and shareholder of Morphic||Dr. Cui, Dan:|:|Employee and shareholder of Morphic||Dr. Lee, Dooyoung:|:|Employee and shareholder of Morphic||Dr. Mangada, Maloy M.:|:|Employee and shareholder of Morphic||Dr. Jones, Jp:|:|Employee and shareholder of Morphic||Dr. Bain, Gerard:|:|Employee and shareholder of Morphic||Dr. Traber, Peter G.:|:|Consultant and shareholder of Morphic||Dr. Vrishabhendra, Leela H.: No conflict of interest||Dr. Krzeski, Piotr W.:|:|No relevant disclosures (Employee and shareholder of Medpace)||Dr. Vande Casteele, Niels:|:|Research grants and personal fees from R-Biopharm, Takeda and UCB; and personal fees from Alimentiv, Celltrion and Prometheus||Ms. Reardon, Marianne M.:|:|Receiving consulting fees from Morphic||Dr. Stern, Theresa P.:|:|Receiving consulting fees from Morphic||Dr. Soo, Carolyn L.:|:|Employee and shareholder of Morphic||Dr. Nguyen, Hanh:|:|Employee and shareholder of Morphic||Dr. Rogers, Bruce N.:|:|Employee and shareholder of Morphic||Dr. Linde, Peter G.:|:|Employee and shareholder of Morphic

P307 Dr. Wang, Zhigang: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Dr. Declerck, Paul: No conflict of interest||Dr. Dreesen, Erwin:|:|Financial support for postdoctoral research from the Research Foundation – Flanders (FWO), Belgium (grant number 12X9420N) |Consultancy fees: Argenx and Janssen (all honoraria/fees paid to the University).

P308 Dr. Macaluso, Fabio Salvatore:|:|Fabio Salvatore Macaluso served as advisory board member and/or received lecture grants from AbbVie, Biogen, Janssen, Pfizer, MSD, Samsung Bioepis, Takeda Pharmaceuticals||Dr. Maida, Marcello: No conflict of interest||Dr. Ventimiglia, Marco: No conflict of interest||Dr. Orlando, Ambrogio:|:|Ambrogio Orlando served as advisory board member for AbbVie, MSD, Takeda Pharmaceuticals, and received lecture grants from AbbVie, Janssen, MSD, Pfizer, Sofar, Chiesi, and Takeda Pharmaceuticals.

P309 Dr. Moens, Annick:|:|AM is a doctoral fellow of the Research Foundation Flanders (FWO), Belgium.||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm||Dr. Alsoud, Dahham: No conflict of interest||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

P310 Dr. CHOI, Sarah: No conflict of interest||Dr. Lightner, Amy: No conflict of interest||Dr. Lipman, Jeremy: No conflict of interest||Dr. Hull, Tracy: No conflict of interest||Dr. Steele, Scott: No conflict of interest||Dr. Holubar, Stefan: No conflict of interest||Dr. Rieder, Florian: No conflict of interest

P311 Ms. Van den Berghe, Nathalie: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Ferring, Takeda Pharmaceuticals, Janssen and R Biopharm||Ms. Ballet, Vera: No conflict of interest||Mrs. Gils, Ann:|:|A Gils reports financial support for research from Pfizer, MSD and Takeda; lecture fees from MSD, Janssen Biologicals, Pfizer, Takeda, Novartis and AbbVie; consultancy fees from Takeda; and advisory board fees from Takeda. KU Leuven holds a license agreement with R-Biopharm, apDia and Merck. ||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Prof. Declerck, Paul: No conflict of interest||Dr. Thomas, Debby: No conflict of interest

P312 Ms. VAN DE MEEBERG, Maartje: No conflict of interest||Ms. Lin, Marry: No conflict of interest||Dr. Seinen, Margien: No conflict of interest||Dr. Fidder, Herma: No conflict of interest||Prof. Dr. Oldenburg, Bas: No conflict of interest||Prof. Dr. Bouma, Gerd: No conflict of interest||Prof. Dr. de Jonge, Robert: No conflict of interest||Dr. Bulatović Ćalasan, Maja: No conflict of interest

P313 Dr. Vázquez Morón, Juan María: No conflict of interest||Mrs. Martínez Rodríguez, María del Mar: No conflict of interest||Dr. Olmedo Martin, Raúl: No conflict of interest||Mr. Hernández Martínez, Álvaro: No conflict of interest||Mrs. Núñez Ortiz, Andrea: No conflict of interest||Mr. Rueda Sánchez, Jesús: No conflict of interest||Argüelles Arias, Federico: No conflict of interest||Mr. Caballero Mateos, Antonio: No conflict of interest||Mrs. Iglesias Flores, Eva: No conflict of interest||Mr. Viejo Almanzor, Alejandro: No conflict of interest||Dr. Pallarés Manrique, Héctor: No conflict of interest

P314 Dr. Goll, Rasmus: No conflict of interest||Dr. Kay-Martin, Johnsen: No conflict of interest||Dr. Viola, Anna: No conflict of interest||Prof. Dr. Paulssen, Eyvind: No conflict of interest||Dr. Moe, Øystein Kittel: No conflict of interest||Prof. Dr. Cui, Guanglin: No conflict of interest||Prof. Dr. Fries, Walter: No conflict of interest||Prof. Dr. Florholmen, Jon: No conflict of interest

P315 Dr. Tatosian, Daniel:|:|employee of Bristol Myers Squibb Company.||Dr. Shen, Jun:|:|employee of Bristol Myers Squibb Company||Dr. Chen, Lu:|:|employee of Bristol Myers Squibb Company||Mr. Lavigne, Jean:|:|employee of Certara USA, Inc.||Dr. Teuscher, Nathan:|:|employee of Certara USA, Inc.||Dr. Harris, Sarah:|:|employee of Bristol Myers Squibb Company.||Dr. Chitkara, Denesh:|:|employee of Bristol Myers Squibb Company.||Dr. Tirucherai, Giridhar S.:|:|employee of Bristol Myers Squibb Company.||Dr. Marta, Cecilia:|:|employee of Bristol Myers Squibb Company.

P316 Dr. Mortensen, Joachim:|:|Full time employee at Nordic Bioscience||Prof. Karsdal, Morten Asser:|:|Full time employee and hold stocks in Nordic Bioscience||Prof. Dr. Grønbæk, Henning: No conflict of interest||Dr. Hvas, Christian Lodberg: No conflict of interest||Dr. Dige , Anders: No conflict of interest||Dr. Bay-Jensen, Anne-Christine:|:|Full time employee and hold stocks in Nordic Bioscience

P317 Mr. Van Linschoten, Reinier: No conflict of interest||Ms. Visser, Elyke: No conflict of interest||Ms. Niehot, Christa: No conflict of interest||Prof. Dr. van der Woude, Janneke:|:|Prof. Dr. van der Woude reports personal fees from Abbvie and Celltrion, and grants from Pfizer and Janssen outside the submitted work.||Prof. Dr. Hazelzet, Jan: No conflict of interest||Dr. van Noord, Desirée:|:|Dr. van Noord reports grants from AbbVie, Falk, Ferring, Janssen, MSD, Pfizer, and Takeda and personal fees from Takeda and Janssen outside the submitted work.||Dr. West, Rachel:|:|Dr. West reports grants from AbbVie, Falk, Ferring, Janssen, MSD, Pfizer, and Takeda and personal fees from AbbVie, Janssen, and Pfizer outside the submitted work.

P318 Dr. Ko, Kwan Lung: No conflict of interest||Dr. Lam, Yuk Fai: No conflict of interest||Dr. Cheung, Ka Shing: No conflict of interest||Prof. Dr. Hung, Fan Ngai: No conflict of interest||Prof. Dr. Leung, Wai Keung: No conflict of interest

P319 Dr. García García, María José:|:|MJ García has received financial support for travelling and educational activities from MSD, Janssen, Abbvie, Takeda and Ferring.||Dr. Rivero, Montserrat:|:|M Rivero has served as a speaker and advisory member for Abbvie, MSD and Janssen.||Dr. Miranda-Bautista, José: No conflict of interest||Dr. Bastón-Rey, Iria: No conflict of interest||Dr. Mesonero, Francisco: No conflict of interest||Dr. Leo-Carnerero, Eduardo:|:|E Leo-Carnerero has served as speaker for and has received research funding from Abbvie, Takeda, Janssen, Ferring and Pfizer.||Dr. Casas-Deza, Diego:|:|D Casas-Deza has received financial support for travelling and educational activities from MSD, Janssen, Ferring, Tillots, Takeda and Abbvie||Prof. Cagigas Fernández, Carmen: No conflict of interest||Dr. Martin-Cardona, Albert:|:|A Martin-Cardona has received financial support for travelling and educational activities from Abbvie, Biogen, Ferring, Jannsen, MSD, Takeda, Dr Falk Pharma and Tillotts.||Dr. El Hajra, Ismael: No conflict of interest||Dr. Hernández-Aretxabaleta, Nerea: No conflict of interest||Prof. Pérez-Martínez, Isabel: No conflict of interest||Dr. Fuentes-Valenzuela, Esteban: No conflict of interest||Dr. Jiménez, Nuria: No conflict of interest||Dr. Rubín de Célix, Cristina: No conflict of interest||Prof. Gutiérrez, Ana:|:|A Gutiérrez has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Pfizer, Kern Pharma, Takeda, Janssen, Ferring, Faes Farma, Shire Pharmaceuticals, Tillotts Pharma, Chiesi and Otsuka Pharmaceutical.||Prof. Suárez Ferrer, Cristina:|:|C Suárez Ferrer has served as a speaker or has received education funding from MSD, Abbvie, Pfizer, Janssen, Takeda and Ferring.||Dr. Huguet, José María:|:|JM Huguet has served as a speaker, or has received research or education funding from MSD, Abbvie, Pfizer, Takeda, Janssen, Sandoz, Ferring and Faes Farma.||Dr. Fernández-Clotet, Agnes: No conflict of interest||Dr. González-Vivó, María: No conflict of interest||Dr. Del Val, Blanca: No conflict of interest||Dr. Castro-Poceiro, Jesús: No conflict of interest||Dr. Melcarne, Luigi:|:|L Melcarne has served as a speaker has received financial support for educational activities from MSD, Janssen, Abbie, Takeda, Ferring, Dr.Falk, Pfizer, Sandoz, Tillotts Pharma Ferring||Dr. Dueñas, Carmen: No conflict of interest||Dr. Izquierdo, Marta: No conflict of interest||Dr. Monfort, David: No conflict of interest||Dr. Bouhmidi, Abdel: No conflict of interest||Dr. Ramírez De la Piscina, Patricia: No conflict of interest||Dr. Romero, Eva: No conflict of interest||Dr. Molina, Gema: No conflict of interest||Dr. Zorrilla , Jaime: No conflict of interest||Dr. Calvino-Suárez, Cristina: No conflict of interest||Dr. Sánchez, Eugenia: No conflict of interest||Dr. Nuñez, Andrea: No conflict of interest||Dr. Sierra, Olivia: No conflict of interest||Dr. Castro, Beatriz: No conflict of interest||Prof. Zabana, Yamile:|:|Y Zabana: has received support for conference attendance, speaker fees, research support and consulting fees of Abvvie, Adacyte, Almirall, Amgen, Dr Falk, FAES Pharma, Ferring, Jannsen, MSD, Otsuka, Pfizer, Shire, Takeda and Tillots.||Dr. González-Partida, Irene: No conflict of interest||Prof. Chaparro, María:|:|M Chaparro has served as a speaker, or has received research or education funding from MSD, Abbvie, Hospira, Pfizer, Takeda, Janssen, Ferring, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma.||Prof. Gisbert, Javier P.:|:|JP Gisbert has served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Pfizer, Kern Pharma, Biogen, Mylan, Takeda, Janssen, Roche, Sandoz, Celgene, Gilead, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical, and Vifor Pharma.

P320 Prof. Knyazev, Oleg: No conflict of interest||Kagramanova, Anna Valeryevna: No conflict of interest||Ms. Lishchinskaya, Albina: No conflict of interest||Ms. Shkurko, Tatyana: No conflict of interest||Ms. Li, Irina: No conflict of interest||Prof. Parfenov, Asfold: No conflict of interest

P321 Mr. Ten Bokkel Huinink, Sebastiaan: No conflict of interest||Prof. Dr. van der Woude, Janneke: No conflict of interest||Dr. Casanova, Maria Jose: No conflict of interest||Dr. Bouguen, Guillaume: No conflict of interest||Dr. Mak, Joyce Wing Yan: No conflict of interest||Dr. Molnar, Tamas: No conflict of interest||Dr. Seidelin, Jacob: No conflict of interest||Dr. Aurelien, Amiot: No conflict of interest||Prof. Dr. D'Haens, Geert: No conflict of interest||Dr. Riviere, Pauline: No conflict of interest||Guidi, Luisa: No conflict of interest||Dr. Renata, Bor: No conflict of interest||Lin, Wei-Chen: No conflict of interest||Dr. de Vries, Annemarie: No conflict of interest

P322 Dr. Ergenç, Ilkay: No conflict of interest||Dr. Kani, Haluk Tarık: No conflict of interest||Dr. Karabacak, Murat: No conflict of interest||Dr. Cömert Özer, Elif: No conflict of interest||Dr. Mehdiyev, Shahin: No conflict of interest||Dr. Jafarov, Fuad: No conflict of interest||Dr. Abacar, Kerem Yiğit: No conflict of interest||Dr. Kutluğ Ağaçkıran, Seda: No conflict of interest||Dr. Seven Sevik, Gizem: No conflict of interest||Dr. Alibaz Öner, Fatma: No conflict of interest||Prof. Dr. İnanç, Nevsun: No conflict of interest||Prof. Dr. Atagündüz, Mehmet Pamir: No conflict of interest||Prof. Dr. Gençosmanoğlu, Dilek Seçkin: No conflict of interest||Prof. Dr. Özen Alahdab, Yeşim: No conflict of interest||Prof. Dr. Ergun, Tülin: No conflict of interest||Prof. Dr. Direskeneli, Rafi Haner: No conflict of interest||Prof. Dr. Atuğ, Özlen: No conflict of interest

P323 Dr. Kojima, Kentaro: No conflict of interest||Dr. Yokoyama, Keiko: No conflict of interest||Dr. Kaku, Koji: No conflict of interest||Dr. Takashima, Yusuke: No conflict of interest||Dr. Sato, Toshiyuki: No conflict of interest||Dr. Kawai, Mikio: No conflict of interest||Dr. Kamikozuru, Koji: No conflict of interest||Dr. Takagawa, Tetsuya: No conflict of interest||Dr. Yokoyama, Yoko: No conflict of interest||Dr. Watanabe, Kenji: No conflict of interest

P324 Dr. Dalal, Rahul: No conflict of interest||Dr. Esckilsen, Scott: No conflict of interest||Dr. Barnes, Edward:|:|Dr. Barnes has served as a consultant for AbbVie, Gilead, Pfizer, Takeda, and Target RWE||Ms. McClure, Emma: No conflict of interest||Ms. Goodrick, Hannah: No conflict of interest||Dr. Allegretti, Jessica:|:|Dr. Allegretti serves as a consultant for Takeda, Janssen, Pfizer, Pandion, Servatus, Finch Therapeutics, Iterative Scopes and Artugen and has grant support from Merck.

P325 Dr. Parakkal, Deepak: No conflict of interest||Dr. Johnson, Amanda: No conflict of interest||Dr. Fenster, Marc: No conflict of interest||Dr. Ramos, Gui: No conflict of interest||Dr. Zulqarnain, Mir: No conflict of interest||Prof. Dr. Ullman, Thomas: No conflict of interest||Dr. Huang, Lulu: No conflict of interest||Dr. Gutierrez, Alexandra: No conflict of interest||Ms. Bruss, Alexandra: No conflict of interest||Dr. Ungaro, Ryan: No conflict of interest||Dr. Cohen, Benjamin: No conflict of interest||Dr. Gaurav, Syal: No conflict of interest||Dr. Anish, Patel: No conflict of interest||Dr. Sasankan, Priya: No conflict of interest||Dr. Costable, Nicholas: No conflict of interest||Dr. Pekow, Joel: No conflict of interest||Dr. Wang, Wenfei: No conflict of interest||Prof. Dr. Rubin, David: No conflict of interest||Dr. Ciorba, Matthew: No conflict of interest||Dr. Beniwal-Patel, Poonam: No conflict of interest||Prof. Dr. Loftus, Edward: No conflict of interest||Prof. Dr. Yarur, Andres: No conflict of interest

P326 Ungaro, Ryan:|:|Ryan Ungaro has served as an advisory board member or consultant for AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Pfizer, and Takeda; research support from AbbVie, Boehringer Ingelheim, and Pfizer.||Dr. Chou, Bonnie:|:|Bonnie Chou is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options. ||Dr. Mo, Jason:|:|Jason Mo is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options. ||Dr. Ursos, Lyann:|:|Lyann Ursos is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options. ||Dr. Twardowski, Rachel:|:|Rachel Twardowski is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options. ||Dr. Candela, Ninfa:|:|Ninfa Candela is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options. ||Dr. Colombel, Jean-Frederic:|:|Jean-Frederic Colombel has received research grants from AbbVie, Janssen Pharmaceuticals and Takeda; has received payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb Company, Ferring Pharmaceuticals, Shire, Takeda and Tillots; has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen Pharmaceuticals, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development.

P327 Dr. Scribano, Maria Lia:|:|Advisory board member and/or a speaker for Abbvie, Celltrion, Janssen, Pfizer, Takeda.||Dr. Aratari, Annalisa: No conflict of interest||Dr. Neri, Benedetto: No conflict of interest||Dr. Bezzio, Cristina: No conflict of interest||Dr. Balestrieri, Paola: No conflict of interest||Dr. Falasco, Giuliano: No conflict of interest||Dr. Camastra, Caterina: No conflict of interest||Dr. Pantanella, Paolo: No conflict of interest||Dr. Monterubbianesi, Rita: No conflict of interest||Dr. Tullio, Alessandro: No conflict of interest||Dr. Saibeni, Simone:|:|Advisory board and lecture fees for Arena, Gilead, Janssen, Takeda, AbbVie||Dr. Papi, Claudio:|:|Consultancy fees and/or educational grants from Abbvie, MSD, Takeda, Pfizer, Janssen-Cilag, Chiesi, Sofar, Ferring and Zambon||Prof. Dr. Biancone, Livia:|:|Fees grant for speaker from Ferring, Abbvie, Janssen and Zambon||Dr. Cosintino, Rocco: No conflict of interest||Dr. Faggiani, Roberto: No conflict of interest

P328 Mr. RUEDA SANCHEZ, Jesus: No conflict of interest||Ms. Cabello Ramirez, Mercedes: No conflict of interest||Mr. Camara Baena, Sergio: No conflict of interest||Ms. Keco Huerga, Alma: No conflict of interest||Mr. Garcia de la Borbolla Serres, Jesus: No conflict of interest||Mr. Castro Fernandez, Manuel: No conflict of interest||Ms. Grande Santamaria, Lourdes: No conflict of interest

P329 Dr. Marsilio, Ilaria: No conflict of interest||Dr. MANIERO, Daria: No conflict of interest||Dr. Lorenzon, Greta: No conflict of interest||Dr. Rigo, Alessandra: No conflict of interest||Dr. Cardin, Romilda: No conflict of interest||Dr. Facchin, Sonia: No conflict of interest||Dr. Barberio, Brigida: No conflict of interest||Dr. D'Incà, Renata: No conflict of interest||Dr. Zingone, Fabiana: No conflict of interest||Dr. Bahur, Bayda:|:| full-time employee of ProciseDx Inc, and hold options to purchase shares||Dr. Bray, Kurt B.:|:|full-time employee of ProciseDx Inc, and hold options to purchase shares||Savarino, Edoardo Vincenzo: No conflict of interest

P330 Dr. Derikx, Lauranne: No conflict of interest||Mrs. Dolby, Heather: No conflict of interest||Mr. Plevris, Nikolas:|:|Nikolas Plevris has speaker fees from Jannssen and takeda|||Mrs. Lucaciu , Laura: No conflict of interest||Mrs. Rees, Caitlin: No conflict of interest||Dr. Lyons, Matthew: No conflict of interest||Dr. Siakavellas, Spyros:|:|Spyros Siakavellas has a support grant from the Greek Group for the study of IBD and speaker fees from Pfizer and Janssen.||Mr. Constantine-Cooke, Nathan: No conflict of interest||Mr. Noble, Colin: No conflict of interest||Mrs. O’Hare, Claire: No conflict of interest||Mrs. Merchant, Lynne: No conflict of interest||Dr. Arnott, Ian: No conflict of interest||Dr. Jones, Gareth-Rhys: No conflict of interest||Prof. Lees, Charlie:|:|Professor Charlie Lees has received research support from Abbvie and Gilead, acted as a consultant to Abbvie, Janssen, Takeda, Pfizer, Galapagos, MSD, Hospira, Pharmacosmos, GSK, Gilead, Topivert, Vifor Pharma, Dr Falk, Oshi Health, Trellus Health and Iterative Scopes; he has received speaking fees and travel support from Pfizer, Janssen, Abbvie, Galapagos, MSD, Takeda, Shire, Ferring, Hospira, Warner-Chilcott and Dr Falk.

P331 Ms. Crouwel, Femke: No conflict of interest||Ms. Simsek, Melek:|:|M. Simsek has received an unrestricted research grant from TEVA||Dr. De Boer, Marjon A.: No conflict of interest||Prof. Dr. Mulder, Chris J.J.: No conflict of interest||Dr. Buiter, Hans J.C.: No conflict of interest||Dr. De Boer, Nanne K.:|:|NK de Boer has served as a speaker for AbbVie and MSD and has served as consultant and principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Dr. Falk, TEVA Pharma BV, MLDS and Takeda.

P332 Dr. Shen, Jun:|:|employee of Bristol Myers Squibb Company.||Dr. Tatosian, Daniel: No conflict of interest||Dr. Sid-Otmane, Lamia:|:|employee of Certara USA, Inc.||Dr. Teuscher, Nathan:|:|employee of Certara USA, Inc||Dr. Chen, Lu:|:|employee of Bristol Myers Squibb Company.||Dr. Zhang, Peijin:|:|employee of Bristol Myers Squibb Company.||Dr. Tirucherai, Giridhar S.:|:|employee of Bristol Myers Squibb Company.||Dr. Chitakara, Denesh:|:|employee of Bristol Myers Squibb Company.||Dr. Marta, Cecilia:|:|employee of Bristol Myers Squibb Company.

P333 Dr. Kakkadasam Ramaswamy, Pradeep: No conflict of interest||Dr. Subhaharan, Deloshaan: No conflict of interest||Dr. Willmann, Laura: No conflict of interest||Dr. Edwards, John: No conflict of interest||Dr. Shukla, Dheeraj: No conflict of interest||Dr. Bhullar, Maneesha: No conflict of interest||Dr. Moattar, Hadi: No conflict of interest||Dr. Dorrington, Alexander: No conflict of interest||Dr. Ishaq, Naveed: No conflict of interest||Dr. McIvor, Carolyn: No conflict of interest||Dr. Mohsen, Waled: No conflict of interest

P334 Dr. Ungaro, Ryan C.:|:|Grants: AbbVie, Boehringer Ingelheim, Pfizer Inc|Personal fees: Eli Lilly, Janssen, Pfizer Inc, Takeda|Other: Career Development Award from the National Institutes of Health (K23KD111995‐01A1)||Dr. Ciorba, Matthew A.:|:|Grants: Incyte, Pfizer Inc|Personal fees: Bristol-Myers Squibb, Pfizer Inc||Dr. Rogler, Gerhard:|:|Grants: AbbVie, Ardeypharm, Augurix, Calypso, Falk, Ferring, Flamentera, MSD, Novartis, Pfizer Inc, Roche, Takeda, Tillotts, UCB, Zeller|Personal fees: AbbVie, AstraZeneca, Augurix, Bristol-Myers Squibb, Boehringer Ingelheim, Calypso, Celgene, Falk, Ferring, Fisher, Genentech, Gilead, Janssen, MSD, Nestlé, Novartis, Pfizer Inc, Phadia, Pharmabiome, Roche, Takeda, Tillotts, UCB, Vifor, Vital Solutions, Zeller|Other: Directorship(s): Pharmabiome||Dr. Sharara, Ala I.:|:|Grants: Ferring, Gilead, Janssen, Pfizer Inc, Takeda|Personal fees: AbbVie, Amgen, Arena, Ferring, Gilead, Janssen, Pfizer Inc, Sandoz, Takeda, Tillotts||Dr. Sunna, Nancy:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Connelly, Susan B.:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Mundayat, Rajiv:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Panés, Julian:|:|Grants: AbbVie, Pfizer Inc|Personal fees: AbbVie, Arena, Biogen, Boehringer Ingelheim, Celgene, Genentech, Gilead, GlaxoSmithKline, GoodGut, Immunic, Janssen, MSD, Nestlé, Origo, Pfizer Inc, Progenity, Robarts Clinical Trials, Roche, Takeda, Theravance, Wasserman

P335 Dr. Oh, Kyunghwan: No conflict of interest||Prof. Dr. Hong, Sung Noh: No conflict of interest||Prof. Dr. Kim, Eun Soo: No conflict of interest||Prof. Dr. Na, Soo-Young: No conflict of interest||Prof. Dr. Kang, Sang-Bum: No conflict of interest||Prof. Dr. Koh, Seong-Joon: No conflict of interest||Prof. Dr. Bang, Ki Bae: No conflict of interest||Prof. Dr. Jung, Sung-Ae: No conflict of interest||Prof. Dr. Kim, Kyeong Ok: No conflict of interest||Prof. Dr. Choi, Chang Hwan: No conflict of interest||Prof. Dr. Ye, Byong Duk:|:|Financial support: This study was supported by grant number 2020IT0012 from the Asan Institute for Life Sciences, Seoul, Korea.||Conflicts of interest: Byong Duk Ye has received a research grant from Celltrion|and Pfizer Korea; consulting fees from AbbVie Korea, Celltrion, Chong Kun Dang|Pharm, Daewoong Pharma, Ferring Korea, Janssen Korea, Kangstem Biotech, Korea United Pharm., LG|Chem, Medtronic Korea, Pfizer Korea, Shire Korea, Takeda Korea, IQVIA, and|Takeda; and speaking fees from AbbVie Korea, Celltrion, Ferring Korea, Janssen|Korea, Pfizer Korea, Shire Korea, Takeda Korea, and IQVIA. However, none of|these conflicts are related to work performed for this study.

P336 Dubinsky, Marla C.:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||D’Haens, Geert R.:|:|Personal fees: AbbVie, Ablynx, Allergan, Amakem, Amgen, AM Pharma, Arena, AstraZeneca, Avaxia, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronics, Dr. Falk Pharma, Echo Pharmaceuticals, Eli Lilly, Engene, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Gossamer Bio, Hospira, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Nextbiotics, Norgine, Novo Nordisk, Otsuka, Pfizer Inc, Photopill, Progenity, Prometheus Laboratories/Nestlé, Protagonist, Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestlé, SetPoint Medical, Shire, Teva, TiGenix, Tillotts, TopiVert, Versant, Vifor||Sandborn, William J.:|:|Grants: AbbVie, Abivax, Arena, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, Janssen, Pfizer Inc, Prometheus Biosciences, Seres, Shire, Takeda, Theravance Biopharma|Personal fees: AbbVie, Abivax, Admirx, Alfasigma, Alimentiv (previously Robarts Clinical Trials, owned by Alimentiv Health Trust), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Eli Lilly, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), InDex Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer Inc, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma|Other: Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock, stock options; Prometheus Laboratories – stock, stock options, consultant; Ventyx Biosciences – stock, stock options; Vimalan Biosciences – stock, stock options||Ng, Siew C.:|:|Grants: AbbVie, Ferring, Olympus|Personal fees: AbbVie, Ferring, Janssen, Menarini, NIL, Pfizer Inc, Takeda, Tillotts|Other: Directorship: Microbiota I-Center ||Panés, Julian:|:|Grants: AbbVie, Pfizer Inc|Personal fees: AbbVie, Arena, Biogen, Boehringer Ingelheim, Celgene, Genentech, Gilead, GlaxoSmithKline, GoodGut, Immunic, Janssen, MSD, Nestlé, Origo, Pfizer Inc, Progenity, Robarts Clinical Trials, Roche, Takeda, Theravance, Wasserman||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Lazariciu, Irina:|:|Other: Employee: IQVIA (paid contractor to Pfizer Inc)||Gardiner, Sean:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Mundayat, Rajiv:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Kulisek, Nicole:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Torres, Joana:|:|Grants: AbbVie, Janssen|Personal fees: Arena, Galapagos, Gilead, Janssen, Pfizer Inc

P337 Mr. CHUNG, Aaron: No conflict of interest||Dr. Carroll, Matthew: No conflict of interest||Mrs. Almeida, Patricia: No conflict of interest||Mrs. Petrova, Alexandra: No conflict of interest||Dr. Mould, Diane: No conflict of interest||Dr. Wine, Eytan: No conflict of interest||Dr. Huynh, Hien: No conflict of interest

P338 Dr. Suarez Ferrer, Cristina Julia: No conflict of interest||Mesonero , Francisco: No conflict of interest||Mrs. Caballol, Berta: No conflict of interest||Mrs. Saiz Chumillas, Rosa: No conflict of interest||Mrs. Bastón-Rey, Iria: No conflict of interest||Rubin de Celix, Cristina: No conflict of interest||Melcarne, Luigi: No conflict of interest||Caballero Mateos, Antonio: No conflict of interest||Calafat, Margalida: No conflict of interest||Alonso Galan, Horacio: No conflict of interest||Vega Villaamil, Pablo: No conflict of interest||Castro Senosiain, Beatriz: No conflict of interest||Rodriguez Diaz, Carmen Yolanda: No conflict of interest||Plaza Santos, Rocio: No conflict of interest||Marques Cami, Miguel: No conflict of interest||Rodriguez Grau, Maria Carmen: No conflict of interest||Ramirez, Fernando: No conflict of interest||Lopez-García, Alicia: No conflict of interest||Gomez Pastrana, Barbara: No conflict of interest||Gonzalez Partida, Irene: No conflict of interest||Botella Mateu, Belen: No conflict of interest||Cuevas del Campo, Lidia: No conflict of interest||Gonzalez Peña, Elena: No conflict of interest||Iyo, Eduardo: No conflict of interest||Elosua Gonzalez, Alfonso: No conflict of interest||Sainz, Empar: No conflict of interest||Hernandez, Luis: No conflict of interest||Perez Galindo, Pablo: No conflict of interest||Rueda Garcia, Jose Luis: No conflict of interest||Martin-Arranz, Maria Dolores: No conflict of interest||Lopez Sanroman, Antonio: No conflict of interest||Fernandez-Clotet, Agnes: No conflict of interest||Sicilia, Beatriz: No conflict of interest||Calviño Suárez, Cristina: No conflict of interest||Mañosa Ciria, Miriam: No conflict of interest||Barreiro-De Acosta, Manuel: No conflict of interest

P339 Ms. SCHAAFSMA, Irene: No conflict of interest||Mrs. Hoogenboom, Froukje: No conflict of interest||Dr. Visschedijk, Marijn: No conflict of interest||Dr. Prins, Jelmer: No conflict of interest||Prof. Dr. Dijkstra, Gerard: No conflict of interest

P340 Ms. Karki, Chitra:|:|Chitra Karki is a salaried employee of Takeda Pharmaceuticals USA, Inc.||Ms. Latremouille-Viau, Dominick:|:|Dominick Latremouille-Viau is an employee of Analysis Group, Inc., a consulting company that received funding from Takeda Pharmaceuticals USA, Inc.||Dr. Gilaberte, Inmaculada:|:|Inmaculada Gilaberte is a salaried employee of Takeda Pharmaceuticals USA, Inc.||Dr. Hantsbarger, Gary:|:|Gary Hantsbarger is a salaried employee of Takeda Pharmaceuticals USA, Inc.||Dr. Romdhani, Hela:|:|Hela Romdhani is an employee of Analysis Group, Inc., a consulting company that received funding from Takeda Pharmaceuticals USA, Inc.||Lightner, Amy:|:|Amy Lightner is a consultant for Takeda Pharmaceuticals USA, Inc.

P341 Dr. Koletzko, Leandra: No conflict of interest||Dr. Klucker, Elisabeth: No conflict of interest||Mrs. Le Thi, Giang: No conflict of interest||Mrs. Breiteneicher, Simone: No conflict of interest||Dr. Rubio-Acero, Raquel: No conflict of interest||Dr. Neuhaus, Lukas: No conflict of interest||Dr. Stark, Renee: No conflict of interest||Dr. Standl, Marie: No conflict of interest||Prof. Dr. Hölscher, Michael: No conflict of interest||Dr. Török, Helga: No conflict of interest||Prof. Dr. Koletzko, Sibylle: No conflict of interest||Dr. Schwerd, Tobias: No conflict of interest

P342 Dr. Ruiz-Argüello, Maria Begoña: No conflict of interest||Mr. Pascual, Javier:|:|Progenika employee||Ms. Del Río, Lorena:|:|Progenika employee||Ms. Urigoitia, Ane:|:|Progenika employee||Ms. Balo Farto, Cristina: No conflict of interest||Dr. Fernández, Carlos: No conflict of interest||Dr. Mera, Antonio: No conflict of interest||Dr. De Toro, Javier: No conflict of interest||Dr. Nagore, Daniel:|:|Progenika employee||Dr. Ametzazurra, Amagoia:|:|Progenika employee

P343 Prof. Dr. Mantzaris, Gerassimos: No conflict of interest||Dr. Vraka, Marina: No conflict of interest||Dr. Beka, Helen: No conflict of interest||Dr. Georgiadi, Tereza: No conflict of interest||Dr. Albani, Fotini: No conflict of interest||Dr. Veretanos, Christos: No conflict of interest||Dr. Mountaki, Katerina: No conflict of interest||Dr. Trikola, Artemis: No conflict of interest||Dr. Archavlis, Emmanuel: No conflict of interest||Dr. Christidou, Aggeliki: No conflict of interest||Dr. Manolakis, Anastasios: No conflict of interest||Dr. Viazis, Nikolaos: No conflict of interest||Dr. Karampekos, George: No conflict of interest||Dr. Philippidis, George: No conflict of interest||Dr. Hatzievangelinou, Christina: No conflict of interest||Dr. Tsatsa, Anastasia: No conflict of interest||Ms. Georgiadou, Anastasia: No conflict of interest||Ms. Panagopoulou, Spyridoula: No conflict of interest

P344 Mr. Hanzel, Jurij:|:|JH reports personal fees from Biogen, personal fees from Janssen, personal fees from Takeda, personal fees from Alimentiv.||Dr. Strik, Anne: No conflict of interest||Dr. Gecse, Krisztina:|:|KG has received consultancy fees and/or speaker’s honoraria fromfrom AbbVie, Boehringer Ingelheim, Celltrion, Ferring, Gilead, Immunic Therapeutics, Janssen, Pfizer, Sandoz, Samsung Bioepis, Takeda and Tillotts.||Prof. D'Haens, Geert:|:|GD has served as advisor for Abbvie, Ablynx, Alimentiv, Allergan, Amakem, Amgen, AM Pharma, Arena Pharmaceuticals, AstraZeneca, Avaxia, Biogen, Bristol Meiers Squibb, Boerhinger Ingelheim, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronics, Ferring, DrFALK Pharma, Eli Lilly, Engene, Galapagos, Genentech/Roche, Gilead, Glaxo Smith Kline, Hospira/Pfizer, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millennium/Takeda, Mitsubishi Pharma, Merck Sharp Dome, Mundipharma, Nextbiotics, Novonordisk, Otsuka, Pfizer/Hospira, Photopill, Prometheus laboratories/Nestle, Progenity, Protagonist, Salix, Samsung Bioepis, Sandoz, Seres/Nestle, Setpoint, Shire, Teva, Tigenix, Tillotts, Topivert, Versant and Vifor; received speaker fees from Abbvie, Biogen, Ferring, Johnson and Johnson, Merck Sharp Dohme, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium/Takeda, Tillotts and Vifor.||Dr. Dreesen, Erwin: No conflict of interest

P345 Mrs. Day, Alice: No conflict of interest||Dr. Yao, Chu Kion: No conflict of interest||Dr. Costello, Sam: No conflict of interest||Prof. Dr. Andrews, Jane: No conflict of interest||Dr. Bryant, Robert: No conflict of interest

P346 Dr. Adler, Jeremy:|:|Janssen Research & Development, LLC||Dr. Kandavel, Prashanthi: No conflict of interest||Ms. Eder, Sally: No conflict of interest||Dr. Saeed, Shehzad:|:|Abbvie Speaker's Bureau

P347 Mr. Attauabi, Mohamed:|:|Research grants from Takeda. None of these pertain to the research submitted here.||Dr. Höglund, Camilla: No conflict of interest||Dr. Fassov, Janne: No conflict of interest||Dr. Pedersen, Kenneth Bo: No conflict of interest||Dr. Bansholm Hansen, Heidi: No conflict of interest||Dr. Wildt, Signe:|:|Advisory Boards: Takeda and Tillotts||Dr. Dam Jensen, Michael:|:|Personal fee from Tillotts Pharma not pertained to the research submitted here||Dr. Neumann, Anders: No conflict of interest||Dr. Lind, Cecilie: No conflict of interest||Dr. Albæk Jacobsen, Henrik: No conflict of interest||Dr. Popa, Ana-Maria: No conflict of interest||Prof. Dr. Kjeldsen, Jens:|:|Teaching fee from TAKEDA. Otherwise, no conflicts of interest.||Dr. Pedersen, Natalia: No conflict of interest||Dr. Molazahi, Akbar: No conflict of interest||Dr. Haderselv, Kent: No conflict of interest||Dr. Aalykke, Claus:|:|Personal fees for participating in Advisory Boards of Ferring, Tillots, Takeda, and Janssen||Dr. Knudsen, Torben:|:|Advisory Boards: Janssen, Takeda, Tillotts, speaker fee: Takeda, Pfizer, MSD, Research grant: Takeda||Dr. Cebula, Wojciech: No conflict of interest||Prof. Dr. Munkholm, Pia: No conflict of interest||Prof. Dr. Bendtsen, Flemming:|:|Research grant from Ferring, Tillotts. None of these pertain to the research submitted here.||Prof. Dr. Seidelin, Jakob Benedict:|:|Research grants from Takeda and the Capital Region Denmark, national coordinator of studies from AbbVie, Arena Pharmaceuticals, Ely Lilly, and Boehringer Ingelheim. None of these pertain to the research submitted here.||Dr. Johan, Burisch:|:|personal fees from AbbVie, Janssen-Cilag, Celgene, MSD, Samsung Bioepis, and Pfizer grants and personal fees from Takeda and Tillots Pharma. None of these pertain to the research submitted here.

P348 Dr. Kabir, Misha: No conflict of interest||Prof. Thomas-Gibson, Siwan: No conflict of interest||Prof. Hart, Ailsa: No conflict of interest||Dr. Wilson, Ana: No conflict of interest

P350 Dr. Rioux, Louis Charles: No conflict of interest||Dr. Bernard, Edmond-Jean: No conflict of interest||Ms. Bourgault, Manon: No conflict of interest||Ms. Mondragon, Pamela: No conflict of interest||Ms. Rioux, Victoria: No conflict of interest

P351 Prof. Dr. Sładek, Malgorzata: No conflict of interest||Dr. Krucka-Kawalec , Marta: No conflict of interest||Dr. Wojtas, Ewa: No conflict of interest||Mr. Jagielski , Paweł: No conflict of interest||Dr. Stochel-Gaudyn, Anna: No conflict of interest

P352 Dr. Lenti, Marco Vincenzo: No conflict of interest||Dr. Dolby, Vivien: No conflict of interest||Dr. Clark, Tanya: No conflict of interest||Dr. Hall, Veronica: No conflict of interest||Dr. Tattersall, Suzanne: No conflict of interest||Dr. Fairhurst, Francesca: No conflict of interest||Dr. Kenneth, Catherine: No conflict of interest||Dr. Walker, Rachel: No conflict of interest||Dr. Kemp, Karen: No conflict of interest||Dr. Borg-Bartolo, Simon: No conflict of interest||Dr. Limdi, Jimmy: No conflict of interest||Dr. Taylor, Jo: No conflict of interest||Dr. Townsend, Tristan: No conflict of interest||Dr. Subramanian, Sree: No conflict of interest||Dr. Storey, Daniel: No conflict of interest||Dr. Assadsangabi, Arash: No conflict of interest||Dr. Stansfield, Catherine: No conflict of interest||Dr. Smith, Paul: No conflict of interest||Dr. Byrne, Debra: No conflict of interest||Dr. De Silvestri, Annalisa: No conflict of interest||Dr. Selinger, Christian: No conflict of interest

P353 Mr. Volkers, Adriaan: No conflict of interest||Dr. Bosuyt, Peter:|:|Peter Bossuyt has received financial support for research from AbbVie, Mundipharma, Pfizer, Janssen, Amgen and Mylan; lecture fees from AbbVie, Takeda, Pfizer and Janssen; advisory board fees from Abbvie, Arena pharmaceuticals, BMS, Takeda, Hospira, Janssen, MSD, Mundipharma, Roche, Pfizer, Sandoz, Galapagos, PSI-CRO and Pentax.||Ms. de Jong, Jitteke: No conflict of interest||Prof. Dr. D'Haens, Geert:|:|Has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamerbio, Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, L Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint, Tillotts.|Reports speaker fees from AbbVie, Biogen, Ferring, Johnson & Johnson, MSD, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium/Takeda, Tillotts and Vifor.|||Dr. Löwenberg, Mark:|:|Mark Löwenberg has served as speaker and/or principal investigator for: Abbvie, Celgene, Covidien, Dr. Falk, Ferring Pharmaceuticals,|Gilead, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, Protagonist therapeutics, Receptos, Robarts Clinical Trials, Takeda, Tillotts, Tramedico.|He has received research grants from AbbVie, Merck Sharp & Dohme, Dr Falk, Achmea healthcare and ZonMW.

P354 Dr. Haenen, Shana: No conflict of interest||Prof. Dr. Sabino, João: No conflict of interest||Dr. Bislenghi, Gabriele: No conflict of interest||Prof. Dr. D'Hoore, André: No conflict of interest||Prof. Dr. Ferrante, Marc: No conflict of interest||Prof. Dr. Vermeire, Séverine: No conflict of interest

P355 Dr. Taxonera Samso, Carlos:|:|CT has served as a speaker, consultant, and advisory board member for MSD, AbbVie, Pfizer, Takeda, Janssen, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, and Tillots.||Dr. Martínez-Montiel, Pilar: No conflict of interest||Dr. Barreiro-De-Acosta, Manuel:|:|MBA has served as a speaker, consultant, and advisory member for or has received research funding from MSD, AbbVie, Janssen, Kern Pharma, Celltrion, Takeda, Gillead, Celgene, Pfizer, Sandoz, Biogen, Fresenius, Ferring, Faes Farma, Dr. Falk Pharma, Chiesi, Gebro Pharma, Adacyte and Vifor Pharma.||Dr. Vera, Isabel:|:|IV has served as a speaker, consultant and advisory member for and has received funding from MSD, Abbvie, Pfizer, Ferring, Shire Pharmaceuticals, Takeda, and Jannsen.||Dr. Lorente, Rufo: No conflict of interest||Dr. Vega, Pablo: No conflict of interest||Dr. Diz-Lois, María Teresa: No conflict of interest||Dr. Fuentes Coronel, Ana María: No conflict of interest||Dr. Pérez Calle, José Lázaro: No conflict of interest||Dr. Casis, Begoña:|:|BA has served as a speaker, consultant, and advisory board member for MSD, Abbvie, Ferring, Shire, Takeda, and Janssen.||Dr. Ferreiro, Rocio: No conflict of interest||Dr. Calvo, Marta: No conflict of interest||Mr. Olivares, David: No conflict of interest||Dr. Alba, Cristina: No conflict of interest

P356 Carlson, Sean: No conflict of interest||Dr. McCartney, Sara: No conflict of interest||Dr. Harrow, Paul: No conflict of interest

P357 Dr. Rodríguez-Lago, Iago: No conflict of interest||Dr. Fernández-Clotet, Agnès: No conflict of interest||Dr. Mesonero, Francisco: No conflict of interest||Dr. García-Alonso, Francisco Javier: No conflict of interest||Dr. Casanova, María José: No conflict of interest||Dr. Fernández-de la Varga, Margarita: No conflict of interest||Dr. Cañete, Fiorella: No conflict of interest||Dr. de Castro, Luisa: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest||Dr. Sicilia, Beatriz: No conflict of interest||Dr. Cano, Victoria: No conflict of interest||Dr. Merino, Olga: No conflict of interest||Dr. Riestra, Sabino: No conflict of interest||Dr. González-Partida, Irene: No conflict of interest||Dr. Surís, Gerard: No conflict of interest||Dr. Torrealba, Leyanira: No conflict of interest||Dr. Ferreiro-Iglesias, Rocío: No conflict of interest||Dr. Castro, Beatriz: No conflict of interest||Dr. Márquez, Lucía: No conflict of interest||Dr. Sobrino, Ana: No conflict of interest||Dr. Elorza, Ainara: No conflict of interest||Dr. Calvet, Xavier: No conflict of interest||Dr. Varela, Pilar: No conflict of interest||Dr. Betoré, Elena: No conflict of interest||Dr. Bujanda, Luis: No conflict of interest||Dr. Lario, Laura: No conflict of interest||Dr. Manceñido, Noemí: No conflict of interest||Dr. García-Sepulcre, Mariana: No conflict of interest||Dr. Iglesias, Eva: No conflict of interest||Dr. Rodríguez, Cristina: No conflict of interest||Dr. Piqueras, Marta: No conflict of interest||Dr. Ferrer Rosique, Juan Ángel: No conflict of interest||Dr. Lucendo, Alfredo: No conflict of interest||Ms. Benítez, Olga: No conflict of interest||Dr. García, Melody: No conflict of interest||Dr. Olivares, David: No conflict of interest||Dr. González-Muñoza, Carlos: No conflict of interest||Dr. Cabriada, José Luis: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

P358 Cheon, Jae Hee: No conflict of interest||Dr. Kang, Hyoun Woo: No conflict of interest||Mr. Lee, Sang Joon: No conflict of interest||Mr. Kim, Sung Hyun: No conflict of interest

P359 Prof. Knyazev, Oleg: No conflict of interest||Dr. Kagramanova, Anna: No conflict of interest||Dr. Lishchinskaya, Albina: No conflict of interest||Dr. Noskova, Karina: No conflict of interest||Dr. Chernova, Marina: No conflict of interest||Dr. Shkurko, Tatyana: No conflict of interest||Dr. Veselov, Alexey: No conflict of interest||Kulakov, Dmitry: No conflict of interest||Dr. Li, Irina: No conflict of interest||Prof. Parfenov, Asfold: No conflict of interest

P360 Dr. Marrero Torres, Ricardo: No conflict of interest||Dr. Coste-Sibilia, Santiago: No conflict of interest||Mr. Nieves-Jimenez, Humberto: No conflict of interest||Dr. Torres, Guillermo: No conflict of interest||Dr. Torres, Esther A.: No conflict of interest

P361 Ms. DE GREEF, Ine: No conflict of interest||Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion.||Dr. Bislenghi, Gabriele:|:|Speakers fees from Takeda and Janssen ||Mrs. Terrasson, Isabelle: No conflict of interest||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Dr. D’Hoore, André: No conflict of interest||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

P362 Dr. WONG, Serre-Yu: No conflict of interest||Ms. Dixon, Rebekah: No conflict of interest||Dr. Gold, Stephanie: No conflict of interest||Ms. Vicky, Martinez: No conflict of interest||Mr. Helmus, Drew: No conflict of interest||Dr. Cadwell, Ken:|:|Dr. Cadwell reported receiving research funding from Pfizer, Takeda, and Abbvie; has consulted for or received an honorarium from Puretech Health, Genentech, and Abbvie; and holds U.S. patent 10,722,600 and provisional patent 62/935,035. ||Dr. Colombel, Jean-Frederic:|:|. Dr. Colombel reported receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb Company, Ferring Pharmaceuticals, Shire, Takeda and Tillots; has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen Pharmaceuticals, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix, Viela bio; and holding stock options in Intestinal Biotech Development.

P363 Ms. Ouboter, Laura: No conflict of interest||Dr. Barnhoorn, Marieke: No conflict of interest||Dr. van Pel, Melissa: No conflict of interest||Prof. Dr. Zwaginga, Jaap Jan: No conflict of interest||Dr. Hawinkels, Lukas: No conflict of interest||Dr. Maljaars, Jeroen: No conflict of interest||Prof. Dr. Koning, Frits: No conflict of interest||Prof. Dr. Verspaget, Hein: No conflict of interest||Dr. van der Meulen - de de Jong, Andrea: No conflict of interest

P364 Golovics, Petra: No conflict of interest||Gonczi, Lorant: No conflict of interest||Dr. Reinglass, Jason: No conflict of interest||Dr. Verdon, Christine: No conflict of interest||Dr. Pundir, Sheetal: No conflict of interest||Dr. Afif, Waqqas: No conflict of interest||Dr. Wild, Gary: No conflict of interest||Prof. Dr. Bitton, Alain: No conflict of interest||Dr. Bessissow, Talat: No conflict of interest||Prof. Dr. Lakatos, Péter Laszlo: No conflict of interest

P365 Ghosh, Subrata:|:|Steering committees for AbbVie, Boehringer Ingelheim, Celgene and Janssen, and an advisory committee for AbbVie; speaker fees from AbbVie, Janssen, Pfizer and Takeda; consultancy with Boehringer Ingelheim, Celgene, Eli Lilly, Gilead and Roche.||Casellas, Francesc:|:|Research funding from AbbVie, Ferring, MSD, Shire, Takeda and Zambon; speaker fees from AbbVie, Chiesi, Ferring, Gebro, MSD, Shire, Takeda and Zambon.||Mrs. Kligys, Kristina:|:|Employee of AbbVie and may own stock or options.||Sanchez Gonzalez, Yuri:|:|Employee of AbbVie and may own stock or options.||Peyrin-Biroulet, Laurent:|:|Personal fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, BMS, Boehringer Ingelheim, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius Kabi, Genentech, Gilead, Hikma, Index Pharmaceuticals, Janssen, Lilly, MSD, Mylan, Nestle, Norgine, Oppilan Pharma, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity Therapeutics, Theravance, Tillotts, Takeda and Vifor; grants from AbbVie, MSD and Takeda; stock options with CTMA.

P366 D'Haens, Geert:|:|Geert D’Haens has received financial support for research from AbbVie, Bühlmann Laboratories, Ferring, DrFALK Pharma, Johnson and Johnson, GlaxoSmithKline, Medtronics, Millennium/Takeda, MSD, Photopill, Prometheus Laboratories, Robarts Clinical Trials and Setpoint lecture fees from AbbVie, Biogen, Ferring, DrFALK Pharma, Johnson and Johnson, Giuliani, Millennium/Takeda, MSD, Norgine, Otsuka, Shire, Tillotts, UCB and Vifor consultancy fees from AbbVie, Ablynx, Actogenix, Amakem, Amgen, AM Pharma, AstraZeneca, Biogen, Bristol-Myers Squibb, Boehringer Ingelheim, Cosmo Pharmaceuticals, Elan, Ferring, Celgene/Receptos, Celltrion, Johnson and Johnson, Engene, Galapagos, Gilead, GlaxoSmithKline, Immunic Therapeutics, Lycera, Medimetrics, Medtronics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Novo Nordisk, Otsuka, Hospira/Pfizer, PDL, Prometheus Laboratories, Protagonist, Salix, Samsung Bioepis, Sandoz, Setpoint, Shire, TEVA, Tigenix, Tillotts, Topivert, UCB, Versant, Vifor and is the director of Robarts Clinical Trials. ||Dr. Candela, Ninfa:|:|Ninfa Candela is an employee of Takeda Pharmaceuticals USA, Inc. and has stock or stock options. ||Dr. Uddin, Sharif:|:|Sharif Uddin is an employees of Takeda Pharmaceuticals USA, Inc. and has stock or stock options. ||Dr. Peterson, Theresa:|:|Theresa Peterson is an employee of Takeda Pharmaceuticals USA, Inc. and has stock or stock options. ||Dr. Dubinsky, Marla:|:|Marla Dubinsky has received consulting fees from Arena, Abbvie, BMS, Celgene, Eli Lilly, Janssen, Pfizer, Prometheus Biosciences and Takeda, and grant support from Abbvie, Janssen and Pfizer.|||Prof. Colombel, Jean-Frederic:|:|Jean-Frederic Colombel has received grant support, consulting fees, advisory board fees, and lecture fees from AbbVie, Janssen, and Takeda consulting fees, advisory board fees, and lecture fees from Amgen, Ferring, Shire, and Allergan consulting fees and advisory board fees from Arena, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enterome, Genentech, Ipsen, Landos, MedImmune, Merck, Novartis, Pfizer, TiGenix and Viela and has stock options in Intestinal Biotech Development and Genfit.

P367 Dr. Kaazan, Patricia: No conflict of interest||Dr. Tan , Zhi: No conflict of interest||Dr. Maiyani, Prakashkumar: No conflict of interest||Dr. Mickenbecker, Matthew: No conflict of interest||Mrs. Edwards, suzanne: No conflict of interest||Dr. McIvor, Carolyn: No conflict of interest||Prof. Andrews , Jane M:|:|Nil conflicts of interest.|All work is provided by researcher's in kind time

P368 Ms. PEDRO, Juliana: No conflict of interest||Dr. Rodrigues, Inês: No conflict of interest||Dr. Fernandes, Samuel: No conflict of interest||Dr. Gonçalves, Ana Rita: No conflict of interest||Dr. Bernardo, Sónia: No conflict of interest||Dr. Baldaia, Cilénia: No conflict of interest||Dr. Valente, Ana: No conflict of interest||Dr. Moura Santos, Paula: No conflict of interest||Dr. Correia, Luís: No conflict of interest||Prof. Tato Marinho, Rui: No conflict of interest

P369 Mr. Kugel, Tilman:|:|T. Kugel has received consulting fees from AbbVie for writing his diploma thesis.||Prof. Dr. Maaser, Christian:|:|C. Maaser has received lecture and consulting fees from AbbVie||Prof. Dr. Kucharzik, Torsten:|:|T. Kucharzik has received lecture and consulting fees from AbbVie||Dr. Fischer, Imma:|:|I. Fischer has received consulting fees from AbbVie. ||Dr. Kolterer, Stefanie:|:|S. Kolterer is an AbbVie employee and may own AbbVie stock or options. The design, study conduct, and funding for the study was provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the congress abstract. ||Hammer, Leonie:|:|L. Hammer is an AbbVie employee and may own AbbVie stock or options. The design, study conduct, and funding for the study was provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the congress abstract. ||Mr. Rath, Stefan:|:|S. Rath is an AbbVie employee and may own AbbVie stock or options. The design, study conduct, and funding for the study was provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the congress abstract. ||Prof. Dr. Sturm, Andreas:|:|A. Sturm has received lecture and consulting fees from AbbVie

P370 Dr. Kokkotis, Georgios: No conflict of interest||Dr. Zampeli, Evanthia: No conflict of interest||Dr. Tzouvala, Maria: No conflict of interest||Dr. Giotis, Ioannis: No conflict of interest||Mr. Orfanos, Philippos: No conflict of interest||Prof. Dr. Benetou, Vassiliki: No conflict of interest||Dr. Stoupaki, Maria: No conflict of interest||Dr. Gizis, Michalis: No conflict of interest||Dr. Kioulos, Nikolaos: No conflict of interest||Dr. Kitsou, Vassiliki: No conflict of interest||Dr. Leontidis, Nikolaos: No conflict of interest||Dr. Leonidakis, Giorgos: No conflict of interest||Dr. Chatzinikolaou, Matina-Lydia: No conflict of interest||Dr. Perlepe, Nikoleta: No conflict of interest||Dr. Koutsounas, Ioannis: No conflict of interest||Prof. Dr. Lagiou, Pagona: No conflict of interest||Prof. Dr. Michopoulos, Spiros: No conflict of interest||Prof. Dr. Bamias, Giorgos: No conflict of interest

P371 Walsh, Alissa Jane: No conflict of interest||Dr. Matini, Lawrence: No conflict of interest||Mrs. Wilson, Jean: No conflict of interest||Ms. Lyden, Sara: No conflict of interest||Dr. Al-Hillawi, Lulia: No conflict of interest||Ms. Kantschuster, Ramona: No conflict of interest||Dr. Kormilitzin, Andrey: No conflict of interest||Mr. Smith, Timothy: No conflict of interest||Ms. Slater, Jessica: No conflict of interest||Mrs. Payton, Sally: No conflict of interest||Mrs. White, Lydia: No conflict of interest||Ms. Woodley, Heather: No conflict of interest||Dr. Brain, Oliver: No conflict of interest||Dr. Palmer, Rebecca: No conflict of interest||Dr. Ambrose, Timothy: No conflict of interest||Prof. Dr. Satsangi, Jack: No conflict of interest||Prof. Dr. Travis, Simon P.L.: No conflict of interest

P372 Dr. Mesonero Gismero, Francisco: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Fernández-Clotet, Agnès: No conflict of interest||Leo, Eduardo: No conflict of interest||Caballol, Berta: No conflict of interest||Núñez, Andrea: No conflict of interest||García, Maria José: No conflict of interest||Bertoletti, Federico: No conflict of interest||Mínguez, Alejandro: No conflict of interest||Suris, Gerard: No conflict of interest||Casis, Begoña: No conflict of interest||Ferreiro-Iglesias, Rocío: No conflict of interest||Calafat, Margalida: No conflict of interest||Jiménez, Itxaso: No conflict of interest||Miranda-Bautista, José: No conflict of interest||Lamuela, Luis Javier: No conflict of interest||Fajardo, Ingrid: No conflict of interest||Torrealba, Leyanira: No conflict of interest||Nájera, Rodrigo: No conflict of interest||Sáiz, Rosa María: No conflict of interest||González, Irene: No conflict of interest||Vicuña, Miren: No conflict of interest||García-Morales, Natalia: No conflict of interest||Gutiérrez, Ana: No conflict of interest||López-García, Alicia: No conflict of interest||Benítez, José Manuel: No conflict of interest||Rubín de Célix, Cristina: No conflict of interest||Tejido, Coral: No conflict of interest||Brunet, Eduard: No conflict of interest||Hernández, Alejandro: No conflict of interest||Suárez, Cristina: No conflict of interest||Piqueras, Marta: No conflict of interest||Castaño, Andrés: No conflict of interest||Ramos, Laura: No conflict of interest||Sobrino, Ana: No conflict of interest||Rodríguez-Grau, María Carmen: No conflict of interest||Elosua, Alfonso: No conflict of interest||Montoro, Miguel: No conflict of interest||López-Sanromán, Antonio: No conflict of interest||Barreiro-de Acosta, Manuel: No conflict of interest

P373 Dr. RODRIGUES, Inês: No conflict of interest||Dr. Damião, Filipe: No conflict of interest||Dr. Serrazina, Juliana: No conflict of interest||Dr. Fernandes, Samuel: No conflict of interest||Dr. Bernardo, Sónia: No conflict of interest||Dr. Gonçalves, Ana Rita: No conflict of interest||Dr. Moura Santos, Paula: No conflict of interest||Dr. Baldaia, Cilénia: No conflict of interest||Dr. Valente, Ana: No conflict of interest||Dr. Correia, Luís: No conflict of interest||Prof. Dr. Tato Marinho, Rui: No conflict of interest

P374 Dr. Savelkoul, Edo: No conflict of interest||Mr. Maas, Michiel: No conflict of interest||Dr. Bourgonje, Arno: No conflict of interest||Dr. Crouwel, Femke: No conflict of interest||Dr. Russel, Maurice: No conflict of interest||Dr. Römkens, Tessa:|:|T Römkens has participated in advisory board and/or received financial compensation from the following company: Takeda.||Dr. De Boer, Nanne:|:|N.K.H. de Boer has served as a speaker for AbbVie, Takeda and MSD. He has served as consultant and principal investigator for Takeda and TEVA Pharma B.V. He has received (unrestricted) research grants from Dr. Falk and Takeda.||Prof. Dr. Dijkstra, Gerard:|:|G. Dijkstra unrestricted research grants from Abbvie, Takeda and Ferring Pharmaceuticals. Advisory boards for Mundipharma and Pharmacosmos. Received speakers fees from Takeda and Janssen Pharmaceuticals.||Dr. Hoentjen, Frank:|:|F. Hoentjen has served on advisory boards, or as speaker or consultant for Abbvie, Celgene, Janssen‐Cilag, MSD, Takeda, Celltrion, Teva, Sandoz and Dr Falk , and has received unrestricted grants from Dr Falk, Janssen‐Cilag, Abbvie.

P375 Dr. Zhang, Nanhua: No conflict of interest||Dr. Liu, Chunyan: No conflict of interest||Dr. King, Eileen: No conflict of interest||Dr. Chen, Shiran: No conflict of interest||Dr. Olano, Kelly: No conflict of interest||Dr. Steiner, Steven: No conflict of interest||Dr. Colletti, Richard:|:|Consultant to Janssen R&D.||Dr. Saeed, Shehzad:|:|Speaker’s Bureau and Consultancy: Abbvie, Inc||Dr. Strauss, Richard:|:|Richard Strauss is an employee of Janssen Research & Development, LLC and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. ||Dr. Volger, Sheri:|:|Sheri Volger is an employee of Janssen Research & Development, LLC and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. ||Dr. Lo, Kim Hung:|:|Kim Hung Lo is an employee of Janssen Research & Development, LLC and owns stock in Johnson & Johnson, of which Janssen is a subsidiary. ||Dr. Wang, Yiting:|:|Yiting Wang is an employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.

P376 Oddsson, Saemundur:|:|Saemundur Oddsson is the CMO and co-founder of Sidekick Health||Dr. Gunnarsdottir, Thrudur: No conflict of interest||Mrs. Johannsdottir, Lilja: No conflict of interest||Dr. Amundadottir, Maria:|:|Maria Amundadottir is an employee at Sidekick Health||Mrs. Frimannsdottir, Arna:|:|Arna Frimannsdottir is an employee of Sidekick Health||Mrs. Ylanne, Karoliina:|:|Karoliina Ylanne is an employee at Sidekick Health||Dr. Molander, Pauliina: No conflict of interest||Dr. Islind, Anna: No conflict of interest||Dr. Oskarsdottir, Maria: No conflict of interest||Dr. Thorgeirsson, Tryggvi:|:|Tryggvi Thorgeirsson is the CEO and co-founder of Sidekick Health

P377 Dr. Bokemeyer, Bernd:|:|Bernd Bokemeyer received consultancy and speaking fees from Abbvie, MSD, Takeda, Pfizer, Celltrion, Biogen, Janssen, Celgene and Galapagos Biopharma Deutschland GmbH. ||Mr. Picker, Nils:|:|Nils Picker is an employee of Ingress-health, the work of IPAM and Ingress-health in this study was funded by Galapagos NV. ||Prof. Wilke, Thomas:|:|Thomas Wilke is an employee of IPAM; the work of IPAM and Ingress-health in this study was funded by Galapagos NV.||Mr. Rosin, Ludger:|:|Ludger Rosin is an employee of Galapagos Biopharma Deutschland GmbH.||Mr. Patel, Haridarshan:|:|Haridarshan Patel is an employee of Immensity Consulting, Inc., which received funding from Galapagos NV.

P378 Dr. Gatti, Simona: No conflict of interest||Dr. Cianfruglia, Laura: No conflict of interest||Dr. Galeazzi, Tiziana: No conflict of interest||Dr. Palpacelli, Alessandra: No conflict of interest||Dr. Quattrini, Sara: No conflict of interest||Dr. Quatraccioni, Claudia: No conflict of interest||Dr. Catassi, Giulia: No conflict of interest||Dr. Monachesi, Chiara: No conflict of interest||Dr. Di Sario, Antonio: No conflict of interest||Prof. Armeni, Tatiana: No conflict of interest||Prof. Dr. Catassi, Carlo: No conflict of interest

P379 Mr. Hilley, Patrick: No conflict of interest||Dr. Li Wai Suen, Christopher: No conflict of interest||Dr. Srinivasan, Ashish: No conflict of interest||Dr. Choy, Matthew C: No conflict of interest||Dr. De Cruz, Peter: No conflict of interest

P380 Dr. Temido, Maria José: No conflict of interest||Portela, Francisco: No conflict of interest||Dr. Lopes, Sandra: No conflict of interest||Dr. Mendes, Sofia: No conflict of interest||Dr. Ferreira, Margarida: No conflict of interest||Dr. Ferreira, Manuela: No conflict of interest||Dr. Figueiredo, Pedro: No conflict of interest

P381 Mrs. Risager Christensen, Katrine:|:|participated in advisory board for Gilead Nordic, received unrestricted grants from Pfizer and Gilead Nordics||Dr. Steenholdt, Casper:|:|has served as speaker and advisory board member for MSD||Dr. Buhl, Sine: No conflict of interest||Ms. Skougaard, Marie: No conflict of interest||Dr. Brynskov, Jørn:|:|consultant and/or advisory board fees and/or research grants from Abbvie, Pfizer, MSD, Takeda, Janssen, Gilead||Dr. Ainsworth, Mark A.: No conflict of interest||Mrs. Schjødt Jørgensen, Tanja:|:|Speakers bureau/Consultant of: AbbVie, Pfizer, Roche, Novartis, UCB, Biogen, Gilead and Eli Lilly||Dr. Kristensen, Lars Erik: No conflict of interest

P382 Ms. Zvuloni, Maya: No conflict of interest||Dr. Matar, Manar: No conflict of interest||Dr. Levi, Rachel: No conflict of interest||Prof. Shamir, Raanan: No conflict of interest||Prof. Assa, Amit: No conflict of interest

P383 Prof. Dr. Peyrin-Biroulet, Laurent:|:|LPB has received consulting fees from AbbVie, Allergan, Alma, Amgen, Applied Molecular Transport, Arena, Biogen, BMS, Boehringer Ingelheim, Celgene, Celltrion, Enterome, Enthera, Ferring, Fresenius Kabi, Galapagos, Genentech, Gilead, Hikma, Index, Inotrem, Janssen, Eli Lilly, MSD, Mylan, Nestlé, Norgine, Oppilan, OSE Immunotherapeutics, Pfizer, Pharmacosmos, Roche, Samsung Bioepis, Sandoz, Sterna, Sublimity, Takeda, Theravance, Tillotts and Vifor grants from AbbVie, MSD and Takeda and stock options from CTMA. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Loftus Jr, Edward V:|:|EVL has received consulting fees from AbbVie, Allergan, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Calibr, Celgene, Celltrion, Eli Lilly, Genentech, Gilead, Iterative Scopes, Janssen, Ono, Pfizer, Sun, Takeda and UCB and grants from AbbVie, Amgen, Bristol Myers Squibb, Celgene, Genentech, Gilead, Janssen, Pfizer, Receptos, Robarts Clinical Trials, Takeda, Theravance and UCB. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Hibi, Toshifumi:|:|TH has received lecture fees from AbbVie GK, Aspen Japan K.K., Ferring, Gilead, Janssen, JIMRO, Mitsubishi Tanabe, Mochida, Pfizer and Takeda advisory/consulting fees from AbbVie GK, Apo Plus Station, Bristol Myers Squibb, Celltrion, EA, Eli Lilly, Gilead, Janssen, Kyorin, Mitsubishi Tanabe, Nichi-Iko, Pfizer, Takeda and Zeria and grants from AbbVie GK, EA, JIMRO, Otsuka and Zeria. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Ms. Birchwood, Christine:|:|CB is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Yun, Chohee:|:|CY is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Mrs. Zhao, Sally:|:|SZ is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Ms. Liu, Xiaopeng:|:|XL is an employee and shareholder of Gilead Sciences, Inc. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Rogler, Gerhard:|:|GR has received consulting fees from Abbvie, Augurix, BMS, Boehringer Ingelheim, Calypso, Celgene, FALK, Ferring, Fisher, Genentech, Gilead, Janssen, MSD, Novartis, Pfizer, Phadia, Roche, UCB, Takeda, Tillotts, Vifor, Vital Solutions and Zeller speaker fees from Abbvie, AstraZeneca, FALK, Janssen, MSD, Pfizer, Phadia, Takeda, Tillotts, UCB, Vifor and Zeller and grants from AbbVie, Ardeypharm, Augurix, Calypso, FALK, Flamentera, MSD, Novartis, Pfizer, Roche, Takeda, Tillotts, UCB and Zeller. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Danese, Silvio:|:|SD has received lecture fees from AbbVie, Amgen, Ferring, Gilead, Janssen, Mylan, Pfizer and Takeda and consulting fees from AbbVie, Allergan, Amgen, AstraZeneca, Athos Therapeutics, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Eli Lilly, Enthera, Ferring, Gilead, Hospira, Inotrem, Janssen, Johnson & Johnson, MSD, Mundipharma, Mylan, Pfizer, Roche, Sandoz, Sublimity, Takeda, TiGenix, UCB and Vifor. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne,

P384 Dr. Ametzazurra, Amagoia:|:|Progenika employee||Mr. Pascual, Javier:|:|Progenika employee||Mrs. Del Rio, Lorena:|:|Progenika employee||Maguregui, Ainara:|:|Progenika employee||Dr. Nagore, Daniel:|:|Progenika employee||Dr. Ruiz-Argüello, M. Begoña:|:|Progenika employee

P385 Paupard, Thierry:|:|Janssen, Takeda, Pfizer, Amgen, Ferring||Dr. richez, cecile: No conflict of interest||Dr. verlynde, juliette: No conflict of interest||Dr. zaharia, ohana: No conflict of interest||Dr. quartier, gilles: No conflict of interest||Dr. hudziak, hervé: No conflict of interest||Dr. delhoustal, laurence: No conflict of interest

P386 Dr. MARDARE, Roxana: No conflict of interest||Ms. Burgess, Natasha: No conflict of interest||Mr. Studart, Dominic: No conflict of interest||Dr. Deb, Protima: No conflict of interest||Dr. Gasparetto, Marco: No conflict of interest||Prof. Croft, Nick: No conflict of interest||Dr. Naik, Sandhia: No conflict of interest||Dr. Kadir, Ahmed: No conflict of interest

P387 Dr. Lin, Simeng:|:|Dr. Lin reports non-financial support from Pfizer, non-financial support from Ferring, outside the submitted work||Ms. Bewshea, Claire: No conflict of interest||Dr. Chanchlani, Neil: No conflict of interest||Dr. Chee, Desmond:|:|Dr. Chee reports non-financial support from Ferring, personal fees and non-financial support from Pfizer, outside the submitted work.||Prof. Pollok, Richard CG:|:|Dr. Pollok reports acting as consultant, advisory board member, speaker or recipient of educational grant from Dr Falk, Ferring, Janssen, Pharmacosmos and Takeda. ||Dr. Kennedy, Nicholas A.:|:|Dr. Kennedy reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; grants and non-financial support from AbbVie, grants and personal fees from Celltrion, personal fees and non-financial support from Janssen, personal fees from Takeda, personal fees and non-financial support from Dr Falk, outside the submitted work.||Prof. Ahmad, Tariq:|:|Dr. Ahmad reports grants and non-financial support from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study; personal fees from Biogen inc, grants and personal fees from Celltrion Healthcare, personal fees and non-financial support from Immundiagnostik, personal fees from Takeda, personal fees from ARENA, personal fees from Gilead, personal fees from Adcock Ingram Healthcare, personal fees from Pfizer, personal fees from Genentech, non-financial support from Tillotts , outside the submitted work. ||Dr. Goodhand, James R.:|:|Dr. Goodhand reports grants from F. Hoffmann-La Roche AG, grants from Biogen Inc, grants from Celltrion Healthcare, grants from Galapagos NV, non-financial support from Immundiagnostik, during the conduct of the study.

P388 Dr. Mishkin, Daniel:|:|Consulting-Janssen, Consulting, ownership-GI Reviewers, LLC, Investigator, Consultant-Hoffman Roche, Investigator, Consultant-Takeda, Investigator, Consultant-Leading Biopharm Limited, Investigator, Consultant-Immunic AG, Investigator, Consultant-Linical, Investigator, Consultant-Suzhou, Investigator, Consultant-Covance, Investigator, Consultant-Reistone, Investigator, Consultant-Tianjin Pharmaceuticals, Investigator, Consultant-Arena pharmaceuticals, Investigator, Consultant-Novartis, Investigator, Consultant-Abivax, Investigator, Consultant-GlaxoSmithKline, Investigator, Consultant-OSE Immunotherapeutics, Investigator, Consultant-Bausch Salix, Investigator, Consultant-Braintree pharmaceuticals, Investigator, Consultant-Schipher Medicine Corporation, Investigator, Consultant-Assembly Biosciences, Consultant-Bioclinica, Consultant-ERT, Consultant-ICON, Consultant-Axiom, Consultant-Perceptive, Other- Investigator, Consultant, and Steering Committee Member for Janssen||Dr. Marano, Colleen:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Simi, Allison:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Lynch, John:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Ms. Noonan, Lenore:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Zhang, Hongyan:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Sands, Bruce E.:|:|Consulting-Janssen, Other-Investigator, Consultant, and Steering Committee Member for Janssen||Prof. Reinisch, Walter:|:|Consulting-Janssen, Other-Investigator, Consultant, and Steering Committee Member for Janssen

funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Dr. Colombel, Jean-Frederic:|:|JFC has received grants from AbbVie, Janssen and Takeda lecture fees from AbbVie, Amgen, Allergan, Bristol Myers Squibb, Ferring, Shire, Takeda and Tillots consulting fees from AbbVie, Amgen, Arena, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Eli Lilly, Enterome, Ferring, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix and Viela bio and stock options from Intestinal Biotech Development. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.||Prof. Dr. Feagan, Brian:|:|BF has received grants/consulting fees from AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Janssen/Centocor, Johnson & Johnson/Janssen, Pfizer, Receptos and Takeda consulting fees from Ablynx, ActoGeniX, AdMIRx, Akebia, Allergan, Atlantic, Avaxia, Avir, Baxter, Biogen Idec, BiomX, Boehringer Ingelheim, Boston, Calypso, Celgene, Elan/Biogen, enGene, Ferring, Galapagos, Genentech/Roche, gIcare, Gilead, Given Imaging, Gossamer, GSK, Inception IBD, Ironwood, Japan Tobacco Company, Kyowa Hakko Kirin, Lexicon, Eli Lilly, Lycera, Merck, Mesoblast, Millennium, Nestlé, NextBiotix, Novartis, Novo Nordisk, Par’Immune, Progenity, Prometheus, Protagonist, Qu, Salix, Shire, Sienna, Sigmoid, Synergy, Teva, TiGenix, Tillotts, UCB, Vertex, VHsquared, Vivelix, Wyeth, Zealand and Zyngenia and is Senior Scientific Director of Alimentiv. This study was funded by Gilead Sciences Inc. Medical writing support was provided by Svetha Sankar, BSc BVMS of PharmaGenesis Melbourne, Melbourne, Australia and funded by Gilead Sciences Inc.

P389 Dr. Saiz Chumillas, Rosa Maria: No conflict of interest||Dr. Alba Hernández, Lorena: No conflict of interest||Dr. Chivato Martín-Falquina, Irene: No conflict of interest||Dr. Badia Aranda, Ester: No conflict of interest||Dr. Arias García, María Lara: No conflict of interest||Dr. Sicilia Aladrén, Beatriz: No conflict of interest

P390 Dr. PATEL, Preekesh: No conflict of interest||Dr. Wu, Linus: No conflict of interest

P391 Ms. Verburgt, Charlotte: No conflict of interest||Mr. Heutink, W. Pepijn: No conflict of interest||Ms. Kuilboer, Lot I.M.: No conflict of interest||Ms. Dickmann, Julie D.: No conflict of interest||Ms. van Etten-Jamaludin, Faridi S: No conflict of interest||Prof. Dr. Benninga, Marc A.: No conflict of interest||Prof. Dr. de Jonge, Wouter J.: No conflict of interest||Dr. Van Limbergen, Johan E: No conflict of interest||Dr. Tabbers, Merit M.: No conflict of interest

P392 Ms. Van Erp, Liselot W.: No conflict of interest||Mr. Groenen, Marcel J.M.: No conflict of interest||Ms. Heida, Wendy: No conflict of interest||Ms. Wisse, Jolien: No conflict of interest||Ms. Roosenboom, Britt: No conflict of interest||Mr. Wahab, Peter J.: No conflict of interest

P393 Cazzetta, Susan:|:|Employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options.||Dr. Chen, Grace:|:|Former employee of Takeda Pharmaceuticals USA, Inc. and may have received stock/stock options.||Pedarla, Vasantha:|:|Employee of STATinMED Research, Plano, TX, paid consultants of Takeda Pharmaceuticals USA, Inc.||Null, Kyle:|:|Employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options.||Rana Khan, Qasim:|:|Employee of Takeda Pharmaceuticals USA, Inc. and may receive stock/stock options.||Dr. Schwartz, David:|:|Employee of Vanderbilt University, paid consultant of Takeda Pharmaceuticals USA, Inc.

P394 Sorokina Alexdóttir, Marta: No conflict of interest||Dr. Bourgonje, Arno R.: No conflict of interest||Dr. Asser Karsdal, Morten: No conflict of interest||Dr. Bay-Jensen, Anne-Christine: No conflict of interest||Prof. Dr. Faber, Klaas Nico: No conflict of interest||Dr. Loveikyte, Roberta: No conflict of interest||Dr. van Dullemen, Hendrik M.: No conflict of interest||Dr. Visschedijk, Marijn C.: No conflict of interest||Dr. Festen, Eleonora A. M.: No conflict of interest||Dr. K. Weersma, Rinse: No conflict of interest||Dr. Dijkstra, Gerard: No conflict of interest||Dr. Mortensen, Joachim H.: No conflict of interest

P395 Pai, Rish:|:|Consultant for Eli Lilly, Genentech, AbbVie, Allergan, and Robarts Clinical Trials||Dr. De Hertogh, Gert:|:|Consulting fees from GlaxoSmithKline, Shire Pharmaceuticals, Teva Pharma, Galapagos, Genentech, Novartis Pharma, Fast Forward Pharmaceuticals, Takeda, and Janssen R&D||Dr. Reinisch, Walter:|:| Speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor and Yakult; consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, ioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Intrinsic Imaging, Janssen, Johnson|& Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD,|Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter|& Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid,|Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia and 4SC; advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, BoehringerIngelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia and 4SC; received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik and MSD. ||Dr. Harpaz, Noam:|:|Consultant and/or service contracts with Abbvie, Celgene, Bristol Meyer Squibb, Eli Lilly, Janssen||Dr. Feagan, Brian:|:|Grant/Research Support from AbbVie Inc., Amgen Inc., AstraZeneca/MedImmune Ltd., Atlantic Pharmaceuticals Ltd., Boehringer-Ingelheim, Celgene Corporation, Celltech, Genentech Inc/Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline (GSK), Janssen Research & Development LLC., Pfizer Inc., Receptos Inc. / Celgene International, Sanofi, Santarus Inc., Takeda Development Center Americas Inc., Tillotts Pharma AG, UCB; Consultant for Abbott/AbbVie, AgomAB Therapeutics, Allakos, Allergan, Amgen, Applied Molecular Transport Inc, Aptevo Therapeutics, Astra Zeneca, Atlantic Pharma, BioMx Israel, Boehringer-Ingelheim, Bristol-Myers Squibb, Calypso Biotech, Celgene, Connect BioPharma, Disc Medicine Inc., Everest Clinical Research Corp., Galapagos, Galen Atlantica, Genentech/Roche, Gilead, Gossamer Pharma, GSK, Hoffmann-LaRoche, Index Pharma, Janssen, Kyowa Kakko Kirin Co Ltd., Leadiant, Lilly, Lument AB, Merck, Millenium, Mylan, Nestles, Nextbiotix, Origo BioPharma, Pandion Therapeutics, ParImmune, Parvus Therapeutics Inc., Pfizer, Prometheus Therapeutics and Diagnostics, Progenity, Protagonist, Qu Biologics, Rebiotix, Receptos, Salix Pharma, Sandoz, Sanofi, Shire, Surrozen Inc., Takeda,Tillotts, UCB Pharma, VHsquared Ltd., Viatris, Ysios, Zealand Pharma; Speakers Bureau for AbbVie, Janssen, Takeda, Tillotts; Advisory Board member for AbbVie, Allergan, Amgen, Astra Zeneca, Boehringer-Ingelheim, Bristol-MyersSquibb, Celgene, Genentech/Roche, Janssen, Novartis, Origo BioPharma, Pfizer, Prometheus, Protagonist, Takeda, Tillotts Pharma; Board of Directors member for Alimentiv Inc||Dr. Agada, Noah:|:|Employee and shareholder of Eli Lilly and Company||Dr. Pollack, Paul:|:|Employee and shareholder of Eli Lilly and Company||Ms. Chan, Lai Shan:|:|Employee and shareholder of Eli Lilly and Company||Dr. Protic, Marijana:|:|Employee and shareholder of Eli Lilly and Company||Dr. Magro, Fernando:|:|Speaker and honoraria from Merck Sharp and Dohme, Abbvie, Vifor, Falk, Laboratórios Vitória, Ferring, Hospira and Biogen

P396 Dr. DE SOMER, Thomas: No conflict of interest||Dr. Deprez, Nele: No conflict of interest||Dr. Baert, Didier: No conflict of interest||Dr. Deceuninck, Mieke: No conflict of interest||Mrs. Huys, Inge: No conflict of interest||Dr. Mattens, Veerle: No conflict of interest||Mrs. Sterckx, An: No conflict of interest||Dr. Vanden Branden, Stijn: No conflict of interest||Dr. Vanderstraeten , Erik: No conflict of interest||Dr. Vandervoort , Jo: No conflict of interest||Mrs. Van Heddegem, Nina: No conflict of interest||Dr. Dewint, Pieter:|:|Pieter Dewint has received financial support for research from Biogen, Mundipharma; lecture fees from Biogen, Janssen; advisory board fees from Janssen, Sandoz, Samsung Bioepis

P397 Iacucci, Marietta: No conflict of interest||Dr. Grisan, Enrico: No conflict of interest||Dr. Labarile, Nunzia: No conflict of interest||Dr. Nardone, Olga: No conflict of interest||Dr. Smith, Samuel CL: No conflict of interest||Dr. Jeffery, Louisa: No conflict of interest||Prof. Ghosh, Subrata: No conflict of interest||Dr. Buda, Andrea: No conflict of interest

P398 Ms. BEVERS, Nanja: No conflict of interest||Dr. van de Vijver, Els: No conflict of interest||Ms. Aliu, Arta: No conflict of interest||Mr. Rezazadeh Ardabili, Ashkan: No conflict of interest||Dr. Rosias, Philippe: No conflict of interest||Dr. Busari, Jamiu: No conflict of interest||Dr. Stapelbroek, Janneke: No conflict of interest||Mrs. Bertrams, Imke: No conflict of interest||Ms. van der Feen, Cathelijne: No conflict of interest||Dr. Oudshoorn , Annemarie: No conflict of interest||Dr. Teklenburg, Sarah: No conflict of interest||Prof. Dr. Escher, Johanna: No conflict of interest||Prof. Dr. Vande Velde, Saskia: No conflict of interest||Dr. Winkens, Bjorn: No conflict of interest||Dr. Raijmakers, Maarten: No conflict of interest||Dr. Vreugdenhil, Anita: No conflict of interest||Dr. Pierik, Marieke: No conflict of interest||Dr. van Rheenen, Patrick: No conflict of interest

P399 Dr. De Gregorio, Michael: No conflict of interest||Dr. Lee, Tanya: No conflict of interest||Mrs. Krishnaprasad, Krupa: No conflict of interest||Amos, Gregory: No conflict of interest||Dr. An, Yoon-Kyo: No conflict of interest||Dr. Bastian-Jordan, Matthew: No conflict of interest||Prof. Begun, Jakob:|:|JB has served as speaker and consultant for AbbVie, Celltrion, Janssen, and Pfizer.||Dr. Borok, Nira: No conflict of interest||Dr. Brown, Dougal J M: No conflict of interest||Dr. Cheung, Wa: No conflict of interest||Prof. Connor, Susan:|:|SC has served as speaker and advisory board member for AbbVie, Celgene, Ferring, Gilead, Janssen, MSD, Novartis, Pfizer, Shire, and Takeda. Unrelated to this study, SC has received educational grants and research support from AbbVie, Aspen, Ferring, Janssen, Orphan, Pfizer, Shire, and Takeda.||Dr. Gerstenmaier, Jan: No conflict of interest||Dr. Gilbert, Lauren E: No conflict of interest||Dr. Gilmore, Robert: No conflict of interest||Dr. Gu, Bonita: No conflict of interest||Dr. Kutaiba, Numan: No conflict of interest||Dr. Lee, Allan: No conflict of interest||Prof. Mahy, Gillian: No conflict of interest||Dr. Srinivasan, Ashish: No conflict of interest||Dr. Thin, Lena: No conflict of interest||Prof. Thompson, Alexander: No conflict of interest||Dr. Welman, Christopher J: No conflict of interest||Dr. Yong, Eric X: No conflict of interest||Prof. De Cruz, Peter:|:|PD has served as speaker, consultant, and advisory board member for AbbVie, Baxter, Ferring, Janssen, Shire, and Takeda.||Prof. van Langenberg, Daniel:|:|DV has served as speaker and consultant for AbbVie, Emerge Health, Janssen, Pfizer, Ferring, and Vifor. Unrelated to this study, DV has received educational grants and research support from Ferring, Pfizer, Shire, and Takeda.||Prof. Sparrow (co-lead senior author), Miles:|:|MS has served as speaker and advisory board member for AbbVie, Celgene, Emerge Health, Janssen, Ferring, MSD, Pfizer, Shire, and Takeda. Unrelated to this study, MS has received educational grants and research support from Ferring, Gilead, and Orphan.||Dr. Ding, Nik S:|:|NSD has served as speaker, consultant, and advisory board member for AbbVie, BMS, Ferring, Gilead, Janssen, Pfizer, Shire, and Takeda.

P400 Dr. Les, Anda: No conflict of interest||Dr. Iacob, Razvan: No conflict of interest||Dr. Cotruta, Bogdan: No conflict of interest||Dr. Saizu, Roxana: No conflict of interest||Prof. Dr. Gheorghe, Liana: No conflict of interest||Prof. Dr. Gheorghe, Cristian: No conflict of interest

P401 Dr. Lamb, Christopher Andrew:|:|Dr. Christopher Lamb reports grants from Genentech, grants and personal fees from Janssen, grants and personal fees from Takeda, grants from AbbVie, personal fees from Ferring, grants from Eli Lilly, grants from Pfizer, grants from Roche, grants from UCB Biopharma, grants from Sanofi Aventis, grants from Biogen IDEC, grants from Orion OYJ, personal fees from Dr Falk Pharma, grants from AstraZeneca, outside the submitted work. ||Prof. Sebastian, Shaji:|:|Professor. Shaji Sebastian reports grants from Biogen, Takeda, AbbVie, Tillotts Pharma, Ferring, Biohit, Advisory board fees from Takeda, AbbVie, Pharmacocosmos, Ferring, Falk Pharma, Cellgene, Tillots Pharma, Biohit, Janssen, personal speaker fees from AbbVie, Biogen, Janssen, Merck, Tillotts, Falk Pharma, outside the submitted work. ||Dr. Kent, Alexandra J:|:|Dr Alexandra Kent reports personal fees from Pfizer, personal fees from Celgene-BMS, personal fees from Tillotts, personal fees from Janssen, personal fees and non-financial support from Dr Falk, personal fees and non-financial support from Takeda, outside the submitted work. ||Dr. Segal, Jonathan P: No conflict of interest||Dr. Gonzalez, Haidee A: No conflict of interest||Prof. Brookes, Matthew J:|:|Professor. Matthew Brookes reports grants from Vifor International, grants from Tillotts Pharma, other from Tillotts Pharma, personal fees from Vifor International, outside the submitted work.||Dr. Mehta, Shameer J: No conflict of interest||Dr. Subramanian, Sreedhar:|:|Dr. Sreedhar Subramanian reports personal fees from Celltrion, personal fees from Janssen, personal fees from Takeda, personal fees from Vifor pharma, personal fees from Boehringer-Ingelheim, outside the submitted work.||Dr. Bhala, Neeraj: No conflict of interest||Dr. Hicks, Lucy C: No conflict of interest||Dr. Conley, Thomas E: No conflict of interest||Dr. Patel, Kamal V:|:|Dr. Kamal Patel reports personal fees and non-financial support from Janssen, personal fees and non-financial support from Abbvie, personal fees and non-financial support from Takeda, personal fees and non-financial support from DrFalk, non-financial support from Ferring, outside the submitted work.||Dr. Walker, Gareth J:|:|Dr. Gareth Walker reports personal fees from AbbVie, personal fees from Falk, personal fees from Janssen, personal fees from Norgine, during the conduct of the study. ||Dr. Kennedy, Nicholas A:|:|Dr. Nicholas Kennedy reports personal fees from Dr Falk, personal fees from Janssen, grants and personal fees from Pharmacosmos, personal fees from Takeda, personal fees from Tillotts, outside the submitted work.

P402 Dr. Phillips, Georgina: No conflict of interest||Dr. Moore-Gillan, Claudia: No conflict of interest||Dr. Mohamed, Zameer: No conflict of interest||Mr. Mikin, Patel: No conflict of interest||Dr. Peake, Simon: No conflict of interest||Dr. Hicks, Lucy: No conflict of interest

P403 Dr. Ferreiro Iglesias, Rocio: No conflict of interest||Mr. Hernández Camba, Alejandro: No conflict of interest||Mr. Saldaña, Roberto: No conflict of interest||Dr. Rodríguez-Lago, Iago: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Barreiro-de Acosta , Manuel: No conflict of interest

P404 Mr. Picker, Nils:|:|Nils Picker is an employee of Ingress-health; the work of IPAM and Ingress-health in this study was funded by Galapagos NV. ||Dr. Bokemeyer, Bernd:|:|Bernd Bokemeyer received consultancy and speaking fees from Abbvie, MSD, Takeda, Pfizer, Celltrion, Biogen, Janssen, Celgene and Galapagos Biopharma Deutschland GmbH.||Prof. Wilke, Thomas:|:|Thomas Wilke is an employee of IPAM; the work of IPAM and Ingress-health in this study was funded by Galapagos NV.||Mr. Rosin, Ludger:|:|Ludger Rosin is an employee of Galapagos Biopharma Deutschland GmbH. ||Mr. Patel, Haridarshan:|:|Haridarshan Patel is an employee of Immensity Consulting, Inc., which received funding from Galapagos NV.

P405 Dr. Thomas, Debby: No conflict of interest||Mrs. Compernolle, Griet: No conflict of interest||Prof. Dr. Guedelha Sabino, João Pedro:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare|||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG|||Prof. Declerck, Paul: No conflict of interest

P406 Kopylov, Uri:|:|Advisory and speaker fees - Abbvie Janssen MASD Medtronic Takeda Pfizer. Research support- Jannsen Takeda Medtronic||Prof. Burisch , Johan:|:|Personal fees from AbbVie, personal fees from Janssen-Cilag, personal fees from Celgene, grants and personal fees from MSD, personal fees from Pfizer, grants and personal fees from Takeda, grants and personal fees from Tillots Pharma, personal fees from Samsung Bioepis, grants from Bristol Myers Squibb, grants from Novo Nordisk, personal fees from Pharmacosmos, outside the submitted work||Prof. Ben-Horin , Shomron:|:|Advisory board and/or consulting fees from Abbvie, Takeda, Janssen, Celltrion, Pfizer, GSK, Ferring, Novartis, Roche, Gilead, NeoPharm, Galmed & Medial Earlysign and research support from Abbvie, Takeda, Janssen, Celltrion, Pfizer, & Galmed||Mrs. Braegger, Fiona:|:|Full time employee of Takeda Pharmaceuticals Inc.||Mr. Fernández-Nistal , Alonso:|:|Full time employee of Takeda Farmacéutica España S.A.||Dr. Lara, Nuria: No conflict of interest||Prof. Vavricka , Stephan:|:|Consultant fees, unrestricted research grants and speakers fees from Abbott, Celtrion, Ferring, MSD, Pfizer, Sanofi-Aventis, Takeda, Tillots, UCB, Vifor and Falk Pharma.

P407 Dr. Sousa, Paula Cristina:|:|Support for meetings from Janssen. ||Dr. Ministro, Paula:|:|Consultant for Abbvie, Ferring, Hospira, Janssen, MSD, Pfizer, Takeda.||Prof. Dr. Armuzzi, Alessandro:|:|Consulting and/or advisory board fees from AbbVie, Allergan, Amgen, Biogen, Bristol‐Myers Squibb, Celgene, Celltrion, Ferring, Janssen, Lilly, MSD, Mylan, Pfizer, Samsung Bioepis, Sandoz and Takeda; lecture and/or speaker bureau fees from AbbVie, Amgen, Biogen, Ferring, Janssen, MSD, Mitsubishi‐Tanabe, Nikkiso, Pfizer, Sandoz, Samsung Bioepis and Takeda; and research grants from MSD, Pfizer and Takeda||Prof. Dr. Dignass, Axel:|:|Research support or principal investigator for Abbvie, Dr. Falk Pharma, Celgene, Gilead, Janssen and Takeda; acted as a consultant for AbbVie, Amgen, BMS, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Fresenius Kabi, Celltrion, Janssen, MSD, Pfizer, Roche, Takeda, Tillotts, and Vifor; participated in speaker bureaus for AbbVie, Falk Foundation, Ferring, Janssen, Med Update, MSD, Pfizer, Roche, Takeda, Tillotts, and Vifor.||Prof. Dr. Høivik, Marte Lie: No conflict of interest||Prof. Dr. Magro, Fernando:|:|Speaker and received honoraria from Merck Sharp & Dohme, Abbvie, Vifor, Falk, Laboratorios Vitoria, Ferring, Hospira, and Biogen.

P408 Dr. Doherty, Jayne: No conflict of interest||Dr. Varley, Rachel: No conflict of interest||Dr. Healy, Martin: No conflict of interest||Dr. Dunne, Cara: No conflict of interest||Dr. Mac Carthy, Finbar: No conflict of interest||Prof. McKiernan, Susan: No conflict of interest||Dr. Hartery, Karen: No conflict of interest||Prof. Kevans, David: No conflict of interest

P409 D’Haens, Geert R.:|:|Personal fees: AbbVie, Ablynx, Allergan, Amakem, Amgen, AM Pharma, Arena, AstraZeneca, Avaxia, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene/Receptos, Celltrion, Cosmo, Covidien/Medtronics, Dr. Falk Pharma, Echo Pharmaceuticals, Eli Lilly, Engene, Ferring, Galapagos, Genentech/Roche, Gilead, GlaxoSmithKline, Gossamer Bio, Hospira, Immunic, Johnson and Johnson, Lycera, Medimetrics, Millennium/Takeda, Mitsubishi Pharma, MSD, Mundipharma, Nextbiotics, Norgine, Novo Nordisk, Otsuka, Pfizer Inc, Photopill, Progenity, Prometheus Laboratories/Nestlé, Protagonist, Robarts Clinical Trials, Salix, Samsung Bioepis, Sandoz, Seres/Nestlé, SetPoint Medical, Shire, Teva, TiGenix, Tillotts, TopiVert, Versant, Vifor||Dubinsky, Marla C.:|:|Grants: AbbVie, Janssen, Pfizer Inc, Prometheus Laboratories|Personal fees: AbbVie, Arena, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Genentech, Janssen, Pfizer Inc, Prometheus Laboratories, Salix, Shire, Takeda, UCB||Regueiro, Miguel:|:|Grants: AbbVie, Janssen, Takeda|Personal fees: AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Gilead, Janssen, Miraca Labs, Pfizer Inc, Salix, Seres, Shire, Takeda, UCB||Santana, Genoile O.:|:|Grants: Eli Lilly|Personal Fees: AbbVie, Ferring, Janssen, Pfizer Inc, Takeda, UCB||Torres, Joana:|:|Grants: AbbVie, Janssen|Personal fees: Arena, Galapagos, Gilead, Janssen, Pfizer Inc||Kulisek, Nicole:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Gardiner, Sean:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Mundayat, Rajiv:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Paulissen, Jerome:|:|Other: Employee: Syneos Health (paid contractor to Pfizer Inc)||Lawendy, Nervin:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Su, Chinyu:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Modesto, Irene:|:|Personal fees: Pfizer Inc|Other: Employee: Pfizer Inc||Sandborn, William J.:|:|Grants: AbbVie, Abivax, Arena, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Gilead, GlaxoSmithKline, Janssen, Pfizer Inc, Prometheus Biosciences, Seres, Shire, Takeda, Theravance Biopharma|Personal fees: AbbVie, Abivax, Admirx, Alfasigma, Alimentiv (previously Robarts Clinical Trials, owned by Alimentiv Health Trust), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Eli Lilly, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), InDex Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer Inc, Progenity, Prometheus Biosciences, Prometheus Laboratories, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma|Other: Spouse: Iveric Bio - consultant, stock options; Progenity - stock; Oppilan Pharma - consultant, stock options; Prometheus Biosciences - employee, stock, stock options; Prometheus Laboratories – stock, stock options, consultant; Ventyx Biosciences – stock, stock options; Vimalan Biosciences – stock, stock options

P410 Dr. Elosua Gonzalez, Alfonso: No conflict of interest||Dr. Rullan Iriarte, María: No conflict of interest||Dr. Rubio Iturria, Saioa: No conflict of interest||Dr. Rodríguez Gutiérrez, Cristina: No conflict of interest||Dr. Vicuña Arregui, Miren: No conflict of interest||Dr. Elizalde Apesteguía, Inmaculada: No conflict of interest||Dr. Aznárez Barrio, María Rosario: No conflict of interest||Dr. Juanmartiñena Fernández, José Francisco: No conflict of interest||Dr. Nantes Castillejo, Óscar: No conflict of interest||Dr. Fernández-Urién, Ignacio: No conflict of interest

P411 Mr. de Voogd, Floris: No conflict of interest||Dr. Duijvestein, Marjolijn: No conflict of interest||Prof. Dr. Ponsioen, Cyriel: No conflict of interest||Dr. Löwenberg, Mark: No conflict of interest||Prof. Dr. D'Haens, Geert: No conflict of interest||Dr. Gecse, Krisztina: No conflict of interest

P412 Dr. Carpio Lopez, Daniel:|:|I have no conflicts of interest regarding specifically this study.|Other potential conflicts of interest:|Research Grants: Janssen|Consultancy/Advisory Board Membership: Abbvie, Amgen, Janssen, Gilead, Kern, MSD, Pfizer, Takeda.|Speaker/lecture fees: Abbvie, Amgen, Fresenius Kabi, Janssen, Kern, MSD, Pfizer, Takeda.||Dr. Calviño-Suarez, Cristina: No conflict of interest||Dr. Martínez-Cadilla, Jesús: No conflict of interest||Dr. Molina, Gemma: No conflict of interest||Dr. Vázquez-Rey, Maria Teresa: No conflict of interest||Dr. Martí, Eva: No conflict of interest||Dr. Fernández-Salgado, Estela: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Dr. Hernández, Vicent: No conflict of interest||Dr. Echarri, Ana: No conflict of interest||Dr. Diz-Lois, Maria Teresa: No conflict of interest||Dr. Baz, Alina: No conflict of interest

P413 Mr. Ladrón Abia, Pablo: No conflict of interest||Dr. Alonso, Noelia: No conflict of interest||Dr. Beltrán, Belén: No conflict of interest||Mr. Minguez, Alejandro: No conflict of interest||Mr. Sáez-González, Esteban: No conflict of interest||Dr. Pons-Beltrán, Vicente: No conflict of interest||Dr. Nos, Pilar: No conflict of interest||Dr. Iborra, Marisa: No conflict of interest

P414 Mr. Mahmoud, Remi: No conflict of interest||Mr. Schultheiss, Johannes: No conflict of interest||Mr. Louwers, Jonas: No conflict of interest||Mr. van der Kaaij, Michiel: No conflict of interest||Mr. van Hellemondt, Boris: No conflict of interest||Dr. Mahmmod, Nofel: No conflict of interest||Dr. van Boeckel, Petra: No conflict of interest||Dr. Jharap, Bindia: No conflict of interest||Dr. Fidder, Herma: No conflict of interest||Prof. Dr. Oldenburg, Bas: No conflict of interest

P415 Dr. MATSUNE, Yusuke: No conflict of interest||Dr. Kouyama, Jyunka: No conflict of interest||Dr. Tsuru, Yuto: No conflict of interest||Dr. Shimizu, Koji: No conflict of interest||Dr. Asami, Shunsuke: No conflict of interest||Dr. Matsuyama, Shinichiro: No conflict of interest||Dr. Katsuki, Shungo: No conflict of interest||Dr. Ishihara, Hiroko: No conflict of interest||Dr. Onizawa, Risa: No conflict of interest||Dr. Shonai, Shiori: No conflict of interest||Dr. Tatsuno, Mizuki: No conflict of interest||Dr. Nishikawa, Yurika: No conflict of interest||Dr. Takeuchi, Kana: No conflict of interest||Dr. Watanabe, Mamoru: No conflict of interest||Dr. Nakamori, Yoshinori: No conflict of interest||Dr. Hirayama, Atsuhiro: No conflict of interest||Dr. Toyoda, Junya: No conflict of interest||Dr. Ikeda, Aya: No conflict of interest||Dr. Madarame, Akira: No conflict of interest||Dr. Nishio, Masashi: No conflict of interest||Dr. Ogashiwa, Tsuyoshi: No conflict of interest||Dr. Matsubayashi, Mao: No conflict of interest||Dr. Fujii, Ayako: No conflict of interest||Dr. Kimura, Hideaki: No conflict of interest||Dr. Kunisaki, Reiko: No conflict of interest

P416 Dr. JOIS, Asha: No conflict of interest||Dr. Perera, Sajini: No conflict of interest||Dr. Simm, Peter: No conflict of interest||Dr. Alex, George: No conflict of interest

P417 Dr. Melotti, Laura: No conflict of interest||Prof. Rizzello, Fernando: No conflict of interest||Dr. Calabrese, Carlo: No conflict of interest||Dr. Dussias, Nikolas: No conflict of interest||Prof. Gionchetti, Paolo: No conflict of interest

P418 Dr. Elosua Gonzalez, Alfonso: No conflict of interest||Dr. Rullan Iriarte, María: No conflict of interest||Dr. Rubio Iturria, Saioa: No conflict of interest||Dr. Oquiñena Legaz, Susana: No conflict of interest||Dr. Rodríguez Gutiérrez, Cristina: No conflict of interest||Dr. Macías Mendizábal, Elena: No conflict of interest||Dr. Borda Martín, Ana: No conflict of interest||Dr. Fernández-Urién Sainz, Ignacio: No conflict of interest||Dr. Nantes Castillejo, Óscar: No conflict of interest

P419 Prof. Dr. Itabashi, Michio: No conflict of interest||Mrs. Hirano, Yuri: No conflict of interest||Prof. Dr. Saito, Takeshi: No conflict of interest||Inoue, Mikihiro: No conflict of interest||Uchida, Keiichi: No conflict of interest||Dr. Arai, Katsuhiro: No conflict of interest||Minakuchi, Emiko: No conflict of interest||Ishihara, Hiroko: No conflict of interest||Onizawa, Risa: No conflict of interest||Hirayama, Atsuhiro: No conflict of interest||Araki, Kentaro: No conflict of interest||Prof. Dr. Kimura, Hideaki: No conflict of interest||Prof. Dr. Kunisaki, Reiko: No conflict of interest

P420 Akriche, Fatma:|:|Fatma Akriche is an employee of Norgine||Mr. Jacob, Ian:|:|Ian Jacob is an employee of Health Economics and Outcomes Research Ltd. and received funding from Norgine to undertake the analysis outlined in this study.||Prof. Dr. Schmidt, Carsten:|:|Carsten Schmidt has received consulting fees from AbbVie, Biogen, Ewopharma, Janssen-Cilag, MSD, Pfizer und, and Takeda; has provided speaking and teaching services for AbbVie, Berlin-Chemie, Biogen, Ewopharma, Falk, Janssen-Cilag, Merckle, MSD, Norgine, Novartis, Olympus, Pentax, Pfizer, Shire, Shield Therapeutics, Takeda, and UCB; and has received grants and research funding form AbbVie.||Dr. Howaldt, Stefanie: No conflict of interest

P421 Mr. Attauabi, Mohamed: No conflict of interest||Dr. Vind, Ida:|:|Personal fees from Abbvie, Janssen-Cilag, MSD, and Tillotts Pharma. None of these pertain to the research submitted here||Dr. Pedersen, Gitte:|:|National coordinator of a study by Pfizer. Personal fees from MSD and Takeda. None of these pertain to the research submitted here||Prof. Dr. Bendtsen, Flemming:|:|Research grant from Ferring, Tillotts. This does not pertain to the research submitted here.||Prof. Dr. Benedict Seidelin, Jakob:|:|Research grants from Takeda and the Capital Region Denmark, national coordinator of studies from AbbVie, Arena Pharmaceuticals, Ely Lilly, and Boehringer Ingelheim. None of these pertain to the research submitted here.||Dr. Burisch, Johan:|:|Personal fees from AbbVie, Janssen-Cilag, Celgene, MSD, Samsung Bioepis, and Pfizer; grants and personal fees from Takeda and Tillots Pharma. None of these pertain to the research submitted here.

P422 Dr. Sokic Milutinovic, Aleksandra: No conflict of interest||Ms. Jevtovic, Milica: No conflict of interest||Dr. Jovicic, Ivana: No conflict of interest

P423 Mr. Picker, Nils:|:|Nils Picker is an employee of Ingress-health; the work of IPAM and Ingress-health in this study was funded by Galapagos NV||Mr. Patel, Haridarshan:|:|Haridarshan Patel is an employee of Immensity Consulting, Inc., which received funding from Galapagos NV.||Prof. Wilke, Thomas:|:|Thomas Wilke is an employee of IPAM; the work of IPAM and Ingress-health in this study was funded by Galapagos NV.||Mr. Rosin, Ludger:|:|Ludger Rosin is an employee of Galapagos Biopharma Deutschland GmbH.||Dr. Bokemeyer, Bernd:|:|Bernd Bokemeyer received consultancy and speaking fees from Abbvie, MSD, Takeda, Pfizer, Celltrion, Biogen, Janssen, Celgene and Galapagos Biopharma Deutschland GmbH.

P424 Dr. Blesl, Andreas: No conflict of interest||Dr. Binder, Lukas: No conflict of interest||Prof. Högenauer, Christoph: No conflict of interest||Dr. Wenzl, Heimo: No conflict of interest||Mrs. Borenich, Andrea: No conflict of interest||Pregartner, Gudrun: No conflict of interest||Prof. Berghold, Andrea: No conflict of interest||Mrs. Mestel, Sigrid: No conflict of interest||Dr. Kump, Patrizia: No conflict of interest||Dr. Baumann-Durchschein, Franziska: No conflict of interest||Prof. Petritsch, Wolfgang: No conflict of interest

P425 Wei, Shu Chen: No conflict of interest||Dr. Lin, Wei-Chen: No conflict of interest||Dr. Chang, Chung-Hsin: No conflict of interest||Dr. Tu, Chia-Hung: No conflict of interest||Dr. Feng, I-Che: No conflict of interest||Dr. Shieh, Ming-Jium: No conflict of interest||Dr. Chung, Chen-Shuan: No conflict of interest||Dr. Yen, Hsu-Heng: No conflict of interest||Dr. Chou, Jen-Wei: No conflict of interest||Dr. Tai, Wei-Chen: No conflict of interest||Dr. Wong, Jau-Min: No conflict of interest||Dr. Liu, Yu-Hwa: No conflict of interest||Dr. Huang, Tien-Yu: No conflict of interest||Dr. Chuang, Chiao-Hsiung: No conflict of interest||Dr. Tsai, Tzung-Jiun: No conflict of interest||Dr. Chiang, Feng-Fan: No conflict of interest||Dr. Lu, Chien-Yu: No conflict of interest||Dr. Hsu, Wen-Hung: No conflict of interest||Dr. Yu, Fang-Jung: No conflict of interest||Dr. Chao, Te-Hsin: No conflict of interest||Dr. Wu, Deng-Chyang: No conflict of interest||Dr. Ho, Ai-Sheng: No conflict of interest||Dr. Lin, Hung-Hsin: No conflict of interest||Dr. Feng, Chun-Lung: No conflict of interest||Dr. Wu, Keng-Liang: No conflict of interest||Dr. Wong, Ming-Wun: No conflict of interest||Dr. Tung, Chien-Chih: No conflict of interest||Dr. Lin, Chun-Chi: No conflict of interest||Dr. Chen, Chia-Chang: No conflict of interest||Dr. Hu, Huang-Ming: No conflict of interest||Dr. Lu, Lung-Sheng: No conflict of interest||Dr. Wang, Huann-Sheng: No conflict of interest||Dr. Wu, I-Chen: No conflict of interest||Dr. Kuo, Hsin-Yu: No conflict of interest||Dr. Wu, Jia-Feng: No conflict of interest||Dr. Shih, Hsiang-Yao: No conflict of interest||Dr. Ni, Yen-Hsuan: No conflict of interest||Tang, Shu-Lun: No conflict of interest||Chang, Hui-Chen: No conflict of interest||Chen, Peng-Hsu: No conflict of interest

P426 Dr. Correa, Gustavo Javier:|:|has received travel support from Ferring, Abbvie, Janssen and Takeda, received lecture fees from Ferring, Biotoscana, Janssen and Abbvie, and received consulting fees from Abbvie and Janssen.||Dr. Yantorno, Martín:|:|has received travel support from Ferring, Abbvie, Janssen and Takeda, received lecture fees from Ferring, Biotoscana, Janssen and Abbvie, and received consulting fees from Abbvie and Janssen.||Dr. Olivera Sendra, Pablo:|:|has received travel support from Ferring, Abbvie and Takeda, and received lecture fees from Takeda, Abbvie and Janssen, and received consulting fees from Abbvie, Takeda and Janssen.||Dr. Lasa, Juan Sebastian:|:|has received travel support from Sanofi Aventis, received lecture fees from Abbvie and Sanofi Aventis.||Dr. Lubrano, Pablo:|:|has received travel support from Ferring, Abbvie and Takeda, and received lecture fees from Takeda, Abbvie, Biotoscana and Janssen.||Dr. Balderramo, Domingo César:|:|has received travel support from Takeda, Abbvie, Janssen and Ferring, received lecture fees from Takeda, Abbvie and Janssen, and participated at advisory boards from Takeda.||Dr. Zubiaurre, Ignacio:|:|has received travel support from Takeda and Abbvie, received lecture fees from Takeda, Abbvie, Janssen and Ferring, participated at advisory boards from Takeda and Abbvie, and is a consultant for Takeda and Abbvie.||Dr. Ruffinengo, Orlando:|:|has received travel support from Takeda, Abbvie and Janssen, received lecture fees from Janssen, received financial support for research from Takeda, Abbvie and Celgene and received consulting fees from Takeda.||Ms. Brion, Laura:|:|is a Takeda employee.||Ms. Leonardi, Daiana Beatriz:|:|is a Takeda employee.||Ms. El-Hakeh, Jazmín:|:|is a Takeda employee.||Dr. Guimaraens, Patricia Noemi:|:|is a Takeda employee.||Sambuelli, Alicia:|:|has received travel support from Ferring, Abbvie and Takeda, and received lecture fees from Biotoscana, Janssen, Abbvie and Takeda.

P427 Prof. Dr. Kim, Joo Sung:|:|Joo Sung Kim reported receiving a research grant from Takeda Korea outside of the submitted work.||Leung, Wai K: No conflict of interest||Wu, Deng-Chyang: No conflict of interest||Lindner, Dirk:|:|Dirk Lindner is an employee of Takeda.||Fadeeva, Olga:|:|Olga Fadeeva is an employee of Takeda.||Demuth, Dirk:|:|Dirk Demuth is an employee of Takeda.

P428 Dr. PEDRO, Juliana: No conflict of interest||Dr. Rodrigues, Inês: No conflict of interest||Dr. Damião, Filipe: No conflict of interest||Dr. Fernandes, Samuel: No conflict of interest||Dr. Gonçalves, Ana Rita: No conflict of interest||Dr. Bernardo, Sónia: No conflict of interest||Dr. Baldaia, Cilénia: No conflict of interest||Dr. Valente, Ana: No conflict of interest||Dr. Moura Santos, Paula: No conflict of interest||Dr. Correia, Luís: No conflict of interest||Prof. Tato Marinho, Rui: No conflict of interest

P429 Dr. Yu, Jongwook: No conflict of interest||Dr. Hyun, Hye Kyung: No conflict of interest||Prof. Dr. Park, Jihye: No conflict of interest||Prof. Dr. Kang, Eun Ae: No conflict of interest||Prof. Dr. Park, Soo Jung: No conflict of interest||Prof. Dr. Park, Jae Jun: No conflict of interest||Prof. Dr. Kim, Tae Il: No conflict of interest||Prof. Dr. Kim, Won Ho: No conflict of interest||Prof. Dr. Cheon, Jae Hee: No conflict of interest

P430 Dr. Gklavas, Antonios: No conflict of interest||Prof. Tiniakos, Dina: No conflict of interest||Dr. Karandrea, Despoina: No conflict of interest||Prof. Karamanolis, Georgios: No conflict of interest||Prof. Bamias, Georgios: No conflict of interest||Prof. Papaconstantinou, Ioannis: No conflict of interest

P431 Dr. MICIC, Dejan:|:|Dejan Micic has received advisory board consulting fees from Takeda Pharmaceuticals||Dr. Jiang, Jeanne:|:|Jeanne Jiang is an employee and stockholder of Takeda Pharmaceuticals||Dr. Chen, Lily:|:|Lily Chen is an employee of Takeda Pharmaceuticals||Dr. Fan, Tao:|:|Tao Fan is an employee and stockholder of Takeda Pharmaceuticals||Dr. Mu, Fan:|:|Fan Mu is an employee of Analysis Group||Ms. Satija, Ambika:|:|Ambika Satija is an employee of Analysis Group||Mr. Downes, Nathaniel:|:|Nathaniel Downes is an employee of Analysis Group||Ms. Shrestha, Swastina:|:|Swastina Shrestha is an employee of Analysis Group||Dr. Wu, Eric:|:|Eric Wu is an employee of Analysis Group||Ms. Swallow, Elyse:|:|Elyse Swallow is an employee of Analysis Group||Dr. Wojtowicz, Abbey:|:|Abbey Wojtowicz is an employee and stockholder of Takeda Pharmaceuticals||Dr. Raphael, Bram P:|:|Bram P. Raphael is an employee and stockholder of Takeda Pharmaceuticals

P432 Dr. P RAMAN, Krithivasan: No conflict of interest||Dr. Agorogianni, Alexandra: No conflict of interest||Dr. Hadjinicolaou, Andreas: No conflict of interest||Ms. Nightingale, Allison: No conflict of interest||Mr. Mayhew, Anna: No conflict of interest||Mr. Munro, Robert: No conflict of interest||Dr. Raine, Tim: No conflict of interest||Dr. McDermott, Edel: No conflict of interest

P433 Dr. Agrawal, Manasi:|:|MA receives research support from the Dickler Family Fund, New York Community Trust and the Helmsley Charitable Trust Fund for SECURE-IBD.||Dr. Petralia, Francesca: No conflict of interest||Dr. Tepler, Adam: No conflict of interest||Ms. Durbin, Laura: No conflict of interest||Prof. Dr. Reinisch, Walter:|:|WR: has served as a speaker for Abbott Laboratories, Abbvie, Aesca, Aptalis, Astellas, Centocor, Celltrion, Danone Austria, Elan, Falk Pharma GmbH, Ferring, Immundiagnostik, Mitsubishi Tanabe Pharma Corporation, MSD, Otsuka, PDL, Pharmacosmos, PLS Education, Schering-Plough, Shire, Takeda, Therakos, Vifor, Yakult. He has been a consultant for Abbott Laboratories, Abbvie, Aesca, Algernon, Amgen, AM Pharma, AMT, AOP Orphan, Arena Pharmaceuticals, Astellas, Astra Zeneca, Avaxia, Roland Berger GmBH, Bioclinica, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Covance, Danone Austria, DSM, Elan, Eli Lilly, Ernest & Young, Falk Pharma GmbH, Ferring, Galapagos, Genentech, Gilead, Grünenthal, ICON, Index Pharma, Inova, Intrinsic Imaging, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, LivaNova, Mallinckrodt, Medahead, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nash Pharmaceuticals, Nestle, Nippon Kayaku, Novartis, Ocera, OMass, Otsuka, Parexel, PDL, Periconsulting, Pharmacosmos, Philip Morris Institute, Pfizer, Procter & Gamble, Prometheus, Protagonist, Provention, Robarts Clinical Trial, Sandoz, Schering-Plough, Second Genome, Seres Therapeutics, Setpointmedical, Sigmoid, Sublimity, Takeda, Therakos, Theravance, Tigenix, UCB, Vifor, Zealand, Zyngenia, and 4SC. He has beenas an advisory board member for Abbott Laboratories, Abbvie, Aesca, Amgen, AM Pharma, Astellas, Astra Zeneca, Avaxia, Biogen IDEC, Boehringer-Ingelheim, Bristol-Myers Squibb, Cellerix, Chemocentryx, Celgene, Centocor, Celltrion, Danone Austria, DSM, Elan, Ferring, Galapagos, Genentech, Grünenthal, Inova, Janssen, Johnson & Johnson, Kyowa Hakko Kirin Pharma, Lipid Therapeutics, MedImmune, Millenium, Mitsubishi Tanabe Pharma Corporation, MSD, Nestle, Novartis, Ocera, Otsuka, PDL, Pharmacosmos, Pfizer, Procter & Gamble, Prometheus, Sandoz, Schering-Plough, Second Genome, Setpointmedical, Takeda, Therakos, Tigenix, UCB, Zealand, Zyngenia, and 4SC. He has received research funding from Abbott Laboratories, Abbvie, Aesca, Centocor, Falk Pharma GmbH, Immundiagnsotik, and MSD.||Prof. Dr. Colombel, Jean-Frederic:|:|JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals and Takeda; receiving payment for lectures from AbbVie, Amgen, Allergan, Inc. Ferring Pharmaceuticals, Shire, and Takeda; receiving consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Janssen Pharmaceuticals, Landos, Ipsen, Medimmune, Merck, Novartis, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development and Genfit.||Dr. Shah, Shailja: No conflict of interest

P434 Dr. Hu, Shurong: No conflict of interest||Dr. Wang, Xiaoying: No conflict of interest||Prof. Shen, Bo: No conflict of interest||Dr. Yu, Qiao: No conflict of interest||Ms. Zheng, Jing-jing: No conflict of interest||Dr. Chen, Yan: No conflict of interest

P435 Prof. Spinelli, Antonino:|:|AS has received consultation fees from Takeda, Pfizer and Sofar. ||Yanai, Henit:|:|HY reports institutional research grants from Pfizer; consulting fees from Abbvie, Ferring, Janssen, Neopharm Ltd., Pfizer, Takeda; honoraria for lectures from Abbvie, Janssen, Pfizer, Takeda; participation on a Data Safety Monitoring Board and Advisory Board from Abbvie, Neopharm Ltd., Pfizer, Takeda.||Lönnfors, Sanna: No conflict of interest||Girardi, Paolo: No conflict of interest||Milicevic, Slobodan:|:|SM is an employee of Takeda and receives stock options.||Carvello, Michele:|:|MC has received fees from Takeda and Pfizer.||Maroli, Annalisa: No conflict of interest||Avedano , Luisa:|:|LA has received fees from Pfizer.

P436 Dr. Macaluso, FabioSalvatore: No conflict of interest||Dr. Cappello, Maria: No conflict of interest||Dr. Busacca, Anita: No conflict of interest||Prof. Fries, Walter: No conflict of interest||Dr. Viola, Anna: No conflict of interest||Dr. Costantino, Giuseppe: No conflict of interest||Dr. Magnano, Antonio: No conflict of interest||Dr. Vinci, Elisa: No conflict of interest||Dr. Ferracane, Concetta: No conflict of interest||Dr. Privitera, Antonino Carlo: No conflict of interest||Dr. Piccillo, Giovita: No conflict of interest||Dr. Belluardo, Nunzio: No conflict of interest||Dr. Giangreco, Emiliano: No conflict of interest||Prof. Romano, Claudio: No conflict of interest||Dr. Citrano, Michele: No conflict of interest||Dr. Graziano, Francesco: No conflict of interest||Dr. Garufi, Serena: No conflict of interest||Dr. Bertolami, Carmelo: No conflict of interest||Dr. Scrivo, Barbara: No conflict of interest||Dr. Renna, Sara: No conflict of interest||Dr. Casà, Angelo: No conflict of interest||Dr. Rizzuto, Giulia: No conflict of interest||Dr. Ventimiglia, Marco: No conflict of interest||Dr. Orlando, Ambrogio: No conflict of interest

P437 Mrs. Meima - van Praag, Elise: No conflict of interest||Mrs. Lansdorp, Corine: No conflict of interest||Ms. Smeekes, Georgina: No conflict of interest||Dr. Gecse, Krisztina: No conflict of interest||Prof. Dr. van Hulst, Rob: No conflict of interest||Dr. Buskens, Christianne: No conflict of interest

P438 Ms. GRINSTED TATE, Lydia: No conflict of interest||Ms. Johnson, Lara: No conflict of interest||Prof. Jones, Georgina: No conflict of interest||Prof. Lobo, Alan: No conflict of interest

P439 Dr. Macaluso, FabioSalvatore: No conflict of interest||Prof. Fries, Walter: No conflict of interest||Dr. Viola, Anna: No conflict of interest||Dr. Costantino, Giuseppe: No conflict of interest||Dr. Muscianisi, Marco: No conflict of interest||Dr. Cappello, Maria: No conflict of interest||Dr. Guida, Laura: No conflict of interest||Dr. Giuffrida, Enrica: No conflict of interest||Dr. Magnano, Antonio: No conflict of interest||Dr. Pluchino, Dario: No conflict of interest||Dr. Ferracane, Concetta: No conflict of interest||Dr. Magrì, Giovanni: No conflict of interest||Dr. Di Mitri, Roberto: No conflict of interest||Dr. Mocciaro, Filippo: No conflict of interest||Dr. Privitera, Antonino Carlo: No conflict of interest||Dr. Camilleri, Salvatore: No conflict of interest||Dr. Garufi, Serena: No conflict of interest||Dr. Renna, Sara: No conflict of interest||Dr. Casà, Angelo: No conflict of interest||Dr. Scrivo, Barbara: No conflict of interest||Dr. Ventimiglia, Marco: No conflict of interest||Dr. Orlando, Ambrogio: No conflict of interest

P440 Dr. Geldof, Jeroen:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Dr. Truyens, Marie:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest. ||Dr. Sabino, João:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||J.S. has received consultancy fees from Janssen and speaker fees from Abbvie and Takeda||Prof. Ferrante, Marc:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||M. F. has received:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speaker’s fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare||Prof. Lambert, Jo:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Prof. Lapeere, Hilde:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Prof. Hillary, Tom:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Prof. Van Laethem, An:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Prof. De Vlam, Kurt:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Prof. Verschueren, Patrick:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||No other conflicts of interest||Prof. Lobaton, Triana:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almirall, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma.||T.L. has received: |Consultancy fee : Janssen, Sandoz and Biogen|Financial support for research : Abbvie, Mylan, MSD, Mundipharma, Biogen, Janssen, Pfizer and Takeda |Speaker fees : Ferring, Abbvie, Janssen, MSD, Takeda and Sandoz||Prof. Vermeire, Séverine:|:|BELCOMID studygroup received research grants from following pharmaceutical companies: Almiral, Roche, Janssen, Pfizer, Eli Lilly, Amgen, Biogen, Mylan, Leo Pharma for this project.||S.V. has received grants from AbbVie, J&J, Pfizer, and Takeda; and has received consulting and/or speaking fees from AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG

P441 Gonczi, Lorant: No conflict of interest||Szanto, Kata: No conflict of interest||Farkas, Klaudia: No conflict of interest||Molnar, Tamas: No conflict of interest||Szamosi, Tamas: No conflict of interest||Schafer , Eszter: No conflict of interest||Golovics, Petra: No conflict of interest||Lovasz, Barbara: No conflict of interest||Patai, Arpad: No conflict of interest||Vincze, Aron: No conflict of interest||Sarlos, Patricia: No conflict of interest||Farkas, Alexandra: No conflict of interest||Dubrovcsik, Zsolt: No conflict of interest||Tóth G., Tamas: No conflict of interest||Prof. Dr. Lakatos, Péter Laszlo: No conflict of interest||Miheller, Pal: No conflict of interest||Ilias, Akos: No conflict of interest

P442 Dr. TZADOK, Roie: No conflict of interest||Dr. Fliss-Isakov, Naomi: No conflict of interest||Dr. Aviv Cohen, Nathaniel: No conflict of interest||Dr. Ron, Yulia: No conflict of interest||Prof. Dr. Maharshak, Nitsan: No conflict of interest||Dr. Hirsch, Ayal: No conflict of interest

P443 Prof. Dr. Laureti, Silvio: No conflict of interest||Dr. Cardelli, Stefano: No conflict of interest||Prof. Dr. Gionchetti, Paolo: No conflict of interest||Prof. Dr. Rizzello, Fernando: No conflict of interest||Dr. Calabrese, Carlo: No conflict of interest||Prof. Dr. Poggioli, Gilberto: No conflict of interest

P444 Matar, Manar: No conflict of interest||Dr. Levi, Rachel: No conflict of interest||Ms. Zvuloni, Maya: No conflict of interest||Prof. Shamir, Raanan: No conflict of interest||Prof. Assa, Amit: No conflict of interest

P445 Dr. Miller, Charles: No conflict of interest||Dr. Kwok, Hanson: No conflict of interest||Dr. Parisi, Ioanna: No conflict of interest||Dr. Harrow, Paul: No conflict of interest||Dr. McCartney, Sara: No conflict of interest||Dr. Vega, Roser: No conflict of interest||Dr. Rahman, Farooq: No conflict of interest||Dr. Seward, Edward: No conflict of interest||Dr. Mehta, Shameer: No conflict of interest||Dr. Lim, Samuel: No conflict of interest||Ms. Sharma, Esha: No conflict of interest||Dr. Samaan, Mark:|:|Dr Samaan has served as a speaker, a consultant and/or advisory board member for Janssen, Sandoz, Takeda, MSD, Falk, Samsung Bioepis, Galapagos, Bristol-Myers Squibb||Dr. Bancil, Aaron: No conflict of interest||Dr. Kok, Klaartje: No conflict of interest||Dr. Shalabi, Ahmed: No conflict of interest||Dr. Johnston, Emma: No conflict of interest||Dr. Katarey, Dev: No conflict of interest||Ms. Taherzadeh, Nina: No conflict of interest||Dr. Murray, Charles: No conflict of interest||Dr. Sharip, Mohammed: No conflict of interest||Dr. Carter, Martyn: No conflict of interest||Dr. Radhakrishnan, Shiva: No conflict of interest||Dr. Peake, Simon: No conflict of interest||Dr. Khakoo, Imran: No conflict of interest||Dr. Wahed, Mahmood: No conflict of interest||Dr. Povlsen, Sebastian: No conflict of interest||Dr. Patel, Mehul: No conflict of interest||Dr. Dubois, Patrick: No conflict of interest||Dr. Finkel, Jemima: No conflict of interest||Dr. Onnie, Clive: No conflict of interest||Prof. Bloom, Stuart:|:|Professor Bloom has acted as an advisor for Takeda, Johnson & Johnson, Sublimity Therapeutics, Tillotts and Janssen

P446 Dr. Soto Sánchez, Ana: No conflict of interest||Dr. Hernandez Camba, Alejandro: No conflict of interest||Dr. Hernández, Moises: No conflict of interest||Dr. Hernández, Guillermo: No conflict of interest||Dr. Pérez Sánchez, Eduardo: No conflict of interest||Dr. Barrera Gómez, Manuel: No conflict of interest

P447 Mr. Li, Yousheng: No conflict of interest||Ms. Yao, Danhua: No conflict of interest

P448 Azevedo, Matheus Freitas Cardoso de:|:|receiving consulting fees from Janssen and Takeda, lecture fees from Janssen, Takeda and Abbvie, and travel grant support from Takeda, Janssen, and Abbvie||Dr. Justus, Filipe Fernandes: No conflict of interest||Dr. Lima, Camila Cunha Gonzaga: No conflict of interest||Dr. Garcia, Karoline Soares: No conflict of interest||Dr. Barros, Luísa Leite: No conflict of interest||Dr. Oba, Jane: No conflict of interest||Dr. Carlos, Alexandre de Sousa:|:|consulting fees from Janssen, Takeda, lecture fees from Janssen, Takeda, and travel grant support from Takeda, Janssen and Abbvie||Dr. Milani, Luciane Reis: No conflict of interest||Prof. Sipahi, Aytan Miranda: No conflict of interest||Prof. Damião, Aderson Omar Mourão Cintra:|:|receiving lecture fees from Janssen, Takeda, and Abbvie, and travel grant support from Takeda||Prof. Queiroz, Natália Sousa Freitas:|:|receiving consulting fees from Janssen, lecture fees from Janssen, Takeda, UCB, and Abbvie, and travel grant support from Takeda, Janssen, and Abbvie

P449 Dr. Doherty, Jayne: No conflict of interest||Dr. Varley, Rachel: No conflict of interest||Dr. Healy, Martin: No conflict of interest||Dr. Dunne, Cara: No conflict of interest||Dr. Mac Carthy, Finbar: No conflict of interest||Prof. Mc Kiernan, Susan: No conflict of interest||Dr. Hartery, Karen: No conflict of interest||Prof. Kevans, David: No conflict of interest

P450 Dr. Ferreiro Iglesias, Rocio: No conflict of interest||Mr. Hernández Camba, Alejandro: No conflict of interest||Mr. Saldaña, Roberto: No conflict of interest||Dr. Rodríguez-Lago, Iago: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

P451 Dr. Khorshid, Mohammed: No conflict of interest||Dr. Dorgham, Dalia: No conflict of interest||Dr. Sharobim, Amin: No conflict of interest||Dr. Attia, Mazen: No conflict of interest||Dr. Hussein, Mohammed: No conflict of interest||Dr. Dorgham, Nevine: No conflict of interest

P452 Dr. Jiang, Caroline Di: No conflict of interest||Dr. Thalagala, Thalagala: No conflict of interest||Ms. Rosembert, Denise: No conflict of interest||Prof. Parkes, Miles: No conflict of interest||Dr. Lee, James: No conflict of interest||Dr. Raine, Tim: No conflict of interest

P453 Mrs. Theodoraki, Eirini: No conflict of interest||Mrs. Orfanoudaki, Eleni: No conflict of interest||Mrs. Foteinogiannopoulou, Kalliopi: No conflict of interest||Ms. Drygiannakis, Ioannis: No conflict of interest||Dr. Koutroubakis, Ioannis E.: No conflict of interest

P454 Dr. Castillo, Gabriel: No conflict of interest||Dr. Sultan, Keith: No conflict of interest||Dr. Kwah, Joann: No conflict of interest||Dr. Chen, Lea Ann: No conflict of interest||Dr. Axelrad, Jordan: No conflict of interest

P455 Ms. Silfen, Alexa: No conflict of interest||Dr. Cohen, Nathaniel: No conflict of interest||Dr. Traboulsi, Cindy: No conflict of interest||Ms. Rodriguez, Tina: No conflict of interest||Dr. Steinberg, Joshua: No conflict of interest||Ms. Singer, Jorie: No conflict of interest||Dr. Patel, Shivani:|:|Shivani Patel has consultant agreements with Janssen, Biotech, and AbbVie.||Prof. Dr. Cohen, Russell:|:|Russell Cohen is on the speaker’s bureau from AbbVie and Takeda. He is a consultant/advisor for AbbVie Laboratories, BM/celgene, Eli Lilly, Gilead Sciences, Janssen, Pfizer, Takeda, UCB Pharma. He has received clinical trial support/grants from Abbvie, BMS/Celgene, Boehringer Ingelheim, Crohn’s and Colitis Foundation of America, Genentech, Gilead Sciences, Hollister, Medimmune, Mesoblast Ltd., Osiris Therpeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres Therapeutics, Takeda Pharma, UCB Pharma. His wife is on the board of directors of Aerpio Theraoeutics, Novus Therapeutics, Vital Therapeutics, Inc, and NantKwest.||Dr. Dalal, Sushila:|:|Sushila Dalal has served as a consultant for Pfizer and is on the speaker’s bureau for AbbVie.||Dr. Micic, Dejan: No conflict of interest||Dr. Pekow, Joel:|:|Joel Pekow has received grant support from AbbVie and Takeda. He has served as a consultant for Veraste,. CVS Caremark and is on the advisory board for Takeda, Janssen and Pfizer.||Dr. Sakuraba, Atsushi: No conflict of interest||Prof. Dr. Rubin, David: No conflict of interest

P456 Dr. Capecchi, Riccardo: No conflict of interest||Prof. Migliorini, Paola: No conflict of interest||Dr. Zanzi, Federico: No conflict of interest||Dr. Maltinti, Simona: No conflict of interest||Prof. Puxeddu, Ilaria: No conflict of interest||Prof. De Bortoli, Nicola: No conflict of interest||Prof. Bellini, Massimo: No conflict of interest||Dr. Costa, Francesco: No conflict of interest||Prof. Marchi, Santino: No conflict of interest||Dr. Bertani, Lorenzo: No conflict of interest

P457 Dr. Klimova, Katerina: No conflict of interest||Dr. Padilla Suarez, Camilo: No conflict of interest

P458 Dr. Mesonero Gismero, Francisco: No conflict of interest||Zabana, Yamile: No conflict of interest||Fernández-Clotet, Agnès: No conflict of interest||Núñez, Andrea: No conflict of interest||Caballol, Berta: No conflict of interest||Sola, Ana: No conflict of interest||García, María José: No conflict of interest||Bertoletti, Federico: No conflict of interest||Mínguez, Alejandro: No conflict of interest||Suris, Gerard: No conflict of interest||Casis, Begoña: No conflict of interest||Ferreiro-Iglesias, Rocío: No conflict of interest||Calafat, Margalida: No conflict of interest||Jiménez, Itxaso: No conflict of interest||Miranda-Bautista, José: No conflict of interest||Lamuela, Luis Javier: No conflict of interest||Fajardo, Ingrid: No conflict of interest||Torrealba, Leyanira: No conflict of interest||Nájera, Rodrigo: No conflict of interest||Sáiz, Rosa María: No conflict of interest||González, Irene: No conflict of interest||Vicuña, Miren: No conflict of interest||García-Morales, Natalia: No conflict of interest||Gutiérrez, Ana: No conflict of interest||López-García, Alicia: No conflict of interest||Benítez, José Manuel: No conflict of interest||Rubín de Célix, Cristina: No conflict of interest||Tejido, Coral: No conflict of interest||Brunet, Eduard: No conflict of interest||Hernández, Alejandro: No conflict of interest||Suárez, Cristina: No conflict of interest||Piquqeras, Marta: No conflict of interest||Castaño, Andrés: No conflict of interest||Ramos, Laura: No conflict of interest||Sobrino, Ana: No conflict of interest||Rodríguez-Grau, Maria Carmen: No conflict of interest||Elosua, Alfonso: No conflict of interest||Montoro, Miguel: No conflict of interest||López-Sanromán, Antonio: No conflict of interest||Barreiro-de Acosta, Manuel: No conflict of interest

P459 Mr. Jójárt, Boldizsár: No conflict of interest||Ms. Molnár, Tünde: No conflict of interest||Ms. Szabó, Viktória: No conflict of interest||Mr. Varga, Árpád: No conflict of interest||Dr. Resál, Tamás: No conflict of interest||Dr. Szántó, Kata: No conflict of interest||Dr. Kata, Diána: No conflict of interest||Dr. Földesi, Imre: No conflict of interest||Prof. Dr. Molnár, Tamás: No conflict of interest||Dr. Maléth, József: No conflict of interest||Dr. Farkas, Klaudia: No conflict of interest

P460 Ms. Sorokina Alexdóttir, Marta: No conflict of interest||Dr. Bourgonje, Arno R.: No conflict of interest||Dr. Asser Karsdal, Morten: No conflict of interest||Dr. Bay-Jensen, Anne-Christine: No conflict of interest||Dr. Faber, Klaas Nico: No conflict of interest||Dr. Loveikyte, Roberta: No conflict of interest||Dr. van Dullemen, Hendrik M.: No conflict of interest||Dr. Visschedijk, Marijn C.: No conflict of interest||Dr. Festen, Eleonora A. M.: No conflict of interest||Dr. Weersma, Rinse K.: No conflict of interest||Dr. Dijkstra, Gerard: No conflict of interest||Dr. Mortensen, Joachim H.: No conflict of interest

P461 Mrs. Zelinkova, Zuzana: No conflict of interest||Kadleckova, Barbora: No conflict of interest||Lucenicova, Jane: No conflict of interest

P462 de Seze, Marie: No conflict of interest||Dr. Billiauws, Lore: No conflict of interest||Bettolo, Joanna: No conflict of interest||Dr. Damas, Victor: No conflict of interest||Ms. Hutinet, Coralie: No conflict of interest||Dr. Bonvalet, Fanny: No conflict of interest||Dr. Cazals-Hatem, Dominique: No conflict of interest||Mr. Villain, Claude: No conflict of interest||Prof. Dr. Bouhnik, Yoram: No conflict of interest||Prof. Dr. Joly, Francisca: No conflict of interest||Dr. Uzzan, Mathieu: No conflict of interest

P463 Dr. Costantino, Andrea:|:|Personal fees from Takeda||Dr. Noviello, Daniele: No conflict of interest||Dr. Conforti, Francesco Simone: No conflict of interest||Prof. Aloi, Marina: No conflict of interest||Prof. Armuzzi, Alessandro:|:|Consultant/ Advisory board: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, Merck, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, and Takeda; Speaker fees: AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Ferring, Gilead, Janssen, Merck, Mitsubishi Tanabe Pharma, Nikkiso, Novartis, Pfizer, Roche, Samsung Bioepis, and Takeda; Research funding: Merck, Pfizer, and Takeda.||Dr. Bossa, Fabrizio:|:|advisory board: biogen, Celgene, MSD, Takeda, janssen. ||Prof. Ficari, Ferdinando: No conflict of interest||Dr. Leone, Salvo: No conflict of interest||Dr. Manguso, Francesco: No conflict of interest||Dr. Mocci, Gianmarco: No conflict of interest||Prof. Orlando, Ambrogio:|:|lecture grants and/or advisory board member for: AbbVie, Chiesi, Janssen, MSD, Pfizer, Samsung Bioepis, Sofar, and Takeda Pharmaceuticals||Prof. Pironi, Loris: No conflict of interest||Dr. Radice, Simona: No conflict of interest||Prof. Rizzello, Fernando: No conflict of interest||Dr. Tongiorgi, Alessandra: No conflict of interest||Prof. Costantino, Claudio: No conflict of interest||Prof. Vecchi, Maurizio:|:|lecturer fees from Abbvie, Ferring, Takeda.|consultant to Abbvie, MSD, Takeda, Janssen-Cilag.||Prof. Caprioli, Flavio:|:|Lecturer fees from Abbvie, Ferring, Takeda, Allergy Therapeutics, Janssen|Research grants from Giuliani, Sofar, MSD, Takeda, Abbvie

P464 Dr. Bokemeyer, Bernd:|:|Bernd Bokemeyer received consultancy and speaking fees from Abbvie, MSD, Takeda, Pfizer, Celltrion, Biogen, Janssen, Celgene and Galapagos Biopharma Deutschland GmbH. ||Mr. Picker, Nils:|:|Nils Picker is an employee of Ingress-health, the work of IPAM and Ingress-health in this study was funded by Galapagos NV.||Prof. Wilke, Thomas:|:|Thomas Wilke is an employee of IPAM; the work of IPAM and Ingress-health in this study was funded by Galapagos NV. ||Mr. Rosin, Ludger:|:|Ludger Rosin is an employee of Galapagos Biopharma Deutschland GmbH. ||Mr. Patel, Haridarshan:|:|Haridarshan Patel is an employee of Immensity Consulting, Inc., which received funding from Galapagos NV.

P465 Dr. Verstockt, Bram:|:|Financial support for research from Pfizer|Consultancy fees from Janssen, Guidepont and Sandoz|Speakers fees from Abbvie, Biogen, Chiesi, Falk, Ferring, Galapagos, Janssen, MSD, Pfizer, R Biopharm, Takeda and Truvion.| ||Dr. Aden, Konrad: No conflict of interest||Dr. Alsoud, Dahham: No conflict of interest||Dr. Outtier, An: No conflict of interest||Prof. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Rosenstiel, Philip: No conflict of interest||Prof. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Prof. De Hertogh, Gert: No conflict of interest||Prof. Schreiber, Stephan: No conflict of interest||Prof. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare

P466 Fasoulas, Kostantinos: No conflict of interest||Soufleris, Konstantinos: No conflict of interest||Kafalis, Nikolaos: No conflict of interest||Kevrekidou, Polyxeni: No conflict of interest||Bouzoukas, Sokratis: No conflict of interest||Stergiou, Evdoxia: No conflict of interest||Dimitriadis, Nikolaos: No conflict of interest||Chatzopoulos, Euthymios: No conflict of interest||Tzilves, Dimitrios: No conflict of interest

P467 LIANG, Jie: No conflict of interest||Dr. Cao, Qian: No conflict of interest||Dr. Chen, Minhu: No conflict of interest||Dr. Wu, Kaichun: No conflict of interest

P468 Raine, Tim:|:|Research/educational grants from AbbVie, Arena, BMS, Celgene, Ferring, Galapagos, Gilead, GSK, Janssen, LabGenius, MSD, Mylan, Novartis, Pfizer, Sandoz, Takeda and UCB speaker/consultation fees from AbbVie, Arena, BMS, Celgene, Ferring, Galapagos, Gilead, GSK, Janssen, LabGenius, MSD, Mylan, Novartis, Pfizer, Sandoz, Takeda and UCB and speaker and/or advisory board fees from AbbVie.||Bokemeyer, Bernd:|:|Consultancy fees from AbbVie, Biogen, Celgene, Ferring, Galapagos, Hexal, Hospira, Janssen, MSD, Pfizer, Shire and Takeda speaker honoraria from AbbVie, Celltrion, Falk, Ferring, Janssen, Merck, MSD, Takeda and Vifor and research grants from AbbVie, Ferring, Given Imaging, Janssen, Pfizer, Takeda and UCB.||Mrs. Finney-Hayward, Tricia:|:|Employee of AbbVie and may own stock and/or options.||Munsaka, Melvin:|:|Employee of AbbVie and may own stock and/or options.||Liu, Meng:|:|Employee of AbbVie and may own stock and/or options.||Louis, Edouard:|:|Research grants from Janssen, Pfizer and Takeda educational grants from AbbVie, Janssen and Takeda speaker fees from AbbVie, Celgene, Falk, Ferring, Janssen, MSD, Pfizer and Takeda consultancy fees from AbbVie and advisory board fees from AbbVie, Arena, Celgene, Eli Lilly, Ferring, Gilead-Galapagos, Janssen, MSD, Pfizer and Takeda.

P469 Dignass, Axel:|:|Served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Pfizer, Biogen, Takeda, Janssen, Roche, Sandoz/ Hexal, Celgene/ BMS, Ferring, Dr. Falk Pharma, Tillotts, Gilead, Galapagos, Amgen, Fresenius Kabi, Med-Update, Streamed-Up, Pharmacosmos, and Vifor.||Dr. Gisbert, Javier:|:|Served as a speaker, a consultant and advisory member for or has received research funding from MSD, Abbvie, Pfizer, Kern Pharma, Biogen, Mylan, Takeda, Janssen, Roche, Sandoz, Celgene, Gilead, Ferring, Faes Farma, Shire Pharmaceuticals, Dr. Falk Pharma, Tillotts Pharma, Chiesi, Casen Fleet, Gebro Pharma, Otsuka Pharmaceutical, and Vifor Pharma.||Dr. Freudensprung, Ulrich:|:|Employee of and may hold stock/stock options in Biogen||Dr. Addison, Janet:|:|Employee of and may hold stock/stock options in Biogen

P470 Mrs. Zelinkova, Zuzana: No conflict of interest||Lipovska, Anna: No conflict of interest||Otottova, Katarina: No conflict of interest||Lucenicova, Jana: No conflict of interest||Kadleckova, Barbora: No conflict of interest

P471 Ms. Fernandez Clotet, Agnes: No conflict of interest||Mr. Panes, Julià: No conflict of interest||Ms. Ricart, Elena: No conflict of interest||Mr. Castro Poceiro, Jesus: No conflict of interest||Ms. Masamunt, Maria Carmen: No conflict of interest||Ms. Rodríguez, Sonia: No conflict of interest||Ms. Caballol, Berta: No conflict of interest||Ms. Ordas, Ingrid: No conflict of interest||Mr. Rimola, Jordi: No conflict of interest

P472 Ghosh, Tito:|:|Sabyasachi Ghosh is an employee of Takeda Pharmaceuticals USA Inc., and has stock or stock options.||Dr. Smith, Ian:|:|Ian Smith is an employee of Optum. Optum received consultancy fees paid by Takeda Pharmaceuticals USA, Inc. to perform data analysis.||Dr. Fehr, Jason:|:|Jason Fehr is an employee of Optum. Optum received consultancy fees paid by Takeda Pharmaceuticals USA, Inc. to perform data analysis.||Dr. Davidson, Jim:|:|Jim Davidson is an employee of Optum. Optum received consultancy fees paid by Takeda Pharmaceuticals USA, Inc. to perform data analysis.||Dr. Fan, Tao:|:|Tao Fan is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options.||Dr. Candela, Ninfa:|:|Ninfa Candela is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options.||Dr. Tsang, Cynthia:|:|Cynthia Tsang is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options.||Dr. Koch, Troy:|:|Troy Koch is an employee of Takeda Pharmaceuticals USA, Inc., and has stock or stock options.

P473 Ms. AMIAMA ROIG, Clara: No conflict of interest||Mrs. Suárez Ferrer, Cristina: No conflict of interest||Mr. Poza Cordón, Joaquin: No conflict of interest||Mr. Rueda García, Jose Luis: No conflict of interest||Mrs. Sánchez Azofra, María: No conflict of interest||Mr. Martín Arranz, Eduardo: No conflict of interest||Ms. González Díaz, Irene: No conflict of interest||Ms. Amor Costa, Carmen: No conflict of interest||Mrs. García Ramírez, Laura: No conflict of interest||Mrs. Martín Arranz, María Dolores: No conflict of interest

P474 Dr. LIBRERO JIMÉNEZ, Marta: No conflict of interest||Ortega Suazo, Eva Julissa: No conflict of interest||Dr. Sánchez Capilla, Antonio Damián: No conflict of interest

P475 Dr. Lundekvam, Jonas Andre: No conflict of interest||Dr. Høivik, Marte Lie:|:|MLH reports speaker fees from AbbVie, Meda, Tillotts and Takeda; advisory board Takeda.||Dr. Anisdahl, Karoline:|:|KA reports consultant fees from Takeda. ||Prof. Dr. Moum, Bjørn:|:|BM reports consultant fees from Takeda, Janssen, AbbVie, Pfizer; advisory board Takeda, Janssen, AbbVie, Pfizer, Sandoz, Pharma Cosmos; speaker fees from Takeda, Janssen, AbbVie, Sandoz, Orion Pharma.||Dr. Medhus, Asle Wilhelm: No conflict of interest

P476 Dr. Chaparro, Maria: No conflict of interest||Ms. Garre, Ana: No conflict of interest||Dr. Iborra, Marisa: No conflict of interest||Dr. Sierra, Mónica: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Dr. Fernández-Clotet, Agnés: No conflict of interest||Dr. de Castro, Luisa: No conflict of interest||Dr. Boscá-Watts, Maia: No conflict of interest||Dr. Casanova, María José: No conflict of interest||Dr. López-García, Alicia: No conflict of interest||Dr. Lorente, Rufo: No conflict of interest||Dr. Rodríguez, Cristina: No conflict of interest||Dr. Carbajo, Ana Y: No conflict of interest||Dr. Arroyo, Maria Teresa: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest||Dr. Hinojosa, Joaquín: No conflict of interest||Dr. Martínez-Pérez, Teresa: No conflict of interest||Dr. Villoria, Albert: No conflict of interest||Dr. Bermejo, Fernando: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Camps, Blau: No conflict of interest||Dr. Cañete, Fiorella: No conflict of interest||Dr. Manceñido, Noemí: No conflict of interest||Dr. Monfort, David: No conflict of interest||Dr. Navarro-Llavat, Mercè: No conflict of interest||Dr. Pérez-Calle, José Lázaro: No conflict of interest||Dr. Ramos, Laura: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Angueira, Teresa: No conflict of interest||Dr. Camo, Patricia: No conflict of interest||Dr. Carpio, Daniel: No conflict of interest||Dr. García-de-la-Filia, Irene: No conflict of interest||Dr. González-Muñoza, Carlos: No conflict of interest||Dr. Hernández, Luis: No conflict of interest||Dr. Huguet, José M.: No conflict of interest||Dr. Morales, Víctor J: No conflict of interest||Dr. Sicilia, Beatriz: No conflict of interest||Dr. Vega, Pablo: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Gisbert, Javier P: No conflict of interest

P477 Chen, Jingjing:|:|Jingjing Chen is an employee of Takeda Pharmaceuticals USA Inc and has stock or stock options. ||Dr. Zhao, Yuxi: No conflict of interest||Dr. Liu, Tina:|:|Tina Liu is a current employee of Vertex Pharmaceuticals Inc and was an employee of Takeda Development Center Americas Inc during the conduct of this study.||Dr. Candela, Ninfa:|:|Ninfa Candela is an employees of Takeda Pharmaceuticals USA Inc and has stock or stock options. ||Dr. Lasch, Karen:|:|Karen Lasch is an employee of Takeda Pharmaceuticals USA Inc and has stock or stock options.

P478 Dr. Olmedo-Martín, Raúl: No conflict of interest||Dr. Martín-Rodríguez, María del Mar: No conflict of interest||Dr. Lorenzo-González, Laura: No conflict of interest||Dr. Lázaro-Sáez, Marta: No conflict of interest||Dr. Lopez-Vico, Manuel: No conflict of interest||Dr. Hernández-Martínez, Álvaro: No conflict of interest||Dr. Argüelles-Arias, Federico: No conflict of interest||Dr. Vázquez-Morón, Juan María: No conflict of interest

P479 Dr. Tavakoli, Paris: No conflict of interest||Prof. Vollmer-Conna, Ute: No conflict of interest||Mr. Hadzi-Pavlovic, Dusan: No conflict of interest||Prof. Grimm, Michael. C: No conflict of interest||Dr. Vázquez-Campos, Xabier: No conflict of interest

P480 Dr. Moore, Alice Catherine: No conflict of interest||Dr. Peake, Simon: No conflict of interest

P481 Viola, Anna: No conflict of interest||Dr. Barbieri , Maria Antonietta: No conflict of interest||Dr. Pisana, Valentina: No conflict of interest||Dr. Cutroneo , Paola Maria: No conflict of interest||Prof. Fries, Walter: No conflict of interest||Prof. Spina, Edoardo: No conflict of interest

P482 Dr. Fiske, Joseph: No conflict of interest||Dr. Liu, Eleanor: No conflict of interest||Prof. Limdi, Jimmy: No conflict of interest||Dr. Conley, Thomas E: No conflict of interest||Dr. Townsend, Tristan: No conflict of interest||Dr. Davies, Mike: No conflict of interest||Dr. Brockwell, Robert: No conflict of interest||Dr. Baig, Daniyal: No conflict of interest||Dr. Abdelbadiee, Sherif: No conflict of interest||Dr. Uney, Anastasia: No conflict of interest||Dr. Liaros, Angela: No conflict of interest||Dr. Gaba, Waqas: No conflict of interest||Dr. Smith, Philip J: No conflict of interest||Dr. Subramanian, Sreedhar:|:|SS has received speaker fees from MSD, Actavis, Abbvie, Dr Falk pharmaceuticals, Shire and received educational grants from MSD, Abbvie, Actavis and is an advisory board member for Abbvie, Dr Falk pharmaceuticals and Vifor pharmaceuticals.

P483 Ms. NOACK, Savannah: No conflict of interest||Dr. Little, Robert: No conflict of interest||Dr. Vaz, Karl: No conflict of interest||Dr. Ward, Mark: No conflict of interest||Dr. Sparrow, Miles: No conflict of interest

P484 Fierens, Liselotte: No conflict of interest||Ms. Geens, Patricia: No conflict of interest||Ms. De Dycker, Els: No conflict of interest||Ms. Paps, Ariane: No conflict of interest||Ms. Lambrechts, Tessy: No conflict of interest||Prof. Dr. Sabino, João:|:|Consultancy fees: Janssen|Speakers fees: Abbvie and Takeda||Prof. Dr. Vermeire, Séverine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda |Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare

P485 Mr. Rezazadeh Ardabili, Ashkan: No conflict of interest||Mr. Wintjens, Dion S J: No conflict of interest||Dr. Mujagic, Zlatan: No conflict of interest||Mrs. Cilissen, Mia: No conflict of interest||Prof. Dr. Stassen, Laurents P S: No conflict of interest||Dr. Haans, Jeoffrey J L: No conflict of interest||Prof. Dr. Jonkers, Daisy M A E:|:|DJ reports grants from Top Knowledge Institute (Well on Wheat), grants from Horizon 2020 DISCOvERIE, grants from NWO-CCC Partnership program (Carbokinetics), all outside the submitted work.||Dr. Pierik, Marie J:|:|MP reports grants and non-financial support from Falk Pharma, grants from European commission, grants from ZONMW (Dutch national research fund), grants and non-financial support from Takeda, grants and non-financial support from Johnson and Johnson, grants and non-financial support from Abbvie, non-financial support from Ferring, non-financial support from Immunodiagnostics, non-financial support from MSD, all outside the submitted work.

P486 Francis, Diana:|:|Employee of Norgine Ltd.||Dr. Hudson, Olga:|:|Employee of Norgine Ltd.

P487 Dr. Oddsson, Saemundur:|:|Saemundur Oddsson is the CMO and co-founder of Sidekick Health ||Dr. Gunnarsdottir, Thrudur:|:|Thrudur Gunnarsdottir is an employee of Sidekick Health.||Mrs. Ylanne, Karoliina:|:|Karoliina Ylanne is an employee of Sidekick Health||Dr. Molander, Pauliina: No conflict of interest||Dr. Thorgeirsson, Tryggvi:|:|Tryggvi Thorgeirsson is the CEO and co-founder of Sidekick Health

P488 Mrs. COSTACHE, Roxana: No conflict of interest||Dr. Iacob, Razvan: No conflict of interest||Dr. Vadan, Roxana: No conflict of interest||Mr. Stroie, Tudor: No conflict of interest||Prof. Dr. Gheorghe, Liana: No conflict of interest||Prof. Dr. Diculescu, Mircea: No conflict of interest||Prof. Dr. Gheorghe, Cristian: No conflict of interest

P489 Mrs. Muñoz-Villafranca, Carmen: No conflict of interest||Mrs. Ogueta, M. Ángeles: No conflict of interest||Mrs. Ramírez de la Piscina, Patricia: No conflict of interest||Ms. Álvarez-Herrero, Begoña: No conflict of interest||Mr. Loizate, Alberto: No conflict of interest||Mr. Gómez-Zabala, Jesus María: No conflict of interest||Ms. De La Maza-Ortiz, Saioa: No conflict of interest||Mr. Aresti, Unai: No conflict of interest||Mr. Gorostiza, Iñigo: No conflict of interest||Mrs. Arreba, Paz: No conflict of interest||Ms. Irigoyen, María: No conflict of interest||Mrs. Ortiz de Zárate, Jone: No conflict of interest

P490 Dr. Mikail, Maria: No conflict of interest||Dr. Malhi, Gurpreet: No conflict of interest||Dr. Wilson, Aze: No conflict of interest||Dr. Khanna, Reena: No conflict of interest

P491 Dr. Innocenti, Tommaso: No conflict of interest||Dr. Roselli, Jenny: No conflict of interest||Dr. Lynch, Erica Nicola: No conflict of interest||Dr. Apolito, Pasquale: No conflict of interest||Dr. Parisio, Laura: No conflict of interest||Dr. Bagnoli, Siro: No conflict of interest||Dr. Macrì, Giuseppe: No conflict of interest||Dr. Rogai, Francesca: No conflict of interest||Prof. Dr. Milani, Stefano: No conflict of interest||Prof. Dr. Galli, Andrea: No conflict of interest||Dr. Milla, Monica: No conflict of interest||Dr. Dragoni, Gabriele: No conflict of interest

P492 Sarbagili Shabat, Chen: No conflict of interest||Dr. Albenberg, Lindsey: No conflict of interest||Dr. Van Limbergen, Johan: No conflict of interest||Dr. Otley, Anthony: No conflict of interest||Mrs. Yaakov, Michal: No conflict of interest||Dr. Wine, Eytan: No conflict of interest||Dr. Weiner, Dror: No conflict of interest||Prof. Dr. Levine, Arie: No conflict of interest

P493 Ms. LEE, Kate: No conflict of interest||Ms. Lim, Francesca: No conflict of interest||Dr. Colombel, Jean-Frederic: No conflict of interest||Dr. Hur, Chin: No conflict of interest||Dr. Faye, Adam: No conflict of interest

P494 Walsh, Alissa Jane: No conflict of interest||Dr. Matini, Lawrence: No conflict of interest||Dr. Kormilitzin, Andrey: No conflict of interest||Mrs. Wilson, Jean: No conflict of interest||Ms. Lyden, Sara: No conflict of interest||Dr. Al-Hillawi, Lulia: No conflict of interest||Ms. Kantschuster, Ramona: No conflict of interest||Mrs. White, Lydia: No conflict of interest||Mrs. Payton, Sally: No conflict of interest||Dr. Brain, Oliver: No conflict of interest||Dr. Palmer, Rebecca: No conflict of interest||Dr. Ambrose, Timothy: No conflict of interest||Prof. Dr. Satsangi, Jack: No conflict of interest||Prof. Dr. Travis, Simon P.L.: No conflict of interest

P495 Knödler, Laura-Louise: No conflict of interest||Dr. Thomann, Anne: No conflict of interest||Mr. Karthikeyan, Sandeep: No conflict of interest||Ms. Atanasova, Konstantina: No conflict of interest||Prof. Dr. Bernstein, Charles: No conflict of interest||Prof. Dr. Ebert, Matthias: No conflict of interest||Prof. Dr. Lis, Stefanie: No conflict of interest||Dr. Reindl, Wolfgang: No conflict of interest

P496 Dr. SMITH, Philip J: No conflict of interest||Mr. Storey, Daniel: No conflict of interest||Ms. Gregg, Belle: No conflict of interest||Ms. Critchley, Lisa: No conflict of interest||Mrs. Stenson, June: No conflict of interest||Mr. Kneebone, Andrew: No conflict of interest||Ms. Rimmer, Tracy: No conflict of interest||Ms. Burke, Stevena: No conflict of interest||Mr. Hussain, Shamas: No conflict of interest||Ms. Teoh, Wan Yi: No conflict of interest||Mr. Vazeille, Stephan: No conflict of interest||Dr. Serna, Solange: No conflict of interest||Dr. Bond, Ashley: No conflict of interest||Dr. Steel, Alan: No conflict of interest||Dr. Dibb, Martyn: No conflict of interest||Dr. Collins, Paul: No conflict of interest||Dr. Derbyshire, Edmund: No conflict of interest||Dr. Bodger, Keith: No conflict of interest||Prof. Probert, Christopher: No conflict of interest||Dr. Verma, Ajay: No conflict of interest||Dr. Subramanian, Sreedhar: No conflict of interest

P497 Ms. Kantasiripitak, Wannee:|:|Conference registration fee: AbbVie||Prof. Dr. Mathôt, Ron: No conflict of interest||Prof. Dr. Oldenburg, Bastiaan: No conflict of interest||Buisson, Anthony: No conflict of interest||Prof. Dr. Ferrante, Marc:|:|Financial support for research: Abbvie, Amgen, Biogen, Janssen, Pfizer, and Takeda|Consultancy fees: Abbvie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher|Speakers fees: Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare|||Prof. Dr. Laharie, David: No conflict of interest||Prof. Dr. D’Haens, Geert:|:|Geert D’Haens Has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamerbio, Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, L Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint, Tillotts.|Reports speaker fees from AbbVie, Biogen, Ferring, Johnson & Johnson, MSD, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium/Takeda, Tillotts and Vifor. ||Prof. Dr. Vermeire, Severine:|:|Financial support for research: AbbVie, J&J, Pfizer, and Takeda|Consulting and/or speaking fees: AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG|||Dr. Dreesen, Erwin:|:|ED is a postdoctoral research fellow of the Research Foundation – Flanders (FWO), Belgium (grant number 12X9420N) and received consultancy fees from argenx and Janssen (all honoraria/fees paid to the University). |Conference registration fee:AbbVie

P498 Aksan, Aysegül:|:|Consultancy, congress expenses, research funding: Vifor Pharma and Immundiagnostik.||Dr. Aksan, Sami: No conflict of interest||Dr. Farrag, Karima: No conflict of interest||Prof. Dr. Schröder, Oliver: No conflict of interest||Prof. Dr. Stein, Jürgen Michael:|:|Consultancy: Abbvie, Bristol Myers Squibb, Dr Schär, Falk, Ferring, Fresenius Kabi, Immundi-agnostik, Janssen, Medice, MSD, Pfizer, Pharmacosmos, Shire, Takeda, Thermofisher, Vifor. Board member: Abbvie, Bristol Myers Squibb, Dr Schär, Ferring, Fresenius Kabi, Immundiagnos-tik, Janssen, MSD, NPS, Pharmacosmos, Takeda, Vifor and Shield. Lecturing fees: Vifor Pharma.

P499 Dr. Murray, Jennifer: No conflict of interest||Prof. Lindsay, James: No conflict of interest

P500 Ms. Janssen, Laura M.: No conflict of interest||HENDRIX, Evelien: No conflict of interest||Mrs. Spooren, Corinne E.G.M.:|:|CS reports invited speaking fees (outside the submitted work) from Janssen Pharmaceuticals.||Prof. Dr. Stassen, Laurents P.S.: No conflict of interest||Dr. Pierik, Marieke J.:|:|MP reports non-financial support from Abbvie, Falk Pharma, Johnson & Johnson, Takeda, Ferring, Immunodiagnostics, MSD (outside the submitted work).||Prof. Jonkers, Daisy M.A.E.: No conflict of interest

P501 NINH, Giaan: No conflict of interest||Dr. Wewer, Vibeke: No conflict of interest||Dr. Jakobsen, Christian: No conflict of interest

P502 Dr. Gatti, Simona: No conflict of interest||Vallorani, Martina: No conflict of interest||Dr. zoppi, elisabetta: No conflict of interest||Dr. aloi, marina: No conflict of interest||Dr. bramuzzo, matteo: No conflict of interest||Dr. felici, enrico: No conflict of interest||Dr. panceri, roberto: No conflict of interest||Dr. ciacchini, benedetta: No conflict of interest||Dr. catassi, giulia: No conflict of interest||Dr. grazian, federica: No conflict of interest||Prof. catassi, carlo: No conflict of interest

P503 Dr. TODESCHINI, Alessia: No conflict of interest

P504 Dr. Fumery, Mathurin: No conflict of interest||Dr. Filippi, Jerome: No conflict of interest||Prof. Abitbol, Vered: No conflict of interest||Dr. Biron, Amelie: No conflict of interest||Prof. Laharie, David: No conflict of interest||Dr. Serrero, Melanie: No conflict of interest||Dr. Altwegg, Romain: No conflict of interest||Prof. Bouhnik, Yoram: No conflict of interest||Prof. Peyrinbiroulet, Laurent: No conflict of interest||Dr. Gilletta, Cyrielle: No conflict of interest||Prof. Roblin, Xavier: No conflict of interest||Dr. Pineton de Chambrun, Guillaume: No conflict of interest||Prof. Vuitton, Lucine: No conflict of interest||Dr. Bourrier, Anne: No conflict of interest||Prof. Nancey, Stephane: No conflict of interest||Dr. Gornet, Jean-Marc: No conflict of interest||Prof. Nahon, Stephane: No conflict of interest||Prof. Bouguen, Guillaume: No conflict of interest||Prof. Viennot, Stephanie: No conflict of interest||Prof. Pariente, Benjamin: No conflict of interest||Prof. Amiot, Aurelien: No conflict of interest

P505 Dr. NASCIMENTO, Catarina: No conflict of interest||Dr. Morão, Bárbara: No conflict of interest||Dr. Frias Gomes, Catarina: No conflict of interest||Dr. Cúrdia Gonçalves, Tiago: No conflict of interest||Dr. Castro, Francisca: No conflict of interest||Dr. Moreira, Moreira: No conflict of interest||Prof. Dr. Cotter, José: No conflict of interest||Dr. Pereira, Flávio: No conflict of interest||Dr. Caldeira, Ana: No conflict of interest||Dr. Sousa, Rui: No conflict of interest||Dr. Coelho, Rosa: No conflict of interest||Prof. Dr. Macedo, Guilherme: No conflict of interest||Dr. Macedo, Cláudia: No conflict of interest||Dr. Ferreira, Margarida: No conflict of interest||Prof. Dr. Cravo, Marília: No conflict of interest||Dr. Glória, Luísa: No conflict of interest||Prof. Dr. Torres, Joana: No conflict of interest||Dr. Palmela, Carolina: No conflict of interest

P506 Dr. Bertani, Lorenzo: No conflict of interest||Dr. Barberio, Brigida: No conflict of interest||Dr. Zanzi, Federico: No conflict of interest||Dr. Maniero, Daria: No conflict of interest||Dr. Ceccarelli, Linda: No conflict of interest||Dr. Marsilio, Ilaria: No conflict of interest||Dr. Minciotti, Moira: No conflict of interest||Dr. Coppini, Francesca: No conflict of interest||Dr. Lorenzon, Greta: No conflict of interest||Dr. Mumolo, Maria Gloria: No conflict of interest||Prof. Zingone, Fabiana: No conflict of interest||Dr. Costa, Francesco: No conflict of interest||Prof. Savarino, Edoardo Vincenzo: No conflict of interest

P507 Dr. Sahar, Nasr: No conflict of interest||Dr. Dahmani, Wafa: No conflict of interest||Dr. Nour, Elleuch: No conflict of interest||Dr. Aya, Hammami: No conflict of interest||Dr. Wafa, Ben Ameur: No conflict of interest||Prof. Aida, Ben Slama: No conflict of interest||Prof. Ahlem, Brahem: No conflict of interest||Prof. Mehdi, Ksiaa: No conflict of interest||Dr. Hanene, Jaziri: No conflict of interest||Prof. Ali, Jmaa: No conflict of interest

P508 Dr. Rowbotham, David S.:|:|Grant support from NIL, consulting fees from NIL, lecture fees from AbbVie; Janssen Research & Development, LLC., Baxter; Pharmaco; bioCSL; Given imaging; Emerge Health, and has served on the advisory board of AbbVie; Janssen Research & Development, LLC.; Baxter; Pharmaco; Hospira.||Dr. Scherl, Ellen J.:|:|Grant support from AbbVie, AstraZeneca, Crohn’s and Colitis Foundation, Janssen Research & Development, LLC., New York Crohn’s Foundation, Pfizer, UCB, Genentech, Seres Therapeutics, and Celgene; consulting fees: AbbVie, Abgenomics, Crohn’s and Colitis Foundation, Evidera, GI Health Foundation, Janssen, Protagonist, Seres, Takeda Stock: Gilead; speaker fees from GI Health Foundation, Prime Therapeutics.||Dr. Sands, Bruce E.:|:|Reports personal fees from AbbVie, personal fees from Amgen, personal fees from AstraZeneca, personal fees from Bristol-Myers Squibb, grants and personal fees from Celgene, personal fees and non-financial support from Janssen Research & Development, LLC., personal fees and nonfinancial support from MedImmune, grants, personal fees and non-financial support from Takeda, personal fees from Akros Pharma, personal fees from Arena Pharmaceuticals, personal fees from Boehringer-Ingelheim, personal fees from Forward Pharma, personal fees from Immune Pharmaceuticals, personal fees and non-financial support from Lilly, personal fees from Shire, personal fees from Synergy Pharmaceuticals, personal fees from Theravance Biopharma R&D, personal fees from TiGenix, personal fees from TopiVert Pharma, personal fees from Receptos, personal fees from Allergan, personal fees from EnGene, personal fees from Target PharmaSolutions, personal fees from Lycera, personal fees from Lyndra, personal fees from Ironwood Pharmaceuticals, personal fees from Salix, personal fees from Vivelix Pharmaceuticals, personal fees from UCB, personal fees from Oppilan Pharmaceuticals, personal fees from Gilead, personal fees from Rheos Medicines, personal fees from Seres Therapeutics, personal fees from 4D Pharma, personal fees from Capella Bioscience, personal fees from Otsuka , personal fees from Ferring, personal fees from Protagonist Therapeutics, personal fees from Palatin Technologies, grants, personal fees and non-financial support from Pfizer, personal fees from Hoffman-La Roche, personal fees from Prometheus Laboratories.||Dr. Panaccione, Remo:|:|Consulting fees from AbbVie, Janssen Research & Development, LLC., Takeda California, Inc.||Dr. Peyrin-Biroulet, Laurent:|:|Personal fees from AbbVie, Janssen, Genentech, Ferring, Tillots, Pharmacosmos, Celltrion, Takeda, Boerhinger Ingelheim, Pfizer, Index Pharmaceuticals , Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestle, Enterome, Allergan, MSD, Roche, Arena, Gilead, Hikma, Amgen, BMS, Vifor, Norgine ; Mylan, Lilly, Fresenius Kabi, Oppilan Pharma, Sublimity Therapeutics, Applied Molecular Transport, OSE Immunotherapeutics, Enthera, Theravance; grants from Abbvie, MSD, Takeda; stock options: CTMA.||Dr. Zhang, Hongyan:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Miao, Ye:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.||Dr. Leong, Rupert W.:|:|Grant support from NHMRC, GESA, Janssen, Shire, Endochoice, Ferring; and consulting fees from Janssen Research & Development, LLC. Aspen, AbbVie, Celgene, Ferring, Pfizer, Hospira, Novartis, Dr Falk Pharma, MSD, Takeda. ||Dr. Afif, Waqqas:|:|Grant support from Janssen Research & Development, LLC.||Dr. Arasaradnam, Ramesh P.:|:|Grant support and consulting fees from Janssen Research & Development, LLC.||Danese, Silvio:|:|Consulting fees from Allergan, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Celltrion Healthcare, Ferring, Gilead Sciences, Hospira, Inc., Janssen Research & Development, LLC., Johnson & Johnson Health Care Systems, Inc., Pfizer, Sandoz, UCB, Inc., Vifor International Inc.||Dr. Marano, Colleen:|:|Employee of Janssen Research & Development, LLC. and owns stock in Johnson & Johnson, of which Janssen is a subsidiary.

P509 Chaparro, Maria: No conflict of interest||Bastón Rey, Iria: No conflict of interest||Fernández-Salgado, Estela: No conflict of interest||González García, Javier: No conflict of interest||Ramos, Laura: No conflict of interest||Prof. Dr. Diz-Lois Palomares, María Teresa: No conflict of interest||Argüelles, Federico: No conflict of interest||Iglesias Flores, Eva: No conflict of interest||Prof. Dr. Cabello, Mercedes: No conflict of interest||Rubio Iturria, Saioa: No conflict of interest||Núñez Ortiz, Andrea: No conflict of interest||Charro, Mara: No conflict of interest||Ginard, Daniel: No conflict of interest||Dueñas Sadornil, Carmen: No conflict of interest||Merino Ochoa, Olga: No conflict of interest||Busquets, David: No conflict of interest||Iyo, Eduardo: No conflict of interest||Prof. Dr. Gutiérrez Casbas, Ana: No conflict of interest||Ramírez de la Piscina, Patricia: No conflict of interest||Prof. Dr. Boscá-Watts, Marta Maia: No conflict of interest||Prof. Dr. Arroyo, Maite: No conflict of interest||García, María José: No conflict of interest||Hinojosa, Esther: No conflict of interest||Prof. Dr. Gordillo, Jordi: No conflict of interest||Prof. Dr. Martínez Montiel, Pilar: No conflict of interest||Velayos Jiménez, Benito: No conflict of interest||Quílez Ivorra, Cristina: No conflict of interest||Vázquez Morón, Juan María: No conflict of interest||Huguet, José María: No conflict of interest||González Lama, Yago: No conflict of interest||Muñagorri Santos, Ana Isabel: No conflict of interest||Amo, Víctor Manuel: No conflict of interest||Martín Arranz, María Dolores: No conflict of interest||Prof. Dr. Bermejo, Fernando: No conflict of interest||Martínez Cadilla, Jesús: No conflict of interest||Fradejas Salazar, Paola: No conflict of interest||Novella, Cynthia: No conflict of interest||Vispo, Eugenia: No conflict of interest||Prof. Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Prof. Dr. Gisbert, Javier P.: No conflict of interest

P510 Dr. Parlanti, Daniele: No conflict of interest||Prof. Dr. Poggioli, Gilberto: No conflict of interest||Dr. Cardelli, Stefano: No conflict of interest||Dr. Tanzanu, Marta: No conflict of interest||Dr. Boschi, Luca: No conflict of interest||Dr. Rottoli, Matteo: No conflict of interest

P511 Mrs. Einav, Larisa: No conflict of interest||Dr. Hirsch, Ayal: No conflict of interest||Dr. Ron, Yulia: No conflict of interest||Dr. Aviv Cohen, Nathaniel: No conflict of interest||Dr. Anbar, Ronit: No conflict of interest||Mrs. Lahav, Sigalit: No conflict of interest||Prof. Maharshak, Nitsan: No conflict of interest||Dr. Fliss Isakov, Naomi: No conflict of interest

P512 Ms. Jansen, Fenna Minke: No conflict of interest||Ms. Smits, Lisa S.: No conflict of interest||Mr. Thomas, Pepijn W.A.: No conflict of interest||Mr. den Broeder, Nathan: No conflict of interest||Dr. de Jong, Dirk J.: No conflict of interest||Dr. van Dop, Willemijn A.: No conflict of interest||Dr. Hoentjen, Frank: No conflict of interest

P513 Dr. Xu, Cheng: No conflict of interest||Ms. Byman, Victoria: No conflict of interest||Ms. Hossain, Jessica: No conflict of interest||Ms. Storlåhls, Anette: No conflict of interest||Dr. Hedin, Charlotte: No conflict of interest

P514 Prof. Knyazev, Oleg: No conflict of interest||Tishaeva, Irina: No conflict of interest||Dr. Kagramanova, Anna: No conflict of interest||Dr. Shkurko, Tatyana: No conflict of interest||Dr. Veselov, Alexey: No conflict of interest

P515 SCHEFFERS, Linda: No conflict of interest||Dr. van den Berg, Linda E.: No conflict of interest||Dr. Pijnenburg, Mariëlle W.: No conflict of interest||Prof. Dr. Utens, Elisabeth M.: No conflict of interest||Prof. Dr. Dieleman, Gwen C.: No conflict of interest||Prof. Dr. van der Ploeg , Ans T.: No conflict of interest||Prof. Dr. Helbing, Willem A.: No conflict of interest||Prof. Dr. Escher, Johanna C.: No conflict of interest

P516 Dr. Mortensen, Joachim:|:|Full time employee at Nordic Bioscience||Prof. Dr. Feagan, Brian:|:|Full time employee at Alimentiv||Dr. Bay-Jensen, Anne-Christine:|:|Full time employee and hold stocks at Nordic Bioscience||Prof. Karsdal, Morten Asser:|:|Full time employee and hold stocks at Nordic Bioscience||Dr. Horan, Gerald:|:|Full time employee at BMS||Dr. Harris, Sarah:|:|Full time employee at BMS||Dr. Usikin, Keith:|:|Full time employee at BMS

P517 Chiappetta, Michele Francesco: No conflict of interest||Dr. Viola, Anna: No conflict of interest||Dr. Mastronardi, Mauro: No conflict of interest||Dr. Turchini, Laura: No conflict of interest||Dr. Carparellli , Sonia: No conflict of interest||Dr. Orlando, Adele: No conflict of interest||Dr. Biscaglia , Giuseppe: No conflict of interest||Dr. Miranda , Agnese: No conflict of interest||Dr. Guida, Laura: No conflict of interest||Dr. Costantino, Giuseppe: No conflict of interest||Prof. Scaldaferri, Franco: No conflict of interest||Dr. Bossa, Fabrizio: No conflict of interest||Dr. Renna, Sara: No conflict of interest||Dr. Cappello , Maria: No conflict of interest||Dr. Orlando , Ambrogio: No conflict of interest||Prof. Armuzzi, Alessandro: No conflict of interest||Prof. Fries, Walter: No conflict of interest

P518 Mr. EDWARDS, David: No conflict of interest||Dr. Ibrahim, Maryam: No conflict of interest||Dr. Cooney, Rachel: No conflict of interest||Dr. Boulton, Ralph: No conflict of interest

P519 Mrs. HARTL, Christine: No conflict of interest||Prof. Dr. Novacek, Gottfried: No conflict of interest||Dr. Reinisch, Sieglinde: No conflict of interest||Mr. Saciri, Amar: No conflict of interest||Prof. Dr. Reinisch, Walter: No conflict of interest||Dr. Primas, Christian: No conflict of interest||Prof. Dr. Maier, Harald: No conflict of interest

P520 Ms. Lamers, Carlijn R.: No conflict of interest||Ms. van Erp, Liselot W.: No conflict of interest||Ms. Slotegraaf, Anne I.: No conflict of interest||Dr. Groenen, Marcel J.M.: No conflict of interest||Dr. de Roos, Nicole M.: No conflict of interest||Dr. Wahab, Peter J.: No conflict of interest||Prof. Dr. Witteman, Ben J.M.: No conflict of interest

P521 Prof. Dr. Sezgin, Orhan:|:|Research grants from AbbVie.|Speaker fees from AbbVie, Abbott, Celltrion, Takeda, UCB, Abdi İbrahim, Sandoz, Bilim Pharmaceuticals, Gilead.|Consulting fees from Abbvie, Gilead and Takeda. ||Prof. Dr. Atug, Ozlen:|:|Research grant from AbbVie, Celltrion, Lilly.|Consulting fee from Pfizer and Takeda.||Dr. Gonen, Can:|:|Research grant from Lilly, Roche, Takeda, Genentech, Janssen, Abbvie, Bayer.|Speaker fees from Abbvie, Eczacıbaşı-Tillots, Pfizer, Daiichi-Sankyo, Nobel, Merck, UCB, Medtronic.|Consulting fees from Johnson & Johnson, Abbvie, Pfizer, Daiichi-Sankyo, Medtronic.||Dr. Can, Guray:|:|Research grant from Abbvie.||Dr. Duman, Ali Erkan: No conflict of interest||Prof. Dr. Erzin, Yusuf Ziya:|:|Consulting and speaker fees from AbbVie, MSD, UCB, Takeda, Pfizer, Nobel, İLKO, Abdi İbrahim.||Prof. Dr. Yurci, Mustafa Alper:|:|Research grant, consulting and speaker fees from Abbvie, Pfizer, Sanofi Genzyme, Takeda, Abdi İbrahim, Ferring.||Prof. Dr. Alkim, Canan: No conflict of interest||Prof. Dr. Unal Ozcelik, Nalan Gulsen:|:|Research grant from Celltrion, Abbvie, Hoffman La-Roche, Celgene, Lilly.|Speaker fees from Abbvie, Celltrion, Jahnssen, Eczacıbaşı.|Consulting fees from Celltrion, Takeda.||Prof. Dr. Yildirim, Beytullah: No conflict of interest||Prof. Dr. Kayacetin, Ertugrul: No conflict of interest||Prof. Dr. Beyazit, Yavuz: No conflict of interest||Dr. Tayfur Yurekli, Oyku:|:|Speaker fee from Celltrion.||Prof. Dr. Kiyici, Murat:|:|Research grants from AbbVie, Lilly, Galmed, Arena, Novartis.|Speaker fees from AbbVie, Gilead, Abdi İbrahim, Takeda, Novo Nordisk, Drogsan, Janssen, Atabay, Amgen.|Consulting fees from Lilly, Galmed, Arena, Novartis.

P522 Dr. Avni Biron, Irit: No conflict of interest||Prof. Dr. Bar-Gil Shitrit , Ariella: No conflict of interest||Dr. Koslowsky, Binyamin: No conflict of interest||Prof. Dr. Kopylov, Uri: No conflict of interest||Dr. Levartovsky, Asaf: No conflict of interest||Dr. Weisshof, Rony: No conflict of interest||Dr. Aviv-Cohen, Nathanael: No conflict of interest||Prof. Dr. Maharshak, Nitsan: No conflict of interest||Dr. Hovel, David: No conflict of interest||Dr. Naftali, Timna: No conflict of interest||Dr. Goren, Idan: No conflict of interest||Dr. Snir, Ifat: No conflict of interest||Dr. ollech, Jacob: No conflict of interest||Dr. Banai, Hagar: No conflict of interest||Dr. Lena, Broytman: No conflict of interest||Prof. Dr. Dotan, Iris: No conflict of interest||Dr. Yanai, Henit: No conflict of interest

P523 Dr. Fiorino, Gionata: No conflict of interest||Bent-Ennakhil, Nawal: No conflict of interest||Varriale, Pasquale: No conflict of interest||Braegger, Fiona: No conflict of interest||Hoefkens, Eveline: No conflict of interest

P524 Badre, Wafae: No conflict of interest||Bahlaoui, Omar: No conflict of interest||El Rhaoussi, Fatima Zahra: No conflict of interest||Tahiri, Mohamed: No conflict of interest||Haddad, Fouad: No conflict of interest||Hliwa, Wafaa: No conflict of interest

P525 Dr. Lior, Orly: No conflict of interest||Dr. Sergeev, Ilia: No conflict of interest||Mr. Ruhimovich, Nahum: No conflict of interest||Dr. Openheim, Michal: No conflict of interest||Dr. Benjaminov, Fabiana: No conflict of interest||Dr. Feldman, Dan: No conflict of interest||Prof. Ringel, Yehuda: No conflict of interest||Dr. Naftali, Timna: No conflict of interest

P526 Dr. TODESCHINI, Alessia: No conflict of interest

P527

P528 Mrs. Rees, Fiona: No conflict of interest||Mrs. Packham, Angela: No conflict of interest||Mrs. Parmar, Archna: No conflict of interest||Ms. Hills, Emma: No conflict of interest||Dr. Smith, Melissa: No conflict of interest||Mrs. St. Clair Jones, Anja: No conflict of interest

P529 Mrs. Fernandez Cano, Maria Carmen: No conflict of interest||Mr. Sánchez-Capilla, Antonio Damián: No conflict of interest||Ms. Martín-Rodríguez, María Mar: No conflict of interest||Ms. Cabello-Tapia, María José: No conflict of interest||Mr. Redondo-Cerezo, Eduardo: No conflict of interest

P530 Dr. Brinar, Marko: No conflict of interest||Sabic , Marina: No conflict of interest||Turk , Nikša: No conflict of interest||Grgic, Dora: No conflict of interest||Domislovic, Viktor: No conflict of interest||Cukovic Cavka, Silvija: No conflict of interest||Kozmar, Ana: No conflict of interest||Krznaric, Zeljko: No conflict of interest

P531 Dr. Calafat Sard, Margalida:|:|Has served as a speaker or has received research or education funding or advisory fees from Takeda, Pfizzer, Ferring, Janssen, Faes Farma, Falk and MSD||González-Muñoza: , Carlos:|:|has served as speaker or has received research or education funding or advisory fees from Norgine, Janssen, Ferring||Fortuny, Marta: No conflict of interest||Roig, Cristina: No conflict of interest||Calm, Anna: No conflict of interest||Mombiela, Antonio: No conflict of interest||Teller-Martin, Marta: No conflict of interest||Cañete:, Fiorella:|:|has served as a speaker or has received research or education funding or advisory fees from Takeda, Janssen, MSD, and Ferring||Bertoletti, Federico: No conflict of interest||González-González, Laura: No conflict of interest||Gordillo, Jordi: No conflict of interest||Mañosa, Míriam:|:| Has served as a speaker or has received research or education funding or advisory fees from FAES, Ferring MSD, AbbVie, Takeda and Janssen||Garcia-Planella , Esther:|:|has served as a speaker and has received research and educational funding and advisory fees from MSD, AbbVie, Takeda, Kern Pharma, Pfizer, Janssen, Ferring, Shire Pharmaceuticals, and Tillots||Domènech, Eugeni:|:|ED has served as a speaker and has received research and educational funding and advisory fees from MSD, AbbVie, Takeda, Celltrion, Samsung Bioepis, Kern Pharma, Pfizer, Janssen, Celgene, Adacyte Therapeutics, Otsuka Pharmaceuticals, Ferring, Shire Pharmaceuticals, Tillots, Thermofisher, Grifols, Gilead, Roche and Gebro.

Louis, Edouard:|:|Research grants/support, educational grants, consultancy fees and/or honoraria (Takeda). This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.. ||Vinciane, Muls:|:|Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Bossuyt, Peter:|:|Research grants/support, educational grants, consultancy fees and/or honoraria (Takeda). This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Colard, Arnaud:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Nakad, Antoine:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Baert, Didier:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Mana, Fazia:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Caenepeel, Philip:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Vanden Branden, Stijn:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Vermeire, Severine:|:|Research grants/support, educational grants, consultancy fees and/or honoraria (Takeda) Grants (AbbVie, J&J, Pfizer, and Takeda) Consulting and/or speaking fees (AbbVie, Arena Pharmaceuticals, Avaxia, Boehringer Ingelheim, Celgene, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, Hospira, Janssen, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Takeda, Theravance, and Tillots Pharma AG). |This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||D'Heygere, Francois:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Strubbe, Beatrijs:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Cremer, Anneline:|:|Research grants/support, educational grants, consultancy fees and/or honoraria (Takeda) Consultancy fees ( Takeda, Janssen) Speaker fees (Pfizer, Abbvie). |This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Setakhr, Vida:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Baert, Filip:|:|Research grants/support, educational grants, consultancy fees and/or honoraria (Takeda) Grant/Research Support (AbbVie Inc. Amgen Inc. Janssen Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited) Speakers Bureau participant (AbbVie Inc. Ferring Holding SA Janssen Pharmaceuticals, Inc. Merck Sharp & Dohme Corp. Pfizer Inc. and Takeda).Honoraria (AbbVie Inc. Amgen Inc. Arena Pharmaceuticals, Inc. Celgene Corporation Ferring Holding SA Fresenius Kabi AG Galapagos Inc Janssen Pharmaceuticals, Inc. Merck Sharp & Dohme Corp. Pfizer Inc. and Takeda). This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Vijverman, Anne:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Coenegrachts, Jean-Louis:|:|This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda .||Flamme, Frederic:|:|Research grants (Takeda). This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Hantson, Anke:|:|Employee of Takeda Belgium. This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Bennett, Dimitri:|:|Employee of Takeda Takeda stock options. This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Van Gassen, Geert:|:|Employee of Takeda Belgium. This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.||Hantsbarger, Gary:|:|Employee of Takeda Takeda stock options. This study was sponsored by Takeda. Medical writing support provided by Daniella Babu PhD, of Excel Medical Affairs, and funded by Takeda.

P532 Ms. GUO, Huili: No conflict of interest||Tang, Jian: No conflict of interest||Huang, Zicheng: No conflict of interest||Li, Bingyang: No conflict of interest||Yang, Qingfan: No conflict of interest||Chao, Kang: No conflict of interest||Prof. Gao, Xiang: No conflict of interest

P533 Dr. Calvo Moya, Marta Isabel: No conflict of interest||Dr. Omella Usieto, Ignacio: No conflict of interest||Dr. El Hajra Martinez, Ismael: No conflict of interest||Dr. Santos Perez, Elena: No conflict of interest||Dr. Gonzalez Lama, Yago: No conflict of interest||Dr. Ruiz Antoran, Belen: No conflict of interest||Dr. Menchen Viso, Belen: No conflict of interest||Dr. Matallana Royo, Virgina: No conflict of interest||Dr. Gonzalez Partida, Irene: No conflict of interest||Ms. De Lucas Tellez de Meneses, Rocio: No conflict of interest||Mr. Bella del Castillo, Pablo: No conflict of interest||Ms. Gonzalez Rodriguez, Macarena: No conflict of interest||Dr. Vera Mendoza, Maria Isabel: No conflict of interest

P535 Louis, Edouard:|:|Research funding: Takeda, Pfizer, Janssen; Educational Grant: Abbvie, Takeda, Janssen; Speaker fees: Abbvie, Ferring, MSD, Falk, Takeda, Janssen, Pfizer, Celgene; Advisory board: Abbvie, Ferring, MSD, Takeda, Celgene, Janssen, Gilead-Galapagos, Arena, Pfizer, Eli Lilly; Consultant: Abbvie.|This study was sponsored by Takeda. Editing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Nikolaou, Andreas:|:|Employment Evidera.|This study was sponsored by Takeda. Editing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Litkiewicz, Michal:|:|Employment Evidera.|This study was sponsored by Takeda. Editing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Agboton, Christian:|:|Employment Takeda, Ownership of stock/stock options Takeda.|This study was sponsored by Takeda. Editing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Wang, Song:|:|Employment Takeda, Ownership of stock/stock options Takeda.|This study was sponsored by Takeda. Editing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.||Armuzzi, Alessandro:|:|Consultant/ Advisory board: AbbVie, Allergan, Amgen, Arena Pharmaceuticals, Biogen, Bristol-Myers Squibb, Celgene, Celltrion, Ferring, Gilead, Janssen, Lilly, Merck, Mylan, Pfizer, Roche, Samsung Bioepis, Sandoz, and Takeda; Speaker fees: AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Ferring, Gilead, Janssen, Merck, Mitsubishi Tanabe Pharma, Nikkiso, Novartis, Pfizer, Roche, Samsung Bioepis, and Takeda; Research funding: Merck, Pfizer, and Takeda.|This study was sponsored by Takeda. Editing support was provided by Isobel Lever, PhD, of Excel Medical Affairs, and funded by Takeda.

P536 Morales Bermúdez, Ana Isabel: No conflict of interest||Ms. Bravo Aranda, Ana María: No conflict of interest||Martinez Burgos, María: No conflict of interest||Mr. Olmedo Martín, Raúl: No conflict of interest

P537 Dr. GHARBI, Ghada: No conflict of interest||Dr. Bibani, Norsaf: No conflict of interest||Dr. Sabbah, Meriem: No conflict of interest||Dr. Nawel, Bellil: No conflict of interest||Dr. Trad, Dorra: No conflict of interest||Dr. Ouakaa, Asma: No conflict of interest||Dr. Elloumi, Hela: No conflict of interest||Dr. Gargouri, Dalila: No conflict of interest

P538 Ms. Crouwel, Femke: No conflict of interest||Ms. Dijkhuis, Lies E.J.L.: No conflict of interest||Dr. Duijvestein, Marjolijn:|:|M Duijvestein reports advisory fees from Echo Pharma and Robarts Clinical Trials, Inc., speaker fees from Janssen, Merck & Co., Inc., Pfizer, Takeda and Tillotts Pharma, and nonfinancial support from Dr. Falk Pharm.||Dr. Buiter, Hans J.C.: No conflict of interest||Dr. De Boer, Nanne K.:|:|NK de Boer has served as a speaker for AbbVie and MSD and has served as consultant and principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Dr. Falk, TEVA Pharma BV, MLDS and Takeda.||Dr. Hamer, Henrike M.:|:|Reagents and CALiaGold tubes were kindly provided by Sysmex.

P539 Dr. Afzali, Anita:|:|has served as Consultant for AbbVie, Takeda, Janssen, BMS/Celgene, Lilly and Gilead; and has received speaker fees for AbbVie, Takeda, Janssen, and Pfizer||Ms. Kakehi, Sumie:|:|employee and shareholder of Bristol Myers Squibb||Dr. Lapensee, Kenneth:|:|employee and shareholder of Bristol Myers Squibb||Ms. Lukanova, Rina:|:|employee of Adelphi Real World||Dr. Hennessy, Fritha:|:|employee of Adelphi Real World||Ms. Knight, Hannah:|:|employee of Adelphi Real World||Dr. Singh, Komal:|:|employee and shareholder of Bristol Myers Squibb

P540 Mr. Singh, Harpreet:|:|are employee of an independent company, Amaris Consulting Ltd, that received funding for the contribution to the study design and data analyses. ||Mr. Wilson, Liam:|:|employee of an independent company, Amaris Consulting Ltd, that received funding for the contribution to the study design and data analyses. ||Dr. Pandey, Anuja:|:|employee of an independent company, Amaris Consulting Ltd, that received funding for the contribution to the study design and data analyses. ||Dr. Tencer, Tom:|:|employee and shareholder of Bristol Myers Squibb.||Mr. Kumar, Jinender:|:|employee and shareholder of Bristol Myers Squibb.

P541 Ms. Ramos Lopez, Laura: No conflict of interest||Ms. Reygosa, Cristina: No conflict of interest||Dr. Carrillo-Palau, Marta: No conflict of interest||Dr. Alonso-Abreu, Inmaculada: No conflict of interest||Dr. González, Yanira: No conflict of interest||Ms. de la Barreda, Raquel: No conflict of interest||Ms. Amaral , Carla: No conflict of interest||Ms. Hernández, Anjara: No conflict of interest||Ms. Benítez-Zafra, Federica: No conflict of interest||Prof. Dr. Hernández-Guerra, Manuel: No conflict of interest

P542 Dr. Bhangale, Nikhil: No conflict of interest||Dr. Desai, Devendra C.: No conflict of interest||Dr. Abraham, Philip: No conflict of interest||Dr. Gupta, Tarun: No conflict of interest||Dr. Dhoble, Pavan: No conflict of interest

P543 Dr. Regev, Shirley: No conflict of interest||Ms. Goren, Ganit: No conflict of interest||Dr. Schwartz, Doron: No conflict of interest||Mr. Sergienko , Ruslan: No conflict of interest||Prof. Friger, Michael: No conflict of interest||Mrs. Nemirovsky , Anna: No conflict of interest||Prof. Greenberg, Dan: No conflict of interest||Prof. Monsonego, Alon: No conflict of interest||Prof. Sarid, Orly: No conflict of interest||Prof. Slonim-Nevo, Vered: No conflict of interest||Prof. Dr. Odes, Selwyn (Shmuel): No conflict of interest

P544 Mr. Volkers, Adriaan: No conflict of interest||Dr. Löwenberg, Mark:|:|Mark Löwenberg has served as speaker and/or principal investigator for: Abbvie, Celgene, Covidien, Dr. Falk, Ferring Pharmaceuticals,|Gilead, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, Protagonist therapeutics, Receptos, Robarts Clinical Trials, Takeda, Tillotts, Tramedico.|He has received research grants from AbbVie, Merck Sharp & Dohme, Dr Falk, Achmea healthcare and ZonMW.|||Mr. Bray, Kurt:|:|Kurt Bray is a full-time employee of ProciseDx Inc. and Kurt holds options to purchase shares. ||Mr. Bahur, Bayda:|:|Bayda Bahur is a full-time employee of ProciseDx Inc. and Bayda holds options to purchase shares. ||Ms. Braad, Marlou: No conflict of interest||Ms. Abeling, Yara: No conflict of interest||Dr. Gecse, Krisztina:|:|KB Gecse has received grants from Pfizer Inc and Celltrion; consultancy fees from AbbVie, Arena Pharmaceuticals, Galapagos, Gilead, Immunic Therapeutics, Janssen Pharmaceuticals, Novartis, Pfizer Inc., Samsung Bioepis and Takeda; speaker’s honoraria from Celltrion, Ferring, Janssen Pharmaceuticals, Novartis, Pfizer Inc, Samsung Bioepis, Takeda and Tillotts. ||Dr. Duijvestein, Marjolijn:|:|Marjolijn Duijvestein reports advisory fees from Echo Pharma and Robarts Clinical Trials, Inc., speaker fees from Janssen, Merck & Co., Inc., Pfizer, Takeda and Tillotts Pharma, and nonfinancial support from Dr. Falk Pharm. ||Prof. Dr. Ponsioen, Cyriel:|:|Cyriel Ponsioen received grant support form Takeda, consulancy fees from Takeda, Shire, and Pliant, and speaker’s fees from Tillotts and Pfizer.||Prof. Dr. D'Haens, Geert:|:|Has served as advisor for AbbVie, Ablynx, Allergan, Alphabiomics, Amgen, Applied Molecular Therapeutics, Arena Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celltrion, Eli Lilly, Exeliom Biosciences, Ferring, Dr Falk Pharma, Galapagos, Genentech/Roche, Gilead, GSK, Gossamerbio, Pfizer, Immunic, Johnson and Johnson, Kintai Therapeutics, L Takeda, Medtronics, Mitsubishi Pharma, MSD, Mundipharma, ProciseDx, Prodigest, Prometheus Laboratories/Nestlé, Progenity, Protagonist, RedHill, Alimentiv, Samsung Bioepis, Sandoz, Seres, Setpoint, Tillotts.|Reports speaker fees from AbbVie, Biogen, Ferring, Johnson & Johnson, MSD, Mundipharma, Norgine, Pfizer, Samsung Bioepis, Shire, Millenium/Takeda, Tillotts and Vifor.

P545 Dr. Rubstov, Denis: No conflict of interest||Dr. Kakkadasam Ramaswamy, Pradeep: No conflict of interest||Dr. Edwards, John: No conflict of interest||Dr. Shukla, Dheeraj: No conflict of interest||Dr. Willmann, Laura: No conflict of interest||Dr. Moattar, Hadi: No conflict of interest||Dr. Bhullar, Maneesha: No conflict of interest||Dr. Ishaq, Naveed: No conflict of interest||Dr. Dorrington, Alexander: No conflict of interest||Dr. Mohsen, Waled: No conflict of interest

P546 Dr. Resál, Tamás: No conflict of interest||Dr. Farkas, Klaudia: No conflict of interest||Prof. Dr. Molnár, Tamás: No conflict of interest

P547 Dr. Khorshid, Mohammed: No conflict of interest||Dr. Alboraie, Mohamed: No conflict of interest||Dr. Abbas, Wael: No conflict of interest||Dr. Sayed, Zain Elabdeen: No conflict of interest||Dr. El-Nady, Mohamed: No conflict of interest

P548 Dr. Kubesch, Alica: No conflict of interest||Mr. Grimm, Lars: No conflict of interest||Dr. Stratmann, Katharina: No conflict of interest||Dr. Knabe, Mate: No conflict of interest||Dr. Filmann, Natalie: No conflict of interest||Dr. Sprinzl, Kathrin: No conflict of interest||Dr. Hausmann, Johannes: No conflict of interest||Dr. Blumenstein, Irina: No conflict of interest

P549 Dr. Mc Gettigan, Neasa: No conflict of interest||Dr. Leung, Edric: No conflict of interest||Dr. Harhen, Aidan: No conflict of interest||Ms. Anderson, Emma: No conflict of interest||McMahon, Siobhan: No conflict of interest||Dr. Walshe, Margaret: No conflict of interest||Dr. Keohane, John: No conflict of interest||Dr. Sengupta, Subhasish: No conflict of interest

P550 Ms. Lamers, Carlijn R.: No conflict of interest||Dr. de Roos, Nicole M.: No conflict of interest||Ms. Heerink, Henrike H.: No conflict of interest||Mrs. van de Worp - Kalter, Linda A.: No conflict of interest||Prof. Dr. Witteman, Ben J.M.: No conflict of interest

P551 Ferreiro Iglesias, Rocio: No conflict of interest||Dr. Gonzalez-Lopez, Jaime: No conflict of interest||Dr. Calvino-Suarez, Cristina: No conflict of interest||Dr. Mauriz-Barreiro, Violeta: No conflict of interest||Dr. Baston-Rey, Iria: No conflict of interest||Dr. Cruz, Raquel: No conflict of interest||Prof. Dominguez-Munoz, J. Enrique: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

P552 Dr. Xiao, Yasi: No conflict of interest||Dr. AL Khoury, Alex: No conflict of interest||Dr. Golovics, Petra: No conflict of interest||Ms. Kohen, Rita: No conflict of interest||Dr. Afif, Waqqas:|:|AW has been a speaker for Janssen, Prometheus, Dynacare, Takeda, and Abbvie||Dr. Wild, Gary:|:|GW has been a speaker and/or advisory board member for AbbVie, Janssen, Pfizer, Shire and Takeda.||Dr. Friedman, Gad: No conflict of interest||Dr. Galiatsatos, Polymnia: No conflict of interest||Dr. Hilzenrat, Nir: No conflict of interest||Dr. Szilagyi, Andrew: No conflict of interest||Dr. Wyse, Jon:|:|JW has been consultant for Abbvie||Dr. Cohen, Albert:|:|AB has been a member of Advisory Boards- Abbvie, Pfizer, Takeda, Janssen, Merck; also has been Speaker's bureau- Abbvie, Janssen, Takeda, Pfizer.||Dr. Bitton, Alain:|:|AB has been a member of Advisory Boards- Abbvie, Pfizer, Takeda, Janssen, Merck; Speaker's bureau- Abbvie, Janssen, Takeda, Pfizer.||Dr. Bessissow, Talat:|:|TB has been a speaker or advisory board member for Takeda, Janssen, Abbvie, Merck, Pfizer, Pendopharm, Ferring, Shire, Gilead. Unrestricted research grant: AbbVie and Janssen||Dr. Lakatos, Peter L.:|:|PLL has been a speaker and/or advisory board member: AbbVie, Arena Pharmaceuticals, Celltrion, Falk Pharma GmbH, Ferring, Genetech, Janssen, Merck, Pharmacosmos, Pfizer, Roche, Shire and Takeda and has received unrestricted research grant: AbbVie, MSD and Pfizer

P553 Mrs. Barkan, Revital: No conflict of interest||Mr. Shpoker , Leonid: No conflict of interest||Mrs. Abboud, Rasha: No conflict of interest||Mrs. Nafrin, Smadar: No conflict of interest||Mrs. Ganon , Miriam: No conflict of interest||Mrs. Ilsar , Tal: No conflict of interest||Mrs. Volf , Tali: No conflict of interest||Mrs. Markovitch , Lizy: No conflict of interest||Dr. Saban , Mor: No conflict of interest||Dr. Kagan, Ilya: No conflict of interest

P554 Dr. Sina, Marsela: No conflict of interest||Dr. Pemaj, Xhensila: No conflict of interest||Dr. Akshija, Ilir: No conflict of interest||Dr. Hysa, Altin: No conflict of interest||Dr. Koçollari, Adea: No conflict of interest||Prof. Dr. Prifti, Skerdi: No conflict of interest

P555 Dr. NASCIMENTO, Catarina: No conflict of interest||Dr. Revés, Joana: No conflict of interest||Dr. Morão, Bárbara: No conflict of interest||Dr. Frias Gomes, Catarina: No conflict of interest||Dr. Gouveia, Catarina: No conflict of interest||Dr. Palmela, Carolina: No conflict of interest||Dr. Roque Ramos, Lídia: No conflict of interest||Dr. Fidalgo, Catarina: No conflict of interest||Prof. Cravo, Marília: No conflict of interest||Dr. Glória, Luísa: No conflict of interest||Prof. Torres, Joana: No conflict of interest

P556 Dr. Khorshid, Mohammed: No conflict of interest||Dr. Cordie, Ahmed: No conflict of interest||Dr. Abd-Elsalam, Sherief: No conflict of interest

P557 Dr. GE, Xiaolong: No conflict of interest||Dr. Zhou, Wei: No conflict of interest

P558 Mrs. Mackenzie-Smith, Lara: No conflict of interest||Mrs. Wüthrich, Helen: No conflict of interest||Dr. Laoun, Raphael: No conflict of interest

P559 Miranda, Agnese: No conflict of interest||Dr. Cuomo, Antonio: No conflict of interest||Dr. Camera, Silvia: No conflict of interest||Prof. Ciacci, Carolina: No conflict of interest||Dr. De Filippo, Francesca Romana: No conflict of interest||Prof. Gravina, Antonietta Gerarda: No conflict of interest||Dr. D'Onofrio, Vittorio: No conflict of interest||Dr. Melina , Raffaele: No conflict of interest||Dr. Manguso, Francesco: No conflict of interest||Ms. PRIADKO, Kateryna: No conflict of interest||Dr. Facchiano, Angela: No conflict of interest||Dr. Bennato, Raffaele: No conflict of interest||Dr. D'Onofrio, Rossella: No conflict of interest||Prof. Cuomo, Rosario: No conflict of interest||Dr. Mucherino, Caterina: No conflict of interest||Prof. Romano, Marco: No conflict of interest

P560 Dr. Oh, Kyunghwan: No conflict of interest||Prof. Dr. Kim, Jeongseok: No conflict of interest||Ms. Kim, Nayoung: No conflict of interest||Prof. Dr. Yoon, Hyuk: No conflict of interest||Prof. Dr. Lee, Kang-Moon: No conflict of interest||Prof. Dr. Park, Dong Il: No conflict of interest||Prof. Dr. Choi, Chang Hwan: No conflict of interest||Prof. Dr. Lee, Chang Kyun: No conflict of interest||Prof. Dr. Eun, Chang Soo: No conflict of interest||Prof. Dr. Kang, Sang-Bum: No conflict of interest||Prof. Dr. Kim, Eun Soo: No conflict of interest||Prof. Dr. Kim, You Sun: No conflict of interest||Prof. Dr. Jung, Sung-Ae: No conflict of interest||Prof. Dr. Jung, Yunho: No conflict of interest||Prof. Dr. Kim, Tae Oh: No conflict of interest||Prof. Dr. Park, Soo Jung: No conflict of interest||Prof. Dr. Im, Jong Pil: No conflict of interest||Prof. Dr. Seo, Geom-Seog: No conflict of interest||Prof. Dr. Ye, Byong Duk:|:|Financial support: This study was supported by grant number 2020IT0012 from the Asan Institute for Life Sciences, Seoul, Korea.||Conflicts of interest: Byong Duk Ye has received a research grant from Celltrion|and Pfizer Korea; consulting fees from AbbVie Korea, Celltrion, Chong Kun Dang|Pharm, Daewoong Pharma, Ferring Korea, Janssen Korea, Kangstem Biotech, Korea United Pharm., LG|Chem, Medtronic Korea, Pfizer Korea, Shire Korea, Takeda Korea, IQVIA, and|Takeda; and speaking fees from AbbVie Korea, Celltrion, Ferring Korea, Janssen|Korea, Pfizer Korea, Shire Korea, Takeda Korea, and IQVIA. However, none of|these conflicts are related to work performed for this study.

P561 Mr. Wu, Lexi: No conflict of interest||Zhang, Yu: No conflict of interest||Prof. Dr. Cao, Qian: No conflict of interest

P562 Dr. Nagahori, Masakazu: No conflict of interest||Mr. Imai, Takahito: No conflict of interest||Ms. Tairaka, Ai: No conflict of interest

P563 Prof. Dr. Yuksel, Ilhami: No conflict of interest||Dr. Durak, Muhammed Bahaddin: No conflict of interest||Dr. Kilic, Vedat: No conflict of interest||Dr. Kivrakoglu, Fatih: No conflict of interest||Dr. Kosar, Kenan: No conflict of interest||Dr. Erdogan, Cagdas: No conflict of interest||Dr. Alkan, Afra: No conflict of interest

P564 Dr. Silva Mendes, Sofia: No conflict of interest||Dr. Ferreira, Patrícia: No conflict of interest||Dr. Antunes, Pedro: No conflict of interest||Dr. Gonçalves, Margarida: No conflict of interest||Dr. Leal, Tiago: No conflict of interest||Dr. Gonçalves, Bruno: No conflict of interest||Dr. Rebelo, Ana: No conflict of interest||Dr. Arroja, Bruno: No conflict of interest||Dr. Caetano, Ana Célia: No conflict of interest||Dr. Gonçalves, Raquel: No conflict of interest||Dr. Soares, João Bruno: No conflict of interest

P565 Dr. De Castro Parga, Maria Luisa: No conflict of interest||Dr. Pereyra, Diego: No conflict of interest||Mr. Sanromán, Luciano: No conflict of interest||Mrs. Figueira, Montserrat: No conflict of interest||Dr. Hernández, Vicent: No conflict of interest||Dr. Pineda, Juan: No conflict of interest||Dr. Martinez-Cadilla, Jesus: No conflict of interest||Dr. Pereira, Santos: No conflict of interest||Dr. Rodriguez-Prada, José-Ignacio: No conflict of interest

P566 Dr. KORNITZER, Gaël: No conflict of interest||Dr. Breton, Jessica: No conflict of interest||Dr. Poinsot, Pierre: No conflict of interest||Mr. Godin, David: No conflict of interest||Dr. Grzywacz, Kelly: No conflict of interest||Dr. Deslandres, Colette: No conflict of interest||Dr. Groleau, Véronique: No conflict of interest

P567 Ms. Ng, Valerie: No conflict of interest||Mr. Lim, Teong Guan: No conflict of interest||Dr. Ong, Wan Chee: No conflict of interest||Ms. Wong, Shi Yi Amanda: No conflict of interest||Dr. Salazar, Ennaliza: No conflict of interest||Dr. Chan, Pak Wo Webber: No conflict of interest

P568 Dr. Dussias, Nikolas: No conflict of interest||Prof. Rizzello, Fernando: No conflict of interest||Dr. Calabrese, Carlo: No conflict of interest||Sanna Passino, Amalia: No conflict of interest||Dr. Melotti, Laura: No conflict of interest||Dr. Scaioli, Eleonora: No conflict of interest||Dr. Belluzzi, Andrea: No conflict of interest||Prof. Gionchetti, Paolo: No conflict of interest

P569 Dr. Bell, Elaine: No conflict of interest||Dr. Calle, Marinella: No conflict of interest

P570 Dr. Meringer, Hadar: No conflict of interest||Dr. Tzadok, Roie: No conflict of interest||Dr. Mercer, Diego: No conflict of interest||Dr. Handler, Miriel: No conflict of interest||Dr. Barnes, Sophie: No conflict of interest||Dr. Waterman, Matti: No conflict of interest||Dr. Abadi, Subhi: No conflict of interest||Dr. Margalit Yehuda, Reuma: No conflict of interest||Prof. Dr. Kopylov, Uri: No conflict of interest||Prof. Dr. Amitai, Michal Marianne: No conflict of interest||Prof. Dr. Bar-Gil Shitrit, Ariella: No conflict of interest||Dr. Sheynkman, Gennady: No conflict of interest||Dr. Zittan, Eran: No conflict of interest||Prof. Dr. Maharshak, Nitsan: No conflict of interest

P571 Mr. Bachour, Salam: No conflict of interest||Dr. Shah, Ravi: No conflict of interest||Mr. Lyu, Ruishen: No conflict of interest||Dr. Rieder, Florian: No conflict of interest||Dr. Cohen, Benjamin:|:|There are no conflicts of interest that pertain to this study however Benjamin L. Cohen, M.D. receives the following financial support: Advisory Boards and Consultant for Abbvie, Celgene-Bristol Myers Squibb, Pfizer, Sublimity Therapeutics,Takeda, TARGET RWE; CME Companies: Cornerstones, Vindico; Speaking: Abbvie||Dr. Qazi, Taha: No conflict of interest||Dr. Lashner, Bret: No conflict of interest||Dr. Achkar, Jean Paul: No conflict of interest||Dr. Philpott, Jessica:|:|There are no conflicts of interest that pertain to this study, however Dr. Philpott serves on the speakers board for Abbvie||Dr. Lightner, Amy:|:|There are no conflicts of interest pertaining to this study, however Dr. Lightner serves as a consultant for Takeda||Dr. Holubar, Stefan: No conflict of interest||Dr. Regueiro, Miguel: No conflict of interest||Dr. Click , Benjamin: No conflict of interest

P572 Dr. De Castro Parga, Maria Luisa: No conflict of interest||Dr. Alvarez-Smith, Cintia: No conflict of interest||Mr. Sanroman, Luciano: No conflict of interest||Mrs. Figueira, Montserrat: No conflict of interest||Dr. Hernández, Vicent: No conflict of interest||Pineda, Juan: No conflict of interest||Dr. Martinez-Cadilla, Jesus: No conflict of interest||Pereira, Santos: No conflict of interest||Dr. Rodriguez-Prada, Ignacio: No conflict of interest

P573 Dr. HYUN, Hye Kyung: No conflict of interest||Dr. Yu, Jongwook: No conflict of interest||Prof. Dr. Kang, Eun Ae: No conflict of interest||Prof. Dr. Park, Jihye: No conflict of interest||Prof. Dr. Park, Soo Jung: No conflict of interest||Prof. Dr. Park, Jae Jun: No conflict of interest||Prof. Dr. Kim, Tae Il: No conflict of interest||Prof. Dr. Kim, Won Ho: No conflict of interest||Prof. Dr. Cheon, Jae Hee: No conflict of interest

P574 Prof. Hamed, Waleed:|:|No conflicts to declare||Prof. Salem, Osama Ebada:|:|Participated in Advisory Boards and received honorarium from Janssen, AbbVie, Takeda, and Pfizer||Prof. Alharbi, Othman:|:|No conflicts to declare||Sharaf, Mohamed:|:|Employee of Janssen-Cilag Middle East Ltd||Taylor, Catherine:|:|Employee of Janssen||Sherief, Ahmed:|:|Employee of Janssen||Besar, Ahmed:|:|Employee of Janssen

P575 Ms. McCarthy, Nicky: No conflict of interest||Prof. Dr. Schultz, Michael:|:|Speaking honoraria received from AbbVie and Janssen||Dr. Wall, Catherine: No conflict of interest

P576 Ms. MATEOS, Beatriz: No conflict of interest||Dr. Sáez-González, Esteban: No conflict of interest||Dr. Iborra, Marisa: No conflict of interest||Dr. Moret, Inés: No conflict of interest||Mr. Cañada, Antonio: No conflict of interest||Mr. Tortosa, Luis: No conflict of interest||Dr. Bastida, Guillermo: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest||Dr. Cerrillo, Elena: No conflict of interest||Dr. Nos, Pilar: No conflict of interest||Dr. Beltrán, Belén: No conflict of interest

P577 Mrs. AMOR COSTA, Carmen: No conflict of interest||Mr. Suárez Ferrer, Cristina: No conflict of interest||Mr. Poza Cordón, Joaquin: No conflict of interest||Mr. Rueda García, Jose Luis: No conflict of interest||Ms. Sánchez Azofra, María: No conflict of interest||Mr. Martín Arranz, Eduardo: No conflict of interest||Ms. González Diaz, Irene: No conflict of interest||Ms. Amiama Roig, Clara: No conflict of interest||Ms. García Ramirez, Laura: No conflict of interest||Ms. Martín Arranz, María Dolores: No conflict of interest

P578 Dr. Borzan, Vladimir: No conflict of interest||Dr. Orsic Fric, Vlasta: No conflict of interest||Dr. Borzan, Biljana: No conflict of interest

P579 Dr. Bell, Elaine: No conflict of interest||Calle, Marinella: No conflict of interest||Vermeire, Severine:|:| Séverine Vermeire, MD, PhD, has disclosed the following relevant financial relationships:|Served as an advisor or consultant for: AbbVie; Arena; Celgene; Eli Lilly; Ferring; Galapagos; Genentech/Roche; Gilead; Hospira; Janssen; MSD; Mundipharma; Pfizer Inc.; Progenity; Second Genome; Shire; Takeda|Served as a speaker or a member of a speakers bureau for: AbbVie; Ferring; Hospira; Janssen; MSD; Pfizer; Takeda; Tillots|Received grants for clinical research from: AbbVie; Johnson & Johnson; Pfizer; Takeda|Other: Biogen

P580 Ms. St Clair Jones, Anja: No conflict of interest||Ms. Meade, Uchu: No conflict of interest

P581 Dr. Vardanyan, Armen: No conflict of interest||Dr. Ovsyannikova, Valeriya: No conflict of interest||Dr. Peda , Ekaterina: No conflict of interest||Dr. Nanaeva, Bella: No conflict of interest||Prof. Achkasov, Sergey: No conflict of interest

P582 Dr. Kubesch, Alica: No conflict of interest||Ms. Knauer, Friederike: No conflict of interest||Dr. Thomas, Dominique: No conflict of interest||Ms. Jakobi, Katja: No conflict of interest||Dr. Filmann, Natalie: No conflict of interest||Prof. Zeuzem, Stefan: No conflict of interest||Prof. Pfeilschifter, Josef: No conflict of interest||Dr. Grammatikos, Georgios: No conflict of interest||Dr. Blumenstein, Irina: No conflict of interest

P583 Dr. Mocci, Giammarco: No conflict of interest||Dr. Cuomo, Antonio: No conflict of interest||Dr. Allegretta, Leonardo: No conflict of interest||Dr. Aragona, Giovanni: No conflict of interest||Dr. Colucci, Raffaele: No conflict of interest||Dr. Della Valle, Nicola: No conflict of interest||Dr. Ferronato, Antonio: No conflict of interest||Dr. Forti, Giacomo: No conflict of interest||Dr. Gaiani, Federica: No conflict of interest||Dr. Graziani, Maria Giovanna: No conflict of interest||Dr. Lorenzetti, Roberto: No conflict of interest||Prof. Luzza, Francesco: No conflict of interest||Dr. Penna, Antonio: No conflict of interest||Dr. Pica, Roberta: No conflict of interest||Dr. Piergallini, Simona: No conflict of interest||Dr. Rodinò, Stefano: No conflict of interest||Dr. Scarcelli, Antonella: No conflict of interest||Dr. Zampaletta, Costantino: No conflict of interest||Dr. Cicerone, Clelia: No conflict of interest||Dr. Cocco, Andrea: No conflict of interest||Prof. De Angelis, Gianluigi: No conflict of interest||Dr. Donnarumma, Laura: No conflict of interest||Dr. Pranzo, Giuseppe: No conflict of interest||Dr. Franceschi, Marilisa: No conflict of interest||Dr. Gallina, Sara: No conflict of interest||Dr. Grasso, Giuseppina: No conflict of interest||Dr. Larussa, Tiziana: No conflict of interest||Dr. Luppino, Ileana: No conflict of interest||Dr. Faggiani, Roberto: No conflict of interest||Dr. Fanigliulo, Libera: No conflict of interest||Dr. Pagnini, Cristiano: No conflict of interest||Dr. Perazzo, Patrizia: No conflict of interest||Dr. Sacco, Rodolfo: No conflict of interest||Dr. Sebkova, Ladislava: No conflict of interest||Dr. Serio, Maria Elena: No conflict of interest||Dr. De Monti, Alberta: No conflict of interest||Dr. Picchio, Marcello: No conflict of interest||Dr. Elisei, Walter: No conflict of interest||Prof. Maconi, Giovanni: No conflict of interest||Dr. Tursi, Antonio: No conflict of interest

P584 Dr. GREMIDA, Anas: No conflict of interest||Ms. Huang, Katherine: No conflict of interest||Dr. Ciorba, Matthew: No conflict of interest||Dr. Deyali , Chatterjee: No conflict of interest||Dr. Deepak, Parakkal: No conflict of interest

P585 Mr. YOUNG, David: No conflict of interest||Prof. Latter, Sue: No conflict of interest||Dr. Harvey, Justin: No conflict of interest||Ms. Addison, Janet:|:|Employee of and may hold stock/stock options in Biogen.||Dr. Freudensprung, Ulrich:|:|Employee of and may hold stock/stock options in Biogen.||Dr. Cummings, Fraser:|:|Dr Cummings has served as consultant, advisory board member, or speaker for AbbVie, Amgen, Celltrion, Falk, Ferring, Janssen, MSD, Napp Pharmaceuticals, Pfizer, Pharmacosmos, Sandoz, Biogen, Samsung and Takeda. He has received research funding from Biogen, Amgen, Hospira/Pfizer, Celltrion, Janssen, GSK and AZ. The study is an investigator-initiated study funded by Biogen GmbH.

P586 Ms. Sleutjes, Jasmijn: No conflict of interest||Dr. de Vries, Annemarie C.:|:|MLDS, Tramedico (research funding), Jansen, Takeda, Abbvie (advisory board)||Dr. Roeters van Lennep, Jeanine E.: No conflict of interest||Prof. Dr. van der Woude, C. Janneke:|:|Celltrion, Abbvie, Takeda (advisory board)

P587 Dr. Abraham, Bincy:|:|Consultant: Abbvie, Ferring, Janssen, Samsung bioepis, Medtronics, Takeda, Pfizer||Mr. Saleh, Adam: No conflict of interest||Ms. Perry, Caroline: No conflict of interest

P588 Dr. Sina, Marsela: No conflict of interest||Dr. Pengili, Eno: No conflict of interest||Dr. Pemaj, Xhensila: No conflict of interest||Dr. Osmanaj, Dorina: No conflict of interest||Prof. Dr. Bibolli, Ilir: No conflict of interest||Prof. Dr. Prifti, Skerdi: No conflict of interest

P589 Dr. MATTHEWS, Thomas James: No conflict of interest

P590 Dr. Bancil, Aaron: No conflict of interest||Dr. Stevens, Mike: No conflict of interest||Dr. Kok, Klaartje: No conflict of interest

P591 Dr. Sassaki, Ligia Yukie:|:|Abbvie, Janssen, Takeda||Dr. Magro, Daniela Oliveira: No conflict of interest||Dr. Saad-Hossne, Rogerio:|:|Janssen, Takeda, Abbvie||Dr. Baima, Julio Pinheiro: No conflict of interest||Dr. Flores, Cristina: No conflict of interest||Dr. Correia, Lucianna Pereira da Motta Pires: No conflict of interest||Dr. Ferrari, Maria De Lourdes De Abreu: No conflict of interest||Dr. Zacharias, Patricia: No conflict of interest||Dr. Feitosa, Marley Ribeiro: No conflict of interest||Dr. Santos, Carlos Henrique Marques: No conflict of interest||Dr. Lins Neto, Manoel Alvaro De Freitas: No conflict of interest||Dr. Quaresma, Abel Botelho: No conflict of interest||Dr. Lima Junior, Sergio Figueiredo: No conflict of interest||Dr. Vasconcelos, Graciana Bandeira Salgado: No conflict of interest||Dr. Cassol, Ornella: No conflict of interest||Dr. Pinto, Arlene dos Santos: No conflict of interest||Dr. Kurachi, Gustavo: No conflict of interest||Dr. Goncalves Filho, Francisco de Assis: No conflict of interest||Dr. Gasparini, Rodrigo Galhardi: No conflict of interest||Dr. Furlan, Thaísa Kowalski: No conflict of interest||Dr. Catapani, Wilson: No conflict of interest||Dr. Coy, Cláudio Saddy Rodrigues: No conflict of interest||Dr. Menegassi, Vivian de Souza: No conflict of interest||Dr. Colombo, Marilia Majeski: No conflict of interest||Dr. Froes, Renata de Sa Brito: No conflict of interest||Dr. Teixeira, Fabio Vieira: No conflict of interest||Dr. Moraes , Antonio Carlos: No conflict of interest||Dr. Santana , Genoile Oliveira: No conflict of interest||Dr. Parente, José Miguel Luz: No conflict of interest||Dr. Vilela , Eduardo Garcia: No conflict of interest||Dr. Kotze , Paulo Gustavo:|:|Abbvie, Janssen, Takeda, Pfizer, Ferring, Novartis

P592 Dr. Howaldt, Stefanie:|:|Norgine Ltd funded the analysis.||Becker, Clara Katharina:|:|Norgine Ltd funded the analysis.||Becker, Jakob Albrecht:|:|Norgine Ltd funded the analysis.||Poinas , Anne-Claire:|:|Employee of Norgine Ltd.

P593 Dr. Algara San Nicolas, Maria: No conflict of interest||Dr. Masedo Gonzalez, Angeles: No conflict of interest||Gomez Gomez, Gonzalo Jesus: No conflict of interest||Yela San Bernardino, Carmen: No conflict of interest||Casis Herce, Begoña: No conflict of interest||Martinez Montiel, M. Pilar: No conflict of interest

P594 Chiu, Lauren: No conflict of interest||Dr. Digby-Bell, Jonathan: No conflict of interest||Dr. Seah, Jarrel: No conflict of interest||Ms. Melton, Sarah: No conflict of interest||Dr. Taylor, Kirstin: No conflict of interest||Prof. Sparrow, Miles: No conflict of interest

P595 Dr. Freitas, Marta: No conflict of interest||Dr. Capela, Tiago: No conflict of interest||Dr. Macedo Silva, Vítor: No conflict of interest||Dr. Arieira, Cátia: No conflict of interest||Dr. Cúrdia Gonçalves, Tiago: No conflict of interest||Dr. Dias de Castro, Francisca: No conflict of interest||Dr. Moreira, Maria João: No conflict of interest||Prof. Dr. Cotter, José: No conflict of interest

P596 Dr. Kato, Shingo:|:|Lecture fees from AbbVie GK, Janssen Pahrmaceutical KK, Mitsubishi-Tanabe Pharma Corp.; Scholarship donation from AbbVie GK, EA Pharma Co. Ltd. ||Dr. Yamaga, Nagisa: No conflict of interest||Dr. Ishibashi, Akira: No conflict of interest||Dr. Kani, Kazuhito: No conflict of interest||Prof. Yakabi, Koji: No conflict of interest||Prof. Nagoshi, Sumiko: No conflict of interest

P597 Dr. Steinberg, Joshua: No conflict of interest||Mr. Andersen, Michael: No conflict of interest||Dr. Krugliak Cleveland, Noa:|:|Noa Krugliak Cleveland is a consultant to Takeda and reports personal fee from Vindico.||Dr. Traboulsi, Cindy: No conflict of interest||Ms. Rodriguez, Tina: No conflict of interest||Prof. Dr. Cohen, Russell:|:|Russell D. Cohen is on the speaker’s bureau from AbbVie and Takeda. He is a consultant/advisor for AbbVie Laboratories, BM/celgene, Eli Lilly, Gilead Sciences, Janssen, Pfizer, Takeda, UCB Pharma. He has received clinical trial support/grants from Abbvie, BMS/Celgene, Boehringer Ingelheim, Crohn’s and Colitis Foundation of America, Genentech, Gilead Sciences, Hollister, Medimmune, Mesoblast Ltd., Osiris Therpeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres Therapeutics, Takeda Pharma, UCB Pharma. His wife is on the board of directors of Aerpio Theraoeutics, Novus Therapeutics, Vital Therapeutics, Inc, and NantKwest.||Dr. Dalal, Sushila:|:|Sushila R Dalal has served as a consultant for Pfizer and is on the speaker’s bureau for AbbVie.||Dr. Micic, Dejan: No conflict of interest||Dr. Pekow, Joel:|:|Joel Pekow has received grant support from AbbVie and Takeda. He has served as a consultant for Veraste,. CVS Caremark and is on the advisory board for Takeda, Janssen and Pfizer.||Dr. Atsushi, Sakuraba: No conflict of interest||Prof. Dr. Rubin, David:|:|David T. Rubin has received grant support from Takeda; and has served as a consultant for Abbvie, Abgenomics, Allergan Inc., Arena Pharmaceuticals, Bellatrix Pharmaceuticals, Boehringer Ingelheim Ltd., Bristol-Myers Squibb, Celgene Corp/Syneos, Check-cap, Dizal Pharmaceuticals, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, Ichnos Sciences S.A., InDex Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Materia Prima, Narrow River Mgmt, Pfizer, Prometheus Laboratories,Reistone, Takeda, and Techlab Inc. He is also co-founder of Cornerstones Health, Inc. and GoDuRn, LLC; on the Board of Trustees of the American College of Gastroenterology.

P598 Mr. Li, Yousheng: No conflict of interest||Mr. Duan, Yantao: No conflict of interest||Mr. Zhiyuan, Zhou: No conflict of interest||Ms. Danhua, Yao: No conflict of interest

P599 Mrs. RISAGER CHRISTENSEN, Katrine:|:|participated in advisory board for Gilead Nordic, received unrestricted grants from Pfizer and Gilead Nordics||Dr. Steenholdt, Casper:|:|served as speaker and advisory board member for MSD||Ms. Skougaard, Marie: No conflict of interest||Dr. Ainsworth, Mark A.: No conflict of interest||Dr. Brynskov, Jørn:|:|consultant and/or advisory board fees and/or research grants from Abbvie, Pfizer, MSD, Takeda, Janssen, Gilead||Dr. Buhl, Sine: No conflict of interest||Dr. Kristensen, Lars Erik: No conflict of interest||Mrs. Schjødt Jørgensen, Tanja:|:|Speakers bureau/Consultant of: AbbVie, Pfizer, Roche, Novartis, UCB, Biogen, Gilead and Eli Lilly

P600 Dr. Lasa, Juan Sebastian:|:|Has received travel support from Sanofi Aventis, received lecture fees from Abbvie and Sanofi Aventis.||Dr. Sambuelli, Alicia:|:|Has received travel support from Ferring, Abbvie and Takeda, and received lecture fees from Biotoscana, Janssen, Abbvie and Takeda.||Dr. Zubiaurre, Ignacio:|:|Has received travel support from Takeda and Abbvie, received lecture fees from Takeda, Abbvie, Janssen and Ferring, participated at advisory boards from Takeda and Abbvie, and is a consultant for Takeda and Abbvie.||Dr. Correa, Gustavo Javier:|:|Has received travel support from Ferring, Abbvie, Janssen and Takeda, received lecture fees from Ferring, Biotoscana, Janssen and Abbvie, and received consulting fees from Abbvie and Janssen.||Dr. Lubrano, Pablo:|:|Has received travel support from Ferring, Abbvie and Takeda, and received lecture fees from Takeda, Abbvie, Biotoscana and Janssen.||Dr. Balderramo, Domingo César:|:|Has received travel support from Takeda, Abbvie, Janssen and Ferring, received lecture fees from Takeda, Abbvie and Janssen, and participated at advisory boards from Takeda.||Dr. Ruffinengo, Orlando:|:|Has received travel support from Takeda, Abbvie and Janssen, received lecture fees from Janssen, received financial support for research from Takeda, Abbvie and Celgene and received consulting fees from Takeda.||Ms. Brion, Laura:|:|Takeda employee.||Ms. Leonardi, Daiana Beatriz:|:|Takeda employee.||Ms. El-Hakeh, Jazmin:|:|Takeda employee.||Dr. Guimaraens, Patricia Noemí:|:|Takeda employee.||Olivera Sendra, Pablo:|:|Has received travel support from Ferring, Abbvie and Takeda, and received lecture fees from Takeda, Abbvie and Janssen, and received consulting fees from Abbvie, Takeda and Janssen.

P601 Ms. McCarthy, Nicky: No conflict of interest||Prof. Dr. Schultz, Michael:|:|Speaker's honoraria received from AbbVie and Janssen||Dr. Wall, Catherine: No conflict of interest

P602 Mrs. Nørgaard, Josefine:|:|Study is sponsered by Takeda ||Mr. Malte, Rosager: No conflict of interest||Ms. Charlotte, Peters-Lehm: No conflict of interest||Ms. Mette, Bennedsen: No conflict of interest||Ms. Eva, Fjordside: No conflict of interest||Ms. Petra, Weimers: No conflict of interest||Ms. Dorit, Ankersen: No conflict of interest||Ms. Lotte, Sørensen: No conflict of interest||Mr. Johan, Burisch:|:|Mr Burisch has described al previous collaborators/funding in his ECCO profile. ||Ms. Pia, Munkholm:|:|Professor Munkholm has described all conflicts of interest, such as previous collaborators and industry sponsors in her ECCO profile

P603 Dr. BJØRN JENSEN, Camilla: No conflict of interest||Dr. Jarlov Jensen, Kristoffer: No conflict of interest||Dr. Wennerström, Christina:|:|Christina Wennerström is employed by Janssen Cilag AB, who among other products, has blologic therapy in their portfolio||Dr. Sommer, Karen Jytte:|:|Karen Jytte Sommer is employed by Janssen Cilag A/S, who among other products, has blologic therapy in their portfolio.||Burisch, Johan: No conflict of interest||Dr. Petersen, Janne: No conflict of interest

P604 Mr. Brunet, Eduard: No conflict of interest||Melcarne, Luigi: No conflict of interest||Llovet, Laura: No conflict of interest||Vela, Emili: No conflict of interest||Cleries, Montserrat: No conflict of interest||Pontes, Caridad: No conflict of interest||Garcia-Iglesias, Pilar: No conflict of interest||Albert, Villoria: No conflict of interest||Calvet, Xavier: No conflict of interest

P605 Dr. Melcarne, Luigi: No conflict of interest||Prof. Dr. Vergara Gómez, Mercedes: No conflict of interest||Prof. Dr. Villoria Ferrer, Albert: No conflict of interest||Dr. Brunet Mas, Eduard: No conflict of interest||Dr. Garcìa Iglesias, Pilar: No conflict of interest||Dr. Llovet Soto, Laura: No conflict of interest||Ms. Dosal Galguera, Angelina: No conflict of interest||Ms. Monllor Nunell, Teresa: No conflict of interest||Mrs. Alforcea Alcaraz, Sheila: No conflict of interest||Prof. Dr. Calvet Calvo, Xavier: No conflict of interest

P606 Dr. Ballester Ferré, María Pilar: No conflict of interest||Mr. Mesonero, Francisco: No conflict of interest||Mr. Flórez-Diez, Pablo: No conflict of interest||Ms. Gómez, Concepción: No conflict of interest||Mr. Fuentes-Valenzuela, Esteban: No conflict of interest||Ms. Martín, Noelia: No conflict of interest||Ms. Senosiain, Carla: No conflict of interest||Ms. Vela, Milagros: No conflict of interest||Ms. Fernández-Clotet, Agnes: No conflict of interest||Mr. Pérez, Pablo: No conflict of interest||Ms. Rubín de Célix, Cristina: No conflict of interest||Ms. Calviño-Suárez, Cristina: No conflict of interest||Ms. Ferreiro-Iglesias, Rocío: No conflict of interest||Mr. Hermida, Benito: No conflict of interest||Ms. Muñoz, Roser: No conflict of interest||Ms. González-Vivo, Maria: No conflict of interest||Mr. Brunet, Eduard: No conflict of interest||Ms. Jiménez, Nuria: No conflict of interest||Ms. Botella, Belén: No conflict of interest||Mr. Yebra, Jorge: No conflict of interest||Ms. Suárez, Cristina: No conflict of interest||Mr. Bouhmidi, Abdel: No conflict of interest||Ms. Jurado, Rosa María: No conflict of interest||Mr. López, Antonio: No conflict of interest||Ms. Algarra, Ángela: No conflict of interest||Ms. Besó, Paula: No conflict of interest||Mr. Ponferrada, Ángel: No conflict of interest||Ms. Plaza, Rocio: No conflict of interest||Ms. Dueñas, Carmen: No conflict of interest||Mr. Benítez, José Manuel: No conflict of interest||Ms. Soto, Pilar: No conflict of interest||Mr. Castillo, Edgar: No conflict of interest||Mr. Iyo, Eduardo: No conflict of interest||Mr. Carbonell-Asíns, Juan Antonio: No conflict of interest||Dr. Beltran, Belén: No conflict of interest||Dr. Mínguez, Miguel: No conflict of interest

P607 Dr. Nielsen, Kari Rubek: No conflict of interest||Midjord, Jóngerð: No conflict of interest||Hammer, Turid: No conflict of interest||Lophaven, Søren: No conflict of interest||Burisch, Johan: No conflict of interest

P608 Dr. Zabana Abdo, Yamile: No conflict of interest||Dr. Marín-Jiménez, Ignacio: No conflict of interest||Dr. Rodríguez-Lago, Iago: No conflict of interest||Dr. Ramírez Esteso, Fernando: No conflict of interest||Dr. Meijilde, Susana: No conflict of interest||Dr. Ramos, Laura: No conflict of interest||Dr. Gomollón, Fernando: No conflict of interest||Dr. Muñoz, Fernando: No conflict of interest||Dr. Suris, Gerard: No conflict of interest||Dr. Ortiz de Zárate, Jone: No conflict of interest||Dr. Huguet, José María: No conflict of interest||Dr. Llaó, Jordina: No conflict of interest||Dr. García-Sepulcre, Mariana: No conflict of interest||Dr. Sierra, Mónica: No conflict of interest||Dr. Durà, Miguel: No conflict of interest||Dr. Estrecha, Sandra: No conflict of interest||Dr. Fuentes Coronel, Ana: No conflict of interest||Dr. Hinojosa, Esther: No conflict of interest||Dr. Olivan, Lorenzo: No conflict of interest||Dr. Iglesias, Eva: No conflict of interest||Dr. Gutiérrez, Ana: No conflict of interest||Dr. Varela, Pilar: No conflict of interest||Dr. Rull, Núria: No conflict of interest||Dr. Gilabert, Pau: No conflict of interest||Dr. Hernández-Camba, Alejandro: No conflict of interest||Dr. Brotons, Alicia: No conflict of interest||Dr. Ginard, Daniel: No conflict of interest||Dr. Sesé, Eva: No conflict of interest||Dr. Carpio, Daniel: No conflict of interest||Dr. Aceituno, Montserrat: No conflict of interest||Dr. Cabriada, José Luis: No conflict of interest||Dr. González-Lama, Yago: No conflict of interest||Dr. Jiménez, Laura: No conflict of interest||Dr. Chaparro, María: No conflict of interest||Dr. López-San Román, Antonio: No conflict of interest||Dr. Alba, Cristina: No conflict of interest||Dr. Plaza-Santos, Rocío: No conflict of interest||Dr. Piqueras, Marta: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Esteve, Maria: No conflict of interest

P609 Dr. Ledder, Oren: No conflict of interest||Mrs. Harel, Sasha: No conflict of interest||Dr. Orlanski-Meyer, Esther: No conflict of interest||Dr. Yogev, Dotan: No conflict of interest||Dr. Loewenberg Weisband, Yiska: No conflict of interest||Dr. Greenfeld, Shira: No conflict of interest||Dr. Kariv, Revital: No conflict of interest||Dr. Lederman, Natan: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Dr. Schwartz, Doron: No conflict of interest||Mrs. Focht, Gili: No conflict of interest||Prof. Dotan, Iris: No conflict of interest||Prof. Turner, Dan: No conflict of interest

P610 Dr. Lo, Bobby Zhao Sheng: No conflict of interest||Ms. Mokrowiecka, Anna: No conflict of interest||Mikocka-Walus, Antonina: No conflict of interest||Bernstein, Charles N: No conflict of interest||Trindade, Inês A.: No conflict of interest||Burisch, Johan: No conflict of interest||Barreiro-de Acosta, Manuel: No conflict of interest||Ferreira, Nuno: No conflict of interest||Gearry, Richard B: No conflict of interest||Knowles, Simon R: No conflict of interest

P611 Dr. Algaba Garcia, Alicia: No conflict of interest||Dr. Guerra, Iván: No conflict of interest||Mrs. Castro, Sofía: No conflict of interest||Mrs. Jiménez, Laura: No conflict of interest||Mr. Garza, Daniel: No conflict of interest||Ms. Aller, María del Mar: No conflict of interest||Dr. Granja, Alicia: No conflict of interest||Dr. Guardiola, Antonio: No conflict of interest||Dr. Bellart, María: No conflict of interest||Dr. Pizarro, Nazaret: No conflict of interest||Dr. Bermejo, Fernando: No conflict of interest

P612 Dr. FERRETTI, Francesca: No conflict of interest||Dr. Monico, Maria Camilla: No conflict of interest||Dr. Carvalhas Gabrielli, Anna Maria: No conflict of interest||Dr. Carmagnola, Stefania: No conflict of interest||Dr. Bezzio, Cristina: No conflict of interest||Dr. Saibeni, Simone: No conflict of interest||Dr. Bosani, Matteo: No conflict of interest||Dr. Caprioli, Flavio: No conflict of interest||Dr. Mazza, Stefano: No conflict of interest||Dr. Casini, Valentina: No conflict of interest||Dr. Cortelezzi, Claudio: No conflict of interest||Dr. Parravicini, Marco: No conflict of interest||Dr. Cassinotti, Andrea: No conflict of interest||Dr. Cosimo, Paola: No conflict of interest||Dr. Indriolo, Amedeo: No conflict of interest||Prof. Di Sabatino, Antonio: No conflict of interest||Dr. Lenti, Marco Vincenzo: No conflict of interest||Prof. Pastorelli, Luca: No conflict of interest||Dr. Conforti, Francesco: No conflict of interest||Prof. Ricci, Chiara: No conflict of interest||Prof. Sarzi-Puttini, Piercarlo: No conflict of interest||Prof. Vecchi, Maurizio: No conflict of interest||Prof. Maconi, Giovanni: No conflict of interest||Prof. Ardizzone, Sandro: No conflict of interest

P613 Dr. Kumar, Lakshman: No conflict of interest||Dr. Kiely, Lisa: No conflict of interest||Dr. O'Riordan, Anthony: No conflict of interest||Dr. Barry, Patrick: No conflict of interest

P614 Ms. Zhang, Ling:|:|Employed by Boehringer Ingelheim||Dr. Fan, Yanni:|:|Employed by Boehringer Ingelheim||Dr. Thompson, Jennifer:|:|Employed by Boehringer Ingelheim||Dr. Bohn, Rhonda:|:|Owner and Principal of Bohn Epidemiology||Dr. Negar, Omidakhsh:|:|Employed by Bohn Epidemiology||Dr. Brodovicz, Kimberly:|:|Employed by Boehringer Ingelheim||Dr. Parakkal, Deepak: No conflict of interest

P615 Dr. Chen, Bor-Cheng: No conflict of interest||Dr. WENG, Meng-Tzu: No conflict of interest||Dr. Chang, Chin-Hao: No conflict of interest||Ms. Huang, Ling-Yun: No conflict of interest||Prof. Wei, Shu-Chen: No conflict of interest

P616 Dr. ATIA, Ohad: No conflict of interest||Ms. Friss, Chagit: No conflict of interest||Ms. Mendelovici, Adi: No conflict of interest||Prof. Shteyer, Eyal: No conflict of interest||Dr. Orlanski-Meyer, Esther: No conflict of interest||Dr. Ledderman, Natan: No conflict of interest||Dr. Greenfeld, Shira: No conflict of interest||Prof. Kariv, Revital: No conflict of interest||Loewenberg Weisband, Yisca: No conflict of interest||Dr. Gabay, Hagit: No conflict of interest||Dr. Nevo, Daniel: No conflict of interest||Dr. Matz, Eran: No conflict of interest||Prof. Dotan, Iris: No conflict of interest||Prof. Turner, Dan: No conflict of interest

P617 Dr. El-Matary, Wael:|:|Dr El-Matary served and advisory board member and speaker’s panel for|Abbvie, Canada. |||Dr. Nugent, Zoann: No conflict of interest||Dr. Witt, Julia: No conflict of interest||Prof. Dr. Bernstein, Charles:|:|Dr. Bernstein is supported in part by the Bingham Chair in Gastroenterology.|He is on Advisory Boards for Abbvie Canada, Janssen Canada, Takeda Canada, Pfizer Canada.|He is a Consultant for Mylan Pharmaceuticals. He is receiving educational grants from Abbvie|Canada, Pfizer Canada, Shire Canada, Takeda Canada, Janssen Canada. Speaker’s panel for|Abbvie Canada, Janssen Canada, Takeda Canada, and Medtronic Canada. Received research|funding from Abbvie Canada

P618 Ferrante, Marc:|:|Marc Ferrante has received research grants from AbbVie, Amgen, Biogen, Janssen, Pfizer and Takeda; consultancy fees from AbbVie, Boehringer-Ingelheim, Celltrion, Janssen, Lilly, Medtronic, MSD, Pfizer, Sandoz, Takeda and Thermo Fisher; and speakers fees from AbbVie, Amgen, Biogen, Boehringer-Ingelheim, Falk, Ferring, Janssen, Lamepro, MSD, Mylan, Pfizer, Sandoz, Takeda and Truvion Healthcare. ||Prof. Siproudhis, Laurent:|:|Laurent Siproudhis is a member of advisory boards for Takeda, Kyowa Kirin Pharma, Ferring, Sanofi, Medtronic, he was a speaker for Takeda, Abbvie, Janssen, Amgen, Kyowa Kirin Pharma and received research grant from Takeda, MSD, Janssen. ||Prof. Poggioli, Gilberto: No conflict of interest||Prof. Reinshagen, Max:|:|Max Reinshagen is member of advisory board for Abbvie, Janssen, Takeda, MSD, Recordati, Boehringer, Amgen, Biogen.||Dr. Milicevic, Slobodan:|:|Slobodan Milicevi is employee of Takeda. ||Mrs. Roset, Montserrat:|:|Montserrat Roset is employee of IQVIA.||Mrs. Bent-Ennakhi, Nawal:|:|Nawal Bent-Ennakhil is employee of Takeda. ||Mr. D‘Ambrosio, Rocco:|:|Rocco D‘Ambrosio is employee of Takeda. ||Mr. Fernandez-Nistal, Alonso:|:|Alonso Fernandez-Nistal is employee of Takeda. ||Prof. Panes, Julian:|:|Julian Panes is a member of advisory board for Takeda, Abbvie, Arena, Boehringer-Ingelheim, Celgene, Galapagos, Genentech-Roche, GSK, Immunic, Janssen, Novartis, Origo, Pandion, Pfizer, Progenity, Prometheus, Theravance, and Wasserman, he was a speaker for Takeda, Abbvie, Janssen, Biogen and received research grant from Abbvie and Pfizer.

P620 Dr. Malhi, Gurpreet: No conflict of interest||Mr. Chambers, Jason: No conflict of interest||Dr. Minhas, Gurjot: No conflict of interest||Dr. Mikail, Maria: No conflict of interest||Dr. Khanna, Reena: No conflict of interest||Dr. Wilson, Aze: No conflict of interest

P621 Dr. Nardone, Olga Maria: No conflict of interest||Mr. Manfellotto, Francesco: No conflict of interest||Dr. D'Onofrio, Caterina: No conflict of interest||Dr. Rocco, Alba: No conflict of interest||Dr. Annona, Giovanni: No conflict of interest||Dr. Sasso, Francesca: No conflict of interest||Dr. De Luca, Paquale: No conflict of interest||Dr. Imperatore, Nicola: No conflict of interest||Dr. Testa, Anna: No conflict of interest||Dr. de Sire, Roberto: No conflict of interest||Prof. Biffali, Elio: No conflict of interest||Prof. Castiglione, Fabiana: No conflict of interest

P622 Mrs. Plotkin, Luba: No conflict of interest||Mrs. Focht, Gili: No conflict of interest||Mrs. Harel, Sasha: No conflict of interest||Prof. Dr. Dotan, Iris: No conflict of interest||Mrs. Greenfeld, Shira: No conflict of interest||Mrs. Kariv, Revital: No conflict of interest||Mrs. Gabay, Hagit: No conflict of interest||Mrs. Loewenberg Weisband, Yisca: No conflict of interest||Prof. Dr. Turner, Dan: No conflict of interest

P623 Martino, Giuseppina: No conflict of interest||Dr. Carparelli, Sonia: No conflict of interest||Dr. Marseglia, Antonio: No conflict of interest||Dr. Pastore, Maria Rosa: No conflict of interest||Dr. Placentino, Maria: No conflict of interest||Mrs. Nardella, Marianna: No conflict of interest||Dr. Guerra, Maria: No conflict of interest||Dr. Palmieri, Orazio: No conflict of interest||Dr. Latiano, Anna: No conflict of interest||Dr. Perri, Francesco: No conflict of interest||Mrs. Ercolino, Filomena: No conflict of interest||Dr. Bossa, Fabrizio: No conflict of interest

P624 Mr. RODRIGUES BOARINI, Lucas: No conflict of interest||Prof. Sobrado Jr, Carlos Walter:|:|SPEAKER JANSSEN AND TAKEDA||Ms. Facanali, Carolina Bortolozzo Graciolli: No conflict of interest||Dr. Queiroz, Natalia Sousa Freitas:|:|Speaker and advisory board member Janssen, Takeda and Abbvie||Mr. Albuquerque, Idblan Carvalho:|:|Speaker Abbvie, Janssen, Takeda and UCB||Boarini, Paulo: No conflict of interest||Boarini, Marcelo Rodrigues: No conflict of interest||Dr. Borba, Marcelo Rodrigues: No conflict of interest||Prof. Nahas, Sergio Carlos: No conflict of interest||Prof. Cecconello, Ivan: No conflict of interest

P625 Guerra Marina, Ivan: No conflict of interest||Dr. Algaba, Alicia: No conflict of interest||Mrs. Castro, Sofía: No conflict of interest||Mrs. Jiménez, Laura: No conflict of interest||Mr. Garza, Daniel: No conflict of interest||Mrs. Aller, María del Mar: No conflict of interest||Dr. Granja, Alicia: No conflict of interest||Dr. Guardiola, Antonio: No conflict of interest||Dr. Gil, Marina: No conflict of interest||Dr. Ruiz, Paloma: No conflict of interest||Dr. Bermejo, Fernando: No conflict of interest

P626 García Mateo, Sandra: No conflict of interest||Martínez-Domínguez, Samuel Jesús: No conflict of interest||Aso Gonzalvo, María Concepción: No conflict of interest||Gargallo-Puyuelo, Carla Jerusalén: No conflict of interest||Gallego Llera, Beatriz: No conflict of interest||Arroyo Villarino, Maria Teresa: No conflict of interest||Laredo de la Torre, Viviana: No conflict of interest||Nocito Colon, María Mercedes Lourdes: No conflict of interest||Lario Quilez, Laura: No conflict of interest||Refaie, Engy: No conflict of interest||Latre Santos, Marta: No conflict of interest||Gomollón García, Fernando: No conflict of interest

P627 Dr. Lewis, James: No conflict of interest||Dr. Shan, Mingyang:|:|Employee and shareholder at Eli Lilly and Company ||Dr. Xhou, Xian:|:|Employee at Eli Lilly and Company ||Dr. Naegeli, April:|:|Employee and shareholder at Eli Lilly and Company ||Dr. Hunter, Theresa:|:|Employee and shareholder at Eli Lilly and Company.

P628 Ms. Liava, Christina: No conflict of interest||Dr. Sinakos, Emmanouil: No conflict of interest||Dr. Dimitroulas, Theodoros: No conflict of interest||Dr. Navrozidou, Christina: No conflict of interest||Prof. Dr. Akriviadis, Evangelos: No conflict of interest

P629 Dr. Peña-Sánchez, Juan Nicolás: No conflict of interest||Osei, Jessica A.: No conflict of interest||Dr. Rohatinsky, Noelle: No conflict of interest||Dr. Lu, Xinya: No conflict of interest||Dr. Risling, Tracie: No conflict of interest||Boyd, Ian: No conflict of interest||Wicks, Kendall: No conflict of interest||Quintin, Carol-Lynne: No conflict of interest||Dickson, Alyssa: No conflict of interest||Dr. Fowler, Sharyle A: No conflict of interest

P630 Dr. Gutiérrez Casbas, Ana: No conflict of interest||Dr. Zapater, Pedro: No conflict of interest||Dr. Ricart, Elena: No conflict of interest||Dr. González-Vivó, María: No conflict of interest||Dr. Gordillo, Jordi: No conflict of interest||Dr. Olivares, David: No conflict of interest||Dr. Vera-Mendoza, Isabel: No conflict of interest||Dr. Mañosa, Miriam: No conflict of interest||Dr. P. Gisbert, Javier: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest||Dr. Sánchez-Rodríguez, Eugenia: No conflict of interest||Dr. Boscá, Maia: No conflict of interest||Dr. Laredo, Viviana: No conflict of interest||Dr. Camps, Blau: No conflict of interest||Dr. Marín-Jíménez, Ignacio: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Martín-Arranz, María Dolores: No conflict of interest||Dr. Muñoz, Roser: No conflict of interest||Dr. Navarro-Llavat, Mercé: No conflict of interest||Dr. Sierra, Eva: No conflict of interest||Dr. Madero, Lucía: No conflict of interest||Dr. Vela, Milagros: No conflict of interest||Dr. Pérez-Calle, José: No conflict of interest||Dr. Sainz, Empar: No conflict of interest||Dr. Calvet, Xavi: No conflict of interest||Dr. Sicilia, Beatriz: No conflict of interest||Dr. Morales, Victor: No conflict of interest||Dr. Bermejo, Fernando: No conflict of interest||Dr. Fernández-Salazar, Luis: No conflict of interest||Dr. Van Domselaar, Manuel: No conflict of interest||Dr. De Castro, Luisa: No conflict of interest||Dr. Rodríguez, Cristina: No conflict of interest||Dr. Muñoz-Villafranca, Carmen: No conflict of interest||Dr. Lorente, Rufo: No conflict of interest||Dr. Rivero, Montserrat: No conflict of interest||Dr. Iglesias, Eva: No conflict of interest||Dr. Herreros, Belen: No conflict of interest||Dr. Barreiro-de-Acosta, Manuel: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Prof. Francés, Rubén: No conflict of interest

P631 Dr. Cappello, Maria: No conflict of interest||Dr. Guida, Laura: No conflict of interest||Dr. Di Giorgio, Francesca Maria: No conflict of interest||Dr. Busacca, Anita: No conflict of interest||Dr. Carrozza, Lucio: No conflict of interest||Mrs. Ciminnisi, Stefania: No conflict of interest||Prof. Almasio, Piero Luigi: No conflict of interest

P632 García Mateo, Sandra: No conflict of interest||Dr. Martínez-Domínguez, Samuel Jesús: No conflict of interest||Dr. Gargallo-Puyuelo, Carla Jerusalén: No conflict of interest||Prof. Dr. Gomollón García, Fernando: No conflict of interest

P633 Abou Rached, Antoine: No conflict of interest||Saba, Jowana: No conflict of interest||Yared, Fares: No conflict of interest||saniour, Joyce: No conflict of interest||Abou Khalil, Melissa: No conflict of interest||Al Bacha, Rose: No conflict of interest||Khalil, Pierre: No conflict of interest||Bou Jaoude, Joe: No conflict of interest

P634 Dr. Bertani, Lorenzo: No conflict of interest||Dr. Ferraro, Sara: No conflict of interest||Dr. Bartolini, Claudia: No conflict of interest||Dr. Convertino, Irma: No conflict of interest||Dr. Giometto, Sabrina: No conflict of interest||Dr. Cappello, Emiliano: No conflict of interest||Dr. Valdiserra, Giulia: No conflict of interest||Dr. Tillati, Silvia: No conflict of interest||Prof. Blandizzi, Corrado: No conflict of interest||Dr. Lucenteforte, Ersilia: No conflict of interest||Dr. Gini, Rosa: No conflict of interest||Dr. Tuccori, Marco: No conflict of interest||Dr. Costa, Francesco: No conflict of interest

P635 Dr. Nardone, Olga Maria: No conflict of interest||Dr. de Sire, Roberto: No conflict of interest||Dr. Ponsiglione, Andrea: No conflict of interest||Dr. Rispo, Antonio: No conflict of interest||Dr. Testa, Anna: No conflict of interest||Dr. Villani, Guido: No conflict of interest||Prof. Camera, Luigi: No conflict of interest||Prof. Castiglione, Fabiana: No conflict of interest

P636 Prof. Dr. Bamias, Giorgos: No conflict of interest||Dr. Kokkotis, Georgios: No conflict of interest||Dr. Christodoulou, Dimitrios: No conflict of interest||Dr. Delis, Vasileios: No conflict of interest||Dr. Gatopoulou, Anthia: No conflict of interest||Dr. Giouleme, Olga: No conflict of interest||Dr. Kalantzis, Chrisostomos: No conflict of interest||Dr. Kapsoritakis, Andreas: No conflict of interest||Dr. Karatzas, Pantelis: No conflict of interest||Dr. Karmiris, Konstantinos: No conflict of interest||Dr. Katsanos, Konstantinos: No conflict of interest||Kevrekidou, Polyxeni: No conflict of interest||Dr. Mathou, Nicoletta: No conflict of interest||Dr. Michalopoulos, Georgios: No conflict of interest||Michopoulos, Spyridon: No conflict of interest||Dr. Papaconstantinou, Ioannis: No conflict of interest||Dr. Polymeros, Dimitrios: No conflict of interest||Dr. Potamianos, Spyros: No conflict of interest||Dr. Poulopoulos, Georgios: No conflict of interest||Dr. Protopappas, Andreas: No conflict of interest||Dr. Soufleris, Konstantinos: No conflict of interest||Dr. Theodoropoulou, Angeliki: No conflict of interest||Dr. Triantafillidis, John K: No conflict of interest||Dr. Triantafyllou, Konstantinos: No conflict of interest||Dr. Tsiolakidou, Georgia: No conflict of interest||Dr. Tsironi, Eftychia: No conflict of interest||Dr. Tzouvala, Maria: No conflict of interest||Dr. Viazis, Nikos: No conflict of interest||Dr. Zacharopoulou, Eirini: No conflict of interest||Dr. Zampeli, Evanthia: No conflict of interest||Dr. Papatheodoridis, George: No conflict of interest||Dr. Mantzaris, Gerasimos J: No conflict of interest

P637 Rezazadeh Ardabili, Ashkan: No conflict of interest||Creemers, Rob H: No conflict of interest||Prof. Dr. Jonkers, Daisy M A E:|:|DJ reports grants from Top Knowledge Institute (Well on Wheat), grants from Horizon 2020 DISCOvERIE, grants from NWO-CCC Partnership program (Carbokinetics), all outside the submitted work.||Dr. Romberg-Camps, Mariëlle J L: No conflict of interest||Dr. Pierik, Marie J:|:|MP reports grants and non-financial support from Falk Pharma, grants from European commission, grants from ZONMW (Dutch national research fund), grants and non-financial support from Takeda, grants and non-financial support from Johnson and Johnson, grants and non-financial support from Abbvie, non-financial support from Ferring, non-financial support from Immunodiagnostics, non-financial support from MSD, all outside the submitted work.||Dr. van Bodegraven, Ad A:|:|AvB has served as speaker, adviser and/or principal investigator for AbbVie, Arandal, Arena, Celgene, Ferring, Janssen, MSD, Pfizer, Roche, Takeda, TEVA, and received research grants from TEVA, Eurostars funding, ZonMW, all outside the submitted work.

P638 Dr. Del Hoyo Francisco, Javier: No conflict of interest||Dr. Millán, Mónica: No conflict of interest||Dr. Garrido-Marín, Alejandro: No conflict of interest||Dr. Nos, Pilar: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest||Dr. Bujanda, Luís: No conflict of interest||Dr. de la Portilla, Fernando: No conflict of interest||Dr. Aguas, Mariam: No conflict of interest

P639 Iglay, Kristy:|:|Kristy Iglay consulted on this project through CERobs Consulting. CERobs Consulting received funding from Takeda Pharmaceuticals to perform the systematic literature review.||Dr. Bennett, Dimitri:|:|Dimitri Bennett is a salaried employee of Takeda Pharmaceuticals.||Dr. Kappelman, Michael:|:|Michael Kappelman consulted for Abbvie, Janssen, Pfizer, and Takeda, is a shareholder in Johnson & Johnson, and has received research support from Pfizer, Takeda, Janssen, Abbvie, Lilly, Genentech, Boehringer Ingelheim, Bristol Myers Squibb, Celtrion, and Arenapharm.||Mr. Thai, Sydney:|:|Sydney Thai consulted on this project through CERobs Consulting. CERobs Consulting received funding from Takeda Pharmaceuticals to perform the systematic literature review.||Ms. Aldridge, Molly:|:|Molly Aldridge consulted on this project through CERobs Consulting. CERobs Consulting received funding from Takeda Pharmaceuticals to perform the systematic literature review.||Ms. Karki, Chitra:|:|Chitra Karki is a salaried employee of Takeda Pharmaceuticals||Dr. Cook, Suzanne:|:|Suzanne Cook consulted on this project through CERobs Consulting and is a salaried employee of Takeda Pharmaceuticals.

P640 Ms. Ramos, Lizzie: No conflict of interest||Ms. Anca, Maria: No conflict of interest||Dr. Feliciano, Karla: No conflict of interest||Prof. Dr. Amaya, Claudia: No conflict of interest||Dr. Perez, Annette:|:|Dr Annette Perez is an employee of AbbVie and owns AbbVie stocks. ||Dr. Torres, Esther A:|:|Dr. Esther A Torres has received research and educational grants to the University of Puerto Rico from AbbVie, she is an investigator in AbbVie studies.

P641 García Mateo, Sandra: No conflict of interest||Refaie, Engy: No conflict of interest||Martínez-Domínguez, Samuel Jesús: No conflict of interest||Gargallo-Puyuelo, Carla Jerusalén: No conflict of interest||Lario Quilez, Laura: No conflict of interest||Carrera-Lasfuentes, Patricia: No conflict of interest||Arroyo Villarino, María Teresa: No conflict of interest||Aso Gonzalvo, María Concepción: No conflict of interest||Gomollón García, Fernando: No conflict of interest

P642 Dr. Sciberras, Martina: No conflict of interest||Dr. Nascimento, Catarina: No conflict of interest||Dr. Tabone, Trevor: No conflict of interest||Dr. Karmiris, Konstantinos: No conflict of interest||Dr. Nikolaou, Penelope: No conflict of interest||Dr. Theodoropoulou, Angeliki: No conflict of interest||Dr. Mula, Abigail: No conflict of interest||Dr. Goren, Idan: No conflict of interest||Dr. Yanai, Henit: No conflict of interest||Dr. Amir, Hadar: No conflict of interest||Dr. Mantzaris, Gerassimos: No conflict of interest||Dr. Georgiadi, Tereza: No conflict of interest||Dr. Foteinogiannopoulou, Kalliopi: No conflict of interest||Prof. Koutroubakis, Ioannis: No conflict of interest||Dr. Allocca, Mariangela: No conflict of interest||Dr. Fiorino, Gionata: No conflict of interest||Dr. Furfaro, Federica: No conflict of interest||Prof. Katsanos, Konstantinos H: No conflict of interest||Dr. Fousekis, Fotios: No conflict of interest||Dr. Michalopoulos, George: No conflict of interest||Dr. Torres, Joana: No conflict of interest||Dr. Ellul, Pierre: No conflict of interest

P643 Dr. BALRAM, Bhairavi: No conflict of interest||Dr. Al Khoury, Alex: No conflict of interest||Dr. Bessissow, Talat: No conflict of interest||Dr. Afif, Waqqas: No conflict of interest||Dr. Gonczi, Lorant: No conflict of interest||Dr. Abreu, Maria: No conflict of interest||Lakatos, Péter Laszlo: No conflict of interest

P644 Ms. Magro, Daniela Oliveira: No conflict of interest||Prof. Kotze, Paulo Gustavo: No conflict of interest||Dr. Quaresma, Abel Botelho:|:|Abbvie, Janssen, Apsen||Prof. Damiao, Aderson Omar Mourao Cintra:|:|Abbvie, Janssen, Takeda, Pfizer||Mr. Valverde, Douglas Andreas: No conflict of interest||Prof. Panaccione, Remo:|:|AbbVie, Amgen,|AstraZeneca, Axcan Pharma (now Aptalis), Biogen Idec,|Bristol- Myers Squibb, Centocor, ChemoCentryx, Eisai Medical|Research Inc., Elan Pharmaceuticals, Ferring, Genentech,|GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Millennium|Pharmaceuticals (now Takeda Oncology), Ocera Therapeutics|Inc., Otsuka America Pharmaceutical, Pfizer, Shire|Pharmaceuticals, Prometheus Laboratories, Schering- Plough|Corporation, Synta Pharmaceuticals Corp., Teva, UCB Pharma|and Warner Chilcott.||Ms. Coward, Stephanie: No conflict of interest||Prof. Ng, Siew C:|:|AbbVie, Ferring, Janssen, Menarini|and Takeda,||Prof. Kaplan, Gilaad G: No conflict of interest||Prof. Coy, Claudio Saddy Rodrigues: No conflict of interest

P645 Dr. Sciberras, Martina: No conflict of interest||Dr. Nascimento, Catarina: No conflict of interest||Dr. Tabone, Trevor: No conflict of interest||Prof. Dr. Karmiris, Konstantinos: No conflict of interest||Dr. Nikolaou, Penelope: No conflict of interest||Dr. Theodoropoulou, Angeliki: No conflict of interest||Dr. Mula, Abigail: No conflict of interest||Dr. Goren, Idan: No conflict of interest||Dr. Yanai, Henit: No conflict of interest||Dr. Amir, Hadar: No conflict of interest||Dr. Mantzaris, Gerassimos: No conflict of interest||Dr. Georgiadi, Tereza: No conflict of interest||Dr. Foteinogiannopoulou, Kalliopi: No conflict of interest||Prof. Koutroubakis, Ioannis: No conflict of interest||Dr. Allocca, Mariangela: No conflict of interest||Dr. Fiorino, Gionata: No conflict of interest||Dr. Furfaro, Federica: No conflict of interest||Prof. Katsanos, Konstantinos H: No conflict of interest||Dr. Fousekis, Fotios: No conflict of interest||Dr. Michalopoulos, George: No conflict of interest||Dr. Torres, Joana: No conflict of interest||Dr. Ellul, Pierre: No conflict of interest

P646 Mr. Nieves-Jimenez, Humberto: No conflict of interest||Dr. Solis-Pomales, Cristina: No conflict of interest||Ms. Ortiz-Domenech, Stephanie: No conflict of interest||Ms. Marrero-Concepcion, Fabiola: No conflict of interest||Mrs. Marrero-Irizarry, Janice: No conflict of interest||Dr. Torres, Esther. A.: No conflict of interest

P647 Williams, Paul:|:|Paul Williams is an employee of IQVIA. IQVIA received funding for the recruitment of physicians, development, and administration of the survey and for the analysis, reporting and dissemination of the results.|||Dr. Klersy, Catherine: No conflict of interest||Ms. Karki, Chitra:|:|Chitra Karki is a salaried employee of Takeda Pharmaceuticals.||Dr. Bennett, Dimitri:|:|Dimitri Bennett is a salaried employee of Takeda Pharmaceuticals.||Dr. Rodríguez, Ana María:|:|Ana María Rodríguez is an employee of IQVIA. IQVIA received funding for the recruitment of physicians, development, and administration of the survey and for the analysis, reporting and dissemination of the results.||Dr. Ciccocioppo, Rachele:|:|Rachele Ciccocioppo consulted on this project and received funding from Takeda Pharmaceuticals to participate in the review and advisory board. Rachele Ciccocioppo also received support for travel from Takeda, Janssen and AbbVie.

P648 Dr. LINDOSO, Livia: No conflict of interest||Dr. Oba, Jane: No conflict of interest||Dr. Miranda, Luana C. A.: No conflict of interest||Dr. Deboni, Mariana: No conflict of interest||Dr. Jiro Ozaki, Marcos: No conflict of interest||Dr. Lima, Dandara C. C.: No conflict of interest||Dr. Queiroz, Ligia B.: No conflict of interest||Ms. Astley, Camilla: No conflict of interest||Prof. Gualano, Bruno: No conflict of interest||Dr. Polanczyk, Guilherme V.: No conflict of interest||Dr. K. Toma, Ricardo: No conflict of interest||Prof. Dr. da Silva, Clovis Artur Almeida: No conflict of interest

P649 Dr. Watanabe, Kenji:|:|Kenji Watanabe has received research funding from AbbVie Japan, EA Pharma Co., Ltd, JIMRO Co., Ltd, KYORIN Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Ltd, and Zeria Pharmaceutical Co., Ltd; consultancy fees from AbbVie Japan, EA Pharma Co., Ltd, Janssen Pharmaceuticals, Inc, JIMRO Co., Ltd, Kissei Pharmaceutical Co., Ltd, KYORIN Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Ltd, Olympus Corporation, Takeda, Pfizer Japan, and Zeria Pharmaceutical Co., Ltd; and lecture fees from AbbVie Japan, Astellas, Covidien Japan Inc, EA Pharma Co., Ltd, Janssen Pharmaceuticals, Inc, JIMRO Co., Ltd, Kissei Pharmaceutical Co., Ltd, KYORIN Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Ltd, Nippon Kayaku, Pfizer Japan, Olympus Corporation, and Zeria Pharmaceutical Co., Ltd. ||Mr. Gardiner, Sean:|:|employees and stockholders of Pfizer Inc.||Ms. Arai, Shoko:|:|employees and stockholders of Pfizer Inc.

P650 Mrs. Mackenzie-Smith, Lara: No conflict of interest||Mrs. Wüthrich, Helen: No conflict of interest||Dr. Laoun, Raphael: No conflict of interest

P651 Dr. Bertani, Lorenzo: No conflict of interest||Dr. Ferraro, Sara: No conflict of interest||Dr. Bartolini, Claudia: No conflict of interest||Dr. Convertino, Irma: No conflict of interest||Dr. Giometto, Sabrina: No conflict of interest||Dr. Cappello, Emiliano: No conflict of interest||Dr. Valdiserra, Giulia: No conflict of interest||Dr. Tillati, Silvia: No conflict of interest||Prof. Blandizzi, Corrado: No conflict of interest||Dr. Lucenteforte, Ersilia: No conflict of interest||Dr. Gini, Rosa: No conflict of interest||Dr. Tuccori, Marco: No conflict of interest||Dr. Costa, Francesco: No conflict of interest

P652 Prof. Uspenskiy, Yury: No conflict of interest||Prof. Galagudza, Mikhail: No conflict of interest||Dr. Ivanov, Sergei: No conflict of interest||Dr. Fominikh, Yulia: No conflict of interest||Mr. Dreval, Ruslan: No conflict of interest||Dr. Mayorova, Olga: No conflict of interest

P653 Dr. mtir, Maha: No conflict of interest||Dr. cherif, dhouha: No conflict of interest||Dr. kchir, hela: No conflict of interest||Dr. hassine, hajer: No conflict of interest||Prof. maamouri, nadia: No conflict of interest

P654 Dr. Kyriakos, Nikolaos: No conflict of interest||Mr. Papaefthymiou, Apostolis: No conflict of interest||Mr. Giakoumis, Marios: No conflict of interest||Dr. Galanopoulos, Michail: No conflict of interest||Dr. Galanis, Petros: No conflict of interest||Mr. Mylonas, Iordanis: No conflict of interest||Dr. Karatzas, Pantelis: No conflict of interest||Dr. Mantzaris, Gerasimos: No conflict of interest||Dr. Liatsos, Christos: No conflict of interest

P655 Dr. Carrillo Palau, Marta: No conflict of interest||Dr. Hernández-Camba, Alejandro: No conflict of interest||Dr. Hernández Álvarez-Buylla, Noemi: No conflict of interest||Mrs. Ramos, Laura: No conflict of interest||Dr. Alonso-Abreu, Inmaculada: No conflict of interest||Mrs. Vela, Milagros: No conflict of interest||Ms. Hernández-Pérez, Anjara: No conflict of interest||Mrs. Arranz, Laura: No conflict of interest||Dr. Hernández-Guerra, Manuel: No conflict of interest||Dr. Ferraz-Amaro, Iván: No conflict of interest

P656 Dr. Iglay, Kristy:|:|CERobs Consulting received funding from Takeda Pharmaceuticals to perform the systematic literature review. Kristy Iglay consulted on this project through CERobs Consulting||Dr. Bennett, Dimitri:|:|Dimitri Bennett is a salaried employee of Takeda Pharmaceuticals||Dr. Kappelman, Michael:|:|Michael Kappelman consulted for Abbvie, Janssen, Pfizer, and Takeda, is a shareholder in Johnson & Johnson, and has received research support from Pfizer, Takeda, Janssen, Abbvie, Lilly, Genentech, Boehringer Ingelheim, Bristol Myers Squibb, Celtrion, and Arenapharm.||Ms. Karki, Chitra:|:|Chitra Karki is a salaried employee of Takeda Pharmaceuticals.||Dr. Cook, Suzanne:|:|Suzanne Cook consulted on this project through CERobs Consulting and is a salaried employee of Takeda Pharmaceuticals

P657 Tomasic, Vedran: No conflict of interest||Dr. Bišćanin, Alen: No conflict of interest||Dr. Ćaćić, Petra: No conflict of interest||Dr. Kralj, Dominik: No conflict of interest||Dr. Dorosulić, Zdravko: No conflict of interest||Dr. Ogresta, Doris: No conflict of interest||Dr. Hrabar, Davor: No conflict of interest

P658 Ms. Müller, Corinna: No conflict of interest||Dr. Aksan, Sami: No conflict of interest||Dr. Farrag, Karima:|:|Payment for research work: Immundiagnostik AG. Lecturing fees and congress expenses: Janssen.||Prof. Dr. Schröder, Oliver: No conflict of interest||Aksan, Aysegül:|:|Consultancy, congress expenses, research funding: Vifor Pharma and Immundiagnostik.||Prof. Dr. Stein, Jürgen Michael:|:| Consultancy: Abbvie, Bristol Myers Squibb, Dr Schär, Falk, Ferring, Fresenius Kabi, Immundi-agnostik, Janssen, Medice, MSD, Pfizer, Pharmacosmos, Shire, Takeda, Thermofisher, Vifor. Board member: Abbvie, Bristol Myers Squibb, Dr Schär, Ferring, Fresenius Kabi, Immundiagnos-tik, Janssen, MSD, NPS, Pharmacosmos, Takeda, Vifor and Shield. Lecturing fees: Vifor Pharma.

P659 Banerjee, Rupa:|:|Dr Banerjee received grant from Helmsley Charitable trust||Dr. Pal, Partha: No conflict of interest||Dr. Tevethia, Harshvardhan: No conflict of interest||Dr. Ganesh, Girish: No conflict of interest||Mrs. Chandayapeta, Jayashree: No conflict of interest||Mrs. Adigopula, Bhargavi: No conflict of interest||Ms. Mudigonda, Shirisha: No conflict of interest||Dr. Reddy, D Nageshwar: No conflict of interest

P660 Dr. Malhi, Gurpreet: No conflict of interest||Dr. Mikail, Maria: No conflict of interest||Mr. Chambers, Jason: No conflict of interest||Dr. Khanna, Reena: No conflict of interest||Dr. Wilson, Aze: No conflict of interest

P661 Mauriz Barreiro, Maria Violeta: No conflict of interest||Prof. Ruano-Raviña, Alberto: No conflict of interest||Dr. Baston-Rey, Iria: No conflict of interest||Dr. Ferreiro-Iglesias, Rocio: No conflict of interest||Dr. Calviño-Suarez, Cristina: No conflict of interest||Prof. Barros-Dios, Juan Miguel: No conflict of interest||Prof. Dominguez-Muñoz, J. Enrique: No conflict of interest||Dr. Barreiro-de Acosta, Manuel: No conflict of interest

P662 Ms. Mueller, Sabrina:|:|Sabrina Mueller works as a consultant at Ingress-Health who have recieved financial support for this study||Dr. Khalid, Mona:|:|NA||Dr. Patel, Hari:|:|Haridarshan Patel is an employee of Immensity Consulting, Inc., which received funding from Galapagos NV. ||Prof. Dr. Wilke, Thomas:|:|Thomas Wilke has received honoraria from several pharmaceutical/consultancy companies (Novo Nordisk, Abbvie; Merck; GSK, BMS, LEO Pharma, Astra Zeneca, Bayer, Boehringer Ingelheim, Pharmerit). ||Mr. Dittmar, Axel:|:|NA

P663 Dr. Radhakrishnan, Shiva Thambiah: No conflict of interest||Dr. Vasireddy, Anushkumar: No conflict of interest||Ms. Gallagher, Kate I: No conflict of interest||Dr. Hicks, Lucy C: No conflict of interest||Powles, Sam T: No conflict of interest||Dr. Chong, Leo: No conflict of interest||Peake, Simon T: No conflict of interest||Prof. Orchard, Tim R: No conflict of interest||Williams, Horace R T: No conflict of interest

P664 Dr. Bertani, Lorenzo: No conflict of interest||Dr. Bartolini, Claudia: No conflict of interest||Dr. Ferraro, Sara: No conflict of interest||Dr. Convertino, Irma: No conflict of interest||Dr. Giometto, Sabrina: No conflict of interest||Dr. Tillati, Silvia: No conflict of interest||Dr. Valdiserra, Giulia: No conflict of interest||Dr. Cappello, Emiliano: No conflict of interest||Prof. Blandizzi, Corrado: No conflict of interest||Dr. Lucenteforte, Ersilia: No conflict of interest||Dr. Gini, Rosa: No conflict of interest||Dr. Tuccori, Marco: No conflict of interest||Dr. Costa, Francesco: No conflict of interest

P665 Ms. Sleutjes, Jasmijn: No conflict of interest||Dr. Roeters van Lennep, Jeanine E.: No conflict of interest||Mr. Verploegh, Pepijn J.P.: No conflict of interest||Dr. van Doorn, Martijn B.A.: No conflict of interest||Dr. Vis, Marijn: No conflict of interest||Prof. Dr. van der Woude, C. Janneke:|:|Celltrion, Abbvie, Takeda (advisory board)||Dr. de Vries, Annemarie C.:|:|MLDS, Tramedico (research funding), Jansen, Takeda, Abbvie (advisory board)

P666 Dr. RESÁL, Tamás: No conflict of interest||Dr. Farkas, Klaudia: No conflict of interest||Prof. Dr. Molnár, Tamás: No conflict of interest

P667 Dr. Torres, Esther A:|:|Investigator and educator with research and educational grants from AbbVie Corp granted to the University of Puerto Rico||Ms. Ramos, Lizzie: No conflict of interest||Ms. Sanchez, Andrea: No conflict of interest||Dr. Amaya, Claudia: No conflict of interest||Dr. Perez-Gilbe, Annette:|:|Enployee of AbbVie Corp. Owns AbbVie stocks

P668 Ms. Erbach, Johanna: No conflict of interest||Ms. Arnold, Anne:|:|Employee of Immundiagnostik AG||Mr. Bonn, Florian:|:|Employee of Immundiagnostik AG||Prof. Dr. Stein, Jürgen Michael:|:|Consultancy: Abbvie, Bristol Myers Squibb, Dr Schär, Falk, Ferring, Fresenius Kabi, Immundi-agnostik, Janssen, Medice, MSD, Pfizer, Pharmacosmos, Shire, Takeda, Thermofisher, Vifor. Board member: Abbvie, Bristol Myers Squibb, Dr Schär, Ferring, Fresenius Kabi, Immundiagnos-tik, Janssen, MSD, NPS, Pharmacosmos, Takeda, Vifor and Shield. Lecturing fees: Vifor Pharma.||Prof. Dr. Schröder, Oliver: No conflict of interest||Aksan, Aysegül:|:|Consultancy, congress expenses, research funding: Vifor Pharma and Immundiagnostik.

P669 Dr. Haglund, Sofie: No conflict of interest||Dr. Söderman, Jan: No conflict of interest||Prof. Almer, Sven: No conflict of interest

P670 Dr. Lee, Ho-Su: No conflict of interest||Mr. Jung, Seulgi: No conflict of interest||Prof. Dr. Ye, Byong Duk: No conflict of interest||Ms. Baek, Jiwon: No conflict of interest||Ms. Park, Dohoon: No conflict of interest||Prof. Dr. Park, Sang Hyoung: No conflict of interest||Prof. Dr. Yang, Suk-Kyun: No conflict of interest||Prof. Dr. Song, Kyuyoung: No conflict of interest

P671 Dr. Salazar, Juliana: No conflict of interest||Dr. Gordillo Abalos, Jordi: No conflict of interest||Dr. Fernández, Agnès: No conflict of interest||Dr. Esteve, Maria: No conflict of interest||Dr. Pérez Gisbert, Javier: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Lucendo, Alfredo: No conflict of interest||Dr. Márquez, Lucia: No conflict of interest||Dr. Guardiola, Jordi: No conflict of interest||Dr. Martin, Maria Dolores: No conflict of interest||Dr. Iglesias, Eva: No conflict of interest||Dr. Monfort, David: No conflict of interest||Dr. Villoria, Albert: No conflict of interest||Dr. Cañete, Fiorella: No conflict of interest||Dr. Bell, Olga: No conflict of interest||Dr. Ricart, Elena: No conflict of interest||Dr. Zabana, Yamile: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Garcia-Planella, Esther: No conflict of interest

P672 Ms. DE CASTELBAJAC, Flore: No conflict of interest||Dr. Charbit-Henrion, Fabienne: No conflict of interest||Prof. Goulet, Olivier: No conflict of interest||Dr. Cerf-Bensussan, Nadine: No conflict of interest||Prof. Treton, Xavier: No conflict of interest||Dr. Stefanescu, Carmen: No conflict of interest||Dr. Cazals-Hatem, Dominique: No conflict of interest||Dr. Billiauws, Lore: No conflict of interest||Prof. Bouhnik, Yoram: No conflict of interest||Prof. Joly, Francisca: No conflict of interest||Dr. Uzzan, Mathieu: No conflict of interest

P673 Ms. ELLUL, Sarah: No conflict of interest||Mr. Rausch, Philipp: No conflict of interest||Dr. Pisani, Anthea: No conflict of interest||Bang, Corinna: No conflict of interest||ellul, Pierre: No conflict of interest||Franke, Andre: No conflict of interest

P674 Mrs. Oliver, Lia: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Amoedo, Joan: No conflict of interest||Dr. Ramió-Pujol, Sara: No conflict of interest||Dr. Malagón, Marta: No conflict of interest||Dr. Serrano, Marta: No conflict of interest||Dr. Bahí, Anna: No conflict of interest||Mr. Lluansí, Aleix: No conflict of interest||Dr. Gilabert, Pau: No conflict of interest||Dr. Miquel-Cusachs, Josep Oriol: No conflict of interest||Dr. Sàbat, Miriam: No conflict of interest||Dr. Guardiola, Jordi: No conflict of interest||Dr. Serra-Pagès, Mariona: No conflict of interest||Prof. Garcia-Gil, Jesús: No conflict of interest||Dr. Aldeguer, Xavier: No conflict of interest

P675 Dr. Pisani, Anthea: No conflict of interest||Dr. Rausch, Philipp: No conflict of interest||Dr. Ellul, Sarah: No conflict of interest||Dr. Bang, Corinna: No conflict of interest||Dr. Tabone, Trevor: No conflict of interest||Dr. Marantidis Cordina, Claire: No conflict of interest||Dr. Zahra, Graziella: No conflict of interest||Dr. Ellul, Pierre: No conflict of interest||Prof. Franke, Andre: No conflict of interest

P676 Dr. Wauters, Lucas: No conflict of interest||Dr. Tito, Raul: No conflict of interest||Mr. Ceulemans, Matthias: No conflict of interest||Dr. Moens, Annick: No conflict of interest||Dr. Outtier, An: No conflict of interest||Prof. Dr. Sabino, João: No conflict of interest||Prof. Ferrante, Marc: No conflict of interest||Prof. Dr. Vermeire, Séverine: No conflict of interest||Prof. Dr. Vanuytsel, Tim: No conflict of interest||Prof. Dr. Raes, Jeroen: No conflict of interest

P677 Dr. Herrera De Guise, Claudia Maria: No conflict of interest||Dr. Sarrabayrouse, Guillaume: No conflict of interest||Dr. Varela, Encarna: No conflict of interest||Dr. Robles, Virginia: No conflict of interest||Dr. Borruel, Natalia: No conflict of interest||Dr. Mayorga, Luis Fernando: No conflict of interest||Dr. Casellas, Francesc: No conflict of interest||Ibarz, Arantxa: No conflict of interest||Perez, Zahira: No conflict of interest||Robles, Maria: No conflict of interest||Dr. Guarner, Francisco: No conflict of interest

P678 Mrs. Oliver, Lia: No conflict of interest||Dr. Amoedo, Joan: No conflict of interest||Dr. Julià, David: No conflict of interest||Dr. Camps, Blau: No conflict of interest||Dr. Ramió-Pujol, Sara: No conflict of interest||Dr. Malagón, Marta: No conflict of interest||Dr. Torres, Paola: No conflict of interest||Dr. Domènech, Eugeni: No conflict of interest||Dr. Guardiola, Jordi: No conflict of interest||Dr. Serra-Pagès, Mariona: No conflict of interest||Prof. Garcia-Gil, Jesús: No conflict of interest||Dr. Aldeguer, Xavier: No conflict of interest

P679 KROPP, Camille:|:|I am employed by Ysopia Bioscience as part of a Cifre thesis between INRAE and Ysopia Bioscience.||Dr. Le Corf, Katy:|:|Ysopia Bioscience employee||Dr. Relizani, Karima:|:|Ysopia Bioscience employee||Mr. Tambosco, Kevin: No conflict of interest||Dr. Martinez, Ccori:|:|Ysopia Bioscience employee||Dr. Chain, Florian: No conflict of interest||Dr. Rawadi, Georges:|:|Ysopia Bioscience employee||Dr. Langella, Philippe: No conflict of interest||Dr. Claus, Sandrine:|:|Ysopia Bioscience employee||Dr. Martin, Rebeca: No conflict of interest

P680 Mrs. Á Fríðriksmørk Berbisá, Marjun: No conflict of interest||Dr. Rubek Nielsen, Kári: No conflict of interest||Ms. Midjord, Jóngerð: No conflict of interest||Dr. Oddmarsdóttir Gregersen , Noomi: No conflict of interest||Dr. Ingham, Anna Cäcilia: No conflict of interest||Dr. Burisch, Johan: No conflict of interest||Dr. Gratton Vang, Amanda: No conflict of interest

P681 Mrs. BECKER, Heike: No conflict of interest||Mr. Kameli, Nader: No conflict of interest||Mrs. Rustichelli, Alice: No conflict of interest||Mrs. Britt, Heijnens: No conflict of interest||Dr. Stassen, Frank: No conflict of interest||Dr. Penders, John: No conflict of interest||Prof. Dr. Jonkers, Daisy: No conflict of interest

P682 Ms. SINIAGINA, Maria: No conflict of interest||Markelova, Maria: No conflict of interest||Boulygina, Eugenia: No conflict of interest||Laikov, Alexander: No conflict of interest||Khusnutdinova, Dilyara: No conflict of interest||Dr. Abdulkhakov, Sayar: No conflict of interest||Dr. Grigoryeva, Tatyana: No conflict of interest

P683 Dr. Goren, Idan: No conflict of interest||Dr. Ian, White: No conflict of interest||Dr. Reshef, Leah: No conflict of interest||Dr. Sharar Fischler, Tali: No conflict of interest||Dr. Pauker, Maor: No conflict of interest||Mr. Silverman, Jacob: No conflict of interest||Prof. Dr. Dotan, Iris: No conflict of interest||Dr. Yanai, Henit: No conflict of interest

P684 Dr. Verma, Abhishek: No conflict of interest||Dr. Axelrad, Jordan:|:|JEA receives research support from BioFire Diagnostics and has received consultancy fees from Janssen. JEA receives research support from the Crohn’s and Colitis Foundation and The National Institute of Diabetes and Digestive and Kidney Diseases K23DK124570.

P685 Dr. Pisani, Anthea: No conflict of interest||Dr. Rausch, Philipp: No conflict of interest||Dr. Ellul, Sarah: No conflict of interest||Dr. Bang, Corinna: No conflict of interest||Dr. Tabone, Trevor: No conflict of interest||Dr. Marantidis Cordina, Claire: No conflict of interest||Dr. Zahra, Graziella: No conflict of interest||Dr. Ellul, Pierre: No conflict of interest||Prof. Franke, Andre: No conflict of interest

P686 Mrs. Oliver, Lia: No conflict of interest||Dr. Ramió-Pujol, Sara: No conflict of interest||Dr. Amoedo, Joan: No conflict of interest||Dr. Malagón, Marta: No conflict of interest||Dr. Serrano, Marta: No conflict of interest||Dr. Bahí, Anna: No conflict of interest||Mr. Lluansí, Aleix: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Pardo, Laura: No conflict of interest||Dr. Serra-Pagès, Mariona: No conflict of interest||Dr. Aldeguer, Xavier: No conflict of interest||Prof. Garcia-Gil, Jesús: No conflict of interest

P687 Mrs. Oliver, Lia: No conflict of interest||Dr. Ramió-Pujol, Sara: No conflict of interest||Dr. Malagón, Marta: No conflict of interest||Dr. Serrano, Marta: No conflict of interest||Dr. Bahí, Anna: No conflict of interest||Dr. Busquets, David: No conflict of interest||Dr. Torrealba, Leyanira: No conflict of interest||Dr. Serra-Pagès, Mariona: No conflict of interest||Dr. Aldeguer, Xavier: No conflict of interest||Prof. Garcia-Gil, Jesús: No conflict of interest

P688 Ms. ELLUL, Sarah: No conflict of interest||Dr. Rausch , Philipp: No conflict of interest||Dr. PIsani, Anthea: No conflict of interest||Dr. Bang, Corinna: No conflict of interest||Ellul, Pierre: No conflict of interest||Prof. Dr. Franke, Andre: No conflict of interest

P689 Dr. Alves Da Silva, Joana: No conflict of interest||Dr. Pereira Guedes, Tiago: No conflict of interest||Dr. Falcão, Daniela: No conflict of interest||Dr. Neves, Sara: No conflict of interest||Dr. Costa, Paula: No conflict of interest||Dr. Lago, Paula: No conflict of interest||Prof. Pedroto, Isabel: No conflict of interest||Dr. Salgado, Marta: No conflict of interest

P690 Dr. BARYSHNIKOVA, Natalia: No conflict of interest||Prof. Uspenskiy, Yury: No conflict of interest||Dr. Suvorova, Maria: No conflict of interest||Dr. Lyudyno , Victoria: No conflict of interest||Prof. Suvorov, Alexander: No conflict of interest